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Abstract
Cyclopropanes and carbohydrates are materials of great interest to chemists. Ring
opening reactions of cyclopropanated carbohydrates have excellent potential for syn-
thesis, due to the many diverse structures that may be obtained. The work described
in this thesis explores the scope of such ring opening reactions, and extends to the
synthesis and reactions of several novel cyclopropanated carbohydrates, in which
synthesis of a natural product was also investigated.
Several bicyclic gem-dihalocyclopropanes, including 97, were synthesised. Base–
mediated cyclopropane ring opening of 97 in the presence of nucleophiles afforded a
series of 2-C -branched glycosides 389 and 390 (Chapter 2), whereas silver–promoted
ring expansion provided access to seven–membered rings (255 and 256) (Chapter
3). Studies on the mechanisms of the ring opening processes were also carried out.
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Ring–opening reactions of carbohydrate–derived gem-dihalocyclopropanes were also
applied to the exploration of possible routes to the natural product (−)-TAN-2483B
(154). Attempts to convert d-galactose and d-xylose into the dihydropyran 193
are the subject of Chapter 4, while the transformation of d-mannose into 193 and
subsequent efforts to prepare the natural product 154 are discussed in Chapter 5.
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(−)-TAN-2483BR = H, CH2OH R
′ = H, CH2OPG
PG = protecting group
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Chapter 1
Introduction
1.1 Cyclopropanes
Cyclopropanes are of interest in organic synthesis as targets themselves, or as sub-
strates for further reactions,2 which can provide access to complex and syntheti-
cally challenging structures. These highly strained three–membered rings have been
known for over a century, since W. H. Perkin described the first synthesis of a cy-
clopropane derivative in 1884, through attack of diethyl malonate dianion upon 1,2-
dibromoethane.3,4 Subsequently, a large volume of research involving cyclopropanes
has evolved, and discussions of their synthesis and reactions have been the subject
of several books5,6 and reviews.7–10
1.1.1 Synthesis of Cyclopropanes
The generation of cyclopropanes has been thoroughly investigated, with many well–
documented procedures providing cyclopropanes of varying functionality. Two of the
most commonly employed procedures are the Simmons–Smith and Ma¸kosza cyclo-
propanations (Scheme 1.1). The Simmons–Smith reaction forms a cyclopropane (1)
through formal addition of carbene (:CH2) to an olefin (2), which installs a methy-
lene bridge.11 gem-Dihalocyclopropanes (3) are predominantly formed using the
biphasic Ma¸kosza cyclopropanation.12 This reaction involves base–mediated depro-
tonation of a haloform, which then forms the corresponding dihalocarbene (:CX2),
1
which may be trapped by an olefin substrate. The research presented in this thesis
involves the synthesis and reactions of ring–fused gem-dihalocyclopropanes.
R'''
R'R
R''R'''
R'R
R''
R'''
R'R
R''
XX
'':CH2'' :CX2
Simmons–Smith Ma¸kosza
1 2 3
Scheme 1.1 Common cyclopropanation methodologies11,12
1.1.2 Ring Expansion of gem-Dihalocyclopropanes
Ring–fused cyclopropanes undergo ring–expansion reactions, in which the carbon
provided by the cyclopropane is used to create a larger ring, as exemplified in
Scheme 1.2. gem-Dihalocyclopropanes such as 4 undergo ring opening through ei-
ther a thermal or halophile–mediated process. The use of silver salts is an excellent
way of mediating this reaction, as the silver ion abstracts a halogen atom, to pro-
vide an intermediate such as 5.8 The departed halogen will be trapped as a silver
halide salt, therefore it cannot attack intermediate 5. Instead, in the presence of a
chosen nucleophile, an allyl–functionalised product (6) is formed, which may be ex-
ploited using cross-coupling reactions or other processes to form a variety of complex
targets, including natural products.13–15
X
X
X X
Nucelectrocyclic nucleophilic
ring opening attack
4 5 6
Scheme 1.2 gem-Dihalocyclopropane ring opening
Ring expansions of bicyclo[n.1.0] species offer elegant ways of synthesising rings that
may be less readily available by other means. In 1967, Sandler demonstrated that
cyclopropanes such as 7 can undergo ring–expansion reactions to generate allylic
acetates (8) (Scheme 1.3).16 This sequence highlights the synthetic utility of these
cyclopropanes, enabling the conversion of olefins (9) into products such as 8.
Br
Br
ii)
Br
i)
OAc
9 7 8
Reagents and Conditions: i) CHBr3, KO
tBu, pentane, 0 ◦C to r.t.; ii) AgOAc, AcOH, reflux.
Scheme 1.3 Conversion of gem-dihalocyclopropane 7 into an allylic acetate16
Skattebøl reported one of the earliest examples of cyclopropane ring expansion, using
pyran–based gem-dichlorocyclopropane 10.17 Upon treatment with potassium tert-
2
butoxide, functionalised oxepine 11 was isolated in 79% yield (Scheme 1.4). The
nucleophile selectively attacked the oxygenated carbon, as participation of the pyran
oxygen(see 12), provided oxonium ion 13, which led to selective formation of acetal
11.
i)O Cl
Cl
O
Cl
O
O
Cl
O
Cl
10
1113
12
Reagents and Conditions: i) KOtBu, tBuOH, reflux.
Scheme 1.4 Ring expansion of cyclopropanated pyran 1017
Several decades ago, the likely mechanism for electrocyclic ring–opening reactions
was proposed by Woodward and Hoffmann,18 then later DePuy et al. established
the “cis-in trans-out” rule for disrotatory gem-dihalocyclopropane electrocyclic ring
opening.19,20 The diagram below (Scheme 1.5) illustrates the two possible modes for
bicyclic gem-dihalocyclopropanated substrates, in which substituents cis- to the
departing halogen rotate inwards, and trans-substituents rotate outwards. Cyclo-
propyl bicycles such as 4, upon loss of halogen X2 would create highly strained
transoid rings as exemplified by intermediate 14. A seven–membered ring such as
14 is incapable of incorporating a trans-double bond, which limits ring opening to
the cis-in mode in which the endo-halogen departs, creating cisoid intermediates
such as 15.
H H
X2X1 X2
H H
H H
X1
14 4 15
–X2 –X1
Scheme 1.5 Exemplification of DePuy’s “cis-in, trans-out” rule19,20
1.2 Cyclopropanated Carbohydrates
Carbohydrate chemistry is a well–established area of research that has experienced
significant growth in recent years, with renewed interest in oligo- and polysaccha-
ride synthesis, as well as increasing complexity in monosaccharide derivatisation.21
Carbohydrates are naturally occurring, readily available and inexpensive chiral pool
reagents. They are comprised of polyhydroxylated scaffolds, containing many stere-
3
ocentres which may be exploited in syntheses of chiral compounds. Established
procedures for a variety of chemical transformations, such as protecting group strate-
gies, are well grounded. Allowances for chemical sensitivity, in addition to strategies
providing high selectivity and efficiency are often well precedented.
Synthesis and subsequent derivatisation of cyclopropyl carbohydrates remains a rel-
atively small area of research and, of this work, only a small fraction is devoted
to reactions of the cyclopropyl moiety.10,22 Research on cyclopropanated carbohy-
drates is almost equally divided between pyranose– and furanose–based sugars. The
majority of furanoside cyclopropanes have been synthesised by Simmons–Smith cy-
clopropanation of unsaturated sugars, often yielding conformationally constrained
nucleosides.23 Conversely, pyranoside chemistry within this field is more varied, as
demonstrated below. The following section will provide selected literature examples
of cyclopropanation of carbohydrates, via both intra- and intermolecular processes.
1.2.1 Synthesis of Cyclopropanated Carbohydrates
Cyclopropanes may be synthesised using a wide range of methods, usually through
addition of a carbene source to an olefin (see subsection 1.1.1). The synthesis of
cyclopropanated carbohydrates almost always involves construction of a cyclopropyl
ring onto a pre–existing carbohydrate scaffold. A selection of examples detailing the
synthesis of cyclopropanated sugars is shown below.
Intramolecular Cyclopropanations
While a great number of cyclopropanated carbohydrates are synthesised via in-
termolecular reactions, there have been many intramolecular syntheses, often us-
ing quite clever methodology. A notable example of cyclopropanation via an ex-
ocyclic carbanion was reported by Voelter et al., forming a 3,4-fused cyclopropyl
ring (Scheme 1.6). Treatment of triflate 16 with acetonitrile and LDA, followed by
treatment with additional base provided intermediate 17. This anion opened the
neighbouring epoxide to afford cyclopropyl product 18.24
Spanevello and Testero found γ-bromoketone 19 provided access to cyclopropane 20
through treatment with silver fluoride in pyridine (Scheme 1.7).25 This presumably
arose through formation of an enolate, due to deprotonation at C-4 and subsequent
silver–assisted attack upon the bromomethyl moiety. An increase in yield was ob-
served if the iodo-analogue was employed.
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OTfO O
OBn O
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OBn O OBn
OHH
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i)
CN NC
34
16 17 18
Reagents and Conditions: i) MeCN, LDA, HMPA, THF, −78 ◦C.
Scheme 1.6 Exocyclic carbanion–mediated cyclopropanation24
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O
BzO
OMe O
O
OMeH
BzO
i)
4
19 20
Reagents and Conditions: i) AgF, pyridine, r.t.
Scheme 1.7 Silver–mediated synthesis of 4,5-cyclopropanated carbohydrate 2025
An excellent example of cyclopropane formation through concomitant ring contrac-
tion has been reported by Okabe and Sun.26 Through the use of a homo–Ferrier rear-
rangement,27 dihydropyran derivative 21 was converted into a furanocyclopropane,
through reaction with a protected cytidine base (22) and ethyl aluminium chloride
(Scheme 1.8). As the mesylate leaving group was at the homoallylic position, the
Ferrier–type rearrangement created a bond between C-2 and C-4. The cyclopropyl
ring was formed stereoselectively, affording nucleosides 23 and 24 as a 1:1 anomeric
mixture.
O
MsO
TBSO N N
OTMS
NHTMS
24
i) O
TBSO
N
H H
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O
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21 22 23, 24
Reagents and Conditions: i) EtAlCl2, MeCN, reflux.
Scheme 1.8 Ring–contraction cyclopropanation26
The above examples demonstrate that intramolecular cyclopropanation provides a
range of intriguing structures. However, a large number of cyclopropyl sugars have
also been synthesised through intermolecular cyclopropane formation. Simmons–
Smith cyclopropanation (and variations) involves the addition of carbene, whilst
other cyclopropanation methods usually append cyclopropanes with additional func-
tionality.
5
Simmons-Smith Cyclopropanations
The Simmons–Smith method of cyclopropanation11 has been used extensively, and
is the most commonly employed procedure for the synthesis of cyclopropyl targets.
An early application of this procedure with unsaturated sugars was published in
1969, involving protected 2,3-unsaturated pyranose sugar 25.28 A zinc–copper cou-
ple, prepared from zinc metal and copper diacetate, was used in the presence of
diiodomethane to generate a carbenoid intermediate, providing cyclopropane 26
(Scheme 1.9). Due to zinc coordination with the oxygens adjacent to the olefin,
carbene addition occurred exclusively at the α-face.
i)O
O
O
Ph
OMe O
O
O
Ph
OMe
H
H
25 26
Reagents and Conditions: i) CH2I2, Zn/Cu, Et2O, 20
◦C.
Scheme 1.9 Simmons–Smith cyclopropanation of 2,3-unsaturated sugar 2528
More recent publications report the cyclopropanation of sugars using the Furukawa
modification of the Simmons–Smith methodology, in which the zinc–copper couple
is replaced by diethyl zinc.29,30 Two products obtained in this way are shown below
(Figure 1.1). Simmons–Smith cyclopropanation of an unsaturated d-xylose deriva-
tive provided cyclopropane 27 in a 60:1 diastereomeric ratio with the stereoisomeric
cyclopropane.31 This cyclopropanated derivative was used in the synthesis of confor-
mationally restricted nucleosides, a field which has led to a huge amount of research
concerning cyclopropanated sugars.23 The Hoberg group synthesised glucal–derived
cyclopropane 28 in 87% yield, as a single diastereoisomer.32
O
AcO
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OBn
BnO
BnO
H
H HO
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27 28
Figure 1.1 Simmons–Smith derived cyclopropanes31,32
Cyclopropanations with Diazo Reagents
Diazo–based carbenoid sources have often been used for cyclopropane synthesis.
The most common method involves the catalysed addition of ethyl diazoacetate to
olefins, thereby affording a cyclopropane with ethoxycarbonyl functionality. Fur-
thermore, it is complementary to the Simmons–Smith reaction, as the direction
of attack of the diazo reagent is controlled by steric factors. Several reports of
6
diazoacetate–mediated cyclopropanations of glycals have been published,33,34 as ex-
emplified below (Scheme 1.10). Alkene 29 in the presence of Rh2(OAc)4 catalyst
was treated with ethyl diazoacetate to form substituted cyclopropane 30.35 Car-
benoid addition occurred exclusively at the less sterically hindered α-face, with
the ethoxycarbonyl moiety in the exo-configuration, whereas Simmons–Smith cyclo-
propanation of alkene 29 would likely provide carbene addition to the β-face, due
to coordination of the zinc species with the C-3 silyloxy moiety.
O
TBSO
TBSO
OTBS
O
TBSO
TBSO
OTBS
CO2Et
H
H
i)
29 30
Reagents and Conditions: i) CH(N2)CO2Et, Rh2(OAc)4, CH2Cl2, r.t.
Scheme 1.10 Ethyl diazoacetate–mediated cyclopropanation35
Diazomethane may undergo cycloaddition with unsaturated sugars, then subse-
quent photolysis may eliminate molecular nitrogen to provide a cyclopropane deriva-
tive. This provides methylene–functionalised cyclopropanes, analogous to Simmons–
Smith cyclopropanation. Robins and Samano investigated the use of diazomethane
to form spirocyclopropanes from furanose sugars with unsubstituted exocyclic dou-
ble bonds.36
Vasella and co–workers have published numerous papers on reactions with glyco-
sylidene diazirine carbenes, such as d-glucose derivative 31. This substrate has
been used as a carbene source for the synthesis of several anomeric spirocyclic cy-
clopropanes, using olefins such as dihydrofuran and dihydropyran.37 Another report
involved addition of fullerene C60 providing fullerene-cyclopropane-carbohydrate hy-
brid 32 (Scheme 1.11).38
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31 32
Reagents and Conditions: i) C60, toluene, 23
◦C.
Scheme 1.11 Preparation of a cyclopropyl–linked fullerene–sugar conjugate38
Ylide–Based Cyclopropanations
It has been shown that cyclopropane rings may be formed, or undergo reactions in a
similar manner to olefins. An early synthesis of a cyclopropanated sugar used a phos-
7
phonate ylide to convert an epoxide into a cyclopropane, analogous to the Horner-
Wadsworth-Emmons (HWE) conversion of aldehydes into alkenes (Scheme 1.12).39
Thus, treatment of epoxide 33 with triethyl phosphonoacetate and sodium hydride
allowed replacement of the bridging oxygen with an ethyl acetate group (34).
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33 34
Reagents and Conditions: i) (EtO)2P(O)CH2CO2Et, NaH, dioxane, 80
◦C.
Scheme 1.12 HWE–type cyclopropanation39
Sakakibara et al. have investigated the reaction of sulfur ylides with 3-nitro-2,3-
unsaturated carbohydrates. Reaction of β-anomer 35 led to the expected cyclo-
propane 36 in 75% yield, with no evidence of attack at the β-face (Scheme 1.13).40
Unlike most examples mentioned within this section, the authors believe cyclopropa-
nation occurs in a stepwise manner, through ylide attack at C-2 to generate inter-
mediate 37, followed by attack of the anionic C-3 carbon, and ejection of DMSO.
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Reagents and Conditions: i) Me2S(OMe)I, NaH, DMSO, r.t.
Scheme 1.13 A cyclopropane synthesised from an S -ylide40
Dihalocarbene–Based Cyclopropanations
The first synthesis of a cyclopropanated sugar was published by the Brimacombe
group four decades ago.41 The authors utilised dichlorocarbene, synthesised in situ
from sodium methoxide and ethyl trichloroacetate,42 for the cyclopropanation of tri-
O-methyl-d-glucal (38). The authors assumed that carbene addition occurred ex-
clusively at the α-face due to steric constraints, providing gem-dichlorocyclopropane
39 in 82% yield (Scheme 1.14). This method of gem-dihalocyclopropanation has in
more recent times been superseded by Ma¸kosza cyclopropanation, which provides
similar reactivity and efficiency, while using more readily available reagents.
Petter and Powers synthesised spirocycles 40 and 41 through Ma¸kosza cyclopropa-
nation of l-arabinose–derived sugar 42 (Scheme 1.15). Partial steric hindrance of
both faces resulted in a diastereomeric mixture of cyclopropanes, slightly favouring
40 as the major product.43
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Reagents and Conditions: i) EtOCOCCl3, NaOMe, hexane, r.t.
Scheme 1.14 The first reported cyclopropanated carbohydrate (39)41
O
O
O
OBn O
O
O
OBn
Cl
Cl
O
ClClO
O
OBn
i)
42 40 41
Reagents and Conditions: i) CHCl3, TEBAC, benzene, NaOH(aq).
Scheme 1.15 Formation of spirocyclopropane sugars43
Recently, two fascinating reports of dihalocarbene addition onto unsaturated sug-
ars have been published, both including comparisons with Simmons–Smith car-
bene addition. In 1995, Nagarajan et al. reported the cyclopropanation of sev-
eral glycals, including tri-O-benzyl-d-galactal (43) and di-O-benzyl-l-rhamnal (44)
(Scheme 1.16).44 As expected, Simmons–Smith cyclopropanation exclusively gave
the oxygen–directed product stereoisomers. Cyclopropanes with opposite stereo-
chemistry across the 1,2-bond were prepared using Ma¸kosza cyclopropanation.12
Thus, α-cyclopropyl galactal (45), and rhamnal (46) derivatives were obtained stere-
oselectively in 92% and 95% yield respectively. Through the use of bromoform, the
gem-dibromo- analogues were isolated in 64–84% yield.45
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Reagents and Conditions: i) CHCl3, TEBAC, NaOH(aq), r.t.
Scheme 1.16 Cyclopropanations reported by Nagarajan44,45
Experimentation with 4,5-unsaturated sugars by the Corsaro group has further ex-
tended the scope of this chemistry. Cyclopropanation of carbohydrates such as
47 was achieved stereoselectively to provide cyclopropane adducts including 48
(Scheme 1.17). Cyclopropanation of substrates with less–bulky protecting groups
9
on the top face led to a mixture of cyclopropanes, due to the carbene species at-
tacking both faces.46
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Reagents and Conditions: i) CHCl3, TEBAC, NaOH(aq), r.t.
Scheme 1.17 Stereoselective cyclopropanations of 4,5-unsaturated sugars46
As detailed above, a great number of cyclopropanated sugars have been synthesised
over the last four decades, covering the majority of the most common methods of
cyclopropanation. The following section presents and discusses the various reactions
of cyclopropanated sugars that have so far been investigated.
1.2.2 Reactions of Cyclopropanated Carbohydrates
While many cyclopropanated carbohydrates have been reported, only a fraction have
been derivatised through reaction of the cyclopropane moiety. There are several
procedures commonly employed that retain the cyclopropyl ring, such as reductive
dehalogenation of a gem-dihalocyclopropane. Of particular relevance to this research
are syntheses involving cleavage of the cyclopropane. For a bicyclic system such as
generic cyclopropyl sugar 49, two types of cleavage are possible (Scheme 1.18). The
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Scheme 1.18 Ring opening and ring expansion of cyclopropanes
majority of ring cleavages occur through the red paths, in which either the 1,7- or
the 2,7-bond is broken, to provide branched products 50 and/or 51. Such reactions
can be regarded as cyclopropane ring–opening reactions, as the cyclopropane ring
is opened, whereas the other ring remains unchanged. Alternatively, cleavage of the
10
1,2-bond provides products such as 52, via the blue path. This provides a single,
unbranched ring one carbon greater in size than the larger ring of the starting
material. This transformation will be referred to as a ring expansion.
Ring–Opening Reactions of Cyclopropanated Carbohydrates
Radical–Initiated Reactions
Some of the most commonly observed reactions of cyclopropanated carbohydrates
are radical–mediated ring–opening processes. Within this field, the Gurjar group
have published many fascinating results, including those involving spirocyclopropan-
ated sugars. Functionalisation of a furanose sugar afforded alkyne 53 (Scheme 1.19),
which upon reaction with tributyltin hydride and AIBN led to an elegant radical
cascade reaction. Mechanistically, bromine abstraction led to cyclopropane ring
opening, providing a C-3 allyl-substituted radical intermediate. Two sequential
radical cyclisations took place involving the alkyne and the allylic pi-bond to pro-
vide epimeric tetracycles 54 and 55.47 Similar substrates lacking an alkyne tether
have been shown to provide gem-diallyl functionality at C-3, in the presence of
allyltributylstannane.48,49
O
O
O
Br
OH
O
O
O
HOH H
i)3
53 54, 55
Reagents and Conditions: i) Bu3SnH, AIBN, toluene, 100
◦C.
Scheme 1.19 Cascade radical cyclisation of cyclopropane 5347
Glycal–derived cyclopropane 56 was prepared with a xanthate tether, to allow rad-
ical initiation at C-8 (Scheme 1.20). Ring–opened product 57 was obtained, in
addition to a similar amount of ring–expanded sugar 58.50 This represents one of
the few ring expansion reactions of non–halogenated cyclopropanated sugars.
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Reagents and Conditions: i) Bu3SnH, AIBN, toluene, reflux.
Scheme 1.20 Ring–opened and ring–expanded cyclopropane derivatives50
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Electrophilic Halogen–Mediated Reactions
1,2-cyclopropanated sugars can be opened using electrophilic halogenation, analo-
gous to haloetherification. Danishefsky et al. utilised this methodology, involving
pseudo-sugar 59 (Scheme 1.21). Treatment with N -iodosuccinimide and methanol
provided ring–opened substrate 60, which was used to synthesise the highlighted
portion of epothilone A (61) and B (62).51 Ley and co–workers utilised similar
methodology in their work towards the total synthesis of altohyrtin A (spongistatin
1).52 These examples demonstrate the excellent utility of cyclopropanes in forming
quaternary carbons, which otherwise may be inaccessible.
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Reagents and Conditions: i) NIS, MeOH, r.t.
Scheme 1.21 Synthesis of epothilones via cyclopropane 5951
Nagarajan used a haloetherification strategy with isomeric cyclopropanes 63 and
64, obtained through Simmons–Smith cyclopropanation and a Ma¸kosza cyclopropa-
nation/reduction sequence, respectively. Cyclopropane 63 has the methylene bridge
on the β-face due to zinc–coordination with the neighbouring benzyloxy substituent.
Conversely, α-face cyclopropane 64 was obtained due to sterically directed dihalocar-
bene addition. NBS–mediated ring opening provided a variety of glycosides in good
yields, through solvolysis (Scheme 1.22).45 Simmons–Smith–derived cyclopropane
63 formed α-glycosides exclusively; cyclopropane 64 provided anomeric mixtures of
glycosides (65 and 66). A later report demonstrated similar reactivity with sugar–
derived nucleophiles. In this case, only three equivalents of nucleophile were used
(in acetonitrile), rather than a solvolytic quantity. Thus, longer reaction times at
room temperature were required to provide disaccharides in 60–66% yield.53
Sridhar and co–workers exploited the functionality of a methyl diazoacetate–derived
cyclopropyl sugar to synthesise glyco–amino acids.33 Cyclopropane 69 was sub-
jected to a haloetherification–type reaction in the presence of NIS and diacetone
d-galactose (70), through promotion with catalytic TMSOTf (Scheme 1.23). The
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Scheme 1.22 Synthesis of various cyclopropane–derived disaccharides45,53
obtained α-iodoester 71 was then treated with sodium azide and subjected to a
Staudinger reaction to provide glyco–amino acid 72. The authors extended this
methodology to involve several different glycal–derived cyclopropanes, and numer-
ous glycosyl acceptors.
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Scheme 1.23 Synthesis of glyco–amino acid 7233
Miscellaneous Ring Opening Reactions
Madsen et al. have developed a synthesis of 2-C -branched carbohydrates through
platinum–catalysed ring opening of cyclopropane 73 (Scheme 1.24). Treatment with
Zeise’s dimer led to insertion into the 1,7-bond. Nucleophilic attack by a range
of alcohols, including monosaccharides, afforded 2-C -branched glycosides such as
74.54,55 Yields were consistently high, with predominant or selective formation of
the α-anomer. Work with the electrophilic catalyst PdCl2(PhCN)2 and BnOH, led
to a rearrangement of cyclopropane 73 to provide olefin 75.55
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Reagents and Conditions: i) methyl 2,3,4-tri-O-benzyl-α-d-glucoside, [Pt(C2H4)Cl2]2, CH2Cl2,
r.t.; ii) BnOH, PdCl2(PhCN)2, CH2Cl2, r.t.
Scheme 1.24 Platinum–catalysed ring opening of cyclopropane 7354,55
The Theodorakis group used an acid–mediated cyclopropane ring–opening reac-
tion in their studies towards the synthesis of the natural product (+)-norrisolide
(76). Initial reaction of the ethyl diazoacetate–derived cyclopropane 77 with sul-
furic acid in ethanol led to the expected solvolytic opening, with concomitant loss
of the isopropylidene group, liberating epimeric diols 78 and 79 (Scheme 1.25).34 A
later method used methanesulfonic acid to achieve the desired ring opening. In the
absence of an external nucleophile, intramolecular lactonisation ensued, providing
lactone 80, which retained the acetonide under the milder conditions.56,57 Gharpure
et al. have used similar methodology to synthesise a range of products derived from
either ring expansion or ring–opening processes.58 Branched furanone and pyranone
products, in addition to several furanofuranone bicycles too numerous to discuss
here, were all obtained from a single cyclopropane.
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Reagents and Conditions: i) H2SO4, EtOH, 25
◦C; ii) MeSO3H, Acetone, 25
◦C.
Scheme 1.25 Ring opening reactions of cyclopropanated sugar 7734,56,57
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Ring–Expansion Reactions of Cyclopropanated Carbohydrates
While the above examples demonstrate ring opening of cyclopropyl sugars provides
great scope for synthesis of branched chain sugars, there have been several reports
of ring opening of cyclopropanated carbohydrates via cleavage of the fused bond.
Such cleavage leads to ring expansion; for example, a bicyclo[4.1.0]heptane skeleton
expands to form a seven–membered ring.
Ring Expansions of Simmons–Smith Derived Cyclopropanes
Boyer and Lallemand utilised a ring expansion as a crucial step in the total synthesis
of (+)-calystegine B2 (81, Scheme 1.26). Cyclopropane 82 was treated with iron
trichloride in DMF to provide chlorinated ketone 83.59
OTBS
BnO
BnO
OBn
OTMS
H
OTBS
BnO
BnO
BnO
O
Cl
HO
HO
HO
H
NHO
i)
(+)-calystegine B2
82 83 81
Reagents and Conditions: i) FeCl3, DMF, 70
◦C.
Scheme 1.26 Synthesis of (+)-calystegine B259
Hoberg and co–workers have published several papers on the ring expansion of
Simmons–Smith derived cyclopropanated glycals. Of particular interest are their
studies on cyclopropanes such as 84, which have been used to provide seven–
membered oxacycles. Lewis acid–mediated reaction of cyclopropane 84 with several
silylated nucleophiles afforded ring-expanded products 85 and 86 in yields of 67–
93%, along with small quantities of diene 87 (Scheme 1.27).60 While the anomeric
stereoselectivity was poor, the galactal series provided much higher anomeric selec-
tivity, using cyclopropane 88.61 This substrate incorporates a higher degree of steric
hindrance upon the β-face, which leads to preference for nucleophilic attack at the
α-face. Diastereoselectivites for oxepines such as 89 were obtained in ratios of up
to 80:1 in favour of the α-anomer.
Ring Expansions of Dihalocarbene–Derived Cyclopropanes
gem-Dihalocyclopropyl carbohydrates undergo ring expansion reactions10 in the
presence of halophilic silver salts. This leads to a monohalogenated pi-allyl cationic
species (see subsection 1.1.2), which then may be attacked by various nucleophiles.
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Reagents and Conditions: i) TMSNuc, TMSOTf, MeCN, −40 ◦C to r.t.; ii) TMSAllyl, TMSOTf,
MeCN, −40 ◦C to r.t.
Scheme 1.27 Glucal and galactal–derived oxepines60,61
The first reported ring expansion of a cyclopropyl sugar was published by Gross et al.
in 1979.62 3,4-Cyclopropyl sugar 90 was treated with silver perchlorate in methanol
(Scheme 1.28), leading to an epimeric mixture of olefins 91 and 92 in 61% yield.
The chlorinated analogue also underwent a similar ring–expansion reaction.
OBr
Br
O
O
O
O
O
Br3
4
OMei)
O
O
O
O
90 91, 92
Reagents and Conditions: i) AgClO4, K2CO3, MeOH, 60
◦C.
Scheme 1.28 Ring expansion of cyclopropanated sugar 9062
gem-Dibromocyclopropyl oxazines 93 and 94, accessible from d-glyceraldehyde as
a diastereomeric mixture (Scheme 1.29), were reacted with excess potassium car-
bonate in refluxing methanol to provide oxazepine 95. The utility of the product
structure was demonstrated through the use of palladium–catalysed cross–coupling
reactions. Suzuki reaction of 95 with phenylboronic acid provided coupled product
96; similar products were obtained through Sonogashira, Stille and Heck method-
ologies.63
O N
O
OOMeBrBr
Bn O
N
O
O
Bn
Br
MeO OMe
O
N
O
O
Bn
Ph
MeO OMei) ii)
93, 94 95 96
Reagents and Conditions: i) K2CO3, MeOH, reflux; ii) PhB(OH)2, Pd(OAc)2, PPh3, K2CO3,
DMF, 70 ◦C.
Scheme 1.29 Oxazepine formation and Suzuki coupling63
Ring expansion of gem-dihalocyclopropanated carbohydrates has also been reported
by the Nagarajan group. Ring opening of cyclopropane 97 failed to occur in the
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presence of silver ion and Lewis acid catalysis in acetic acid; at room temperature,
no reaction was observed, while under reflux the sugar was destroyed. However,
the reaction proceeded well in a solution of excess potassium carbonate in refluxing
methanol, and was reported to lead to the ring-expanded oxepine anomers 98 and
99. These products were isolated in a combined yield of 67% (1.3:1 ratio), though
the stereochemistry of each anomer was not determined (Scheme 1.30).45 Similar
results were obtained through using the corresponding d-galactose– and d-xylose–
based cyclopropanes, providing mixtures of oxepines in yields of 55–70%.
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BnO OMe
H
H
i)
97 98, 99
Reagents and Conditions: i) K2CO3, MeOH, reflux.
Scheme 1.30 Reported ring expansion of glycal–derived cyclopropane 9745
Jayaraman has recently extended this methodology to the synthesis of septanosides,
the seven–membered ring glycosides. As shown in Scheme 1.31, 2-benzyloxyglucal
100 was cyclopropanated at the α-face to provide cyclopropane 101, which was
ring–expanded to provide oxepine derivative 102 in excellent yield.64 An oxidation,
reduction and hydrogenolysis sequence ultimately provided methyl septanoside 103.
Similar methodology using galactose–based precursors led to septanoside 104.
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Reagents and Conditions: i) CHBr3, TEBAC, NaOH(aq), r.t., 81%; ii) NaOMe, toluene,
reflux, 94%.
Scheme 1.31 Formation of septanosides via cyclopropane 10164
Further extension of the above methodology to include a wide range of glycosyl
acceptors as nucleophiles was recently reported.65 gem-Dichlorocyclopropane 105
was subjected to ring expansion in the presence of potassium carbonate in refluxing
toluene. A variety of phenols and two sugars were used as nucleophiles, generat-
ing numerous oxepines as shown generically by structure 106 (Scheme 1.32). Yields
were excellent when phenols were employed (76–85%), while the sugar–derived nucle-
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ophiles provided good yields of 58% and 63%. Subsequent oxidation, reduction and
hydrogenation provided a variety of septanosides (107). A glycosyl amine analogue
was obtained through use of sodium azide as a nucleophile in the ring expansion of
cyclopropane 105.65
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Reagents and Conditions: i) NucH, K2CO3, toluene, reflux; ii) RuCl3, NaIO4, EtOAc, MeCN,
r.t.; iii) NaBH4, MeOH, 0
◦C; iv) Pd/C, H2, EtOAc, MeOH, r.t.
Scheme 1.32 Formation of septanosides via cyclopropane 10565
A very recent paper by Jayaraman describes the synthesis of disaccharides 108 and
109 and trisaccharides 110 and 111 through similar methodology.66 Using gly-
cals derived from d-lactose and d-maltose, the multi–step sequence discussed above
(Scheme 1.32) provided disaccharides 108 and 109, through cyclopropane ring ex-
pansion with methanol. The d-lactose–derived cyclopropane was also ring expanded
with the previously employed sugar nucleophiles (methyl 2,3,4-tri-O-benzyl-α-d-
glucoside and methyl 2,3-di-O-benzyl-α-d-arabinoside) to provide trisaccharides 110
and 111 respectively (Figure 1.2), incorporating the seven–membered oxepine ring.
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Figure 1.2 Formation of septanoside–based trisaccharides via cyclopropanes66
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1.3 Oxepanes, Oxepines and Septanoses
The most common ring sizes encountered in organic compounds are undoubtedly
the five– and six–membered rings. While seven–membered rings are much less com-
mon, they nevertheless occupy an important area of organic chemistry. These rings
are present in the structures of several well–known natural products such as (−)-
colchicine (112) and ciguatoxin (113) (Figure 1.3).
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Figure 1.3 Seven–membered ring natural products
Seven–membered oxacycles are often encountered in structures of synthetic targets.
The parent structures are oxepane (114), the fully saturated seven–membered ring,
and oxepine (115), the fully unsaturated analogue (Figure 1.4). Partially saturated
derivatives are also commonly termed oxepines (or oxepenes). Thus, oxacycle 116
is named 2,5,6,7-tetrahydrooxepine, though for convenience may be referred to as
an oxepine (or oxepene). The synthesis of oxepines and oxepanes has been achieved
through numerous means,67,68 several of which involved application of cyclopropane
chemistry.45,64–66
O O O
oxepane oxepine 2,5,6,7-tetrahydrooxepine
114 115 116
Figure 1.4 Seven–membered oxacycles
Sugars containing a seven–membered ring are termed septanoses (as compared to
the pyranoses and furanoses). Relative to their smaller counterparts, little research
has been published on these carbohydrates.69 d-Glucose exists in both pyranose
and furanose forms when in aqueous solution, however a tiny portion is thought to
be present as d-glucoseptanose (117) (Figure 1.5). While this structure contains
an oxepane ring, it still is a six–carbon sugar (hexose). The seven carbon homo-
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logues of the naturally occurring sugars are known as the heptoses, and those that
incorporate an oxepane ring (118) are termed heptoseptanoses. A few examples
of heptoseptanosides have been investigated, leading to the synthesis of compounds
such as 119, an oxepane–based nucleoside.70
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Figure 1.5 Examples of septanose carbohydrates70
There are many reports of interesting and varied syntheses of septanoses within
the chemical literature, several of which utilise cyclopropanes (see section 1.2.2).
Several cyclisation strategies68 such as ring–closing metathesis have been used, as
exemplified by the work of Peczuh and co–workers.71,72 Diene 120 was reacted with
Schrock catalyst 121 to provide a septanose glycal, which was later epoxidised to
provide 122 (Scheme 1.33). Treatment of epoxide 122 with different nucleophiles
under various conditions provided several d-idoseptanoside derivatives (123 and
124), with predominant or exclusive formation of the α-anomers.
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Scheme 1.33 RCM–based synthesis of septanoses71,72
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1.4 Furo[3,4-b]pyran-5-ones
The furo[3,4-b]pyran-5-one bicycle (Figure 1.6) is an interesting heterocycle, though
little research on this structure has been published. It is present in certain natural
product families, and has featured as a synthetic target in several publications.
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Figure 1.6 Furo[3,4-b]pyran-5-one
1.4.1 Syntheses of Furo[3,4-b]pyran-5-ones
Hoffmann and Nowakowski synthesised a furo[3,4-b]pyran-5-one derivative in their
approach to the synthesis of the macrolide lasonalide A (125) (Scheme 1.34).73
Starting from ketone 126 (obtained from furan and 1,1,3,3-tetrabromoacetone),
functionalisation at the α-centre provided quaternary compound 127. Ketone re-
duction and subsequent protection, ozonolysis of the alkene bridge, then reduc-
tion provided diol 128. Finally, to differentiate between the two hydroxyls, base–
mediated lactonisation provided furo[3,4-b]pyran-5-one derivative 129. This pro-
vided a masked form of the highlighted portion of lasonalide A (125).
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Reagents and Conditions: i) (−)-bis [(S )-1-phenylethyl]amidolithium, LiCl, NCCO2Me, THF,
−94 ◦C; ii) NaH, BnOCH2Cl, dioxane, 0
◦C to r.t.; iii) NaBH4, CeCl3, MeOH, EtOH, −78
◦C;
iv) TBSOTf, lutidine, CH2Cl2, 0
◦C to r.t.; v) O3, MeOH, CH2Cl2, −78
◦C then NaBH4, EtOH,
−30 ◦C; vi) imidazole, MeCN, 100 ◦C.
Scheme 1.34 Synthesis of a fragment of lasonalide A73
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Another synthesis of furo[3,4-b]pyran-5-ones proceeds through a multi–component
reaction. Shaabani and co–workers report that reaction of an isocyanide (130),
a functionalised acetylene (131), and tetronic acid (132, 2,4(3H,5H )-furandione)
provides complex furo[3,4-b]pyran-5-one products (133) (Scheme 1.35).74 Several
different isocyanides and acetylenes were chosen, and yields ranged from 68–80%,
requiring very mild conditions to achieve formation of the bicycle.
i) O
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O
R N C
CO2R'
CO2R'
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O
O CO2R'
R'O2C
RHN
130 131 132 133
R = cyclohexyl, tBu
R′ = Me, Et
Reagents and Conditions: i) CH2Cl2, r.t.
Scheme 1.35 Synthesis of furo[3,4-b]pyran-5-ones via a multi–component reac-
tion74
A series of natural product–derived furo[3,4-b]pyran-5-ones have been obtained from
reaction of 6-O-palmitoyl-l-ascorbic acid (134) with acrolein (135), to provide in-
termediate 136 (Scheme 1.36).75 The unmasked ketone of intermediate 136 reacts
with the alcoholic solvent, promoting cyclisation to provide furo[3,4-b]pyran-5-ones
137.
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Reagents and Conditions: i) ROH, 70 ◦C.
Scheme 1.36 Vitamin C–derived furo[3,4-b]pyran-5-ones75
Paquette and Sivik reported the synthesis of simple furo[3,4-b]pyran-5-ones de-
rived from 2,3-dihydropyran (138).76 Thus, α-chloropropionyl chloride (139) in
the presence of triethylamine generated chloromethylketene, which provided bi-
cycle 140, upon reaction with 138 (Scheme 1.37). Dechlorination with a zinc–
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copper couple, followed by Baeyer–Villiger oxidation provided furo[3,4-b]pyran-5-
one 141. Phenylselenation at C-4a, followed by oxidative elimination provided
α, β-unsaturated lactone 142. Isomerisation afforded bicycle 143, in which the
dihydrofuran ring of this derivative was then converted into the fully unsaturated
form, for use in Diels–Alder reactions.
i) ii), iii)
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Reagents and Conditions: i) NEt3, hexane, 0
◦C; ii) Zn, Cu(OAc)2, NEt3, NH4Cl, MeOH, 0
◦C;
iii) m-CPBA, CH2Cl2, −25
◦C; iv) KHMDS, PhSeCl, THF, −78 ◦C to r.t.; v) m-CPBA,
NaHCO3, CH2Cl2, 0
◦C to r.t.; vi) RhCl3 · 3H2O, NEt3, EtOH, 90
◦C.
Scheme 1.37 Synthesis of furo[3,4-b]pyran-5-ones from 2,3-dihydropyran76
1.4.2 Furo[3,4-b]pyran–based Natural Products
Relatively few natural products are known to incorporate the furo[3,4-b]pyran-5-one
ring system; only the fusidilactones,77,78 massarilactones,79–81 (−)-TAN-2483 A and
B,82 (−)-waol A83 and waol B84 compounds appear to exhibit this ring structure.
These compounds have all been isolated from various fungi, and exhibit numerous
structural similarities and bioactivities. Shown below are representative examples
from each of these natural product families (Figure 1.7).
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Figure 1.7 Selected examples of furo[3,4-b]pyran–based natural products
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Fusidilactones
Krohn and co–workers isolated fusidilactones A (144), B (145) and C (146) from
cultures of the fungal endophyte Fusidium sp. (Figure 1.8).77 The crude extracts
from which these products were isolated displayed antifungal activity against Eu-
rotium repens and Fusarium oxysporum, and moderate antibacterial activity against
E. coli and Bacillus megaterium. More recently, fusidilactones D (147) and E (148)
were obtained, which differ from fusidilactones A and B only in the degree of hy-
droxylation in the sidechain.78 Hsung et al. have published initial results in their
approach to the synthesis of the complex hexacycle (+)-fusidilactone C (146).85
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Figure 1.8 Fusidilactones A–E77,78
Massarilactones
The Gloer group isolated massarilactones A (149) and B (150) from the aquatic
fungus Massarina tunicata (Figure 1.9).79 Later work by the Krohn group led to the
discovery of additional furo[3,4-b]pyran–based secondary metabolites, namely mas-
sarilactone C (151) and D (152), both isolated from the endophytic fungus Conio-
thyrium sp.80 Further work led to the isolation of massarilactones E–G, structurally
similar to 149 and 151.81 Massarilactones A and B exhibit antibacterial activity
against Bacillus subtilis, with (−)-massarilactone B also able to inhibit Staphylococ-
cus aureus.79 Despite promising activity in crude extracts, massarilactones C and D
appeared to be biologically inactive against Bacillus megaterium, in addition to the
Microbotryum violaceum fungus, and the Chlorella fusca green alga.80
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Figure 1.9 Massarilactones A-D79,80
(−)-TAN-2483 A and (−)-TAN-2483 B
In 1998 Hayashi and co–workers published a patent regarding compounds (−)-TAN-
2483A (153) and (−)-TAN-2483B (154), isolated from a filamentous fungus culture
(Figure 1.10).82 Initial biological tests upon TAN-2483A showed good inhibition of
the c-src tyrosine kinase enzyme, responsible for cell growth, in addition to inhibition
of bone resorption that is initiated by the parathyroid hormone.82
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(−)-TAN-2483A (−)-TAN-2483B
Figure 1.10 TAN-2483 natural products82
Waol Compounds
Mizoue and co–workers reported the isolation of δ-lactone FD-211 (155), which
was obtained from the fungus Myceliophthora lutea (Figure 1.11).83 This lactone
demonstrated activity against a broad spectrum of tumour cell lines. FD-211 was
later termed waol A, when a close relative, waol B (156) was later isolated from
the same fungal species.84 Later, a preliminary paper reported the partial synthesis
of structure 155.86 More recently, the Snider group have published work indicating
that waol A and B do not have structures 155 and 156, and the correct structures
of waol A and B were confirmed by synthesis to be 157 and 158 respectively.87
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Figure 1.11 Initial and revised structures of waol A and B83,84,87
1.4.3 Syntheses of Furo[3,4-b]pyran–Based Natural Prod-
ucts
The Snider group has published the only known reports on the total synthesis of
these furo[3,4-b]pyran-5-one natural products.87,88 After proposing alternative struc-
tures for waol A and B, an elegant synthetic route was developed that provided access
to representatives of the fusidilactone, massarilactone, waol and TAN-2483 natural
products incorporating the furo[3,4-b]pyran-5-one bicycle.
(−)-TAN-2483A and (−)-waol A were both synthesised using the route shown below
(Scheme 1.38). Aldol reaction of lactone 159 and aldehyde 160 led to a mixture of β-
hydroxy lactone 161 (38%) and the corresponding C-4 epimer (14%).87,88 Compound
161 was subjected to iodoetherification to provide 162 (88%), with the required
configuration at C-2. To complete the synthesis, treatment of iodide 162 with
triethylamine led to the formation of an intermediate epoxide, which underwent
elimination to afford (−)-TAN-2483A (153) in 79% yield. Use of an alternative
lactone (163), led to the synthesis of waol A (157), which was subjected to lactone
hydrolysis and reaction with diazomethane, to generate waol B (158).87,88
Snider applied similar methodology to the synthesis of (−)-massarilactone B and
an approach to (+)-fusidilactone B.88 Beginning from lactone 166 (Scheme 1.39),
repetition of the above aldol coupling provided 167 and the corresponding C-4
epimer. Iodoetherification of 167 provided bicycle 168 in 33% yield over two steps.
This intermediate was used to synthesise (−)-massarilactone B (150) and diol 169,
a truncated form of (+)-fusidilactone B (145).
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Scheme 1.38 Syntheses of (−)-TAN-2483A (153) and (−)-waol A (157)87,88
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Scheme 1.39 Synthesis of (−)-massarilactone B (150) and diol 16988
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Finally, Snider attempted to synthesise (−)-TAN-2483B. As this compound is the
C-7a epimer of (−)-TAN-2483A, the general synthetic scheme used in the previ-
ous syntheses needed to be elaborated. Initial attempts began with bicyclic iodide
168, a synthetic intermediate in the above syntheses (Scheme 1.39).88 Treatment
of intermediate 168 with base provided compound 170 (Scheme 1.40), a stereo-
chemical isomer of (−)-TAN-2483B in which the configurations at C-2 and C-3 are
different. Epimerisation of the C-3 alcohol was achieved through oxidation to ke-
tone 171, followed by reduction to alcohol 172, the C-2 epimer of (−)-TAN-2483B.
Unfortunately, silica–based chromatographic purification of ketone 171 resulted in
the rapid isomerisation to enol 173. It was proposed that this occurs through tau-
tomerisation of the C-3 ketone to an enol across the 2,3-bond, followed by a Claisen
rearrangement. Due to this observation, attempts to epimerise C-2 were abandoned.
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Reagents and Conditions: i) DBU, THF, 25 ◦C; ii) Dess-Martin periodinane, CH2Cl2, 25
◦C;
iii) NaBH4, CeCl3 · 7H2O, MeOH, 25
◦C.
Scheme 1.40 Attempted synthesis of (−)-TAN-2483B88
A final attempt at synthesising (−)-TAN-2483B involved an alternative method of
pyran formation, using the previously undesired minor aldol product 174 (4-epi -
167) from the synthesis of (−)-massarilactone B (Scheme 1.39).88 It was expected
that epoxidation of the 2,3-bond and subsequent attack by the C-7a alcohol would
provide bicycles 175 and 176, of which the former could provide access to (−)-
TAN-2483B. However, epoxidation occurred at both olefins, and the 2,3-epoxide
products underwent cyclisation to exclusively provide bicycle 176. It is noteworthy
that the bicyclic configuration of (−)-TAN-2483B has the propenyl sidechain and
the lactone moiety in a trans-configuration; in contrast, the methodology employed
by Snider invariably produces a cis-configuration. Snider’s several unsuccessful at-
tempts to synthesise (−)-TAN-2483B indicate alternative methodology is required
for the synthesis of this natural product. While many of the syntheses discussed in
subsection 1.4.1 demonstrate the furo[3,4-b]pyran-5-one skeleton is accessible using
efficient sequences, none of the methods detailed provide functionality similar to that
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Scheme 1.41 Attempted epoxide–mediated synthesis of (−)-TAN-2483B88
of the furo[3,4-b]pyran-5-one–based natural products. This therefore shows multi-
step sequences such as those used by Snider88 are valid, unless the products from
multicomponent couplings such as that reported by Shaabani74 could be elaborated
further to provide access to biologically relevant targets.
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1.5 Research Objectives
The research contained within this thesis is comprised of two main parts. Ring
expansion studies of selected cyclopropanated carbohydrates will be explored, with
the intention of extending the limited range of available reactions so far reported
in the scientific literature. Secondly, through application of this methodology, or
variations thereof, a synthesis of furo[3,4-b]pyran-5-one–based natural products will
be investigated.
1.5.1 Ring–Expansion Studies
In the interests of synthesising various oxepines of structure 177 (Scheme 1.42),
methodology that extends the work of Nagarajan45 incorporating a variety of nucle-
ophiles will be explored. Oxepines 177 might be obtained through ring–expansion
reactions of cyclopropanated carbohydrates 178.
O
OR
RO Br
Br
RO
RO O
Br
Nuc
RORO
177 178
Scheme 1.42 Synthesis of hexose–derived cyclopropanes
This area of research will involve synthesis of cyclopropanated carbohydrates, via
cyclopropanation of glycals. Peracetylated glycals 179, 180 and 181 will be formed
from the respective carbohydrate parents d-glucose (182), d-galactose (183) and
d-xylose (184), through the well–established Fischer glycal synthesis, via peracety-
lation, anomeric bromination and zinc reduction (Scheme 1.43).89 Deprotection to
afford free glycals 185, 186 and 187, followed by benzylation will furnish the pro-
tected glycals (188, 43, 189), used as cyclopropanation precursors.
The glycals will then be cyclopropanated using the established Ma¸kosza method of
cyclopropane formation.12 Literature precedence indicates a mild alternative to the
standard Ma¸kosza cyclopropanation procedure is probably required to avoid starting
material degradation.45 The majority of work will focus on the cyclopropanation of
d-glucose derivative 188 (Scheme 1.44), in which it is possible that both diastere-
omers 97 and 190 will be obtained, due to cyclopropanation from both the top
and bottom face of glucal derivative 188. The reaction should favour cyclopropane
97, with carbene addition occurring from the opposite face to the neighbouring C-3
benzyloxy substituent.
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0 ◦C to r.t.; iv) NEt3, MeOH(aq), r.t.; v) NaOMe, MeOH, r.t.; vi) BnBr, NaH, DMF, 0
◦C to r.t.
Scheme 1.43 Synthesis of acetyl and benzyl glycals
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Scheme 1.44 Synthesis of glucose–derived cyclopropanes 97 and 190
Upon generation of cyclopropanes such as 97, ring expansion studies will be car-
ried out primarily by extending the methodology employed by Nagarajan.45 The
base–mediated ring expansions will be attempted using a variety of nucleophiles, as
discussed in chapter 2 (Scheme 1.45). While Nagarajan used potassium carbonate
in methanol, it is likely that use of a slight excess of a stronger, nucleophilic base
will also provide efficient reaction. This might permit the use of a non–nucleophilic
solvent, hence more complicated nucleophiles could be used. As discussed earlier
(page 3), participation of the pyran ring oxygen (forming a glycosyl cation) indicates
nucleophilic attack should occur predominantly at the anomeric centre, to provide
oxepines 191 and 192. Reaction rates and anomeric stereoselectivity will be of in-
terest, particularly when this methodology is applied to d-galactose and d-xylose
derivatives.
Nagarajan was unable to synthesise ring–expanded products when using silver salts.
It is proposed that through careful analysis and modification of the reaction con-
ditions, oxepines might be obtained without significant degradation of the starting
material. This research will be covered in chapter 3.
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Scheme 1.45 Cyclopropane ring–expansion
1.5.2 Synthesis of (−)-TAN-2483B
Snider was able to synthesise many furo[3,4-b]pyran-5-one–based natural products,
however the attempted synthesis of (−)-TAN-2483B was unsuccessful.88 Access to
(−)-TAN-2483B (154) appears to be viable through use of a cyclopropanated car-
bohydrate, as indicated below (Scheme 1.46). (−)-TAN-2483B might be accessed
from advanced intermediate 193, which comprises most of the carbon skeleton of
(−)-TAN-2483B (Scheme 1.46); only sidechain elaboration and lactone formation
are required. Intermediate 193 could be accessed from a simple naturally occur-
ring hexose or pentose (194), through a cyclopropanation/ring expansion sequence,
followed by further functional group interconversions.
O
O
HO
O
O
X
OH
H H
PGO
PGO
O
OH
HO OH
OHR'R
154 193 194
(−)-TAN-2483B R′ = H, CH2OHR = H, CH2OPG
Scheme 1.46 Cyclopropyl carbohydrate–based retrosynthesis of (−)-TAN-2483B
The stereogenic centres at positions C-2 and C-3 of (−)-TAN-2483B closely resemble
those of d-galactose. Therefore, it was initially proposed that (−)-TAN-2483B might
be obtained as shown in the retrosynthetic scheme below (Scheme 1.47). (−)-TAN-
2483B (154) could be formed via advanced intermediate 195, through regioselective
deprotection of the p-methoxybenzylidene acetal,90 then an oxidation, olefination
and deprotection sequence. It was thought alcohol 196 would provide lactone 195
through carbonylation or carboxylation of the alkenyl halide, then lactonisation.
Alcohol 196 might be synthesised from cyclopropane 197 through an intramolec-
ular cyclopropane–opening reaction, followed by chelation–controlled addition of a
methyl group to the aldehyde. Cyclopropane 197 would be in equilibrium with the
corresponding ring–closed sugar 198. This cyclopropane could be accessed from
2,3-unsaturated sugar 199, through cyclopropanation and protection/deprotection
steps. Finally, 2,3-unsaturated sugar 199 would be easily obtained through a Ferrier
rearrangement27 of tri-O-acetyl-d-galactal.
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Scheme 1.47 Retrosynthesis of galactose–based (−)-TAN-2483B route
Alternatively, (−)-TAN-2483B could be accessed from a glycal–derived oxepine, such
as the pentose sugar d-xylose. This could prove advantageous, due to the ease of
synthesis of glycals. Furthermore, the above d-galactose route calls for intramolecu-
lar nucleophilic attack following cyclopropane ring–opening reaction. Obtaining the
desired product, with the correct stereochemistry might be challenging. d-Xylose
also contains the stereochemical configuration analogous to (−)-TAN-2483B, there-
fore the following retrosynthetic analysis (Scheme 1.48) could be effective for this
total synthesis. It was proposed that (−)-TAN-2483B might be accessed from ad-
vanced intermediate 200, through a carbonylation/lactonisation sequence. Alcohol
200 could be accessed from triene 201 through cis-selective Jacobsen epoxidation;91
removal of protecting groups and intramolecular epoxide ring opening would likely
provide 200. This would incorporate the only stereocentres not derived from the
sugar starting material via asymmetric epoxidation. In turn, triene 201 could be
synthesised from 202 through an oxidation/olefination sequence. Alcohol 202 could
be accessed from 203 through deacetylation, followed by a (Z )-selective Wittig ole-
fination. The required oxepine 203 could be synthesised from cyclopropane 204,
through a ring–expansion reaction. Cyclopropane 204 could be accessed from di-
O-acetyl-d-xylal, through deprotection, then reprotection with an appropriate pro-
tecting group, followed by cyclopropanation. The p-methoxybenzyl protecting group
was initially chosen, as it was expected to provide sufficient stability, while enabling
an orthogonal deprotection strategy (using DDQ90).
Finally, a bicyclo[3.1.0]hexane–derived cyclopropanated carbohydrate could also pro-
vide access to (−)-TAN-2483B. d-Mannose could be used in this type of synthesis,
as illustrated in Scheme 1.49. Using a deprotection/diol cleavage sequence, then ole-
fination and deprotection, (−)-TAN-2483B (154) might be accessed from advanced
intermediate 205. This lactone might in turn be generated from intermediate 206,
through carbonylation and lactonisation. Alcohol 206 could arise from reducing
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Scheme 1.48 Retrosynthesis of (−)-TAN-2483B using a xylose–based route
sugar 207 through an olefination/epoxidation route, followed by an epoxide ring
opening to generate the pyran ring of 206. Substrate 207 could be synthesised
from cyclopropane 208 through the application of a ring–expansion/deprotection
sequence. Finally, cyclopropane might be obtained from known glycal 209, which
is in turn derived from d-mannose.34
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Scheme 1.49 Retrosynthesis of mannose–based (−)-TAN-2483B route
Efforts towards the synthesis of (−)-TAN-2483B through use of d-galactose and d-
xylose are discussed in chapter 4, and the successful synthesis of the carbon skeleton
of the furo[3,4-b]pyran-5-one bicycle is discussed in chapter 5.
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Chapter 2
Base–Mediated Ring–Opening
Reactions
2.1 Introduction
Ring–opening reactions of cyclopropanated carbohydrates are of significant interest
as a means of synthesising unusual carbohydrates and carbohydrate mimics. Stud-
ies of cyclopropyl sugars have been reported often,9,22 including a few examples
of gem-dihalocyclopropanated carbohydrates used in ring–opening reactions.62,63
The Nagarajan group45 has described the synthesis of several carbohydrate deriva-
tives incorporating an oxepine ring. Cyclopropane starting materials such as 97
(Scheme 2.1), easily accessible from protected glycals, were reported to undergo
regioselective ring opening. Although several silver–promoted reaction conditions
were investigated by Nagarajan, none proved fruitful. However, employing several
equivalents of potassium carbonate in methanol92 under reflux temperatures, al-
lowed conversion of cyclopropane 97 into oxepines 98 and 99. This base–mediated
methodology would have great synthetic value if the nucleophile could be varied
and used in only moderate excess. Repetition and extension of this methodology
for preparing oxepines, through exploration of different cyclopropane precursors,
nucleophiles and reaction conditions was a major focus of this research.
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Scheme 2.1 Nagarajan’s reported oxepine synthesis45
2.2 Synthesis of Cyclopropanes 97 and 190
Studies began with d-glucose (182), a readily available sugar with good prece-
dence as a cyclopropane substrate, as demonstrated by Nagarajan.45 Conversion of
d-glucose into d-glucal involved the use of methodology pioneered by Fischer93–95
and refined by others.89,96 Synthesis began with peracetylation of d-glucose (182)
using acetic anhydride and catalytic perchloric acid (Scheme 2.2); α-bromoglycoside
210 was obtained through addition of hydrobromic acid. Upon isolation of crude gly-
cosyl halide 210, reaction in the presence of zinc dust provided tri-O-acetyl-d-glucal
(179), the first potential substrate for cyclopropanation. In the interests of incor-
porating more stable protecting groups, 179 was deprotected using triethylamine
in aqueous methanol. The resulting d-glucal (185) was purified in good yield (66%
from d-glucose), by precipitation of impurities from a methanol/acetone/diethyl
ether solvent mixture. d-Glucal (185) was then perbenzylated upon treatment with
an excess of sodium hydride, followed by addition of benzyl bromide. Thus, tri-
O-benzyl-d-glucal (188) was obtained in very good yield (84%). Both protected
glycals 179 and 188 were used as substrates for cyclopropanation.
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Reagents and Conditions: i) Ac2O, HClO4, 40–50
◦C, 30 min; ii) HBr, AcOH, r.t., 90 min;
iii) Zn, AcOH(aq), 0
◦C to r.t., overnight; iv) NEt3, MeOH(aq), r.t., 90 min, 66% from d-glucose;
v) BnBr, NaH, DMF, 0 ◦C to r.t., overnight, 84%.
Scheme 2.2 Synthesis of acetyl glucal (179) and benzyl glucal (188)
The original procedure for Ma¸kosza cyclopropanation involves a biphasic system, in
which the aqueous phase is comprised of a caustic solution of 50% (w/w) sodium
hydroxide in water.12 Nagarajan’s synthesis of cyclopropane 97 from glycal 188
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utilised a subsequent modification by Ma¸kosza, wherein the aqueous phase employs
a comparatively low concentration of sodium hydroxide. A high concentration of
potassium fluoride is employed, to ensure the water activity of the solution is com-
parable to 50% (w/w) sodium hydroxide in water.97 This modification allows for
carbene addition to substrates that would normally not survive the highly basic
conditions of standard Ma¸kosza cyclopropanation. With this in mind, attempts
to synthesise gem-dihalocyclopropanated carbohydrates began with tri-O-acetyl-d-
glucal (179) (Scheme 2.3). This material was subjected to Ma¸kosza cyclopropa-
nation, using the modified Ma¸kosza conditions employed by Nagarajan for the cy-
clopropanation of glycal 188 [6% (w/w) sodium hydroxide, 47% (w/w) potassium
fluoride, 47% (w/w) water].45 Unfortunately, glycal 179 was not stable under these
conditions, and only degraded material was recovered after extraction with diethyl
ether. This, together with TLC and NMR evidence, indicated significant loss of
the acetate protecting groups. The use of ultrasound has been reported to improve
cyclopropanations,9,98 providing much faster reaction rates. It was thought that ul-
trasonicating the reaction of 179 with bromoform and 50% (w/w) aqueous sodium
hydroxide might promote carbene addition before significant deprotection occurs.
These conditions led to consumption of starting material in approximately 2 hours,
but isolated yields of cyclopropanes 211 and 212 were poor, ranging from 5–10%,
presumably again due to loss of the acetate groups and subsequent retention of the
resulting polar material in the aqueous phase upon workup.
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Scheme 2.3 Cyclopropanation of tri-O-acetyl-d-glucal (179)
The use of chloroform to generate the corresponding gem-dichlorocyclopropanes
encountered similar difficulties. Incorporation of a variety of cosolvents (dichloro-
methane, diethyl ether or toluene) was also explored, but failed to do more than
aid stirring of the viscous reaction mixtures. These observations show that the ac-
etate groups are too labile under Ma¸kosza conditions. Therefore, the more robust
substrate tri-O-benzyl-d-glucal (188) was subsequently employed for cyclopropana-
tions.
Nagarajan previously reported that the original Ma¸kosza cyclopropanation of tri-O-
benzyl-d-glucal (188) was initially unsuccessful, presumably due to the use of 50%
(w/w) sodium hydroxide in water.45 When this reaction was repeated under ultra-
sonication conditions (to promote efficient carbene addition), a complicated mixture
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of inseparable products was obtained. Therefore, the modified potassium fluoride
method of Ma¸kosza was attempted. This reaction proceeded efficiently, using either
ultrasonication or magnetic stirring. Thus, cyclopropane 97 was obtained in 66%
yield, along with a minor amount (10%) of isomer 190 (formed due to carbene ad-
dition from the top face), previously unreported by Nagarajan (entry 1, Table 2.1).
Cyclopropane 97 was obtained as a white solid, which was stable at room temper-
ature under air for several months. Cyclopropane 190 was isolated as an unstable
yellow oil. It was stored under argon in the freezer, but even under these conditions
it degraded into an unidentifiable mixture within a few months.
Table 2.1 Cyclopropanation of tri-O-benzyl-d-glucal (188)a
O
OBn
BnO
BnO
O
OBn
BnO
BnO
O
OBn
BnO
BnO
H
H
H
H
Br
Br
Br
Br
i)
1
23
1
23
188 97 190
Reagents and Conditions: i) CHBr3, TEBAC, NaOH/KF(aq), r.t. or 20–30
◦C.
Entry Reaction method Reaction time Recovered 188 Yield (97) Yield (190)
1 magnetic stirring 2 d 1% 66% 10%
2 magnetic stirring 2 d 16% 63% 7%
3 ultrasonication 10 x 10 min 42% 35% 5%
4 ultrasonication 8 x 30 min 30% 48% 6%
5 ultrasonication 12 x 30 min 28% 43% 7%
6 ultrasonication 12 x 30 min 30% 48% 8%
aall yields are of isolated products
The major isomer 97 was easily identified by NMR spectroscopy, with a charac-
teristic doublet of doublets at 1.87 ppm in the proton spectrum, corresponding to
the H-2 methine at the ring junction. This proton coupled to H-1 (J = 7.8 Hz),
which was significantly further downfield at 3.94 ppm, due to the attached pyran
ring oxygen. A coupling constant of 4.9 Hz was observed between H-2 and H-3. All
characterisation data agreed very well with that reported by Nagarajan.
The minor isomer 190 had a similar proton NMR spectrum to that of 97. The
H-2 methine appeared as a triplet (J = 8.1 Hz) at 2.30 ppm, due to coupling with
H-1 (at 4.07 ppm), and H-3. This indicated all three protons were on the α-face,
therefore this product was the β-cyclopropyl product. Conversely, major isomer
97 was determined to be the α-cyclopropyl product, due to the observed coupling
constant (4.9 Hz) between H-2 and H-3.
The use of ultrasonication was explored to optimise this reaction (Table 2.1, entries
3–6). Extended periods of sonication caused the sonication bath to heat up, which
could have allowed cyclopropane ring–opening reactions to occur, and reduce the
yield of cyclopropanes. Therefore, the temperature was maintained between 20–
38
30 ◦C through replacement of the water in the sonication bath at regular intervals.
Sonication led to improved conversion, as cyclopropanes were generated in good
yield after several hours sonication. However, as starting material was usually re-
covered upon purification, reversion to the conventionally stirred reaction described
by Nagarajan was deemed prudent, requiring a less complicated experimental pro-
cedure.
This cyclopropanation was now a very effective means of providing major cyclo-
propane 97, though it was occasionally quite temperamental (compare entries 1 and
2, Table 2.1). Typically once all reagents were added, a clear biphasic mixture was
observed, which steadily turned dark–brown throughout the course of the reaction.
However, several times when this reaction was performed, the mixture would only
turn a pale–yellow colour, which usually indicated a lack of any significant reactiv-
ity. Presumably, this variable nature between successive reactions is responsible for
several discrepancies in yield as shown in Table 2.1.
2.3 Base–Mediated Methanolysis of
Cyclopropanes 97 and 190
Initial attempts to form oxepines began with repetition of Nagarajan’s methodology,
in which cyclopropane 97 was dissolved in methanol, treated with an excess of potas-
sium carbonate, then refluxed.45 This provided a 1:1.1 (β:α) mixture of anomeric
sugars, with yield, anomeric ratio and analytical data all in excellent agreement
with Nagarajan’s report. The proton NMR spectra of the two separable anomers
showed acetal resonances at 5.19 and 5.05 ppm, in addition to alkene peaks at 6.81
and 6.78 ppm (Figure 2.1). However, the lack of significant coupling between the
olefinic proton (presumed to be H-3) and the allylic proton (H-4) warranted closer
analysis. Upon performing nOe experiments, an unexpected correlation between
the acetal and olefinic protons was observed, in both directions, with both anomers.
Subsequent investigation of the full series of both 1D and 2D NMR spectra confirmed
that this reaction actually provided the 2-C -branched pyranose sugars 213 and 214,
and not the oxepine structures previously assigned by Nagarajan45 (Scheme 2.4).
The anomeric configurations were individually assigned based on nOe correlations
across the pyran ring oxygen (Figure 2.2). The less polar (minor) anomer was
subjected to irradiation of the anomeric proton, which provided an enhancement
of H-5, indicative of the β-anomer, 213. The more polar (major) anomer was
identified when, on irradiation of the anomeric proton, an enhancement of the H-6
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Figure 2.1 1H-NMR spectra of 213 and 214
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Reagents and Conditions: i) K2CO3, MeOH, reflux, 8 h, 68%.
Scheme 2.4 Base–mediated ring opening of cyclopropane 97
protons was observed, indicative of the α-anomer, 214. In the proton NMR spectra
(Figure 2.1), the olefinic proton of 213 (δH 6.81 ppm) appeared as a narrow doublet
(J = 1.7 Hz), which was confirmed to be due to an allylic coupling with H-1 upon
examination of the COSY spectrum. The olefinic proton of 214 (δH 6.78 ppm)
appeared as a singlet. The carbon NMR spectrum indicated the two carbon shifts
of each product were quite different, with olefinic signals occurring at 137.5 (C-2)
and 112.6 (C-7) ppm for 213, and 137.0 (C-2) and 114.7 (C-7) ppm for 214.
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Figure 2.2 Selected NMR correlations of 213 and 214
Product 214 was then derivatised, which provided more conclusive proof of the un-
usual 2-C -branched structure. A portion of anomer 214 was subjected to lithium–
halogen exchange, through treatment with n-butyllithium. Upon generation of the
corresponding lithiated alkene, addition of water led to the exocyclic methylene
derivative 215 (Scheme 2.5). This structure was easily confirmed by proton NMR,
with three singlets observed near 5 ppm, attributed to the acetal proton (5.06 ppm),
and the two protons of the exocyclic methylene group (5.16, 5.30 ppm). Further-
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more, sugar 215 has been reported previously,99 obtained through a Vilsmeier–
Haack reaction of tri-O-benzyl-d-glucal (188) and, after several functional group
transformations, Ferrier rearrangement. Gratifyingly, the reported NMR data was
in excellent agreement with that of product 215 obtained from the above lithium–
halogen exchange.
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Reagents and Conditions: i) n-BuLi, THF, −78 ◦C, 1 h; ii) H2O, −78
◦C to r.t., 30 min, 29%
over 2 steps.
Scheme 2.5 Lithium–halogen exchange of bromoalkene 214
2-C -Methylene sugars have received some attention in the literature, with many
reports involving the synthesis of carbohydrates similar to 215, albeit derived from
non–cyclopropyl precursors.100–102 2-C -Halomethylene sugar derivatives have previ-
ously been obtained using Wittig chemistry.103 The halomethylene branch has also
been observed in nature, as seen within malyngamides such as 216 (Figure 2.3).104
Even more exciting is the presence of these moieties within 2-C -substituted nucle-
oside derivatives. DMDC (217) and tezacitabine (218) both inhibit the ribonu-
cleotide reductase enzyme, and have been evaluated in Phase I clinical trials.105
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Figure 2.3 Selected methylene and halomethylene compounds104,105
With the structures of pyranoside sugars 213 and 214 correctly identified, opti-
misation of this reaction was required prior to use with alternative substrates and
nucleophiles. It was hypothesised that the use of sodium methoxide might lead to
more efficient reactivity, due to the greater concentration of the methoxide anion,
when compared to methanolic potassium carbonate. Therefore, cyclopropane 97
was initially reacted with an excess of commercially available sodium methoxide
and the non–nucleophilic solvent THF. Unfortunately, only a fraction of starting
material was consumed after reaction overnight, even though reflux conditions were
used, providing a very similar temperature to that of refluxing methanol (methanol
b.p. 64.7 ◦C, c.f. THF b.p. 65–67 ◦C). Preparation of fresh sodium methoxide was
carried out by dissolving a known amount of sodium in methanol, then complete
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removal of methanol. However, this was even less successful, with no consumption
of starting material observed at all after three hours reaction at THF reflux. It was
intriguing to find that the addition of a small excess of methanol provided signifi-
cantly greater reactivity, leading to isolation of the pyranoside sugars 213 and 214
in very good yield (up to 71%). This reaction was performed using a freshly pre-
pared solution of sodium methoxide (approximately 1.5 eq.) in a minimal volume
of methanol. This solution was treated with the cosolvent THF, followed by the
cyclopropane.
A comparison of various potassium carbonate and sodium methoxide–based reac-
tions was instructive in optimising the reaction (Table 2.2). Nagarajan’s method,45
with methanol as the solvent, provides isomers 213 and 214 in good yield (entry 1).
Use of sodium methoxide enabled a faster reaction (entry 2); a relatively small ex-
cess of methanol is required, while still achieving very good yields (entry 3). While
this reaction proceeds at room temperature, the reaction was more sluggish, and
unreacted starting material (27%) was recovered from the reaction after 1.5 hours
(entry 4). Finally, the isomeric cyclopropane 190 was also subjected to these condi-
tions (entry 5), but reacted much more slowly than 97. After 3 hours at reflux the
reaction was terminated and a portion of starting material (16%) was later isolated.
Table 2.2 Base–mediated ring–opening of cyclopropanes 97 and 190a
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BnO
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or97 190 213 214
Entry Substrate Base Nucleophile, Solvent Conditions Yield, Ratio
(213:214)
1 97 6 eq. K2CO3 250 eq. MeOH reflux, 8 h 68%, 1.2:1
2 97 6 eq. NaOMe 34 eq. MeOH, THF reflux, 3 h 64%, 1.5:1
3 97 1.5 eq. NaOMe 7.5 eq. MeOH, THF reflux, 1.25 h 71%, 1:2.2
4 97 1.0 eq. NaOMe 14 eq. MeOH, THF r.t., 1.5 h 60%, 1:1
5 190 1.5 eq. NaOMe 12 eq. MeOH, THF reflux, 3 h 48%, 1:2.3
aall yields and ratios are of isolated products
Discrepancies exist between different reactions, possibly due to the varying quality of
the solvents, which could have been slightly wet. THF was distilled from the sodium
benzophenone ketyl radical before use, whereas methanol was distilled over sodium,
but then stored until required. It is likely the methanol could have become slightly
wet before certain reactions were performed. For a reaction involving 1.5 equivalents
of base (concentration of 0.15 molL−1), only 0.3% (v/v) of water is required to
convert the base into sodium hydroxide. Therefore, it is likely that the differences
in reaction rate, and also in anomeric ratios, could be due to varying amounts of
sodium methoxide and sodium hydroxide in the reaction.
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The comparative reactivity of cyclopropanes 97 and 190 appeared quite different,
therefore it was deemed necessary to perform a comparative reaction, that could be
monitored by NMR experiment to prove the cyclopropanes were indeed reacting at
different rates. A ca. 5:4 ratio mixture of cyclopropanes 97 and 190 was dissolved
in THF-d8, then treated with a solution of sodium methoxide in methanol. Pro-
ton NMR spectra were obtained at various times, with integrations of the relevant
peaks (H-2 of 97 and 190, H-1 and H-7 of 213 and 214) used to determine ap-
proximate amounts of the components of the reaction mixture. It became evident
that cyclopropane 97 is very much more reactive than isomeric cyclopropane 190
(Table 2.3). Unfortunately, an excessive amount of starting material was employed,
which consequently provided poorly resolved NMR spectra. Therefore, the ratios
of reaction components are not very accurate, except for the percentages obtained
after isolation (entry 120 min).
Table 2.3 Comparison of the reactivity between cyclopropanes 97 and 190ab
O
OBn
BnO
BnO
OMeO
OBn
BnO
BnO
Br
Br
Br
O
OBn
BnO
OMe
Br
BnOi)
H
H
R
R2
1
7
1
7
R =
R =
97
190
213 214
Reagents and Conditions: i) NaOMe, MeOH, THF-d8, r.t.
Time (min) 97 190 213 214
0 56% 44% 0% 0%
15 50% 36% 4% 9%
65 15% 39% 17% 29%
115 11% 40% 19% 29%
120 15% 26% 29% 31%
aall values were determined through 1H-NMR integrations
bapproximate error 5–10% in all measurements
2.4 Mechanistic Studies
The base–mediated ring–opening reactions of cyclopropanes 97 and 190 provide
2-C -branched products, rather than the ring–expanded structures typically obtained
through silver–mediated reactions. Therefore, further investigation was warranted,
in the hope of elucidating mechanistic information. A deuterium–labelling study
was performed, in which methanol-d4 was reacted with sodium, and cyclopropane
97 subsequently added to the resulting solution. The proton NMR spectra of the
separated product anomers showed none of the peaks corresponding to the methoxy
and olefinic protons in products 213 and 214. The carbon NMR spectra failed to
show peaks corresponding to the methoxy carbons or the olefinic carbons, which
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might be expected due to the effect of deuterium coupling: one would expect to
observe the deuterated alkenyl carbon as a triplet, and the deuterated methyl group
as a complex multiplet, with both peaks of very low intensity. However, these peaks
were not visible in the spectrum obtained. With the remaining peaks present in
both carbon and proton spectra matching those of 213 and 214, the products were
identified as tetradeutero products 219 and 220 (Scheme 2.6). Their molecular
weight was corroborated by high–resolution mass spectrometric analysis of anomer
220. This significant result indicates that the H-2 proton of cyclopropane 97 is lost
during the reaction, and that a proton (or deuteron) from methanol is incorporated
into the 2-C -bromomethylene substituent. It appears that the requirement of an
introduced proton (or deuteron) may only be satisfied in the presence of protic
species. This observation suggests that the reason the ring–opening reaction failed
to proceed in the presence of dry sodium methoxide was due to the absence of
methanol (or other protic species), required to provide the necessary proton.
O
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BnO
BnO
H
H
Br
Br
O
OBn
BnO
BnO
Br
OCD3 O
OBn
BnO
BnO
Br
OCD3
i)
D D2
97 219 220
Reagents and Conditions: i) NaOCD3, CD3OD, reflux, 2 h, 49%.
Scheme 2.6 Synthesis of tetradeutero pyranoside sugars 219 and 220
The ring cleavage of 97 in this reaction could arise through several different mech-
anisms, as shown in Scheme 2.7. The different routes would be initiated by two
possible mechanistic pathways: ring–opening of the cyclopropane to form zwitte-
rion 221 (red and black routes), or deprotonation to form the cyclopropyl anion
222 (blue and green routes).
Zwitterion 221 forms through participation of the pyran ring oxygen in cleavage of
the 1,7-exocyclic bond, as shown in the left–hand path of Scheme 2.7 (red path).
This species could react further via two paths, one (shown in black) involving
methanol addition to the zwitterion to provide 229 and 230, which could undergo
elimination of hydrogen bromide, forming 2-C -branched sugars 213 and 214. Al-
ternatively, zwitterion 221 could be protonated at C-7 to form oxonium ion 223,
then deprotonation at C-2 would lead to glycal 226. Loss of a bromide ion from 226
could be driven by participation of the pyran oxygen, to arrive at glycosyl cation
231. Finally, attack by methanol would provide 213 and 214.
The middle path (shown in dark blue) would be dependant on the presence of base,
to provide anion 222. Subsequent rearrangement to anionic glycal 224, then proto-
nation would afford glycal 226, whereupon the previously discussed route applies.
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Scheme 2.7 Mechanism of base–mediated ring opening of cyclopropane 97
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Finally, the right–hand path (shown in green), involving cyclopropene 225, could
also lead to the observed exocyclic bromomethylene sugars. The cyclopropene could
be formed by elimination of HBr across the 2,7-bond (probably via anion 222), and
then could undergo rearrangement to carbene 227 (path shown in light blue) or the
alternative resonance form, zwitterion 228. Addition of methanol to zwitterion 228
could lead to 213 and 214.
Many of the possible mechanisms shown in Scheme 2.7 may be tentatively dismissed,
given results already discussed. While all paths do explain the observed deuterium
incorporation, the paths shown in black, red and dark blue involve neutral species
such as 226, 229 and 230, with a dibromomethyl moiety attached to C-2. This
moiety could ultimately be transformed into the key bromomethylene substituent.
However, both product anomers (213 and 214) were invariably isolated as a single
geometric isomer, with the double bond always in the (E )-configuration, as con-
firmed by nOe studies. None of the (Z )-isomer was observed in the proton NMR
spectra of the crude reaction mixtures. This observation casts doubt upon these
paths, as compounds 226, 229 and 230 would both seem sufficiently long–lived for
free rotation of the 2,7-bond, which could lead to a mixture of (E )/(Z )-isomers.
However, it is possible that the red route might be involved, and the formation of
(Z )-isomer from 226, 229 and 230 is simply a much less favoured process, when
compared to the formation of the observed (E )-isomer (213 and 214).
Evidence for participation of the cyclopropene (225) is more compelling. Cyclo-
propane rearrangements to halomethylene–branched products such as this are prece-
dented,92,106,107 of which some are believed to form via cyclopropenes such as 225.92
However, if the cyclopropene rearranges to carbene 227, insertion into the hydroxyl
bond of methanol is likely, providing bromomethoxymethyl species 232. Alterna-
tively, carbene insertion into one of the neighbouring benzylic CH bonds, would
provide bicyclic pyranofuran 233, or the corresponding eliminated product 234.108
None of these products was observed, therefore it is unlikely carbene 227 is in-
volved. Conversely, zwitterion 228 is likely the predominant resonance form. Due
to the presence of the pyran oxygen, reaction progression via zwitterion 228 is
quite plausible, which would lead to subsequent attack by methanol, providing ob-
served 2-C -branched sugars 213 and 214. In addition, this mechanism would retain
stereochemical integrity of the bromomethylene moiety throughout, which all other
mechanisms in Scheme 2.7 fail to do.
Experiments were then performed to gain further insight into the mechanism of this
reaction. In an attempt to observe the intermediacy of cyclopropene 225, cyclo-
propane 97 was dissolved in THF-d8, then added to sodium methoxide in methanol.
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Proton NMR spectra were obtained at regular intervals, however only starting ma-
terial and products 213 and 214 were observed, indicating that if cyclopropene 225
is present, it is an extremely short–lived species. These proton NMR spectra further
demonstrated how clean this transformation is, as no byproducts were observed dur-
ing the course of this reaction. Attempts to trap the cyclopropene as a Diels-Alder
adduct were undertaken, by replacing the THF solvent with furan.92 Consumption
of starting material was very slow when performed at room temperature, with only
a trace amount of material converted into the previously observed exocyclic bro-
momethylene products 213 and 214. Cyclopropanes may undergo cycloadditions
with a dipolarophile, presumably through zwitterions such as 228.109 To investigate
this, cyclopropane 97 was reacted with sodium hydride in THF in the presence of
methyl acrylate, which was expected to provide a cyclopentyl derivative. Unfor-
tunately, minimal consumption of starting material was observed. Changing the
solvent to DMF led to a faster reaction, generating a complex mixture, from which
none of the expected products could be identified.
As mentioned earlier, this reaction proceeded well in the presence of sodium methox-
ide and methanol, but failed if no methanol was present. This was also observed
when cyclopropene generation was attempted using sodium hydride, with which
cyclopropane 97 was completely unreactive. Use of n-butyllithium led to debromi-
nation of 97, rather than the removal of H-2 (Scheme 2.8). Both starting material
97 (26%), and bromocyclopropane 235 (26%) were isolated from the reaction. The
configuration of 235 at C-7 was determined by nOe experimentation in which irra-
diation of the introduced proton (H-7, 3.01 ppm), led to enhancement of a signal
attributed to either H-3 or H-5, which indicates H-7 is in the endo-position.
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Reagents and Conditions: i) n-BuLi, THF, r.t., 10 min; ii) H2O, r.t., 5 min, 26% over 2 steps.
Scheme 2.8 Reaction of cyclopropane 97 with n-butyllithium
Unfortunately, due to the lack of success in the reactions described above, the exper-
imental results do not provide comprehensive evidence for one mechanism over the
other. However, using the limited information obtained, it is believed that the most
likely mechanism for this base–mediated ring–opening reaction is via cyclopropene
225 and zwitterion 228 (green route), as shown in Scheme 2.7.
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2.5 Base–Mediated Ring Opening with
Alternative Nucleophiles
As this reaction was able to be performed with only a moderate excess of methanol,
it demonstrates that one might employ a variety of nucleophiles. The use of nu-
cleophiles unsuitable as solvents, of significant expense, or those that would com-
plement a larger synthetic goal, could be used to generate a range of 2-C -branched
carbohydrates.
With an improved method for accessing pyranoside sugars 213 and 214, other
alcohols were used as nucleophiles, to determine the versatility of the above meth-
odology. In analogy with the methoxide–based reactions, approximately 1.5 equiv-
alents sodium alkoxide and 5 equivalents alcohol were used in these reactions. Cy-
clopropane 97 reacts with allyl alcohol and benzyl alcohol under these conditions
(Table 2.4). For comparison, the optimised ring–opening reaction with sodium
methoxide in methanol is included (entry 1). The reaction with allyl alcohol and
sodium allyloxide provided glycosides 236 and 237 (entries 2 and 3); benzyl alcohol
and sodium benzyloxide provided glycosides 238 and 239 (entry 4). Good yields
were obtained in all cases, though longer reaction times were required, as compared
to the methanol case. This methodology allows for the construction of a variety of
glycosides of these unusual 2-C -branched sugars.
Table 2.4 Ring opening of cyclopropane 97 with various nucleophilesab
O
OBn
BnO
BnO
ORO
OBn
BnO
BnO
Br
Br
Br
O
OBn
BnO
OR
Br
BnO
H
H
R = MeR = Me
R = AllylR = Allyl
R = BnR = Bn
97 213 214
236 237
238 239
Entry Base Nucleophile Time Yield, Products Ratio (α:β)
1 1.5 eq. NaOMe 7.5 eq. MeOH 1.25 h 71%, 213, 214 1:2.2
2 6.6 eq. AllylONa 5.1 eq. AllylOH 5 h 55%, 236, 237 1:1.9
3 1.7 eq. AllylONa 5.9 eq. AllylOH 5 h 71%, 236, 237 1:2.2
4 3.2 eq. NaOBn 7.1 eq. BnOH 4 h 63%, 238, 239 1.1:1
aall reactions were performed in THF at reflux temperature
ball yields and ratios are of isolated products
The use of carbon– and nitrogen–based nucleophiles was also investigated. Treat-
ment of tert-butyl acetylene with sodium hydride, followed by addition of cyclo-
propane 97 led to consumption of the cyclopropane after 20 hours in refluxing
THF. The crude NMR spectrum of this mixture indicated the presence of several
components, with numerous peaks observed from 5.2 to 5.8 ppm, and 6.7 to 6.9 ppm.
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Unfortunately, these products were unable to be separated and identified. The use of
Meldrum’s acid (2,2-dimethyl-1,3-dioxane-4,6-dione) was also studied, however this
reaction was extremely sluggish. Pre–treating Meldrum’s acid with sodium hydride,
followed by reaction with 97 in refluxing THF for three days provided a mixture
composed of predominantly starting material, with a minor amount of unisolated
material. Presumably this lack of smooth reactivity could be due to the use of aprotic
nucleophiles, which are not able to provide the required proton for the bromomethyl
moiety. Alternatively, deprotonated Meldrum’s acid is resonance stabilised, there-
fore it may not be an appropriate base or nucleophile. Diethylamine was used in
an attempt to extend this methodology to nitrogen nucleophiles. This provided
fairly good reactivity, with almost full conversion observed after 6 hours, providing
glycosylamine derivatives 240 and 241 in approximately 45% yield (Scheme 2.9).
Unfortunately these products were not very stable, and converted into mixtures
of multiple products before full NMR characterisation was performed. These mix-
tures included aldehydic peaks in the proton NMR spectra, possibly indicating the
glycosyl bonds of these sugars are quite labile.
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97 240 241
Reagents and Conditions: i) NaNEt2, HNEt2, THF, reflux, 6 h, 45%.
Scheme 2.9 Synthesis of glycosylamines 240 and 241
2.6 Palladium–Catalysed Coupling Reactions
The exocyclic bromomethylene moiety of the 2-C -branched sugars represents an
excellent substrate for palladium–catalysed cross–coupling reactions. Suzuki and
Stille coupling reactions involving substrate 214 were both investigated. A Suzuki
reaction was performed with methylboronic acid, but the reaction was quite slow,
even though refluxing 1,4-dioxane was employed (Scheme 2.10). A significant por-
tion of starting material was recovered (35%), in addition to the previously formed
exocyclic methylene 215. This presumably indicates palladium undergoes oxidative
addition with substrate 214, however it appears transmetalation with the boronic
acid has failed to occur.
A Stille reaction with substrate 214 was performed in the presence of allyltributyl-
stannane and catalytic palladium-tetrakis(triphenylphosphine). Although the prod-
uct was indistinguishable from the substrate by TLC, after two days the reaction
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Reagents and Conditions: i) Pd(PPh3)4, MeB(OH)2, K2CO3, 1,4-dioxane, reflux, 2 d, 30%.
Scheme 2.10 Attempted Suzuki coupling of 2-C -branched sugar 214
was terminated, and found to have undergone full conversion. Upon purification by
column chromatography, coupled sugar 242 was isolated in 52% yield (Scheme 2.11).
This reaction demonstrates the value of the bromomethylene moiety and the poten-
tial for the rapid assembly of unnatural sugars such as 242. Further investigations
into coupling reactions of these substrates are under investigation within the research
group.
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214 242
Reagents and Conditions: i) Pd(PPh3)4, AllylSnBu3, DMF, 100
◦C, 2 d, 52%.
Scheme 2.11 Stille coupling of 2-C -branched sugar 214
2.7 Reactions of Galactose and Xylose
Derivatives
Investigations then moved on to determine if other sugars could also be used to form
2-C -branched sugars. Nagarajan investigated the base–mediated methanolysis of d-
galactose and d-xylose derived cyclopropanes 45 and 243 (Scheme 2.12).45 While
the products obtained were reported to be oxepines, results discussed in section 2.3
suggest these products may actually be 2-C -branched sugars.
Cyclopropanes derived from d-galactose (183) and d-xylose (184) were investigated,
as these offer alternative stereochemical configurations, complementary to d-glucose.
The glycals were prepared as described for d-glucal (185). Thus, peracetylation of
183 and 184, followed by treatment with hydrobromic acid led to α-bromoglycosides
248 and 249 (Scheme 2.13). Reduction in the presence of zinc dust provided tri-O-
acetyl-d-galactal (180) and di-O-acetyl-d-xylal (181). The zinc reduction for the
d-galactose series was performed at 0 ◦C, then allowed to warm to room temper-
ature overnight. This led to formation of tri-O-acetyl-d-galactal (180), which was
used without purification. However, di-O-acetyl-d-xylal (181) was not stable to
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Scheme 2.12 Nagarajan’s reported synthesis of oxepines 244, 245, 246 and 24745
these zinc reduction conditions, which led to the isolation of 181 in very poor yield
(13%). Following literature precedence,110 the reaction was stirred for three hours
at 0 ◦C, then immediately worked up. The crude product required purification by
column chromatography, providing 181 in 38% yield. Further optimisation was not
investigated, though it has been recommended the reduction takes place below 0 ◦C,
or through the use of a Zn/Cu couple, in order to maximise the yield of 181.
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Reagents and Conditions: i) Ac2O, HClO4, 40–50
◦C, 30 min; ii) HBr, AcOH, r.t., 90 min;
iii) Zn, AcOH(aq), 0
◦C to r.t., overnight; iv) NEt3, MeOH(aq), r.t., 90 min; v) NaOMe, MeOH,
r.t. 90 min; vi) BnBr, NaH, DMF, 0 ◦C to r.t., overnight.
Scheme 2.13 Synthesis of galactose– and xylose–based glycals
The corresponding benzylated glycals were obtained by deprotecting the acetylated
glycals, then reacting glycals 186 and 187 under benzylation conditions as described
previously (section 2.2). Galactose–derived 180 was deprotected using triethylamine
in aqueous methanol, then purified from a methanol/acetone/diethyl ether solvent
mixture, to provide d-galactal (186) in 41% yield from d-galactose. Upon per-
benzylation, tri-O-benzyl-d-galactal (43) was obtained in 62% yield (Scheme 2.13).
For the xylal series, purified di-O-acetyl-d-xylal (181) was deprotected to provide
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d-xylal (187) using catalytic sodium methoxide in methanol, then benzylated prior
to purification. Di-O-benzyl-d-xylal (189) was obtained in 66% yield from 181.
Using the modified Ma¸kosza cyclopropanation conditions discussed previously, cy-
clopropanation of 43 provided a single isomer, cyclopropane 45 (Scheme 2.14), in
very good yield (71%). The spectral data matched that reported previously.45 Due
to the large degree of steric crowding upon the β-face of 43, no β-face cyclopropa-
nation was observed. Cyclopropanation of d-xylose–derived glycal 189 provided
separable cyclopropanes 243 and 250 (76% combined yield), in a 4.8:1 (α:β) iso-
lated ratio. While cyclopropanation was not as stereoselective for glycal 189 as
that for tri-O-benzyl-d-glucal (188) or tri-O-benzyl-d-galactal (43), the isolated
ratio indicates carbene addition to the α-face is still favoured. This provides further
evidence that the C-3 stereochemistry (and presumably, the bulk of the attached
protecting group) is a very dominant factor in directing dibromocarbene addition
to glycals.
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Reagents and Conditions: i) CHBr3, TEBAC, NaOH/KF(aq), r.t., 2 d.
Scheme 2.14 Synthesis of galactose– and xylose–based cyclopropanes
With galactal and xylal–derived cyclopropanes 45, 243 and 250 in hand, base–
mediated cyclopropane ring opening was investigated. Cyclopropane 45 underwent
ring opening in the presence of sodium methoxide and methanol to provide bro-
momethylene sugars 251 and 252 (1:3 ratio β:α), in 65% yield (Scheme 2.15).
This reaction was complete after only 40 minutes in refluxing THF, however the
isolated products were inseparable. Additionally, they were not as stable as the
d-glucose analogues 213 and 214. This led to the NMR samples degrading sig-
nificantly in chloroform-d within hours; consequently, full characterisation was not
possible. The NMR data set of this mixture of compounds was consistent with that
obtained by Nagarajan, in the potassium carbonate mediated ring–opening reac-
tion of 45. Through correlations of the NMR data of 251 and 252 with that of
d-glucose–derived sugars 213 and 214, it is believed products 251 and 252 are also
2-C -bromomethylene derivatives (Scheme 2.15).
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Scheme 2.15 Ring opening of galactose–based cyclopropane 45
Ring opening of major d-xylal–derived cyclopropane 243 was also attempted. This
reaction proceeded very efficiently, with full consumption of starting material ob-
served after just 20 minutes at THF reflux. Upon purification by column chromatog-
raphy, the corresponding bromomethylene sugars 253 and 254 (1:5 ratio β:α) were
obtained in 67% yield (Scheme 2.16). Unfortunately, the minor product was iso-
lated with other impurities, and both isolated products degraded in the NMR tube
overnight, providing complicated mixtures of aldehydic products. It may be noted
that this reaction appears to provide both the fastest conversion, possibly due to
the dryness of the methanol used. This reaction also provided the highest anomeric
selectivity of all base–mediated reactions that have been discussed, which implies
the formation of one anomer over the other is not likely influenced by the steric
environment of the substrate. Comparison of the NMR data of these xylose–derived
products with previously isolated 2-C -bromomethylene sugars, indicates products
253 and 254 are also branched pyranoside sugars (Scheme 2.16).
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Scheme 2.16 Ring opening of xylose–based cyclopropane 243
2.8 Summary of Chapter 2
Cyclopropanes derived from glucose, galactose and xylose glycals have been syn-
thesised. The base–mediated ring–opening reaction of cyclopropane 97 has been
thoroughly investigated, and a structure revision has been provided, indicating the
products from this reaction are in fact 2-C -bromomethylene pyranoside sugars 213
and 214. Derivatisations of selected pyranoside sugars have provided valuable in-
sights into the structure and mechanism of formation of these compounds, and also
demonstrate the synthetic utility of these compounds.
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Chapter 3
Silver–Mediated and Thermal
Ring–Opening Reactions
3.1 Introduction
Ring–expansion reactions of gem-dihalocyclopropanes are known to occur through
the use of Lewis acids (such as halophilic silver(I) salts), or the application of heat
(see subsection 1.1.2).9 Nagarajan trialled the use of several such reaction condi-
tions for the ring expansion of cyclopropane 97, with the expectation of forming
heptoseptanoside sugar derivatives (Scheme 3.1).45 All attempts using either silver–
mediated reaction at room temperature or thermal promotion were unsuccessful.
Having determined that basic conditions produced 2-C -branched sugars 213 and
214, it was envisaged that careful analysis of silver–mediated reaction conditions,
and/or the application of heat might provide access to oxepine structures.
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Scheme 3.1 Ring expansion of cyclopropane 97
Silver–mediated cleavage of gem-dihalocyclopropanes can often provide good regio-
chemical control. Cleavage of the fused bond of cyclopropane 97 would lead to a
seven–membered ring pi-allyl cation intermediate, which would react with a nucle-
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ophile to introduce glycoside functionality (due to the directing effect of the pyran
oxygen). Investigations into the synthesis of septanose sugars with the structures
reported, but not synthesised by Nagarajan et al. were then undertaken.45
3.2 Silver–Mediated Ring–Expansion Reactions
in Acetic Acid
Nagarajan observed that treatment of 97 with acetic acid and silver salts at room
temperature did not lead to any reaction.45 This was confirmed after five days reac-
tion at room temperature in the presence of silver acetate. The reaction was repeated
with the addition of sodium acetate; again, no reaction was observed after four days
at room temperature. The initial unsuccessful reactions at room temperature corre-
lated with the stability of cyclopropane 97 when stored at room temperature. This
indicates that the substrate requires harsher reaction conditions than are needed
for related bicycles containing these strained three–membered rings, which has been
observed in similar cases.111
Nagarajan reported that reaction of 97 in refluxing acetic acid or 1,4-dioxane led to
decomposition of the cyclopropane.45 The reaction of cyclopropane 97 with silver
acetate in acetic acid was trialled at various temperatures (Table 3.1), which grati-
fyingly provided oxepines 257 and 258. Reaction at 70 ◦C provided a very modest
yield (entry 2); increasing the temperature to 90 ◦C led to better conversion into
oxepines (entry 3). Optimal reaction conditions were achieved at 100 ◦C, providing
oxepines 257 and 258 in 52% yield, after only 25 hours reaction (entry 4). How-
ever, these oxepines were almost entirely inseparable by column chromatography,
with only a portion of the major oxepine (258) isolated as a single anomer. As
previously reported by Nagarajan,45 reflux in acetic acid led to extensive decompo-
sition, however by halting the reaction once all starting material had been consumed,
a modest amount of oxepines 257 and 258 (15%) was isolated (entry 5).
Acetyl septanoside products are exceedingly useful substrates, as cleavage of the ac-
etate leads to the corresponding hemiacetals, which may be used in other areas, in-
cluding oligosaccharide synthesis; subsequent applications are discussed in chapter 4.
The identity of these oxepines was determined through extensive NMR studies. In
particular a 1H-1H COSY correlation was observed between the olefinic protons
and an oxymethine, indicating connectivity, in contrast to the 2-C -bromomethylene
sugars discussed in chapter 2.
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Table 3.1 Acetic acid–mediated ring–expansions of cyclopropane 97a
O
BnO
BnO
BnO
Br
OAc O
BnO
BnO
BnO
Br
OAc
+
O
OBn
BnO
BnO
H
H
Br
Br
i)
97 257 258
Reagents and Conditions: i) AgOAc, AcOH.
Entry Temperature Time Recovered 97 Yield (257 and 258) Ratio (β:α)
1 r.t. 5 d quantitative 0% -
2 70 ◦C 3 d 10% 27% 1:2.9
3 90 ◦C 36 h 4% 37% 1:3.4
4 100 ◦C 25 h 0% 52% 1:3.8
5 reflux 5 h 0% 15% 1:1.7
aall yields and ratios are of isolated products
An important goal of this research was to investigate the use of only moderate
excesses of various nucleophiles in ring–opening reactions of cyclopropanated sugars.
This was deemed relevant for the synthesis of acetyl glycosides 257 and 258, in
which milder conditions might lead to an improvement in yield. To achieve oxepine
synthesis with a minimum amount of nucleophile, the use of a non–nucleophilic
solvent was required. The results of the silver–mediated reactions involving acetic
acid indicate that temperatures of approximately 100 ◦C are required, which ruled
out the use of many common, low–boiling solvents (under atmospheric pressure).
Toluene was chosen, due to the relatively high boiling point (110–111 ◦C), low
toxicity and low cost of this solvent. Cyclopropane 97 was dissolved in toluene,
treated with silver acetate (1.5 eq.) and sodium acetate (10 eq.), then the reaction
was left to proceed for two days at 100 ◦C. The reaction rate was significantly slower
than acetic acid solvolysis, but a good yield was obtained (53%) (Scheme 3.2), and
a significant portion of starting material was also recovered (22%). In addition,
a small amount of acetylated glycal 259 was observed (5% yield), due to attack
of acetate at C-2 of cyclopropane 97, rather than C-1. This observation was not
entirely unexpected, as nucleophilic attack could occur at either end of the pi-allyl
intermediate derived from the cyclopropane (attack at either C-1 or C-2). The
high selectivity observed for C-1 substitution is due to the participation of the ring
oxygen, which promotes attack at the glycosyl cation (page 3).
O
OBn
BnO
BnO
H
H
Br
Br +
i)
O
BnO
BnO
BnO
Br
OAc
O
BnO
BnO
BnO
Br
OAc
1
2
α-anomer
β-anomer97 257
258
259
Reagents and Conditions: i) AgOAc, NaOAc, toluene, 100 ◦C, 2 d.
Scheme 3.2 Synthesis of acetoxy oxepines 257, 258 and 259
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Repetition of this reaction using only 5 equivalents of sodium acetate at reflux
led to even greater yields after only 28 hours reaction. Presumably, the elevated
temperature allows for faster reactivity, without significant degradation, as observed
in acetic acid. It was very pleasing to obtain oxepines 257 and 258 in 65% yield,
though acetylated glycal 259 was isolated in a significantly greater quantity than in
the previous reaction (14%). Because of the reduced regioselectivity, future reactions
in toluene were performed at 100 ◦C.
3.3 Ring–Expansions of Cyclopropane 97 with
Alternative Nucleophiles
With the development of methodology that provides oxepines in good yield, addi-
tional nucleophiles were sought to extend this chemistry. Initially the conditions
outlined by Nagarajan were followed;45 treatment of cyclopropane 97 with silver
tetrafluoroborate in methanol provided only recovered starting material, in agree-
ment with previously reported observations. Reaction at 40 ◦C led to a small degree
of reaction, as observed by TLC after one day. The temperature was then elevated
to reflux, then stirred for an additional day. Column chromatography provided two
products in a combined yield of 13%. The proton NMR spectra of these two prod-
ucts indicated that they were different from exocyclic bromomethylene sugars 213
and 214, with the olefinic peaks shifted upfield by approximately 0.5 ppm. For each
product, the olefinic peak was observed as a doublet, with a 1H-1H COSY correla-
tion to an oxymethine. This provided further support that these silver–mediated
reactions form the expected oxepines. Attempts to increase the yield through length-
ening the reaction time were unsuccessful. After five days at reflux, oxepines 98 and
99 were isolated in only 15% combined yield (Table 3.2), with a large proportion of
starting material recovered (61%). These results correlate well with those observed
using acetic acid solvolysis, implying that the temperature used is the main deter-
minant of the rate of reaction. Attempts to increase the nucleophilicity of methanol
through the addition of several equivalents of sodium methoxide provided signifi-
cant consumption of starting material in only 16 hours, but as one might expect,
exocyclic bromomethylene sugars 213 and 214 were observed in similar quantity
(22%) to that of oxepines 98 and 99 (17%). Attempts to use higher temperatures,
through the use of pressurised reaction vessels, is discussed in section 3.7.
This methodology was then extended to provide allyl, benzyl and phenyl glycosides
incorporating an oxepine ring (Table 3.2). Solvolysis was employed in the formation
of allyl septanosides, as refluxing allyl alcohol provides a convenient reaction tem-
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perature (96–98 ◦C). Benzyl alcohol and phenol were employed as stoichiometric
nucleophiles. Although both could function as solvents at 100 ◦C, it was antici-
pated that subsequent removal of these high–boiling alcohols would be problematic,
and the use of moderate excesses of these nucleophiles would further demonstrate
the efficiency of this methodology. These alcohols were employed in the synthesis
of additional septanosides, as shown in Table 3.2. For completeness, key results
mentioned in section 3.2 are included too (entries 2–4).
Table 3.2 Ring–expansion of cyclopropane 97 with various nucleophilesa
O
BnO
BnO
BnO
Br
OR O
BnO
BnO
BnO
Br
OR
+
O
OBn
BnO
BnO
H
H
Br
Br
R = MeR = Me
R = AcR = Ac
R = Allyl R = Allyl
R = BnR = Bn
R = PhR = Ph
97 98 99
257 258
260 261
262 263
264 265
Entry Silver Saltb Nucleophile, Solvent Conditions Yield, Products Ratio (β:α)
1 AgOAc 240 eq. MeOH reflux, 5 d 15%, 98, 99 1:2.8
2 AgOAc 170 eq. AcOH 100 ◦C, 25 h 52%, 257, 258 1:3.8
3 AgOAc 9.9 eq. NaOAc 100 ◦C, 2 d 53%, 257, 258 1:3.7
toluene
4 AgOAc 5.1 eq. NaOAc reflux, 2 d 65%, 257, 258 1:3.8
toluene
5 AgOAc 140 eq. AllylOH reflux, 27 h 51%, 260, 261 1.1:1
4%, 258 -
6 AgNO3 140 eq. AllylOH reflux, 29 h 50%, 260, 261 1:1.8
7 AgOAc 5.0 eq. BnOH 100 ◦C, 2 d 45%, 262, 263 1:1.1
toluene 26%, 257, 258 1:4.6
8 AgNO3 5.3 eq. PhOH 100
◦C, 2 d 45%, 264, 265 6.7:1
aall yields and ratios are of isolated products
bbetween 1.1 and 1.5 eq. of silver salt used in all cases
All reaction times provide good comparative indicators of the time required for com-
plete consumption of starting material; these results indicate a two-fold difference
in reaction time between solvolysis and toluene–based reactions is required. Entries
2, 5 and 6 indicate the reaction time under solvolysis conditions appears to be in-
dependent of solvent used. The relatively small amount of nucleophile employed in
entries 3, 7 and 8 shows the required reaction time is not drastically affected by the
reduction in the amount of nucleophile present.
It is quite noteworthy that entries 5 and 7 provided mixtures of different oxepines,
due to the alcohol and silver counterion both participating as nucleophiles. As
one would expect, relative amounts of the different glycosides are dependant on
the relative amounts of nucleophilic silver counterion and the intended nucleophile.
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Hence, the use of silver nitrate eliminated this problem, due to the non–nucleophilic
nature of the nitrate counterion (entries 6 and 8).
The relative ratios of glycoside anomers proved to be exciting, with α-glycosides
predominating. Despite some anomalous results (e.g. entries 5, 6 and 7), in general
the reaction exhibits good anomeric stereoselectivity. This α-glycoside selectivity
also suggests that the ring–expansion reaction might proceed via a concerted mech-
anism, as shown in the red path (Scheme 3.3), rather than a discrete pi-allyl cation
or glycosyl cation such as 266 (black arrows involved in both paths). Formation of
intermediate 266 from cyclopropane 97 (green path) would allow anomeric mixtures
to form, which does not necessarily agree with the observation that the α-anomer
(256) predominates. However, if factors such as the anomeric effect, or steric con-
straints are involved, the route via glycosyl cation 266 could still be the dominant
pathway. It is also of interest that the bulky phenol nucleophile provided the highest
anomeric selectivity, but for the β anomer (entry 8). This disparity might indicate
that reaction with phenol occurs through S
n
2–type stereoinversion, presumably due
to the high degree of bulkiness of this alcohol.
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BnO
BnO
BnO
Br
ORO
OBn
BnO
BnO
H
H
Br
Br
O
BnO
BnO
BnO
Br
O
BnO
BnO
BnO
Br
OR
ROH
ROH
α-anomer
α-anomer
β-anomer
97
255
256
256
266
Scheme 3.3 Mechanism of the ring–expansion reaction of cyclopropane 97
The use of nucleophiles other than alcohols was briefly explored, with little suc-
cess. Attempts to generate amino–functionalised septanosides with benzylamine
and silver nitrate surprisingly led to the previously obtained benzyl O-glycosides
262 and 263, albeit in very low yield (15%). This was possibly due to loss of
benzyl protecting groups, and subsequent attack of the benzyl alcohol obtained.
TLC evidence indicated some deprotection of the material; peaks attributed to ben-
zyl alcohol and benzaldehyde were observed in the crude proton NMR spectrum.
Use of cyclohexylamine led to very complicated mixtures, none of which were able
to be characterised. The anion of Meldrum’s acid was also used, in the hope that
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C -glycosyl sugars could be accessed. Unfortunately, this reaction provided low mass
recovery. A small amount of acetate oxepines 257 and 258 (7% combined yield)
was isolated, due to interception of the silver counterion. Bicyclic acetal 267 was
isolated from the same reaction in 13% yield, which arose from intramolecular nucle-
ophilic attack of the C-6 benzyloxy group of the starting material (Scheme 3.4).112
It is likely the bulk of Meldrum’s acid was too great to access the cyclopropane,
which therefore allowed intramolecular cyclisation to occur. The preference for the
C-6 substituent as nucleophile is supported by the fact that no other bicyclic acetals
were observed. It is likely the relative distance and configurations of the other ben-
zyl ethers attached to C-3 and C-4, precluded these substituents from participating
in the reaction. It is likely, that upon silver–mediated ring opening of 97, the C-6
benzyloxy substituent attacks the C-1 glycosyl cation. This provides an intermedi-
ate oxonium species (268), which could eject a benzylic cation, presumably through
displacement by acetate ion. Fraser–Reid has reported similar reactivity, involving
attack of a benzyl ether group upon an electrophilic centre, leading to subsequent
loss of a benzylic cation, as proposed in Scheme 3.4.113
i) O
BnO
BnO
Br
OO
OBn
BnO
H
H
Br
Br
BnO
4
6
3
O
BnO
BnO
Br
O
Bn
1
97 268 267
Reagents and Conditions: i) AgOAc, Meldrum’s Acid, NaH, DMF, 100 ◦C, 2 d, 13%.
Scheme 3.4 Synthesis of bicyclic acetal 267
The complete lack of participation of anionic Meldrum’s acid was quite disappoint-
ing, as it appears to fail to provide either 2-C -bromomethylene pyranoside sugars un-
der basic conditions (page 49), or C -functionalised oxepines under silver–mediated
conditions. While further study of carbon nucleophiles is warranted, these observa-
tions imply that departure from oxygen nucleophiles may provide limited success.
3.4 Scope of Oxepine Synthesis
Alternative oxepine formation conditions were explored, in order to provide further
information in regards to the ring–expansion reaction. An early attempt to syn-
thesise allyl alcohol–based pyranoside products 236 and 237 (see section 2.5), used
potassium carbonate, which led to a combination of pyranoside sugars 236 and 237
(41%) and oxepines 260 and 261 (11%) after 11 hours at reflux (Scheme 3.5). It
is presumed that the basicity of the reaction was not sufficient to override the com-
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peting thermal process, yet the use of refluxing allyl alcohol was enough to ensure
some material underwent ring expansion to the observed oxepine products. In con-
trast, when sodium allyloxide was employed, exclusive formation of 2-C -branched
products was observed. However, the formation of oxepines 260 and 261 even in
the absence of a silver salt implies oxepine formation from cyclopropane 97 may be
a thermally induced process.
i)
O
BnO
BnO
BnO
Br
O
+
O
OBn
BnO
BnO
H
H
Br
Br
O
OBn
BnO
BnO
Br
O
H
97 260, 261236, 237
Reagents and Conditions: i) K2CO3, AllylOH, reflux, 11 h, 52%.
Scheme 3.5 Synthesis of 2-C -branched sugars and oxepines
To determine if ring expansion was due to the presence of silver ion or the tempera-
tures employed, a ring–expansion reaction of 97 with sodium acetate in toluene was
performed. Consumption of starting material occurred within two days, as previ-
ously observed. However, after purification, mass recovery was low, with oxepines
257 and 258 obtained in only 18% yield, in addition to minor amounts of unidenti-
fied products (Table 3.3, entry 2). For comparison, the previous reaction with silver
acetate and sodium acetate is detailed in entry 1.
Table 3.3 Miscellaneous ring–expansions of cyclopropane 97a
O
BnO
BnO
BnO
Br
OAcO
OBn
BnO
BnO
H
H
Br
Br
O
BnO
BnO
Br
O
α-anomer
β-anomer
or
97 257
258
267
Entry Silver Saltb Nucleophile, Solvent Conditions Yield, Products Ratio (β:α)
1 AgOAc 9.9 eq. NaOAc 100 ◦C, 2 d 53%, 257, 258 1:3.7
toluene
2 - 5.0 eq. NaOAc 100 ◦C, 2 d 18%, 257, 258 1:2.1
toluene
3 AgOAc 5.3 eq. NaOAc 100 ◦C, 2 d 49%, 257, 258 1.2:1
DMF
4 AgOAc - 100 ◦C, 22 h 38%, 267 -
toluene
aall yields and ratios are of isolated products
bbetween 1.2 and 1.5 eq. of silver salt, if used
Use of an alternative solvent was also explored. Good conversion of cyclopropane
97 was achieved in DMF, providing oxepines 257 and 258 (49% yield), though
two days reaction was still required (entry 3). However, the anomeric ratio had
changed dramatically from approximately 3.5:1 in favour of α-anomer 258, to only
1.2:1 in favour of β-anomer 257 (Table 3.3). These observations indicate the choice
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of solvent has minimal influence upon the rate of reaction, but may dramatically
reduce the anomeric stereoselectivity previously seen.
An investigation into the behaviour of cyclopropane 97 in the absence of added nu-
cleophile was explored. Thus, a solution of 97 and silver acetate in toluene was re-
fluxed for 22 hours (entry 4). Upon purification of the complicated mixture obtained,
bicyclic acetal 267 was obtained in 38% yield, with no acetate–derived oxepines ob-
served (Table 3.3). Benzyl acetate was present in the proton NMR spectrum of the
crude product. This result indicates that, when the intermolecular nucleophile is
present in low concentration, internal attack by an appropriate benzyloxy group is
preferred.
The oxepine formation reaction appears to be dependant on temperature, yet has no
significant rate dependence on solvent, nucleophile or silver salt used. It appears that
effective ring expansion often requires addition of a silver salt to aid cyclopropane
ring cleavage, otherwise low yields are obtained. Furthermore, as the majority of
oxepine syntheses were regioselective, participation of the glycosyl cation interme-
diate is likely. Substitution at C-2 of cyclopropane 97, which provided glycal 259,
was only observed when acetate was used.
3.5 Oxepines Derived from Galactose and Xylose
The ring expansions of d-galactose and d-xylose–derived cyclopropanes 45 and
243 were briefly investigated. Optimised methodology from the d-glucose series
(Table 3.2, entries 3 and 4) was employed, using approximately 1.5 equivalents of
silver acetate and 5 equivalents of sodium acetate in toluene at 100 ◦C.
Galactose–derived cyclopropane 45 was successfully ring–expanded using these con-
ditions, providing oxepine 269 in 52% yield, with the corresponding β-anomer not
observed (Scheme 3.6). The isolation of a single anomer was very pleasing, demon-
strating the ability of this methodology to provide anomeric selectivity. Additionally,
bicyclic acetal 270 was isolated in 7% yield, presumably formed via intramolecular
nucleophilic attack of the C-4 benzyloxy substituent, providing a bicyclo[3.2.1]octane
skeleton. It is likely the other two benzyloxy substituents at C-3 and C-6 of cyclo-
propane 45 would lie in a pseudo-equatorial conformation, which would lead to the
C-4 benzyloxy substituent oriented in a pseudo-axial conformation. The C-4 oxy-
gen would therefore be in close proximity to the cyclopropane and could provide
competitive nucleophilic attack. This reactivity was observed earlier (pages 60 and
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62) with silver–mediated ring–opening of d-glucal–derived cyclopropane 97 in the
absence an appropriate nucleophile.
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45 269 270
Reagents and Conditions: i) AgOAc, NaOAc, toluene, 100 ◦C, 2 d.
Scheme 3.6 Formation of galactose–derived oxepine 269
Xylose–derived cyclopropane 243 was also subjected to ring–expansion reaction
conditions, providing a mixture of oxepines 271 and 272 (1:1 anomeric ratio)
(Scheme 3.7). While the lack of anomeric selectivity was disappointing, this might
be due to a lack of significant steric bulk near C-1, the centre of nucleophilic attack.
O
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OAc O
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243 271 272
Reagents and Conditions: i) AgOAc, NaOAc, toluene, 100 ◦C, 2 d, 45%.
Scheme 3.7 Formation of xylose–derived oxepines 271 and 272
Due to the selective formation of galactose–derived oxepine 269, it appears likely
that the steric environment of cyclopropane 45 has controlled the anomeric stere-
oselectivity to some extent. This was also implied in the ring expansion of xylose–
derived cyclopropane 243, which provided approximately equal amounts of oxepines
271 and 272, presumably due to the lack of steric bulk.
3.6 Oxepine Derivatisation Reactions
Previously, 2-C -branched methyl glycoside pyranoside sugar 214 was subjected to
lithium–halogen exchange, which upon quenching with water, provided an exocyclic
methylene at C-2. To confirm unequivocally the structure of the above silver–
mediated oxepine products, allyl glycoside 261 was subjected to a similar reaction,
as shown in Scheme 3.8. This reaction provided oxepine 273 in 34% yield as the
only observed product, with the 2,3-olefin exhibiting two separate peaks in the
proton NMR spectrum. These proton resonances coupled with a coupling constant
of 12.0 Hz, as one would expect for a 1,2-cis-disubstituted olefin. A 1H-1H COSY
correlation between H-3 and H-4 was observed, in addition to a two bond HMBC
correlation between C-1 and H-2 was also seen. This provides further evidence that
seven–membered rings have indeed been formed in these reactions.
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Reagents and Conditions: i) n-BuLi, THF, −78 ◦C, 1 h; ii) H2O, −78
◦C to r.t., 30 min, 34%
over 2 steps.
Scheme 3.8 Lithium–halogen exchange of allyl oxepine 261
Allyl glycoside 261 underwent an intramolecular Heck reaction114 to afford bi-
cycle 274 in 47% yield (Scheme 3.9), in addition to recovered starting material
(20%). This reaction highlights the synthetic utility of the alkenyl bromide moi-
ety obtained through cyclopropane ring–expansion methodology. Furthermore, the
synthesis of bicyclic acetal 274 demonstrates the potential of this chemistry for
generating complex structures, of relevance to natural product synthesis.115 The
furano[2,3-b]oxepine bicycle is indeed present in several natural products, including
azadirachtin,116 dysoxyhainanin A,117 and fabianane.118
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261 274
Reagents and Conditions: i) Pd(OAc)2, PPh3, NEt3, THF, reflux, 1 d, 47%.
Scheme 3.9 Heck cyclisation of allyl oxepine 261
3.7 Synthesis of Furanosyl Sugars
The silver–mediated syntheses of oxepines occasionally provided additional prod-
ucts, which were initially overlooked. These reactions occurred under very similar
conditions to the successful oxepine syntheses, with no differences evident. Complex
mixtures of products were obtained in these cases, with proton NMR analysis of the
crude reaction mixtures indicating the presence of unknown products, occasionally
in addition to the previously discussed oxepine derivatives. The first conclusive
determination of these unusual structures occurred in a final attempt to produce
methyl septanosides 98 and 99 under pressure.
As explained earlier, oxepine formation in refluxing methanol provided minimal re-
activity due to the limiting reaction temperature. Later reactions with alternative
nucleophiles at 100 ◦C provided efficient conversion of cyclopropane 97 into oxepines.
A microwave reactor allows reactions to proceed at higher temperatures and pres-
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sures within sealed reaction vessels, and might also aid reaction due to microwave
irradiation.119 The possibility of performing a ring–expansion reaction in methanol
at elevated temperatures through the use of microwave heating and a sealed pressure
vessel was therefore explored.
Initially, a thermal ring–expansion reaction was attempted by simply heating a so-
lution of cyclopropane 97 in methanol to a temperature of 130 ◦C. The microwave
reaction vessel reached a pressure of approximately 8 bar during this reaction. The
high temperature provided rapid consumption of starting material, within a total
reaction time of one hour at 130 ◦C. Upon purification by column chromatogra-
phy, three sugars incorporating a furan ring were isolated in 74% combined yield
(Scheme 3.10). This included isomeric dimethyl acetals 275 and 276 (61% com-
bined yield), in addition to methyl vinyl ether 277 (13%), a structural isomer of the
expected oxepines. The stereochemistries at C-2 and C-3 of 275 and 276, and C-3
of 277 were not determined, as implied in the structures shown.
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Reagents and Conditions: i) MeOH, 130 ◦C, 1 h.
Scheme 3.10 Formation of methylated C -furanosyl sugars 275, 276 and 277
Microwave reaction in the presence of silver salts was then attempted. Performing
the reaction at 100 ◦C provided significantly lower reactivity, with approximately
60% material consumed after 110 minutes reaction. Excluding starting material, all
peaks observed in the NMR spectrum of the crude reaction mixture corresponded to
furanosyl products 275, 276 and 277. Repeating this reaction for a period of only
10 minutes provided a minor amount of oxepines 98 and 99 in 4% combined yield,
with traces of furanosyl products 275 and 277 observed by TLC. This implied the
furanosyl products were formed via oxepines 98 and 99. It was later confirmed that
this chemistry was not limited to microwave–mediated reactions. One attempt at
forming methanol–derived oxepines 98 and 99 via silver–mediated reaction at reflux
for three days led to recovery of starting material (26%) in addition to furanosyl
acetals 275 (9%) and 276 (22%). Microwave reaction provides more efficient reac-
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tivity, due to the elevated temperatures one may access; consequently the reaction
mixtures are often cleaner, as judged by proton NMR analysis of the crude products.
These results indicate the presence of silver ion is not essential for conversion into
oxepines or furanosyl products, but still might facilitate the reaction.
This unusual chemistry was not limited to methanol solvolysis. A solution of cy-
clopropane 97 in refluxing allyl alcohol led to the formation of allylated furanosyl
sugars 278, 279 and 280 in 57% combined yield (Scheme 3.11) as the only isolated
products. This was also observed under silver–mediated conditions using either
silver nitrate or silver trifluoroacetate in allyl alcohol.
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Scheme 3.11 Formation of allylated C -furanosyl sugars 278, 279 and 280
Intrigued by the presence of these methanol and allyl alcohol–derived furanosyl sug-
ars, further analysis of this reaction and the obtained products was warranted. To
confirm the identity of bromoalkene 280 treatment with n-butyllithium was followed
by addition of water, which provided 1,2-disubstituted alkene 281 (Scheme 3.12).
Starting material 280 was not completely consumed, therefore purification was not
attempted. The proton NMR spectrum of the crude reaction mixture displayed a
peak at δH 6.53 ppm corresponding to H-1, with a coupling constant of 12.5 Hz. This
coupling constant is indicative of a trans-configuration for an enol ether moiety,120
which implies that the bromine and alkyloxy substituents are in a cis-relationship.
i), ii)O
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Reagents and Conditions: i) n-BuLi, THF, −78 ◦C, 30 min; ii) H2O, −78
◦C to r.t., 30 min.
Scheme 3.12 Lithium–halogen exchange of bromoalkene 280
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It was observed earlier that silver–mediated microwave reaction provided trace
amounts of oxepine sugars after ten minutes; further reaction provided only fura-
nosyl products. From these results it is believed the furanosyl products are obtained
via oxepines 98 and 99. To confirm this, a sample of purified allyl alcohol–derived
oxepine 261 was subjected to silver nitrate in allyl alcohol. After one day at reflux,
a complex mixture of furanosyl products was obtained, with only a trace of start-
ing material observed in the crude proton NMR spectrum. This indicates that the
furanosyl sugars are formed from the corresponding oxepines.
While this reactivity has been observed in multiple runs of methanol and allyl al-
cohol solvolysis, no furanosyl sugars were observed with reactions involving sodium
acetate. Furthermore, oxepine formation from cyclopropanes involves production of
both silver bromide and the protonated counterion (nitric or tetrafluoroboric acid).
These latter species will acidify the reaction, whereas reactions involving sodium ac-
etate will do so to a lesser extent. The acid-sensitive acetal functionality of the target
oxepines could be activated under such conditions, which might lead to furanosyl
sugar formation.
Attempts to deduce the mechanism of formation of these unexpected C -furanosyl
products from the corresponding oxepines, have led to consideration of several mech-
anisms as outlined in Scheme 3.13. The dark–blue path proposes that under the
acidic conditions of the reaction, if wet, the acetal moiety of generic oxepines 255
and 256 might be hydrolysed to form the reducing sugar 282. This could undergo
an intramolecular 1,4-addition to provide enol 283. Tautomerisation to aldehyde
284, followed by acid–catalysed acetal formation would provide acetal 285. This
route however does not explain the formation of alkene 286. The green path in-
volves acid–catalysed decomposition of the cyclic acetal to oxonium ion 287. This
activated intermediate could undergo intramolecular 1,4-addition to provide fura-
nosyl sugar 286, likely favoured due to the formation of a stable five–membered
ring. Finally, the red path involves a concerted mechanism, wherein the oxepine
ring oxygen could attack the alkene at C-3, forming a new 1,2-olefinic bond. This
could lead to cleavage of the carbon–oxygen bond at C-1, which would provide 286.
The formation of furanosyl acetals (285) from 286 is believed to occur through acid–
catalysed addition of a second equivalent of nucleophile to the enol ether moiety of
bromoalkene 286.
All paths shown involve formation of the 1,2-olefinic bond in which the alkoxy- and
bromo- substituents of these carbons are likely to be in a cis- relationship, providing
alkene 286 with the observed stereochemistry. Upon generation of alkene 286, acid–
catalysed addition of a second equivalent would provide the corresponding acetals
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Scheme 3.13 Mechanism of conversion from oxepines into furanosyl products
shown as 285. The dark–blue path involves acid–catalysed acetal decomposition,
due to the acidic reaction conditions. The formation of 282 is possible if water is
present; which could be due to slightly wet solvents. Alternatively, the green path
involves an intermediate one would expect in acetal decomposition, namely cation
287. Without loss of the alkyloxy group, it is possible for the conjugate cyclisation to
occur, which would in turn quench the carbocation, providing alkene 286. The red
path appears to be an unlikely mechanism, as the propensity for this rearrangement
(either concerted or stepwise), is not very convincing. The green path is presumably
the most likely; even though it is possible the 1,2-bond might rotate (to provide the
(E )-isomer of alkene 286), it is likely 287 is a highly reactive intermediate. It was
thought that reaction in a less acidic environment would suppress formation of these
furanosyl derivatives. Unfortunately, the use of silver carbonate failed to alleviate
this problem; reaction of cyclopropane 97 in the presence of 1.5 equivalents of silver
carbonate led to a complex mixture of furanosyl sugars, with no evidence of oxepine
products formed.
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3.8 Summary of Chapter 3
Through careful examination of methanol and acetic acid solvolysis reactions, silver–
mediated oxepine synthesis from cyclopropane 97 has been achieved. This method-
ology has been extended to include a number of alcohols, whereas reactions involving
carbon– and nitrogen–based nucleophiles met with limited success. Analysis of the
reaction through variation of the solvent, nucleophile and silver salt has also been
achieved. Furthermore, unexpected furanosyl sugars have been obtained through
silver(I)–mediated and thermal reactions, which are believed to occur as a result of
the acid-sensitivity of the glycoside functionality in the oxepine derivatives, and the
stability of the resulting five–membered rings. No distinction between reactions pro-
viding either exclusively oxepine–derived or furan–derived products was observed.
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Chapter 4
Galactose and Xylose–Based
Approaches to (−)-TAN-2483B
4.1 Introduction
The versatile methodology described in chapters 2 and 3 for the synthesis and sub-
sequent ring–opening of gem-dihalocyclopropanated sugars shows excellent poten-
tial for use in complex synthetic routes. The functionality obtained through this
methodology could find application in the synthesis of biologically active natural
products.13 Synthesis of the natural product (−)-TAN-2483B,82,87,88 isolated from a
Japanese fungus, appeared amenable to such chemistry. The synthesis of this nat-
ural product would demonstrate the utility of cyclopropane chemistry, and provide
the first total synthesis of this biologically relevant compound. The stereochemical
configurations at positions C-2 and C-3 of (−)-TAN-2483B (154) correlate well with
the stereochemistry of d-galactose (page 33). A synthetic route to (−)-TAN-2483B
could involve the following sequence (Scheme 4.1).
Beginning from commercially available tri-O-acetyl-d-galactal (180), Ferrier rear-
rangement27 in the presence of thiophenol would afford the known 2,3-unsaturated
sugar 289 (Scheme 4.1).121–123 Deprotection and reprotection would be required to
install the p-methoxybenzylidene protecting group, which may be selectively depro-
tected at C-6. The resulting alkene (290) could subsequently undergo cyclopropa-
nation, which would likely occur preferentially from the α-face; upon deprotection
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Reagents and Conditions: i) PhSH, FeCl3, CH2Cl2, r.t.; ii) NaOMe, MeOH, r.t.;
iii) PMPCH(OMe)2, CSA, DMF, r.t.; iv) CHBr3, TEBAC, NaOH/KF(aq), r.t.; v) NBS,
Acetone(aq), r.t.; vi) AgBF4; vii) MeMgBr; viii) Pd(PPh3)4, CO, NEt3; ix) DIBAL-H;
x) TEMPO, BAIB; xi) 5-ethylsulfonyl-1-phenyl-1H -tetrazole, KHMDS, DME; xii) DDQ.
Scheme 4.1 Proposed synthesis of (−)-TAN-2483B
at the anomeric position, cyclopropyl carbohydrate 291 would be obtained. An
equilibrium should then exist in solution between 291 and the ring–opened form
292. A key reaction of this route involves the subsequent intramolecular nucle-
ophilic attack via silver–promoted ring–opening of cyclopropane 292. A potential
pitfall is the likely propensity for ring opening to form the transoid - allylic cation,
as this intermediate would be acyclic. Nonetheless, it is possible that intramolecular
nucleophilic attack might be concerted with the electrocyclic ring opening, which
would provide the intended product 293. It was envisaged the resulting C -glycosyl
product (293) could then be methylated under chelation–controlled conditions to
form alcohol 294 stereoselectively. Palladium-catalysed carbonylation and lacton-
isation should afford advanced intermediate 195, which incorporates the bicyclic
ring system of (−)-TAN-2483B. Selective deprotection of the p-methoxybenzylidene
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group and oxidation of the primary alcohol might be used to afford aldehyde 295.
Finally, Julia–Kocienski olefination124,125 to append the sidechain (296), followed
by deprotection, would provide (−)-TAN-2483B (154), completing the first total
synthesis of this natural product.
4.2 Synthesis and Cyclopropanations of
2,3-Unsaturated Sugar 290
The p-methoxybenzylidene group was chosen for the protection of the C-4 and C-6
hydroxyls of galactal derivatives, as it was expected to be stable to future reac-
tions, such as the alkaline Ma¸kosza cyclopropanation. This protecting group can
be selectively cleaved at the C-6 hydroxyl using sodium cyanoborohydride, leaving
a p-methoxybenzyl ether at C-4.90 Unfortunately, this acid–sensitive acetal pre-
cludes the use of an alcohol in the Ferrier rearrangement, as the resulting glycoside
would require acidic deprotection. Thiophenol would generate the corresponding
S -thioglycoside, which could be deprotected with NBS or NIS, avoiding the use of
acidic media.
Formation of the required 2,3-unsaturated sugar 290 was attempted as described in
Scheme 4.2. Purified tri-O-acetyl-d-galactal (180) was obtained in 52% yield from
d-galactose. This glycal was then subjected to a Ferrier rearrangement with thio-
phenol,27 using a catalytic amount of iron(III) trichloride.122 Ferrier rearrangement
usually provides α-glycosides as the major product,123 which in this case provided
289 in 46% yield. Unfortunately, the low yield was due to the presence of impurities,
notably the corresponding S -β-glycoside 297, and what is believed to be glycal 298,
which could arise from S
n
2 substitution of the C-3, acetoxy group by thiophenol,
or most likely attack of thiophenol upon intermediate 299 at C-3 rather than C-1.
Neither of these products were investigated further, though analogous compounds
have been reported by Ferrier from the reaction of thiophenol with tri-O-acetyl-d-
glucal.121
With 2,3-unsaturated carbohydrate 289 in hand, a deprotection/reprotection se-
quence was utilised, to provide a substrate suitable for Ma¸kosza cyclopropanation.
Thus, diacetate 289 was hydrolysed using freshly prepared sodium methoxide in
methanol to provide diol 300 in near–quantitative yield (Scheme 4.3). This diol
was protected as a p-methoxybenzylidene acetal, through treatment with anisalde-
hyde dimethyl acetal and a catalytic amount of camphorsulfonic acid, to provide
2,3-unsaturated carbohydrate 290 in 16% yield over six steps from d-galactose.
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Scheme 4.2 Synthesis of thioglycoside 289
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Scheme 4.3 Synthesis of galactose–based substrate 290
Cyclopropanation of alkene 290 was then attempted. Unfortunately, a variety of
gem-dihalocyclopropanation procedures failed to provide the desired cyclopropyl
adducts. Initially alkene 290 was reacted in the presence of bromoform, the phase
transfer catalyst TEBAC, and an aqueous solution of potassium fluoride and sodium
hydroxide. No reaction was observed after eight days, which provided almost com-
plete recovery of starting material. Nagarajan has reported that dichlorocarbene–
mediated Ma¸kosza cyclopropanation of glycals was successful with 50% aqueous
sodium hydroxide,45 therefore this was emulated with substrate 290. Rapid con-
sumption of starting material was observed, though mass recovery was low. The
only identifiable product appeared to be a glycal (approximate yield 15%), proba-
bly formed through a retro–Ferrier rearrangement, as loss of the thiophenyl group
was observed. Possibly this arose due to attack of chloride ion at C-3, though this
compound was not identified. Finally, cyclopropanation with anhydrous potassium
tert-butoxide and bromoform was attempted;126 this provided no observable reaction
after several days.
The lack of reactivity under Ma¸kosza cyclopropanation was presumed to be a result
of steric hindrance; the p-methoxybenzylidene acetal group blocks one face of alkene
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290, the thiophenyl group the other. Unfortunately, as the Ferrier rearrangement
forms predominantly α-glycosides, preparation of a less sterically-hindered substrate
was required.
4.3 Synthesis of Alternative 2,3-Unsaturated
Carbohydrates
Epimerisation of the anomeric thiophenyl group might aid cyclopropanation, as the
lower face of the substrate would be much more accessible to carbene addition.
Thus, thioglycoside 290 was treated with n-butyllithium and quenched with wa-
ter, in the hope epimerisation would occur. Unfortunately, this provided alcohol
301 (50%) and diene 302 (25%) in addition to unreacted starting material (37%)
(Scheme 4.4). A degradation reaction had evidently taken place, presumably aided
by the high conjugation of α, β, γ, δ-unsaturated ester 302. Diene 302 must there-
fore be derived from the carbon backbone of alkene 290. Mechanistically, it appears
that anisaldehyde was ejected from olefin 290, upon which the anisaldehyde would
have been attacked by n-butyllithium to provide 301. Similar reactivity has been
observed previously in the reaction of a related substrate with n-butyllithium, pro-
viding a stereoisomer of diene 302.127
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Reagents and Conditions: i) n-BuLi, THF, −78 ◦C, 1 h.
Scheme 4.4 Unsuccessful epimerisation of 290
The synthesis of other 2,3-unsaturated sugars with reduced steric bulk on the (bot-
tom) α-face was then pursued. Initially, a thiophenol–mediated allylic rearrange-
ment of glycal 180 was attempted, through palladium, rather than Lewis acid catal-
ysis. It was thought that the palladium would complex to the α-face due to the ori-
entation of the C-3 acetoxy group, to form a palladium-pi-allyl complex. This would
cause thiophenol attack at the more accessible β-face.128 Unfortunately, the use of
either Pd(PPh3)4 or PdCl2(dppf) ·CH2Cl2 led to no observed reactivity, possibly due
to catalyst poisoning in the presence of thiophenol. Changing the nucleophile to ei-
ther sodium acetate or p-methoxybenzyl alcohol also failed to show any reactivity,
indicating this palladium–mediated allylic rearrangement was not be feasible.
It was thought this palladium–catalysed allylic rearrangement would be aided by
a better leaving group at C-3. Reaction of d-galactal with anisaldehyde dimethyl
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acetal was catalysed with the mildly acidic salt PPTS (Scheme 4.5). Upon ob-
taining glycal 303, a carbonate group was installed at C-3 through reaction with
methyl chloroformate, to provide glycal 304. No attempts were made to optimise
the low yields obtained in both these reactions. A palladium–mediated Ferrier re-
arrangement was then attempted, using p-methoxybenzyl alcohol. This once again
demonstrated no significant reactivity, with starting material predominating in the
crude reaction mixture. No evidence of the required 2,3-unsaturated sugars was
observed.
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Reagents and Conditions: i) PMPCH(OMe)2, PPTS, MeCN, r.t., 4 h, 31%; ii) MeOCOCl, NaH,
DMF, r.t., overnight, 19%.
Scheme 4.5 Synthesis of carbonate 304
Alternative means of obtaining 2,3-unsaturated substrates were then investigated.
It has been reported that the use of ammonium heptamolybdate in glycal isomeri-
sation may provide access to 2,3-unsaturated sugars.129 This reaction was carried
out in acetic anhydride, and proceeded very quickly: after 30 minutes a complicated
mixture of sugars was obtained. The only separable products were the C-3 epimeric
gulose derivative 305 (8%) (Scheme 4.6), and the desired 2,3-unsaturated carbohy-
drate 306 in 10% yield. Allylic acetate 306 was determined to be the β anomer
through observation of nOe correlations between H-1 and H-5. Due to the low mass
recovery of this reaction, this chemistry was not pursued.
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Scheme 4.6 Isomerisation of 180
The hydrolysis of acetylated glycals has been reported previously.130 Fraser–Reid
and Tam propose that equilibration provides multiple products, including both 2,3-
unsaturated sugars, and ring–opened aldehydic derivatives. A 2,3-unsaturated hemi-
acetal could provide access to an appropriate cyclopropanation substrate, through
subsequent β-selective glycosylation. Glycal 180 was refluxed in water for 100 min-
utes, during which most of the starting material was consumed (16% recovered).
Desired 2,3-unsaturated carbohydrate 307 was obtained in 36% yield, in addition
to an unidentified mixture of aldehydic products, presumed to be 308 and corre-
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sponding isomers arising from acetate migration (Scheme 4.7). Aldehydes such as
308 are likely to arise through isomerisation of the olefin of 307 when in the ring
opened form, and might explain why Fischer named d-glucal with the -al suffix.131
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Scheme 4.7 Hydrolysis of glycal 180
Reducing sugar 307 required conversion into a β-glycoside before cyclopropanation
could be attempted. Formation of the trichloroacetimidate derivative 309 was at-
tempted, as outlined below (Scheme 4.8). A solution of sugar 307 was dissolved in
dichloromethane, then treated successively with DBU and trichloroacetonitrile. Un-
fortunately, no reaction was observed after overnight reaction at room temperature.
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Reagents and Conditions: i) DBU, Cl3CCN, CH2Cl2, r.t., 0%.
Scheme 4.8 Formation of trichloroacetimidate 309
The above discussion has shown that the desired 2,3-unsaturated sugars are difficult
to synthesise and, when obtained, are generally quite unreactive to cyclopropana-
tion conditions. As observed in chapter 2, glycals 188, 43 and 189, which have
less sterically hindered alkenes than 2,3-unsaturated glycosides (such as 290), still
required long reaction times to achieve cyclopropanation. Therefore, it was decided
that the synthesis of (−)-TAN-2483B would not be readily achieved using the above
methodologies, hence alternative strategies were pursued.
4.4 p-Methoxybenzyl–Protected Xylal Route to
(−)-TAN-2483B
It was thought that cyclopropanation of an appropriate glycal could be employed in
the synthesis of (−)-TAN-2483B. The stereochemical configurations at C-3 and C-4
of d-xylal match those at C-2 and C-3 of (−)-TAN-2483B. A retrosynthetic scheme
illustrating how a protected d-xylal–derived oxepine could provide the necessary
requirements has been presented earlier (page 34). A more detailed synopsis of the
proposed d-xylal–based synthesis of (−)-TAN-2483B is shown below (Scheme 4.9).
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x) deprotection; xi) NaH, THF, r.t.; xii) Pd(PPh3)4, CO, NEt3.
Scheme 4.9 Proposed xylose–based synthesis of (−)-TAN-2483B
Protected d-xylal–derived oxepines (203) are accessible from di-O-acetyl-d-xylal
(181) through a four step sequence involving deprotection, reprotection, cyclo-
propanation and silver–mediated ring expansion (see sections 2.7 and 3.5). De-
protection of the anomeric acetate would provide sugar 310, which would be in
equilibrium with the ring–opened form 311. A Wittig reaction might provide diene
202, then the sidechain of (−)-TAN-2483B could be obtained through oxidation
and Julia–Kocienski olefination to provide triene 201. This triene might be selec-
tively epoxidised through the use of (R,R)-Jacobsen’s catalyst (313) (Figure 4.1).91
This reaction is selective for cis-alkenes, and would hopefully provide epoxidation
predominantly on the top face of triene 201. Deprotection to form diol 312 could
be followed by cyclisation through treatment with base. This would provide either
the desired pyran derivative 200 through attack of the C-7 alcohol, or the undesired
furan derivative if the C-6 alcohol attacks the epoxide. If the former cyclisation oc-
curs, a palladium–catalysed carbonylation and lactonisation sequence would provide
(−)-TAN-2483B (154).
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Figure 4.1 (R,R)-Jacobsen’s catalyst91
The p-methoxybenzyl protecting group is stable to a variety conditions, and may
be cleaved through reaction with DDQ, whereas standard debenzylation conditions
(Pd/C, H2) are likely to hydrogenate the double bonds present in the skeleton of
the relevant intermediate. Di-O-(p-methoxybenzyl)-d-xylal (314) was synthesised
from glycal 181 through sodium methoxide–based deprotection, then successive
treatment with sodium hydride and p-methoxybenzyl chloride (Scheme 4.10).
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Reagents and Conditions: i) NaOMe, MeOH, r.t. 1 h; ii) PMBCl, NaH, DMF, 0 ◦C to r.t.,
overnight, 40% over 2 steps; iii) CHBr3, TEBAC, NaOH/KF(aq), r.t., 1 d, 30%.
Scheme 4.10 Synthesis and cyclopropanation of xylose–based glycal 314
Cyclopropanation of glycal 314 was then attempted, using modified Ma¸kosza con-
ditions. After one day the starting material had been consumed, providing cyclo-
propanes 315 and 316 in 30% yield (3.2:1 ratio as determined from the crude proton
NMR spectrum). The xylal skeleton favours carbene addition from the α-face, as
seen in the cyclopropanation of the benzyl analogue 189, which provided a simi-
lar ratio of cyclopropanes (4.8:1). The low yield obtained was presumably due to
degradation of material, as low–polarity spots were observed upon TLC analysis of
the reaction mixture.
Major cyclopropane 315 was then subjected to silver–mediated ring expansion, us-
ing methodology developed earlier (described in section 3.2). Thus, a solution of
cyclopropane 315 in acetic acid was treated with silver acetate, then allowed to
react at 100 ◦C for two days. The major product obtained from this reaction was
neither of the expected acetates 317 and 318, but bicyclic acetal 319, isolated in
40% yield (Scheme 4.11).
78
i)
O
PMBO
OPMB
Br
Br
O
PMBO
Br
O
O
PMBO
PMBO
Br
OAcH
H
α-anomer
β-anomer
315 319 317
318
Reagents and Conditions: i) AgOAc, AcOH, 100 ◦C, 2 d, 41%.
Scheme 4.11 Unsuccessful ring–expansion of cyclopropane 315
The appearance of compound 319 was not entirely unexpected, as previously dis-
cussed reactions have also exhibited similar behaviour. However, this particular reac-
tion was noteworthy, as no acetyl glycosides were observed, even though there was a
solvolytic amount of acetic acid available to participate as the nucleophile. The high
propensity for intramolecular nucleophilic attack suggests that the p-methoxybenzyl
group is too labile for this chemistry, which was further exemplified by the modest
yields obtained in this series of reactions. Therefore, exploration of the benzyl–
protected analogues was then investigated, in the hope of testing further steps of
this d-xylose–based route.
4.5 Benzyl–Protected Xylal Route to
(−)-TAN-2483B
Earlier synthesis of d-xylose–derived acetyl oxepines 271 and 272 (see section 3.5)
provided the opportunity to immediately test the proposed chemistry of benzyl–
protected d-xylal. Initial efforts focused on conversion of oxepines 271 and 272
into 320, through deacetylation and olefination (Scheme 4.12).
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Scheme 4.12 Initial benzyl xylal–based steps to (−)-TAN-2483B
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d-Xylose–derived cyclopropane 243 was subjected to the standard ring–expansion
conditions outlined in chapter 3. Upon isolation of oxepines 271 and 272, the
mixture was purified through a silica plug, then immediately deacetylated using
catalytic sodium methoxide in methanol. However, the isolated product from this
reaction was not the expected heptanose 321. NMR evidence indicated the product
obtained was a mixture of isomers of aldehyde 322, (Scheme 4.13). Unfortunately
the mixture of products attributed to 322 provided extremely complicated NMR
spectra, which were not able to be assigned. In the proton spectrum there was a
series of four aldehydic peaks from 9.5 to 9.4 ppm, which indicated aldehydes with
all possible stereochemical configurations at C-2 and C-3 of 322 might have been
obtained. The carbon NMR spectrum corroborated this observation, with three
resolved peaks in the aldehydic region (192–190 ppm). Approximately half of the
peaks corresponding to sp3-hybridised carbons were observed between 85 and 80 ppm
in the carbon NMR spectrum. Precedence within this research project shows this is
indicative of C -furanosyl sugars; pyranose and heptanose sugars typically have the
vast majority of these signals upfield of 80 ppm.
O
BnO
BnO
Br
OH
O
BnO OBn
Br
O6i)
O
BnO
BnO
Br
OAc
2
3
α-anomer
β-anomer
271 321 322
272
Reagents and Conditions: i) NaOMe, MeOH, r.t., 2 h.
Scheme 4.13 Formation of furanosyl aldehyde 322
The appearance of 322 is most likely due to an intramolecular 1,4-addition of the C-6
hydroxyl to the α, β-unsaturated aldehyde moiety of 323, as shown in Scheme 4.14.
Similar reactivity has been observed earlier (see section 3.7), although this example
appears to show even greater propensity for 1,4-addition than the previously studied
glycosides. As 323 has a free hydroxyl present, 1,4-conjugate addition can occur
much more readily than for glycosides. Skattebøl studied the reaction of simple ac-
etal oxepines with acid, and reported the formation of unexpected products, which
were assigned as pyranosyl aldehydes.17 The proposed mechanism bore strong re-
semblance to that shown in Scheme 4.14, though in the previously reported case, the
α-halo aldehyde (such as 322) was thought to be an intermediate, not an observed
product.
The formation of furanosyl product 322 might be suppressed if aldehyde 323 was
immediately derivatised. Thus, a one–pot synthesis of alkene 320 was attempted,
through addition of a solution of oxepines 271 and 272, in addition to potassium
carbonate to the pre–formed ylide derived from treatment of ethyltriphenylphos-
phonium iodide (324) with KHMDS.132 However, this led to a complex mixture
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Scheme 4.14 Intramolecular 1,4-addition of xylose derivative 323
of products, in which α-hydroxy acetal 325 was the only identifiable component
(Scheme 4.15). Formation of the dimethyl acetal might be rationalised due to the
presence of methanol within the reaction (though acid was not present); hydrolysis
of the bromide moiety might have occurred upon workup.
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Reagents and Conditions: i) K2CO3, Ph3P−CHCH3, MeOH, THF, r.t., 2 h, 24%.
Scheme 4.15 Attempted deprotection/olefination of oxepines 271 and 272
A mixture of oxepines 271 and 272 was subjected to more selective anomeric
deacetylation conditions, using an established procedure133 in which 271 and 272
were treated with acetic acid and ethylene diamine. This buffered system was
thought to be sufficiently mild to avoid any 1,4-addition–derived side products.
Unfortunately, low consumption of starting material was observed when this re-
action was performed, and the only products observed appeared to be aldehydic
C -furanosyl sugars once again, as indicated by both proton and carbon NMR spec-
tra of the crude reaction mixture. Therefore, this route was abandoned due to this
apparently unavoidable molecular rearrangement.
4.6 Summary of Chapter 4
This chapter has detailed the unsuccessful attempts at synthesising (−)-TAN-2483B
from galactose or xylose. Reactions with galactose show preparation of suitable
2,3-unsaturated carbohydrate precursors for cyclopropanation is often difficult, and
these unsaturated sugars are not readily cyclopropanated. Studies involving xylal–
based precursors has shown more success. Unfortunately, oxepines such as 271 and
272 appear to be unsuitable for deprotection at the anomeric centre, as they undergo
facile intramolecular 1,4-addition to provide furanosyl sugars. An alternative route
that circumvents these issues will be discussed in chapter 5.
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Chapter 5
Approaches to (−)-TAN-2483B
from Mannose
5.1 Introduction
The unsuccessful attempts to synthesise (−)-TAN-2483B through the use of d-
galactose–derived alkene 290 and d-xylose–derived cyclopropane 243 (Figure 5.1)
were detailed in chapter 4. Valuable insights into the chemistry involved led to the
development of a new synthetic strategy through the use of d-mannose.
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Figure 5.1 Cyclopropanes 290 and 243
The d-galactose and d-xylose–based routes were unsuccessful for two main reasons:
Firstly, cyclopropanation of 2,3–unsaturated sugars is often difficult, as exemplified
by the attempted cyclopropanation of 290. Whilst xylose–derived cyclopropane 243
was synthesised in good yield, this route subsequently provided furanose sugars,
requiring investigation of alternative routes. However, it appears likely that use
of a lower homologue (Scheme 5.1), such as furanoglycal derivative 326, would be
less prone to such a side reaction, as conjugate addition would provide a highly
unfavourable four–membered oxetane ring (327).
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Scheme 5.1 Intramolecular conjugate addition of 323 vs. 326
With these considerations in mind, a cyclopropanated furanoglycal precursor with
general structure 328 might provide access to (−)-TAN-2483B (154) (Scheme 5.2).
Cyclopropanation of a furanoglycal might proceed more readily than the unsatu-
rated pyranoglycals used previously. gem-Dihalocyclopropanes that are part of the
bicyclo[3.1.0]hexane skeleton have been used previously in natural product synthe-
sis,13 and this provided further encouragement to explore this route.
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(−)-TAN-2483B
Scheme 5.2 Proposed furanoglycal–based route to (−)-TAN-2483B
Fischer’s glycal synthesis provides access to pyranoglycals, however when this meth-
odology is applied to furanose sugars, fully unsaturated furan derivatives are ob-
tained.134 Glycal 209 has been synthesised in four steps from d-mannose through
a radical–mediated process.34 Based on the retrosynthetic scheme previously shown
(page 34), the following synthesis of (−)-TAN-2483B was designed (Scheme 5.3).
Glycal 209 might undergo cyclopropanation to provide 208. Acetate–mediated
ring expansion, followed by deacetylation, would afford hemiacetal 207. The ring–
opened form (329) could undergo a Wittig reaction with an ethylidene ylide, which
could then be stereoselectively epoxidised to form intermediate 330, which con-
tains all the required stereogenic centres of (−)-TAN-2483B. Epoxide 330 could
undergo intramolecular cyclisation reaction, followed by a palladium–catalysed car-
bonylation/lactonisation sequence to provide 205, containing the furo[3,4-b]pyran-
5-one skeleton. Finally, acetonide removal and diol cleavage would provide aldehyde
331. This aldehyde could then undergo Julia–Kocienski olefination to append the
sidechain, then deprotection would provide (−)-TAN-2483B (154).
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Reagents and Conditions: i) CHX3, TEBAC, NaOH/KF(aq), r.t.; ii) AgOAc, NaOAc;
iii) NaOMe, MeOH, r.t.; iv) EtPPh3I, n-BuLi, −78
◦C to r.t.; v) 313, NaOCl(aq), CH2Cl2, r.t.;
vi) NaH, THF, r.t.; vii) Pd(PPh3)4, CO, NEt3; viii) AcOH(aq), r.t.; ix) NaIO4, THF(aq), r.t.;
x) 5-ethylsulfonyl-1-phenyl-1H -tetrazole, KHMDS, DME; xi) deprotection.
Scheme 5.3 Proposed mannose–based synthesis of (−)-TAN-2483B
5.2 Synthesis of Mannose–Based Glycal 209
Synthetic ventures began with d-mannose, which was subjected to a four–step se-
quence previously described by Theodorakis, to afford glycal 209.34 d-Mannose
(332) was reacted in acetone with catalytic iodine, to obtain the diacetonide deriva-
tive 333 in 86% yield.
Diacetonide derivative 333 was then converted into glycosyl chloride 334, through
reaction with tosyl chloride and DMAP.135 Glycosyl chloride 334 was then added
to a freshly prepared solution of sodium naphthalenide in THF. Through radical
initiation at the anomeric centre and loss of acetone, glycal 335 was formed. This
mixture was immediately benzylated to provide fully protected glycal 209, obtained
from d-mannose in 43% yield over four steps.
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Scheme 5.4 Synthesis of mannose–based glycal 209
5.3 Synthesis of the Pyran Ring of
(−)-TAN-2483B
The pyran ring of (−)-TAN-2483B was constructed through a cyclopropanation/ring
expansion sequence of glycal 209 (Scheme 5.5). The first of these steps would pro-
vide cyclopropane 208, which could then undergo ring expansion in the presence
of an acetate nucleophile to provide glycosides 336 and 337. This could then be
deprotected to provide key hemiacetal 207, suitable for homologation to the full
furo[3,4-b]pyran-5-one system.
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Scheme 5.5 Key cyclopropanation/expansion sequence
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5.3.1 Cyclopropanation of Glycal 209
The cyclopropanation of glycal 209 with dibromocarbene was then attempted under
the modified Ma¸kosza conditions used previously. The reaction mixture rapidly
became a very dark–brown colour, and TLC analysis indicated starting material
had been consumed after only 90 minutes. This reaction provided a complicated
mixture of byproducts from which ethyl glycosides 338 and 339 were isolated in a
combined yield of 26% (Scheme 5.6).
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Reagents and Conditions: i) CHBr3, TEBAC, NaOH/KF(aq), r.t., 90 min.
Scheme 5.6 Attempted gem-dibromocyclopropanation of glycal 209
These products were presumably formed by addition of ethanol to the glycal bond.
The bromoform used was stabilised with 1–3% (v/v) ethanol, corresponding to
0.3–0.9 equivalents, relative to the amount of glycal 209. Therefore, a portion
of bromoform was purified to remove the ethanol. Unfortunately, subsequent cyclo-
propanation using this ethanol–free bromoform led to only unidentifiable mixtures
of compounds.
In contrast, cyclopropanation with dichlorocarbene, generated in the presence of
50% (w/w) sodium hydroxide, proceeded much more cleanly. These conditions pro-
vided a much cleaner reaction, with full consumption of starting material observed
after just four hours. Cyclopropane 340 was obtained in 50% isolated yield, after
purification (Scheme 5.7).
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Reagents and Conditions: i) CHCl3, TEBAC, NaOH(aq), r.t., 4 h, 50%.
Scheme 5.7 Synthesis of mannose–based cyclopropane 340
This cyclopropanation proved to be very reproducible, and could be conducted under
air, with no observable loss of yield. While the isolated yield of 50% was modest,
the actual amount of cyclopropane obtained upon workup was significantly higher.
A byproduct ran just below cyclopropane 340 on the TLC plate, which led to poor
separation and yields of this product. The contaminant was believed to be 341,
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due to the presence of two peaks at approximately 6.2 ppm in the proton NMR
spectrum of the crude reaction mixture, which might correspond to H-1 and H-3 of
glycosyl chloride 341. Bergman has observed a similar mixture of cyclopropane and
rearranged derivative when reacting dichlorocarbene with cyclopentene.136 It was
later determined that rigorous purification of this cyclopropane was not necessary
for the next reaction, as byproduct 341 would likely react to provide the same
ring–expanded products as cyclopropane 340. Cyclopropane 340 was obtained in
79% yield when isolated with the contaminant, presumed to be 341, the rearranged
derivative of cyclopropane 340.
5.3.2 Ring Expansion of Mannose–Derived Cyclopropane
340
Cyclopropane 340 was ring–expanded using similar methodology to that featured in
chapters 3 and 4. It was anticipated that the use of acetate as a nucleophile in cyclo-
propyl ring expansion, followed by hydrolysis, would furnish the chloro- version of
intermediate 207 (Scheme 5.5). Furan–fused gem-dichlorocyclopropane 340 would
probably not require the high temperatures needed for pyran–based cyclopropanes
discussed in chapters 3 and 4, due to greater ring strain in the bicyclic system,
and the comparative stability of the six–membered ring products. Thus, the ring–
expansion reaction was performed with silver acetate (1.5 eq.) and sodium acetate
(5 eq.) in refluxing THF (65–67 ◦C), rather than at 100 ◦C in toluene. This reac-
tion proceeded rapidly, with full consumption of starting material observed after four
hours. Upon purification, an inseparable mixture of desired acetyl glycosides 342
and 343 (49%, 3:1 ratio) was obtained (Scheme 5.8). Glycal 344, formed from ac-
etate attack at C-2 of 340, was also obtained (16% yield). This result demonstrates
the efficient formation and ring–expansion of these bicyclo[3.1.0]hexane–based cy-
clopropanes, with both reactions occurring within a few hours. In contrast, the
synthesis (see chapter 2) and ring–expansion (see chapter 3) of glucal–derived cy-
clopropane 97 required two days for each reaction.
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Reagents and Conditions: i) AgOAc, NaOAc, THF, reflux, 4 h.
Scheme 5.8 Ring–expansion of mannose–derived cyclopropane 340
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Direct solvolysis was investigated, through substitution of sodium acetate for acetic
acid. The cyclopropane was treated with silver acetate in a 4:1 mixture of THF and
acetic acid, then refluxed. This led to much better regioselectivity, with a 12:1 ratio
between C-1 (342 and 343) and C-3 (344) acetate isomers. However, the acetyl
glycosides 342 and 343 were isolated in only 56% yield, presumably due to the
presence of acetic acid causing partial deprotection of the isopropylidene protecting
group. To improve the observed regioselectivity, later ring–expansion reactions were
performed using glacial acetic acid as the solvent (342 and 343:344, 30:1 ratio).
The absence of THF also allowed the use of higher temperatures, and a subsequent
reduction in reaction time to only two hours when the reaction was performed at
80 or 90 ◦C. In later reactions partial deprotection was still observed, presumably
due to the presence of water; use of a fresh sample of glacial acetic acid solved this
problem, providing glycosides 342 and 343 in 83% combined yield.
As mentioned above, mixtures of cyclopropane 340 and glycosyl chloride 341 were
isolated together in high yields. It was thought that acetic acid solvolysis of both
these regioisomers would provide glycosides 342 and 343, therefore the crude cy-
clopropanation product was cleaned by rapid elution through silica gel, which min-
imised degradation of 340. The mixture of 340 and 341 was immediately subjected
to silver–mediated acetic acid solvolysis, which provided acetyl glycosides 342 and
343 in 77% yield over two steps (Scheme 5.9). This high yield was very pleasing,
showing that conversion of glycal 209 into acetyl glycosides 342 and 343 was much
more straightforward than the corresponding oxepines described in chapter 3.
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Scheme 5.9 Cyclopropanation and ring–expansion of mannose–derived glycal 209
Deprotection of 342 and 343 utilised sodium methoxide, through addition of a
catalytic amount of sodium to a methanolic solution of acetates 342 and 343.122
Within one hour, full deprotection occurred, then purification by elution through
a silica plug provided hemiacetal 345 in quantitative yield (Scheme 5.10). This
material was deemed to be pure enough for subsequent reactions.
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Scheme 5.10 Synthesis of key hemiacetal 345
5.4 Functionalisation of the Pyran Ring of
(−)-TAN-2483B
5.4.1 Ethylidene Wittig–Based Route
As outlined in Scheme 5.3, (−)-TAN-2483B was thought to be accessible through
synthesis and subsequent reaction of epoxide 330, which might be formed from
masked aldehyde 345 (Scheme 5.11).
Wittig reaction of hemiacetal 345 utilised ethylidenetriphenylphosphorane, gener-
ated from treatment of phosphonium salt 324 with n-butyllithium. After reaction
in refluxing THF, an inseparable mixture of alkene isomers was obtained (2:1 ra-
tio), in favour of the desired (Z )-alkene 346; presumably the small size of the ylide
reagent substituents (H vs. Me) does not exclude formation of the (E )-alkene 347.
Reaction at room temperature was sluggish, and the use of KHMDS led to greater
impurities in crude product mixtures. Use of alternative solvents (CH2Cl2, DME,
DMF) provided mixtures with (Z ):(E ) ratios of only 1.2–1.6. When the reaction
was performed in toluene, significant degradation of material was observed. The
required (Z )-alkene might be accessed through a Corey–Fuchs reaction; subsequent
methylation of the terminal alkyne and cis-selective reduction with Lindlar catalyst
could provide stereoselective access to diene 346.
A cis-selective asymmetric Jacobsen epoxidation was then attempted,91 in which it
was hoped epoxide 330 would be obtained. Initially, a control reaction using (Z )-
hex-3-en-1-ol as the epoxidation substrate provided partial conversion into epoxides.
Use of (R,R)-Jacobsen’s catalyst (313) with olefin 346 should ensure epoxidation
occurs predominantly from the top face to provide the required epoxide 330. This
reaction gave a multitude of products, which appeared to be due to significant
degradation. A portion of starting material (25%) was isolated, in addition to
minor amounts of impure epoxides. Jacobsen epoxidation was therefore abandoned,
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Scheme 5.11 Ethylidene Wittig/epoxide route
as olefin 346 appeared to be relatively unreactive to this epoxidation methodology.
m-CPBA was then employed, though this would generate epoxides under achiral
conditions. As expected, this provided a complex mixture of products, with all
four possible stereoisomers observed (as indicated in the carbon NMR spectrum).
No epoxidation of the chloroalkene was observed. However, the major products
obtained (330 and 348, 1.5:1 ratio), arising from epoxidation of the Z -olefin of
major alkene 346, were able to be isolated and characterised as a mixture.
Intramolecular cyclisation of epoxides 330 and 348 was expected to provide access
to all C-2 and C-3 diastereomers of the cyclic alcohol 349. Reaction with sodium
hydride in THF provided no consumption of starting material, while changing the
solvent to DMF produced a complicated mixture of ring–opened products (349) in
low yield, in addition to a mixture of starting materials 330 and 348. At this point
the mixtures were deemed to be too complicated to pursue further, so alternative
methodology was then investigated.
Iodoetherification of 346 was attempted in aid of providing similar functionality
to pyran 349. This methodology allowed Snider to form the pyran ring of vari-
ous furo[3,4-b]pyran-5-one–derived natural products, through incorporation of the
oxygen bond at C-2 of (−)-TAN-2483B.88 A mixture of alkenes 346 and 347 was
added to a freshly prepared solution of bis(2,4,6-trimethylpyridine)iodine(I) hex-
afluorophosphate (350), generated in situ by treatment of the silver salt (351) with
iodine.137 Unfortunately, the reaction was extremely sluggish, and was terminated
after five days, by which time the electrophilic iodine reagent had decomposed. A
significant amount of material had degraded, and upon purification, starting mate-
rial was recovered (33%), in addition to minor amounts of products of structure 352
(Scheme 5.12).
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Scheme 5.12 Ethylidene Wittig/iodoetherification route
Due to the lack of success with this ethylidene Wittig–derived route, it was decided
that the lower homologue, methylidene Wittig–derived diene 353 might be more
useful for this epoxide–based synthetic strategy (Scheme 5.13). This would help
reduce the number of stereoisomers generated in the olefination and epoxidation
reactions. Diene 353 could be used to form either desmethyl (−)-TAN-2483B (354),
or (−)-TAN-2483B itself (154), through late–stage installation of the methyl group.
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Scheme 5.13 Proposed methylidene Wittig–derived route to (−)-TAN-2483B
5.4.2 Methylidene Wittig–Derived Route
Synthesis of methylidene–derived diene 353 began with treatment of a solution of
methyl triphenylphosphonium bromide with KHMDS, then addition of masked alde-
hyde 345 (Scheme 5.14). This provided diene 353 in 69% yield after 2 hours reaction
at room temperature. Upon obtaining diene 353, epoxidation was attempted using
m-CPBA. Epoxidation predominantly occurred at the terminal olefin, as required,
to afford products 355 and 356 in 49% yield (1.5:1 ratio). Complicated mixtures
of other products were observed, which appear to have derived from epoxidation
of the alkenyl chloride moiety. Asymmetric epoxidation was also attempted using
(R,R)-Jacobsen’s catalyst (313), though diene 353 was not very reactive to this
epoxidation procedure. Epoxides 355 and 356 were obtained in low yield (18%)
and poor diastereoselectivity (1.2:1 ratio), presumably due to the lack of steric dif-
ferentiation of the vinyl olefin.
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Treatment of the mixture of epoxides 355 and 356 (1.5:1 ratio) with sodium hydride
in DMF initiated pyran ring closure through substitution at the epoxide, providing
pyrans 357 and 358 in only 23% yield (1.5:1 ratio), primarily due to incomplete
consumption of starting material (35% recovered). Alternatively, treatment with a
solution of sodium methoxide in methanol provided pyrans 357 and 358 in 42%
yield (3.3:1 ratio), in addition to several minor unidentified products. Comparison
of the NMR data with iodopyran 359 (Scheme 5.15) tentatively suggested the major
product was the desired α-C -glycosyl alcohol 357.
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Scheme 5.14 Methylidene Wittig/epoxide route
Iodoetherification of diene 353 was also explored (Scheme 5.15). This substrate was
much more reactive than the ethylidene analogue, providing iodo sugar 359 in 42%
yield, as a single diastereoisomer, in addition to 38% of recovered starting material
353. The stereochemical configuration of iodopyran 359 was determined through
an nOe correlation; gratifyingly this indicated the stereochemistry of the pyran ring
was consistent with that of (−)-TAN-2483B.
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Scheme 5.15 Methylidene Wittig iodoetherification
Substrates 357 and 358, in addition to iodide 359 were later used for approaches
to the construction of the lactone ring of (−)-TAN-2483B, as discussed below.
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5.4.3 Stabilised Wittig–Based Route to (−)-TAN-2483B
Given the lack of stereoselectivity observed in many of the reactions involving un-
stabilised Wittig–derived dienes 346, 347 and 353, reaction of a stabilised ylide
with hemiacetal 345 might be exploited in a slightly modified strategy. It was
thought that this route would provide intermediate 360 (Scheme 5.16), analogous
to ethylidene Wittig–derived 346 (Scheme 5.11). Unfortunately, this would neces-
sitate late–stage removal of the ester functionality, presumably through a reduc-
tion/deoxygenation sequence. Reaction of hemiacetal 345 with (ethoxycarbonyl-
methylene)triphenylphosphorane provided α, β-unsaturated ester 360 stereoselec-
tively. Base–mediated cyclisation of 360 provided a mixture of functionalised pyrans
361 and 362, of which the former had the same pyran ring stereochemical config-
uration as (−)-TAN-2483B. C -Glycosyl pyrans 361 and 362 were initially formed
in a 1:1.2 ratio, isolated as an inseparable mixture. Their identities were assigned
through nOe correlations; simultaneous irradiation of both H-7 signals provided
enhancement of one of the H-2 protons of 361, and H-3 of 362.
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Scheme 5.16 Ethoxycarbonylmethylene Wittig/epoxide route
Taylor et al. reported intramolecular conjugate additions of this nature proceeded
with greater selectivity for the α-glycosyl configuration when the reaction was per-
formed at colder temperatures.138 In this case, reaction of substrate 360 at 0 ◦C for
one hour gratifyingly provided a mixture of C -glycosyl pyrans 361 and 362 in a 4:1
ratio in favour of the required α-glycosyl compound, 361.
While the pyran ring of (−)-TAN-2483B was now successfully constructed, efforts to
form the furanone ring required additional functionality. As the C-2 methylene group
of 361 is at the α-position of the ester group, a mono-deprotonation/halogenation
sequence would provide an α-halo ester such as 363 (Scheme 5.17). Inseparable
substrates 361 and 362 (4:1 ratio, shown as pure 361) were added to a freshly
prepared solution of LDA, followed by addition of iodine. Upon workup, starting
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materials 361 and 362 (4:1 ratio) were recovered (60%), in addition to previously
isolated unsaturated ester 360 (30%). The re–appearance of ester 360 was probably
due to rearrangement of anion 364. Conjugation within ester 360 indicates anion
364 is more likely to ring open, rather than undergo an intermolecular iodination.
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Scheme 5.17 Mechanism of base–mediated ring opening of ester 361
The difficulty of functionalising the methylene group of pyran 361 is compounded
by the high propensity for formation of the highly conjugated ester 360, which
is likely to occur under basic conditions, regardless of the halogen source used.
In addition, the requirements for late–stage reduction and deoxygenation of the
ester functionality would increase the number of required steps, therefore alternative
methodologies were investigated.
5.4.4 HWE/Ramberg–Ba¨cklund Route to (−)-TAN-2483B
The Ramberg–Ba¨cklund reaction has been widely used139,140 for converting an α-
halo-sulfone into an olefin, through base–mediated elimination of sulfur dioxide. The
Meyers modification141 involves in situ halogenation of a sulfone (365) to provide
the alkene (2) in a single–step, one–pot reaction (Scheme 5.18). The Ramberg–
Ba¨cklund reaction has shown excellent utility with sulfonated carbohydrates, in
which the Franck and Taylor groups have reported many interesting syntheses.142–144
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Reagents and Conditions: i) KOH, CCl4,
tBuOH, r.t.
Scheme 5.18 The Ramberg–Ba¨cklund reaction139–141
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It was anticipated that the following Ramberg–Ba¨cklund approach to (−)-TAN-
2483B would overcome previous difficulties (Scheme 5.19). Thus, HWE reaction of
diethyl methylsulfonylmethylphosphonate (366) with hemiacetal 345, followed by
an intramolecular 1,4-conjugate addition would provide C -glycosyl sugar 367, prob-
ably as a mixture with the β-anomer. Ramberg–Ba¨cklund reaction of this sulfone
would provide vinylic sugar 368. This could be used to construct the bicyclic skele-
ton of (−)-TAN-2483B through lithium–halogen exchange of the alkenyl chloride,
followed by treatment with dry ice, to provide carboxylate functionality. Finally,
treatment with an appropriate electrophilic halogen source could lead to iodolacton-
isation, to provide furo[3,4-b]pyran-5-one–based epimers 369 and 370.
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Reagents and Conditions: i) (EtO)2P(O)CH2SO2Me (366), NaH; ii) base; iii) KOH, CCl4,
tBuOH, r.t.; iv) n-BuLi, CO2, then 350, r.t.
Scheme 5.19 Proposed sulfone–based Ramberg–Ba¨cklund route
The required HWE reagent 366 was first synthesised in 96% yield, through oxida-
tion of commercially available diethyl methylthiomethylphosphonate with catalytic
ammonium heptamolybdate and hydrogen peroxide.145 HWE reaction with hemiac-
etal 345 was then pursued (Scheme 5.20). After deprotonation of 366 with sodium
hydride, hemiacetal 345 was added. After two hours reaction, starting material was
fully consumed, and upon purification, a mixture of pyranosyl sugars 367 and 371
was obtained in 77% combined yield. The absence of α, β-unsaturated sulfone 372
was presumably due to facile cyclisation to the observed products 367 and 371.
Nevertheless, it was extremely pleasing to obtain 367 and 371 in just one step,
and in a surprisingly high isolated ratio of 14:1 in favour of the desired anomer
367 (identified through an nOe correlation). When the reaction was conducted at
0 ◦C, none of minor isomer 371 was observed. Full consumption of starting material
still occurred after two hours, though in some cases a small amount of diene 372
was isolated in addition to 367. Taylor has reported similar results in which in situ
intramolecular cyclisation occurred during coupling of other sulfonylmethylphospho-
nates to carbohydrates.146 The high selectivity for isomer 367 was quite surprising,
as literature precedence involving synthesis of sulfones similar to 367 and 371147
indicate colder temperatures are often required to provide high α-glycosyl selectivity.
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Reagents and Conditions: i) (EtO)2P(O)CH2SO2Me (366), NaH, THF, 0
◦C to r.t., 2 h, 77%.
Scheme 5.20 Synthesis of sulfonated sugar 367
With sulfone 367 in hand, the key Ramberg–Ba¨cklund reaction was attempted, us-
ing Meyers’ conditions (Scheme 5.21).141 Consumption of starting material occurred
within 30 minutes, and a complex mixture of products was obtained, in which the
required vinyl sugar 368 was not readily identifiable. A major component of the
mixture of products was determined to be exocyclic olefin 373, due to elimination
of the sulfonyl group. Presumably this occurred due to the high propensity of this
system to form conjugated dienes, as observed above. It was proposed that the
use of the alumina supported KOH-Al2O3 (as used in the Chan modification of
the Ramberg–Ba¨cklund reaction148), might reduce the detrimental effects observed
under Meyers’ conditions. However, substitution of KOH for KOH-Al2O3 failed to
provide C -glycosyl ethene 368, but afforded pure methylene–branched sugar 373
(26%), in addition to epimerised starting material 371 (39%). Pathak and Pal
have observed similar epimerisation in their attempted synthesis of a sugar with a
pendant vinyl group using the Ramberg–Ba¨cklund reaction.149
i)O
BnO
O
O
Cl
SO2Me
HH O
BnO
O
O
Cl
HH O
BnO
O
O
Cl
H
X
367 368 373
Reagents and Conditions: i) KOH-Al2O3, CCl4,
tBuOH, 35 ◦C 1 h.
Scheme 5.21 Attempted synthesis of alkene 368 under Meyers conditions141
A Ramberg–Ba¨cklund reaction was then attempted using the Chan modification,
which utilises a moderate excess (4 eq.) of dibromodifluoromethane as the halo-
gen source, in addition to KOH-Al2O3.
148 Reaction at 5 ◦C was extremely sluggish,
therefore the reaction was warmed successively to room temperature and dichloro-
methane reflux. Additional portions of dibromodifluoromethane were added ap-
proximately every hour, to compensate for the very low boiling point of this reagent
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(b.p. 23 ◦C). After several hours reaction, the mixture was worked up, providing
recovered starting material 367 (57%), in addition to a small amount of unidentified
material. Maintaining the reaction at 5 ◦C also led to a large portion of recovered
sulfone 367 (67%) after 24 hours. A microwave reaction at 60 ◦C was attempted,
providing greater consumption of starting material. The isolated products consisted
of a small amount of diene 353 (14%), and unidentified materials (Scheme 5.22).
This observed lack of reactivity of sulfone 367 to the Ramberg–Ba¨cklund reaction,
and in particular to the Chan modification, might be circumvented through use of
an activated analogue. Replacement of the terminal methylsulfonyl group with a
benzylsulfonyl group might provide a more reactive substrate. Another research
group has shown that a benzylsulfone was able to undergo a Ramberg–Ba¨cklund
reaction; yet the isopropylsulfone analogue was completely unreactive.150 However,
the inability to transform the resulting Ramberg–Ba¨cklund reaction product into
(−)-TAN-2483B meant investigation into the use of a benzylsulfone analogue was
not pursued.
i)O
BnO
O
O
Cl
SO2Me
HH O
BnO
O
O
Cl
HH OH
BnO
O
O
Cl
X
367 368 353
Reagents and Conditions: i) KOH-Al2O3, CBr2F2,
tBuOH, CH2Cl2, 60
◦C, 30 min.
Scheme 5.22 Attempted synthesis of vinyl sugar 368 under Chan conditions148
Due to the undesired reactivity of sulfone 367 towards Ramberg–Ba¨cklund reaction
conditions, it was thought a stepwise sequence, rather than the one–pot Ramberg–
Ba¨cklund reaction141 might provide access to alkene 368. Direct α-halogenation
of sulfone 367 would provide bromosulfones 374 and/or 375, or iodosulfones 376
and/or 377. These α-halo sulfones could then undergo a classic Ramberg–Ba¨cklund
reaction,139 methodology which has still been employed in recent years.143,151 Efforts
to achieve α-halogenation are detailed in Table 5.1.
It was thought that repetition of the HWE reaction, followed immediately by addi-
tion of iodine, would provide iodosulfone 376 through attack of the C-1 anion (the
likely product after 1,4-addition) upon iodine (entry 1). Unfortunately, this only led
to the previously isolated sulfone 367. Addition of an extra equivalent of sodium
hydride concurrently with the iodine also failed to alter the outcome of the HWE
reaction (entry 2). Attempts were then made to halogenate isolated sulfone 367.
Entry 3 shows that deprotonation with LDA, followed by addition of NIS, failed to
achieve any consumption of starting material. To ensure the halogen source was
present as the deprotonated sulfone was generated, KHMDS was slowly added to a
solution of sulfone 367 and NIS (entry 4). Consumption of the starting material 367
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Table 5.1 Attempts at α-halogenating sulfone 367
i), ii)
O
BnO
O
O
Cl
S
H
O
BnO
O
O
Cl
SO2Me
H
X
H
H
O
BnO
O
O
Cl
S
HH
X
O O
1
X
OO
X = Br
X = Br
X = I
X = I
367
374 376
375 377
Reagents and Conditions: i) Base, THF; ii) Halogen Source
Entry Base Halogen Source Conditions Byproducts
1a - 1.5 eq. I2 r.t., 1 h 367
2 a 1.1 eq. NaH 1.5 eq. I2 r.t., 1 h
b 367
3 1.2 eq. LDA 1.8 eq. NIS i) 0 ◦C, 30 min 367
ii) 0 ◦C, 1 h; r.t. 2 h
4 1.2 eq. KHMDS 1.4 eq. NISc i) 0 ◦C, 15 mind 367
ii) 0 ◦C, 1 h; r.t. 2 h
5 1.2 eq. n-BuLi 1.8 eq. NBS i) −78 ◦C, 30 min 367, 372
ii) 0 ◦C, 1 h; r.t. 2 h 1:1 ratio
aentries 1 and 2 performed on unisolated 367
breagents added concurrently
cadded prior to base
dbase added dropwise over this period
was not observed. Therefore, a final attempt involved addition of n-butyllithium
(entry 5) to a solution of sulfone 367, followed by addition of NBS. The starting
material failed to undergo halogenation, though it was observed that upon workup,
a 1:1 mixture of starting material 367 and ring–opened sulfone 372 was obtained.
The initial HWE product, α, β-unsaturated sulfone 372 was not readily isolated from
the reaction, as the basic reaction conditions facilitated intramolecular conjugate
addition, to provide pyranosyl sulfone 367. It was thought isolation of sulfone
372 and subsequent haloetherification might provide an α-halo sulfone suitable for
a Ramberg–Ba¨cklund reaction, although the electron–withdrawing sulfone would
likely inhibit this reaction to a degree. Carrying out the HWE reaction at −40 ◦C
led to slightly greater proportions of diene 372 in addition to sulfone 367, though
the reaction proved to be inconveniently slow. However, deprotonation of reagent
366 using LDA at 0 ◦C led to isolation of diene 372 in 13% yield, presumably due to
lithium stabilisation of the C-6 hydroxyl of 372 (Scheme 5.23). This yield could not
be increased without causing partial conversion into ring–closed sulfone 367, which
was inseparable from 372 by column chromatography. The small portion of 372
obtained was then subjected to iodoetherification using a freshly prepared solution
of bis(2,4,6-trimethylpyridine)iodine(I) hexafluorophosphate (350). Unfortunately,
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diene 372 appeared to be completely unreactive after several days reaction. Upon
observation of this result, the Ramberg–Ba¨cklund route was abandoned.
i)O
BnO
OH
O
O
Cl
OH
BnO
O
O
Cl
SO2MeH
345 372
Reagents and Conditions: i) (EtO)2P(O)CH2SO2Me (366), LDA, THF, 0
◦C, 3 h, 13%.
Scheme 5.23 Synthesis of α, β-unsaturated sulfone 372
5.5 Approaches to the furo[3,4-b]pyran-5-one
skeleton of (−)-TAN-2483B
The above section detailed various methods for elaborating the pyran ring of (−)-
TAN-2483B, from which methylidene Wittig–derived diene 353 seemed to provide
the greatest potential for use in the construction of the furo[3,4-b]pyran-5-one skele-
ton. Efforts to form the lactone ring required derivatisation of the alkenyl chloride
moiety with carbonyl or carboxyl functionality.
A one–step synthesis of the furo[3,4-b]pyran-5-one skeleton was attempted with alco-
hols 357 and 358, through palladium–catalysed carbonylation (Scheme 5.24). After
reaction overnight, the catalyst had decomposed and only starting material was ob-
served in the crude reaction mixture. A second attempt involved reaction with
PdCl2(PPh3)2, a catalyst which has been used for appending methyl ester function-
ality onto aryl iodides,152 and also chloroalkenes.153 Unfortunately, this provided no
consumption of starting material. Due to this lack of reactivity, alternative means
were sought.
i)O
BnO
O
O
Cl
OH
HH O
BnO
O
O
HH
O
O
X
357, 358 378, 379
Reagents and Conditions: i) CO, Pd(OAc)2, PPh3, NEt3, DMF, r.t., overnight, 0% or CO,
PdCl2(PPh3)2, NEt3, DMF, 60
◦C, 24 h, 0%.
Scheme 5.24 Attempted lactone formation of alcohols 357 and 358
Carboxylation of the alkenyl chloride moiety of iodosugar 359 was attempted,
through treatment with n-butyllithium, and carbon dioxide gas. This led to re-
covery of starting material 359 (63% yield), in addition to previously isolated diene
353 (27% yield). Presumably this reactivity is due to lithium–halogen exchange of
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the iodide, which undergoes facile ring opening to form the stable diene moiety of
353 (Scheme 5.25).
i), ii) OH
BnO
O
O
Cl
O
BnO
O
O
Cl
I
H H
353359
Reagents and Conditions: i) n-BuLi, THF, −78 to 0 ◦C, 1 h; ii) CO2, r.t., 30 min,
27% over 2 steps.
Scheme 5.25 Ring–opening of iodosugar 359
In order to avoid competitive reaction of iodosugar 359 with n-butyllithium, car-
boxylation of diene 353 was attempted. It was expected that the resulting acid
would undergo either iodoetherification then lactonisation, or iodolactonisation fol-
lowed by pyran formation, to form the furo[3,4-b]pyran-5-one skeleton. Initially,
carboxylation of diene 353 was attempted, through treatment with n-butyllithium
and subsequent addition of carbon dioxide. Unfortunately, n-butyllithium appeared
to be unreactive to the alkenyl chloride moiety at either −78 ◦C or 0 ◦C. Use
of tert-butyllithium led to consumption of starting material, but the mixture of
products obtained was complicated, and did not appear to contain any carboxylate
functionality at the site of the alkenyl chloride.
Palladium–catalysed carbonylation in methanol was explored with chloroalkene 353,
in which methyl ester 380 was expected to form (Scheme 5.26). Thus, chloroalkene
353 was treated with the catalyst PdCl2(PPh3)2, triphenylphosphine and triethy-
lamine in methanol, and refluxed under an atmosphere of carbon monoxide. Grat-
ifyingly, this provided consumption of starting material after seven hours under
methanol reflux. The reaction mixture provided a black crude product, which con-
sequently led to difficulties purifying ester 380, isolated in only 41% yield. However,
it is expected that optimisation of this reaction will be possible.
i)OH
BnO
O
O
Cl
H OH
BnO
O
O
H
CO2Me
353 380
Reagents and Conditions: i) CO, PdCl2(PPh3)2, NEt3, MeOH, reflux, 7 h, 41%.
Scheme 5.26 Carbonylation of diene 353
With this successful functionalisation of the alkene moiety, all the carbons of the
furo[3,4-b]pyran-5-one skeleton were present. Construction of the pyran ring was
achieved through iodoetherification (Scheme 5.27), providing a mixture of iodoesters
381 and 382 in 47% unoptimised yield (3:1 ratio). While the stereochemistry of
these epimeric sugars was not proven, comparison of the NMR data with the alkenyl
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chloride analogue (359) allowed tentative assignment of the major isomer to struc-
ture 381, in which the pyran ring stereochemistry is consistent with that of (−)-
TAN-2483B. It may be noted these methyl esters bore similar structural similarities
to the natural product waol B (page 26).
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BnO
O
O
H
CO2Me
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H O
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H
CO2Me
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H
2
380 381 382
Reagents and Conditions: i) 350, CH2Cl2, r.t., 1 d, 47%.
Scheme 5.27 Iodoetherification of ester 380
Lactonisation of iodoesters 381 and 382 was attempted, through treatment with
sodium hydroxide. It was anticipated that this could lead to hydrolysis of either the
iodomethyl (green path) or ester (red path) moieties, to provide intermediates 383
and 384 or 385 and 386 (Scheme 5.28). Either pair of intermediates might undergo
lactonisation to form the required bicycle 378, in addition to the C-7a epimer 379,
which contains the bicycle of (−)-TAN-2483A. Unfortunately though, TLC and
NMR evidence indicated the ester had undergone almost complete saponification.
Additionally, a reduction in the signals corresponding to the iodomethyl moiety was
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Reagents and Conditions: i) NaOH, THF(aq), r.t., 1 d.
Scheme 5.28 Proposed lactonisation of iodoesters 381 and 382
observed in the proton NMR spectrum of the crude product. This indicated hydroxy
acids 387 and 388 had been formed. The crude mixture of these products was
subjected to DCC/DMAP–mediated lactonisation, in the hope of forming furo[3,4-
b]pyran-5-ones 378 and 379. TLC evidence tentatively indicated this reaction might
have produced minute quantities of lactones 378 and 379. However, purification and
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characterisation were not achieved, due to the small amount of material obtained.
Due to time constraints, further investigations into this promising synthetic route
were not pursued.
5.6 Summary of Chapter 5
This chapter has reported the d-mannose–based routes to (−)-TAN-2483B, using a
variety of strategies. While many olefination methodologies were deemed to be too
inconvenient for further use, diene 353 provided access to the full carbon skeleton
of the furo[3,4-b]pyran-5-one bicycle. Although (−)-TAN-2483B was not able to
be synthesised during the timeframe of this research project, the successful synthe-
sis of iodoesters 381 and 382 indicates the synthesis of (−)-TAN-2483B could be
achievable in the near future.
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Chapter 6
Future Work
The results obtained from this project have often been unexpected and interesting,
and thus prompt additional research that was not able to be completed during the
timeframe of this project.
6.1 Ring Opening Studies
As detailed in chapters 2 and 3, cyclopropanes such as 97 undergo a diverse range of
reactions, producing highly functionalised pyranoside (see chapter 2) or septanoside
(see chapter 3) carbohydrates.
As discussed in chapter 2, the synthesis of 2-C -bromomethylene sugars has not been
reported previously. The derivatisation of the bromomethylene moiety could lead to
a wide range of new and interesting 2-C -branched sugars. This research is currently
underway within the research group.
O
OBn
BnO
BnO
Br
OR O
OBn
BnO
BnO
R
OR
389, 390 391, 392
Scheme 6.1 Palladium–catalysed cross–coupling of 2-C -bromomethylene sugars
While this research showed that only O-glycosides were efficiently obtained through
the methodologies described in chapters 2 and 3, additional attempts to provide
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C -glycosyl and N -glycosyl derivatives would be of interest. Initial reactions men-
tioned within this thesis have met with limited success, yet these analogues might
be accessible through optimisation of reaction conditions and through careful choice
of nucleophiles.
O
OBn
BnO
BnO
O
OBn
BnO
BnO
i)
H
H
ii)
Br
Nuc O
BnO
BnO
BnO
Br
Nuc
Br
Br
393, 394 97 191, 192
Reagents and Conditions: i) NaNuc, NucH, THF, reflux; ii) Ag+, NucH, toluene, 100 ◦C.
Scheme 6.2 Reactions of cyclopropane 97 with carbon and nitrogen nucleophiles
As was reported in chapter 2, monohalogenated cyclopropane 235 was obtained from
treatment of dihalocyclopropane 97 with n-butyllithium. The remaining bromine
atom is in the exo-configuration, which implies that this cyclopropane would fail
to undergo ring expansion, due to the “cis-in trans-out” requirement discussed in
subsection 1.1.2. Thus, representative ring–opening reactions of 235 under either
basic or silver–mediated conditions would be of significant interest, and might pro-
vide further mechanistic insight.
O
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BnO
BnO
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BnO
BnO
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H
H
Br ii)
Br
OR O
BnO
BnO
BnO
Br
OR
389, 390 235 255, 256
Reagents and Conditions: i) NaOR, ROH, THF, reflux; ii) Ag+, ROH, toluene, 100 ◦C.
Scheme 6.3 Ring–opening reactions of cyclopropane 235
Finally, a detailed investigation into the microwave–mediated reaction of cyclo-
propanes such as 97 would be of use. Specifically, this may help define the optimal
conditions for selectively generating septanosides or C -furanosyl sugars. Microwave
reactions are generally influenced by the choice of solvent, and the corresponding
ability of that solvent to absorb microwave energy. Therefore, alternative solvents
(e.g. DMF, acetonitrile), may provide more efficient reactivity than solvents reported
in chapter 3.
6.2 Natural Product Synthesis
The synthesis of (−)-TAN-2483B through use of d-galactose or d-xylose (as dis-
cussed in chapter 4) was unsuccessful, therefore pursuing these routes is not likely
to provide much headway. In contrast, work detailed in chapter 5 covered many
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similar approaches to (−)-TAN-2483B through hemiacetal 345, of which several
may be elaborated further, which could provide access to (−)-TAN-2483B.
The ethoxycarbonyl–based Wittig route may hold further promise, if functionalisa-
tion of the α-centre of ester 361 can be achieved. Possibly the 2-(phenylsulfonyl)-
3-phenyl-oxaziridine reagent could effect this transformation.
O
BnO
O
O
Cl
CO2Et
HH i) O
BnO
O
O
Cl
CO2Et
HH
OH
361 395
Reagents and Conditions: i) 2-(phenylsulfonyl)-3-phenyl-oxaziridine, KHMDS.
Scheme 6.4 Synthesis of α-hydroxy ester 395
The sulfone–based HWE route appears to fail from a lack of reactivity in the
Ramberg–Ba¨cklund reaction. Incorporation of a more reactive moiety (e.g. through
use of diethyl benzylsulfonylmethylphosphonate) may allow the Ramberg–Ba¨cklund
reaction of sulfone 396 to occur.150 This could lead to phenyl-TAN-2483B (397).
O
BnO
O
O
Cl
SO2Bn
HH O H
O
O
HO
Ph
396 397
Scheme 6.5 Synthesis of phenyl-TAN-2483B (397)
Finally, the methylidene–derived Wittig route ultimately provided the best results,
with incorporation of the full carbon skeleton of the required furo[3,4-b]pyran-5-
one bicycle. The work described in chapter 5 has demonstrated that this route
shows great promise. The required lactone ring may be constructed through opti-
misation of results discussed in section 5.5, with particular focus on developing an
effective lactonisation strategy. Furthermore, the methyl group attached to C-7 of
(−)-TAN-2483B could be installed through additional steps, or further studies upon
ethylidene–based Wittig products 347 and 346 (see section 5.4) might provide the
completed lactone ring. Completion of the synthesis through sidechain appendation
will in all probability, finally provide access to (−)-TAN-2483B.
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Chapter 7
Experimental
7.1 General Experimental Details
Unless otherwise stated, the following conditions apply. All reactions were per-
formed under argon (zero grade) in vacuum-dried or flame-dried glassware using
dry solvents and standard syringe techniques. Tetrahydrofuran (THF) was freshly
distilled from the sodium benzophenone ketyl radical ion. Acetonitrile (MeCN),
dichloromethane (CH2Cl2), triethylamine (NEt3) and diisopropylamine (
iPr2NH)
were distilled from calcium hydride. Methanol (MeOH) and toluene were distilled
from sodium. Acetone, 1,4-dioxane and water were distilled. Acetic acid (glacial)
and acetic anhydride were used as received. Allyl alcohol (AllylOH), anhydrous
dimethylformamide (DMF), methanol-d4 and THF-d8 were purchased from Aldrich
Chemical Company and were used without further purification. Chloroform and bro-
moform were both used as received (with a small amount of ethanol as stabiliser).
Bleach was prepared as described earlier,91 from a sodium hypochlorite solution of
commercial quality. Sodium hydride (NaH) was obtained as a 60% (w/w) dispersion
in paraffin oil and was used as obtained unless otherwise stated. n-butyllithium was
obtained as a 1.6 molL−1 solution in hexanes, unless otherwise stated. KHMDS was
obtained as a 0.5 molL−1 solution in toluene. Potassium fluoride dihydrate was crys-
tallised from a super–saturated aqueous solution of potassium fluoride. Pyridinium
p-toluenesulfonate (PPTS) was prepared through dissolution of p-toluenesulfonic
acid in an excess of pyridine, then evaporation to dryness. KOH-Al2O3 was pre-
pared as reported by Chan.148 m-CPBA was obtained as an approx. 70% dispersion
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in water and m-chlorobenzoic acid. All other reagents were of commercial quality
and distilled prior to use if necessary.
Reaction progress was monitored using aluminium–backed thin layer chromatogra-
phy (TLC) plates pre–coated with silica UV254 and visualised by either UV radi-
ation (254 nm), or anisaldehyde dip. Purification of products via flash chromatog-
raphy was conducted using a column filled with silica gel 60 (220-240 mesh) with
solvent systems as indicated. Microwave–assisted reactions were carried out in a
Milestone Microsynth reactor, monitored by a fibre optic temperature and pressure
probe. 1H and 13C NMR spectra were recorded on a Varian Unity Inova 500 (500
MHz for 1H and 125 MHz for 13C) spectrometer, NOESY and 31P NMR spectra
were recorded on a Varian Unity Inova 300 (300 MHz for 1H and 121 MHz for 31P).
All chemical shifts (δ) were referenced to solvent peaks if possible (CDCl3:
1H -
7.26 ppm, 13C - 77.0 ppm). Melting points were determined using a Gallenkamp
melting point apparatus and are uncorrected. Optical rotation was measured on
a Perkin–Elmer Polarimeter (sodium lamp). Infrared spectra were obtained on
a Perkin–Elmer Spectrum One FT-IR spectrometer. High-resolution mass spec-
trometry (HRMS) was performed on a Waters Q-TOF PremierTM Tandem Mass
Spectrometer. The structure of each compound is presented with the corresponding
method of preparation.
7.2 Chapter Two Experimental
d-Glucal (185)
Using a modification of Kozikowski’s procedure,89 a magnetically stirred solution of
d-glucose (126 mg, 0.7 mmol) in acetic anhydride (75 mL, 790 mmol) was treated
dropwise with conc. perchloric acid (0.45 mL, 6.9 mmol). Additional d-glucose
(19.9 g, 110.4 mmol) was slowly added over half an hour, at a rate that maintained
a temperature of 40–50 ◦C. Upon complete addition of d-glucose, the solution was
allowed to cool to room temperature, then treated with a 33% (w/w) solution of hy-
drobromic acid in acetic acid (75 mL, 410 mmol). After 90 minutes, the solution was
diluted with dichloromethane (180 mL) and washed with ice–cold water (2 x 50 mL),
then with cold sat. sodium bicarbonate solution (6 x 50 mL). The organic phase was
dried, filtered and concentrated to afford crude tetra-O-acetyl-α-d-glucopyranosyl
bromide (210) as a pale–yellow oil.
A mechanically stirred dispersion of zinc dust (47.9 g, 733 mmol) in water (150 mL)
was cooled to 0 ◦C, then diluted with acetic acid (150 mL), then treated dropwise
with a solution of tetra-O-acetyl-α-d-glucopyranosyl bromide in diethyl ether (150
mL), over one hour. The reaction was allowed to warm to room temperature and left
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to proceed overnight. The solution was filtered, then diluted with dichloromethane
(200 mL). The resulting solution was washed successively with water (3 x 60 mL),
sat. sodium bicarbonate solution (4 x 50 mL), then brine (60 mL). The organic
phase was dried, filtered and concentrated to provide tri-O-acetyl-d-glucal (179) as
an off–white solid (26.6 g).
A solution of triethylamine (110 mL, 780 mmol) in methanol (50% of an aqueous
solution, 1100 mL) was treated with tri-O-acetyl-d-glucal (26.6 g) and stirred for
90 minutes. The mixture was concentrated to liberate d-glucal as a brown oil,
contaminated with triethylamine. The crude mixture was successively treated with
portions of methanol, then concentrated to remove the triethylamine. The oil was
dissolved in methanol (15 mL), then successively diluted with acetone (100 mL) and
diethyl ether (200 mL), which led to the precipitation of impurities. The solution
was filtered and concentrated to afford d-glucal (185) as a brown solid (10.7 g, 66%
crude yield), which was used without further purification.
O
OH
HO
HO
1
2
3
4
5
6 1H-NMR: (D2O) δH 6.38 (dd, J = 6.0, 1.6 Hz, 1H, H-1), 4.79 (com-
plex m, 3H, 3 x OH) 4.77 (dd, J = 6.1, 2.4 Hz, 1H, H-2), 4.19 (dt,
J = 7.1, 2.1 Hz, 1H, H-3), 3.92–3.82 (complex m, 3H, H-5,6), 3.64
(dd, J = 9.0, 7.1 Hz, 1H, H-4); 13C-NMR: (D2O) δC 143.8 (CH,
C-1), 102.7 (CH, C-2), 78.0 (CH, C-5), 68.7 (CH, C-4), 68.2 (CH, C-3), 59.9 (CH2,
C-6); IR (KBr): νmax 3337, 2923, 1650, 1229, 1073 cm
−1.
Tri-O-benzyl-d-glucal (188)
A solution of d-glucal (4.99 g, 34.1 mmol) in DMF (200 mL) was cooled to 0 ◦C,
then treated with sodium hydride (5.33 g, 133 mmol). The solution was stirred at
0 ◦C for 30 minutes, then treated with benzyl bromide (14.0 mL, 118 mmol) and
allowed to warm to room temperature. After 17 hours, the solution was quenched
with water (20 mL) and the product extracted with diethyl ether (3 x 200 mL). The
organic fractions were combined, dried, filtered and concentrated to provide the
crude product as a concentrated solution in DMF. Chromatography of this solution
(9:1 hexanes:ethyl acetate) afforded 188 (11.9 g, 84%) as a pale–yellow solid. The
spectral data matched that reported previously.154
O
OBn
BnO
BnO
1
2
3
4
56 Rf 0.4 (9:1 hexanes:ethyl acetate); m.p. 54–56
◦C (lit.154 m.p. 53–
55 ◦C); 1H-NMR: (CDCl3) δH 7.34–7.26 (complex m, 15H, Bn),
6.42 (dd, J = 6.1, 1.2 Hz, 1H, H-1), 4.88 (dd, J = 6.1, 2.7 Hz, 1H,
H-2), 4.83 (d, J = 11.2 Hz, 1H, PhCH2), 4.64 (d, J = 11.2 Hz, 1H,
PhCH2), 4.64 (d, J = 11.7 Hz, 1H, PhCH2), 4.59–4.51 (complex m, 3H, PhCH2),
4.21 (ddd, J = 6.1, 2.4, 1.5 Hz, 1H, H-3), 4.06 (ddd, J = 8.4, 5.2, 3.1 Hz, 1H, H-5),
3.86 (dd, J = 8.8, 6.1 Hz, 1H, H-4), 3.81 (dd, J = 10.7, 5.1 Hz, 1H, H-6a), 3.76
(dd, J = 10.7, 2.9 Hz, 1H, H-6b); 13C-NMR: (CDCl3) δC 144.7 (CH, C-1), 138.3
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(C, Bn), 138.2 (C, Bn), 138.0 (C, Bn), 128.42 (CH, Bn), 128.41 (CH, Bn), 128.38
(CH, Bn), 127.9 (CH, Bn), 127.8 (CH, Bn), 127.74 (CH, Bn), 127.65 (CH, Bn), 99.9
(CH, C-2), 76.6 (CH, C-4), 75.7 (CH, C-5), 74.4 (CH, C-3), 73.8 (CH2, PhCH2),
73.5 (CH2, PhCH2), 70.5 (CH2, PhCH2), 68.5 (CH2, C-6); IR (KBr): νmax 3066,
3029, 2924, 2911, 2887, 1952, 1650, 1452, 1245, 1096, 740 cm−1.
1,5-Anhydro-3,4,6-tri-O-benzyl-2-deoxy-1,2-C -(dibromomethylene)-d-
glycero-d-gulo-hexitol (97) and 1,5-anhydro-3,4,6-tri-O-benzyl-2-deoxy-
1,2-C -(dibromomethylene)-d-glycero-d-talo-hexitol (190)
A As reported by Nagarajan,45 a solution of tri-O-benzyl-d-glucal (188) (1.14 g,
2.73 mmol) and TEBAC (8 mg, 0.04 mmol) in bromoform (4.5 mL, 51 mmol) was
treated dropwise with a solution of sodium hydroxide (930 mg, 23 mmol) and potas-
sium fluoride dihydrate (6.9 g) in water (7.0 mL). The biphasic mixture was stirred
at room temperature for two days, then diluted with water (20 mL). The mixture
was extracted with diethyl ether (3 x 40 mL), then the organic fractions were com-
bined and washed with brine (20 mL). The ethereal solution was dried, filtered and
concentrated to provide a crude mixture of cyclopropanes 97 and 190 (6.5:1 ratio),
which was purified by column chromatography (9:1 hexanes:ethyl acetate) to liber-
ate cyclopropanes 97 (1.11 g, 66%), as a light–yellow solid and 190 (170 mg, 10%)
as a yellow oil (76% combined yield).
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97: The spectral data matched that which was previously
reported.45 Rf 0.4 (9:1 hexanes:ethyl acetate); m.p. 56–60
◦C
(lit.45 m.p. 58–60 ◦C); [α]21D +59 (c 1.0 CHCl3);
1H-NMR:
(CDCl3) δH 7.44–7.22 (complex m, 15H, Bn), 4.90 (d, J =
11.2 Hz, 1H, PhCH2), 4.81 (d, J = 11.7 Hz, 1H, PhCH2), 4.70 (d, J = 11.7 Hz, 1H,
PhCH2), 4.54 (d, J = 11.5 Hz, 1H, PhCH2), 4.53 (d, J = 12.2 Hz, 1H, PhCH2),
4.44 (d, J = 12.2 Hz, 1H, PhCH2), 3.94 (d, J = 7.8 Hz, 1H, H-1), 3.87 (ddd, J =
7.6, 3.7, 2.8 Hz, 1H, H-5), 3.79 (dd, J = 9.5, 7.6 Hz, 1H, H-4), 3.68 (d, J = 9.5, 4.9
Hz, 1H, H-3), 3.56 (dd, J = 10.6, 2.8 Hz, 1H, H-6a), 3.51 (dd, J = 10.6, 3.8 Hz, 1H,
H-6b), 1.87 (dd, J = 7.8, 4.9 Hz, 1H, H-2); 13C-NMR: (CDCl3) δC 138.1 (C, Bn),
137.9 (C, Bn), 137.7 (C, Bn), 128.5 (CH, Bn), 128.43 (CH, Bn), 128.35 (CH, Bn),
128.2 (CH, Bn), 127.87 (CH, Bn), 127.85 (CH, Bn), 127.78 (CH, Bn), 127.7 (CH,
Bn), 127.6 (CH, Bn), 80.2 (CH, C-5), 79.9 (CH, C-3), 75.0 (CH, C-4), 74.6 (CH2,
PhCH2), 73.3 (CH2, PhCH2), 71.8 (CH2, PhCH2), 70.1 (CH2, C-6), 59.2 (CH, C-1),
35.2 (CH, C-2), 33.9 (C, C-7); IR (KBr): νmax 3032, 2864, 1949, 1586, 1496, 1453,
1365, 1205, 1129, 1097, 1027, 735 cm−1.
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190: Rf 0.2 (9:1 hexanes:ethyl acetate); [α]
21
D −30 (c 1.0
CHCl3);
1H-NMR: (CDCl3) δH 7.44–7.18 (complex m, 15H,
Bn), 4.91 (d, J = 11.7 Hz, 1H, PhCH2), 4.82 (d, J = 11.0
Hz, 1H, PhCH2), 4.71 (d, J = 11.7 Hz, 1H, PhCH2), 4.65 (d,
J = 12.0 Hz, 1H, PhCH2), 4.56 (d, J = 12.0 Hz, 1H, PhCH2), 4.54 (d, J = 11.0
Hz, 1H, PhCH2), 4.17 (apparent t, J = 7.8 Hz, 1H, H-3), 4.07 (d, J = 7.8 Hz, 1H,
H-1), 3.94 (dd, J = 10.4, 7.6 Hz, 1H, H-4), 3.77 (dd, J = 11.0, 1.7 Hz, 1H, H-6a),
3.67 (dd, J = 11.1, 5.3 Hz, 1H, H-6b), 3.50 (ddd, J = 10.4, 5.3, 1.7 Hz, 1H, H-5),
2.30 (apparent t, J = 8.1 Hz, 1H, H-2); 13C-NMR: (CDCl3) δC 138.2 (C, Bn), 138.1
(C, Bn), 137.7 (C, Bn), 128.6 (CH, Bn), 128.3 (CH, Bn), 128.1 (CH, Bn), 127.93
(CH, Bn), 127.88 (CH, Bn), 127.69 (CH, Bn), 127.65 (CH, Bn), 127.5 (CH, Bn),
78.5 (CH, C-3), 78.4 (CH, C-5), 76.4 (CH, C-4), 74.6 (CH2, PhCH2), 73.6 (CH2,
PhCH2), 71.0 (CH2, PhCH2), 68.9 (CH2, C-6), 62.7 (CH, C-1), 33.7 (CH, C-2), 30.8
(C, C-7); IR (KBr): νmax 3024, 2866, 1496, 1453, 1363, 1179, 1093, 1027, 736, 697
cm−1.
B In a slight modification of Nagarajan’s procedure,45 a solution of tri-O-benzyl-
d-glucal (188) (495 mg, 1.19 mmol) and TEBAC (6 mg, 0.03 mmol) in bromoform
(2.0 mL, 23 mmol) was chilled to 0 ◦C, then treated dropwise with a solution of
sodium hydroxide (442 mg, 11.1 mmol) and potassium fluoride dihydrate (3.31 g)
in water (3.3 mL). The biphasic mixture was then sonicated for 10 periods of 10
minutes, maintaining the temperature of the sonicator bath between approximately
20–30 ◦C. The mixture was diluted with water (20 mL), extracted with diethyl
ether (3 x 20 mL), then the organic fractions were combined and washed with brine
(20 mL). The ethereal solution was dried, filtered and concentrated, then purified
by column chromatography (9:1 hexanes:ethyl acetate) to liberate recovered starting
material (188) (208 mg, 42%), in addition to cyclopropanes 97 (243 mg, 35%) and
190 (34 mg, 5%) (40% combined yield).
C In a slight modification of Nagarajan’s procedure,45 a solution of tri-O-benzyl-
d-glucal (188) (501 mg, 1.20 mmol) and TEBAC (6 mg, 0.03 mmol) in bromoform
(2.0 mL, 23 mmol) was chilled to 0 ◦C, then treated dropwise with a solution of
sodium hydroxide (402 mg, 10.1 mmol) and potassium fluoride dihydrate (2.99 g)
in water (3.0 mL). The biphasic mixture was then sonicated for eight periods of 30
minutes, maintaining the temperature of the sonicator bath between approximately
20–30 ◦C. The mixture was diluted with water (20 mL), extracted with diethyl
ether (3 x 20 mL), then the organic fractions were combined and washed with brine
(20 mL). The ethereal solution was dried, filtered and concentrated, then purified
by column chromatography (9:1 hexanes:ethyl acetate) to liberate recovered starting
material (188) (149 mg, 30%), in addition to cyclopropanes 97 (340 mg, 48%) and
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190 (43 mg, 6%) (54% combined yield).
D In a slight modification of Nagarajan’s procedure,45 a solution of tri-O-benzyl-
d-glucal (188) (533 mg, 1.28 mmol) and TEBAC (4 mg, 0.02 mmol) in bromoform
(2.0 mL, 23 mmol) was chilled to 0 ◦C, then treated dropwise with a solution of
sodium hydroxide (401 mg, 10.0 mmol) and potassium fluoride dihydrate (3.01 g)
in water (3.0 mL). The biphasic mixture was then sonicated for 12 periods of 30
minutes, maintaining the temperature of the sonicator bath between approximately
20–30 ◦C. The mixture was diluted with water (20 mL), extracted with diethyl
ether (3 x 20 mL), then the organic fractions were combined and washed with brine
(20 mL). The ethereal solution was dried, filtered and concentrated, then purified
by column chromatography (9:1 hexanes:ethyl acetate) to liberate recovered starting
material (188) (132 mg, 28%), in addition to cyclopropanes 97 (321 mg, 43%) and
190 (56 mg, 7%) (50% combined yield).
E In a slight modification of Nagarajan’s procedure,45 a solution of tri-O-benzyl-
d-glucal (188) (1.00 g, 2.40 mmol) and TEBAC (8 mg, 0.04 mmol) in bromoform
(4.0 mL, 46 mmol) was chilled to 0 ◦C, then treated dropwise with a solution of
sodium hydroxide (0.80 g, 20 mmol) and potassium fluoride dihydrate (6.04 g) in
water (6.0 mL). The biphasic mixture was then sonicated for 12 periods of 30 min-
utes, maintaining the temperature of the sonicator bath at approximately 20–30 ◦C.
The mixture was diluted with water (40 mL), extracted with diethyl ether (3 x
40 mL), then the organic fractions were combined and washed with brine (40 mL).
The ethereal solution was dried, filtered and concentrated then purified by column
chromatography (9:1 hexanes:ethyl acetate) to liberate recovered starting material
(188) (300 mg, 30%), in addition to cyclopropanes 97 (678 mg, 48%) and 190
(110 mg, 8%) (56% combined yield).
F In a slight modification of Nagarajan’s procedure,45 a solution of tri-O-benzyl-d-
glucal (188) (501 mg, 1.20 mmol) and TEBAC (9 mg, 0.04 mmol) in bromoform
(2.0 mL, 23 mmol) was chilled to 0 ◦C, then treated dropwise with a solution of
sodium hydroxide (398 mg, 9.95 mmol) and potassium fluoride dihydrate (3.01 g)
in water (3.0 mL). The biphasic mixture was stirred at room temperature for two
days. The mixture was diluted with water (20 mL), extracted with diethyl ether (3 x
20 mL), then the organic fractions were combined and washed with brine (20 mL).
The ethereal solution was dried, filtered and concentrated, then purified by column
chromatography (9:1 hexanes:ethyl acetate) to liberate recovered starting material
(188) (78 mg, 16%), in addition to cyclopropanes 97 (448 mg, 63%) and 190 (48 mg,
7%) (70% combined yield).
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Methyl 3,4,6-tri-O-benzyl-(2E)-2-C -(bromomethylene)-2-deoxy-β-d-
arabino-hexopyranoside (213) and methyl 3,4,6-tri-O-benzyl-(2E)-2-C -
(bromomethylene)-2-deoxy-α-d-arabino-hexopyranoside (214)
A In repetition of Nagarajan’s procedure,45 a solution of cyclopropane 97 (115
mg, 0.195 mmol) in methanol (2.1 mL) was treated with dry potassium carbonate
(136 mg, 0.984 mmol) and refluxed for eight hours. The solution was separated
between dichloromethane (10 mL) and water (10 mL), then the aqueous phase was
extracted with dichloromethane (2 x 10 mL). The combined organic fractions were
dried, filtered and concentrated to provide crude 2-C -branched sugars 213 and 214
as a yellow oil (1:1.3 ratio). Upon purification by column chromatography (20:1
hexanes:ethyl acetate), recovered starting material 97 (4 mg, 4%) was obtained, in
addition to 2-C -branched sugars 213 (34 mg, 32%) as a colourless oil, and 214 (37
mg, 35%) as a colourless oil (68% combined yield). The spectral data set matched
that for products previously isolated from this reaction (reported as the correspond-
ing oxepines 98 and 99).
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213: Rf 0.35 (9:1 hexanes:ethyl acetate); [α]
17
D +57 (c 1.0
CHCl3);
1H-NMR: (CDCl3) δH 7.41–7.18 (complex m, 15H,
Bn), 6.81 (d, J = 1.7 Hz, 1H, H-7), 5.19 (d, J = 1.7 Hz, 1H,
H-1), 4.73 (d, J = 1.2 Hz, 1H, H-3), 4.64 (d, J = 12.2 Hz, 1H,
PhCH2), 4.60 (d, J = 12.2 Hz, 1H, PhCH2), 4.52 (d, J = 11.5 Hz, 1H, PhCH2),
4.50 (d, J = 12.2 Hz, 1H, PhCH2), 4.43 (d, J = 12.2 Hz, 1H, PhCH2), 4.29 (d, J =
11.5 Hz, 1H, PhCH2), 3.74 (dd, J = 9.0, 1.5 Hz, 1H, H-4), 3.69 (ddd, J = 8.8, 5.1,
2.4 Hz, 1H, H-5), 3.65 (dd, J = 10.9, 2.5 Hz, 1H, H-6a), 3.62 (dd, J = 10.9, 5.3 Hz,
1H, H-6b), 3.47 (s, 3H, Me); 13C-NMR: (CDCl3) δC 138.3 (C, Bn), 138.1 (C, Bn),
137.7 (C, Bn), 137.5 (C, C-2), 128.32 (CH, Bn), 128.27 (CH, Bn), 128.0 (CH, Bn),
127.9 (CH, Bn), 127.8 (CH, Bn), 127.72 (CH, Bn), 127.67 (CH, Bn), 127.5 (CH,
Bn), 112.6 (CH, C-7), 98.9 (CH, C-1), 79.3 (CH, C-4), 76.1 (CH, C-3), 73.1 (CH2,
PhCH2), 71.5 (CH2, PhCH2), 71.4 (CH, C-5), 70.8 (CH2, PhCH2), 69.5 (CH2, C-6),
55.2 (CH3, Me); IR (KBr): νmax 3054, 3027, 2961, 2865, 1629, 1496, 1453, 1345,
1261, 1094, 1072, 802, 735, 697 cm−1.
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214: Rf 0.25 (9:1 hexanes:ethyl acetate); [α]
17
D +18 (c 1.0
CHCl3);
1H-NMR: (CDCl3) δH 7.36–7.24 (complex m, 15H,
Bn), 6.78 (s, 1H, H-7), 5.05 (s, 1H, H-1), 4.71 (d, J = 11.5
Hz, 1H, PhCH2), 4.69 (d, J = 3.7 Hz, 1H, H-3), 4.62 (d, J =
11.7 Hz, 1H, PhCH2), 4.52 (s, 2H, PhCH2), 4.50 (d, J = 11.7 Hz, 1H, PhCH2),
4.48 (d, J = 11.7 Hz, 1H, PhCH2), 3.91 (dd, J = 5.0, 3.8 Hz, 1H, H-4), 3.85 (m,
1H, H-5), 3.83 (dd, J = 10.0, 5.2 Hz, 1H, H-6a), 3.77 (dd, J = 10.0, 5.1 Hz, 1H,
H-6b), 3.47 (s, 3H, Me); 13C-NMR: (CDCl3) δC 138.4 (C, Bn), 138.3 (C, Bn), 137.8
(C, Bn), 137.0 (C, C-2), 128.4 (CH, Bn), 128.33 (CH, Bn), 128.25 (CH, Bn), 127.9
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(CH, Bn), 127.8 (CH, Bn), 127.7 (CH, Bn), 127.56 (CH, Bn), 127.55 (CH, Bn),
114.7 (CH, C-7), 101.1 (CH, C-1), 76.0 (CH, C-4), 74.9 (CH, C-5), 74.6 (CH, C-3),
73.3 (CH2, PhCH2), 72.2 (CH2, PhCH2), 70.9 (CH2, PhCH2), 70.6 (CH2, C-6), 55.8
(CH3, Me); IR (KBr): νmax 3060, 3030, 2912, 2865, 1629, 1496, 1453, 1363, 1303,
1205, 1097, 1072, 1027, 818, 735, 697 cm−1; HRMS:m/z C29H31O
79
5 BrNa
+ [M+Na]+
calcd 561.1253, found 561.1245.
B A portion of methanol (63 µL, 1.6 mmol) was treated with metallic sodium
(6.5 mg, 0.3 mmol), then once the sodium had reacted, the solution was diluted
with THF (1.7 mL), then treated with cyclopropane 97 (100 mg, 0.17 mmol) and
heated at reflux for 75 minutes. The solution was separated between dichloro-
methane (10 mL) and water (10 mL), then the aqueous phase was extracted with
dichloromethane (2 x 10 mL). The combined organic fractions were dried, filtered
and concentrated to provide crude products 213 and 214 as a yellow oil. Upon
separation by column chromatography (9:1 hexanes:ethyl acetate), the previously
isolated 2-C -substituted sugars 213 (20 mg, 22%) and 214 (45 mg, 49%) were ob-
tained (71% combined yield).
C A portion of methanol (200 µL, 4.9 mmol) was treated with metallic sodium
(19 mg, 0.8 mmol), then once the sodium had reacted, the solution was diluted
with THF (1.7 mL), then treated with cyclopropane 97 (85 mg, 0.14 mmol) and
heated at reflux for three hours. The solution was separated between dichloro-
methane (10 mL) and water (10 mL), then the aqueous phase was extracted with
dichloromethane (2 x 10 mL). The combined organic fractions were dried, filtered
and concentrated to provide crude products 213 and 214 as a yellow oil. Upon
separation by column chromatography (9:1 hexanes:ethyl acetate), the previously
isolated 2-C -substituted sugars 213 (30 mg, 38%) and 214 (20 mg, 26%) were ob-
tained (64% combined yield).
D A portion of methanol (0.2 mL, 0.49 mmol) was treated with metallic sodium
(8.5 mg, 0.36 mmol), then once the sodium had reacted, the solution was diluted
with THF (3.4 mL), then treated with cyclopropane 97 (202 mg, 0.343 mmol) and
stirred at room temperature for 90 minutes. The solution was separated between
dichloromethane (10 mL) and water (10 mL), then the aqueous phase was extracted
with dichloromethane (2 x 10 mL). The combined organic fractions were dried, fil-
tered and concentrated to provide crude products 213 and 214 as a yellow oil.
Upon separation by column chromatography (9:1 hexanes:ethyl acetate), the pre-
viously isolated 2-C -substituted sugars 213 (55 mg, 30%) and 214 (55 mg, 30%)
were obtained (60% combined yield).
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E A portion of methanol (26 µL, 0.64 mmol) was treated with metallic sodium
(1.5 mg, 70 µmol) in a clean NMR tube, then once the sodium had reacted, was
treated with a solution of cyclopropane 97 (21 mg, 36 µmol) in THF-d8 (0.85 mL).
The tube was flushed with argon, sealed with a septum, then allowed to react. Pro-
ton NMR spectra were obtained after 0, 7, 25, 49, 102 minutes reaction time. The
solution was separated between dichloromethane (10 mL) and water (10 mL), then
the aqueous phase was extracted with dichloromethane (2 x 10 mL). The combined
organic fractions were dried, filtered and concentrated to provide crude products
213 and 214.
F A portion of methanol (82 µL, 2.0 mmol) was treated with metallic sodium (6 mg,
0.3 mmol), then once the sodium had reacted, the solution was diluted with THF
(1.7 mL). The solution was transferred into a second flask containing minor cy-
clopropane 190 (92 mg, 0.16 mmol) and stirred at reflux for three hours. The
solution was separated between dichloromethane (10 mL) and water (10 mL), then
the aqueous phase was extracted with dichloromethane (2 x 10 mL). The combined
organic fractions were dried, filtered and concentrated to provide crude products
213 and 214 as a yellow oil. Upon separation by column chromatography (9:1 hex-
anes:ethyl acetate), starting material 97 (15 mg, 16%) and the previously isolated
2-C -branched sugars 213 (10 mg, 12%) and 214 (30 mg, 36%) were obtained (48%
combined yield).
G A portion of methanol (50 µL, 0.64 mmol) was treated with metallic sodium
(3 mg, 0.1 mmol) in a clean NMR tube, then once the sodium had reacted, was
treated with a solution of cyclopropanes 97 and 190 (approximate ratio 97:190 5:4,
52 mg, 88 µmol) in THF-d8 (0.85 mL). The tube was flushed with argon, sealed
with a septum, then allowed to react. Proton NMR spectra were obtained after 0,
15, 65, 115 minutes reaction time. The solution was separated between dichloro-
methane (10 mL) and water (10 mL), then the aqueous phase was extracted with
dichloromethane (2 x 10 mL). The combined organic fractions were dried, filtered
and concentrated to provide crude products 213 and 214.
Methyl 3,4,6-tri-O-benzyl-2-deoxy-2-C -(methylene)-α-d-arabino-
hexopyranoside (215)
A A solution of brominated sugar 214 (20 mg, 37 µmol) in THF (0.5 mL) was cooled
to −78 ◦C, then treated with n-butyllithium (50 µL, 80 µmol) and stirred at −78 ◦C
for one hour. The reaction mixture was then treated with water (50 µL, 2.8 mmol)
and immediately allowed to warm to room temperature. After 30 minutes additional
stirring, the reaction mixture was diluted with water (10 mL), then extracted with
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diethyl ether (3 x 10 mL). The ethereal fractions were combined, dried and concen-
trated to provide a colourless oil. This oil was purified by flash chromatography (9:1
hexanes:ethyl acetate), to provide the major observed product, exocyclic olefin 215
as a colourless oil (5 mg, 29%).
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Rf 0.25 (9:1 hexanes:ethyl acetate); [α]
17
D +13 (c 0.3 CHCl3);
1H-NMR: (CDCl3) δH 7.40–7.15 (complex m, 15H, Bn), 5.30
(s, 1H, H-7a), 5.16 (s, 1H, H-7b), 5.06 (s, 1H, H-1), 4.87 (d,
J = 10.7 Hz, 1H, PhCH2), 4.76 (d, J = 11.2 Hz, 1H, PhCH2),
4.70 (d, J = 11.2 Hz, 1H, PhCH2), 4.63 (d, J = 12.0 Hz, 1H, PhCH2), 4.51 (d, J =
12.2 Hz, 1H, PhCH2), 4.49 (d, J = 10.7 Hz, 1H, PhCH2), 4.42 (dd, J = 9.0, 2.0
Hz, 1H, H-3), 3.92 (ddd, J = 9.9, 3.8, 1.9 Hz, 1H, H-5), 3.75 (dd, J = 10.6, 3.9
Hz, 1H, H-6a), 3.69 (dd, J = 10.6, 1.9 Hz, 1H, H-6b), 3.60 (apparent t, J = 9.4
Hz, 1H, H-4), 3.38 (s, 3H, Me); 13C-NMR: (CDCl3) δC 142.3 (C, C-2), 138.32 (C,
Bn), 138.27 (C, Bn), 138.1 (C, Bn), 128.4 (CH, Bn), 128.3 (CH, Bn), 127.9 (CH,
Bn), 127.8 (CH, Bn), 127.7 (CH, Bn), 127.63 (CH, Bn), 127.61 (CH, Bn), 110.7
(CH2, C-7), 102.4 (CH, C-1), 81.2 (CH, C-3), 79.9 (CH, C-4), 74.9 (CH2, PhCH2),
73.5 (CH2, PhCH2), 73.4 (CH2, PhCH2), 71.5 (CH, C-5), 68.8 (CH2, C-6), 54.5
(CH3, Me); IR (KBr): νmax 3029, 2907, 1496, 1454, 1359, 1102, 1067, 1026, 968,
736, 697 cm−1; HRMS:m/z C29H32O5Na
+ [M+Na]+ calcd 483.2147, found 483.2145.
B Using a previously reported procedure,155 a solution of brominated sugar 214
(23 mg, 43 µmol) in 1,4-dioxane (1 mL) was treated successively with potassium car-
bonate (20 mg, 0.15 mmol), palladium-tetrakis(triphenylphosphine) (5 mg, 4 µmol)
and methaneboronic acid (4 mg, 70 µmol), then refluxed for two days. The reaction
mixture was then treated with water (25 µL, 1.4 mmol) and reacted for an additional
five hours. The reaction mixture was diluted with water (10 mL), then extracted
with dichloromethane (2 x 10 mL). The organic fractions were combined, dried and
concentrated to provide a green oil. This oil was purified by flash chromatography
(9:1 hexanes:ethyl acetate), to provide both unreacted starting material 214 (8 mg,
35%) and exocyclic olefin 215 (6 mg, 30%).
Methyl-d 3 3,4,6-tri-O-benzyl-(2E)-2-C -(bromomethylene-d 1)-2-deoxy-β-
d-arabino-hexopyranoside (219) and methyl-d 3 3,4,6-tri-O-benzyl-(2E)-
2-C -(bromomethylene-d 1)-2-deoxy-α-d-arabino-hexopyranoside (220)
Methanol-d4 (0.6 mL, 15 mmol) was treated with metallic sodium (5 mg, 0.2 mmol),
then once the sodium had reacted, the solution was treated with cyclopropane 97
(38 mg, 0.065 mmol) and heated at reflux for two hours. The solution was separated
between dichloromethane (10 mL) and water (10 mL), then the aqueous phase was
extracted with dichloromethane (2 x 10 mL). The combined organic fractions were
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dried, filtered and concentrated to provide tetra-deutero sugars 219 and 220 as
a yellow oil. Upon column chromatography (9:1 hexanes:ethyl acetate), recovered
starting material 97 (5 mg, 13%) was obtained, in addition to 2-C -branched sugars
219 (7 mg, 20%) and 220 (10 mg, 29%), isolated as colourless oils (49% combined
yield).
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219: Rf 0.2 (9:1 hexanes:ethyl acetate);
1H-NMR: (CDCl3)
δH 7.41–7.18 (complex m, 15H, Bn), 5.19 (d, J = 1.7 Hz, 1H,
H-1), 4.73 (d, J = 1.2 Hz, 1H, H-3), 4.64 (d, J = 12.2 Hz,
1H, PhCH2), 4.60 (d, J = 12.2 Hz, 1H, PhCH2), 4.52 (d, J =
11.5 Hz, 1H, PhCH2), 4.51 (d, J = 12.2 Hz, 1H, PhCH2), 4.43 (d, J = 12.2 Hz,
1H, PhCH2), 4.29 (d, J = 11.5 Hz, 1H, PhCH2), 3.74 (dd, J = 9.0, 1.5 Hz, 1H,
H-4), 3.69 (ddd, J = 8.7, 5.5, 2.7 Hz, 1H, H-5), 3.65–3.59 (complex m, 2H, H-6a,b);
13C-NMR: (CDCl3) δC 138.3 (C, Bn), 138.1 (C, Bn), 137.6 (C, Bn), 137.4 (C, C-2),
128.32 (CH, Bn), 128.28 (CH, Bn), 128.0 (CH, Bn), 127.9 (CH, Bn), 127.8 (CH,
Bn), 127.72 (CH, Bn), 127.68 (CH, Bn), 127.5 (CH, Bn), 98.9 (CH, C-1), 79.2 (CH,
C-4), 76.1 (CH, C-3), 73.1 (CH2, PhCH2), 71.5 (CH2, PhCH2), 71.4 (CH, C-5), 70.7
(CH2, PhCH2), 69.5 (CH2, C-6).
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220: Rf 0.15 (9:1 hexanes:ethyl acetate);
1H-NMR: (CDCl3)
δH 7.36–7.24 (complex m, 15H, Bn), 5.05 (s, 1H, H-1), 4.72
(d, J = 11.5 Hz, 1H, PhCH2), 4.69 (d, J = 3.9 Hz, 1H, H-3),
4.62 (d, J = 11.7 Hz, 1H, PhCH2), 4.52 (s, 2H, PhCH2), 4.51
(d, J = 11.8 Hz, 1H, PhCH2), 4.49 (d, J = 11.8 Hz, 1H, PhCH2), 3.91 (dd, J = 5.0,
3.8 Hz, 1H, H-4), 3.85 (m, 1H, H-5), 3.82–3.76 (complex m, 2H, H-6a,b); 13C-NMR:
(CDCl3) δC 138.3 (C, Bn), 138.2 (C, Bn), 137.7 (C, Bn), 136.8 (C, C-2), 128.4 (CH,
Bn), 128.3 (CH, Bn), 128.2 (CH, Bn), 127.9 (CH, Bn), 127.8 (CH, Bn), 127.7 (CH,
Bn), 127.54 (CH, Bn), 127.53 (CH, Bn), 101.0 (CH, C-1), 76.0 (CH, C-4), 74.8 (CH,
C-5), 74.5 (CH, C-3), 73.2 (CH2, PhCH2), 72.2 (CH2, PhCH2), 70.8 (CH2, PhCH2),
70.5 (CH2, C-6); HRMS: m/z C29H27D4O
79
5 BrNa
+ [M+Na]+ calcd 565.1504, found
565.1498.
Allyl 3,4,6-tri-O-benzyl-(2E)-2-C -(bromomethylene)-2-deoxy-β-d-
arabino-hexopyranoside (236) and allyl 3,4,6-tri-O-benzyl-(2E)-2-C -
(bromomethylene)-2-deoxy-α-d-arabino-hexopyranoside (237)
A A solution of allyl alcohol (70 µL, 1.0 mmol) in THF (1.7 mL) was treated with
sodium hydride (12 mg, 0.3 mmol), then once evolution of hydrogen had ceased,
the solution was treated with cyclopropane 97 (103 mg, 0.175 mmol) and heated at
reflux for five hours. The solution was separated between dichloromethane (10 mL)
and water (10 mL), then the aqueous phase was extracted with dichloromethane
(2 x 10 mL). The combined organic fractions were dried, filtered and concentrated
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to provide crude products 236 and 237 as a yellow oil. Upon separation by column
chromatography (14:1 hexanes:ethyl acetate), allyl glycosides 236 (22 mg, 22%) and
237 (48 mg, 49%) were obtained as colourless oils (71% combined yield).
O
OBn
BnO O
Br
BnO
8
9
101
23
4
56
7
236: Rf 0.25 (14:1 hexanes:ethyl acetate); [α]
20
D +66 (c
1.7 CHCl3);
1H-NMR: (CDCl3) δH 7.41–7.18 (complex
m, 15H, Bn), 6.87 (d, J = 1.7 Hz, 1H, H-7), 5.93 (ddd,
J = 17.1, 11.0, 5.6 Hz, 1H, H-9), 5.35 (s, 1H, H-1), 5.28
(dd, J = 17.4, 1.5 Hz, 1H, H-10a), 5.17 (dd, J = 10.5, 1.2 Hz, 1H, H-10b), 4.75 (s,
1H, H-3), 4.65 (d, J = 11.9 Hz, 1H, PhCH2), 4.60 (d, J = 12.0 Hz, 1H, PhCH2),
4.53–4.48 (complex m, 2H, PhCH2), 4.44 (d, J = 12.2 Hz, 1H, PhCH2), 4.33 (dd,
J = 13.1, 5.1 Hz, 1H, H-8a), 4.29 (d, J = 11.5 Hz, 1H, PhCH2), 4.10 (dd, J =
13.1, 6.2 Hz, 1H, H-8b), 3.77–3.74 (complex m, 2H, H-4,5), 3.65–3.60 (complex m,
2H, H-6a,b); 13C-NMR: (CDCl3) δC 138.3 (C, Bn), 138.1 (C, Bn), 137.63 (C, Bn),
137.58 (C, C-2), 134.1 (CH, C-9), 128.32 (CH, Bn), 128.27 (CH, Bn), 128.0 (CH,
Bn), 127.9 (CH, Bn), 127.8 (CH, Bn), 127.73 (CH, Bn), 127.69 (CH, Bn), 127.5
(CH, Bn), 117.2 (CH2, C-10), 112.6 (CH, C-7), 97.1 (CH, C-1), 79.3 (CH, C-4), 76.1
(CH, C-3), 73.1 (CH2, PhCH2), 71.5 (CH2, PhCH2), 71.4 (CH, C-5), 70.8 (CH2,
PhCH2), 69.5 (CH2, C-6), 68.2 (CH2, C-8); IR (KBr): νmax 3087, 3063, 3030, 2906
2865, 1951, 1632, 1496, 1454, 1332, 1206, 1096, 1067, 1028, 927, 811, 736, 697 cm−1.
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237: Rf 0.2 (14:1 hexanes:ethyl acetate); [α]
20
D +11 (c
4.0 CHCl3);
1H-NMR: (CDCl3) δH 7.35–7.25 (complex
m, 15H, Bn), 6.79 (s, 1H, H-7), 5.89 (ddd, J = 16.8,
11.2, 5.4 Hz, 1H, H-9), 5.25 (dd, J = 17.2, 1.6 Hz, 1H,
H-10a), 5.19 (s, 1H, H-1), 5.16 (dd, J = 10.2, 1.2 Hz, 1H, H-10b), 4.72 (d, J =
3.2 Hz, 1H, H-3), 4.72 (d, J = 11.3 Hz, 1H, PhCH2), 4.63 (d, J = 11.8 Hz, 1H,
PhCH2), 4.52 (d, J = 12.2 Hz, 1H, PhCH2), 4.49 (s, 2H, PhCH2), 4.47 (d, J =
11.5 Hz, 1H, PhCH2), 4.35 (dd, J = 13.0, 4.9 Hz, 1H, H-8a), 4.08 (dd, J = 13.0,
5.8 Hz, 1H, H-8b), 3.91–3.87 (complex m, 2H, H-4,5), 3.84–3.78 (complex m, 2H,
H-6a,b); 13C-NMR: (CDCl3) δC 138.4 (C, Bn), 138.2 (C, Bn), 137.7 (C, Bn), 136.7
(C, C-2), 134.0 (CH, C-9), 128.4 (CH, Bn), 128.3 (CH, Bn), 128.2 (CH, Bn), 127.9
(CH, Bn), 127.8 (CH, Bn), 127.7 (CH, Bn), 127.52 (CH, Bn), 127.48 (CH, Bn),
117.1 (CH2, C-10), 114.6 (CH, C-7), 98.8 (CH, C-1), 75.8 (CH, C-4), 74.9 (CH,
C-5), 74.2 (CH, C-3), 73.2 (CH2, PhCH2), 72.1 (CH2, PhCH2), 70.63 and 70.60
(CH2, PhCH2 and CH2, C-6), 68.7 (CH2, C-8); IR (KBr): νmax 3063, 3030, 2864,
1951, 1873, 1631, 1496, 1454, 1365, 1333, 1305, 1207, 1094, 1074, 1027, 819, 735,
697 cm−1; HRMS: m/z C31H33O
79
5 BrNa
+ [M+Na]+ calcd 587.1409, found 587.1403.
B A solution of allyl alcohol (60 µL, 0.9 mmol) in THF (1.7 mL) was treated with
sodium hydride (46 mg, 1.2 mmol), then once evolution of hydrogen had ceased,
the solution was treated with cyclopropane 97 (102 mg, 0.173 mmol) and heated at
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reflux for five hours. The solution was separated between dichloromethane (10 mL)
and water (10 mL), then the aqueous phase was extracted with dichloromethane
(2 x 10 mL). The combined organic fractions were dried, filtered and concentrated
to provide crude products 236 and 237 as a yellow oil. Upon separation by column
chromatography (14:1 hexanes:ethyl acetate), allyl glycosides 236 (19 mg, 19%) and
237 (35 mg, 36%) were obtained (55% combined yield).
Benzyl 3,4,6-tri-O-benzyl-(2E)-2-C -(bromomethylene)-2-deoxy-β-d-
arabino-hexopyranoside (238) and benzyl 3,4,6-tri-O-benzyl-(2E)-2-C -
(bromomethylene)-2-deoxy-α-d-arabino-hexopyranoside (239)
Benzyl alcohol (60 µL, 0.58 mmol) was treated with metallic sodium (6 mg, 0.3
mmol), then once the sodium had reacted, the solution was diluted with THF
(1.7 mL). The solution was then treated with cyclopropane 97 (48 mg, 82 µmol)
and heated at reflux for four hours. The solution was separated between dichloro-
methane (10 mL) and water (10 mL), then the aqueous phase was extracted with
dichloromethane (2 x 10 mL). The combined organic fractions were dried, filtered
and concentrated to provide crude products 238 and 239 as a yellow oil. Upon sep-
aration by column chromatography (14:1 hexanes:ethyl acetate), benzyl glycosides
238 (16.5 mg, 33%) and 239 (15 mg, 30%) were obtained as colourless oils (63%
combined yield).
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238: Rf 0.25 (14:1 hexanes:ethyl acetate); [α]
20
D +27 (c 0.45
CHCl3);
1H-NMR: (CDCl3) δH 7.39–7.18 (complex m, 20H,
Bn), 6.87 (s, 1H, H-7), 5.40 (s, 1H, H-1), 4.87 (d, J = 11.9
Hz, 1H, PhCH2), 4.75 (s, 1H, H-3), 4.63 (d, J = 12.2 Hz, 1H,
PhCH2), 4.62–4.59 (complex m, 2H, PhCH2), 4.51 (d, J = 11.5 Hz, 1H, PhCH2),
4.50 (d, J = 12.2 Hz, 1H, PhCH2), 4.42 (d, J = 12.3 Hz, 1H, PhCH2), 4.28 (d, J =
11.4 Hz, 1H, PhCH2), 3.80–3.75 (complex m, 2H, H-4,5), 3.63–3.60 (complex m, 2H,
H-6a,b); 13C-NMR: (CDCl3) δC 138.3 (C, Bn), 138.0 (C, Bn), 137.7 (C, Bn), 137.62
(C, Bn and C, C-2), 128.4 (CH, Bn), 128.33 (CH, Bn), 128.32 (CH, Bn), 128.28
(CH, Bn), 128.02 (CH, Bn), 127.97 (CH, Bn), 127.9 (CH, Bn), 127.78 (CH, Bn),
127.75 (CH, Bn), 127.70 (CH, Bn), 127.5 (CH, Bn), 112.8 (CH, C-7), 97.1 (CH,
C-1), 79.3 (CH, C-4), 76.0 (CH, C-3), 73.1 (CH2, PhCH2), 71.48 and 71.47 (CH2,
PhCH2 and CH, C-5), 70.8 (CH2, PhCH2), 69.5 (CH2, C-6), 69.1 (CH2, PhCH2);
IR (KBr): νmax 3063, 3030, 2865, 1633, 1496, 1454, 1335, 1207, 1097, 1067, 1027,
807, 733, 694 cm−1.
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239: Rf 0.2 (14:1 hexanes:ethyl acetate); [α]
20
D −20 (c 0.3
CHCl3);
1H-NMR: (CDCl3) δH 7.40–7.24 (complex m, 20H,
Bn), 6.76 (s, 1H, H-7), 5.24 (s, 1H, H-1), 4.91 (d, J = 11.9 Hz,
1H, PhCH2), 4.75 (d, J = 2.4 Hz, 1H, H-3), 4.72 (d, J = 11.5
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Hz, 1H, PhCH2), 4.65 (d, J = 11.7 Hz, 1H, PhCH2), 4.60 (d, J = 11.7 Hz, 1H,
PhCH2), 4.54 (d, J = 11.5 Hz, 1H, PhCH2), 4.47 (d, J = 11.0 Hz, 1H, PhCH2),
4.47 (s, 2H, PhCH2), 3.95–3.92 (complex m, 2H, H-4,5), 3.86 (dd, J = 10.3, 6.1
Hz, 1H, H-6a), 3.82 (dd, J = 10.3, 4.9 Hz, 1H, H-6b); 13C-NMR: (CDCl3) δC 138.3
(C, Bn), 138.2 (C, Bn), 137.7 (C, Bn), 137.5 (C, Bn), 136.6 (C, C-2), 128.62 (CH,
Bn), 128.57 (CH, Bn), 128.4 (CH, Bn), 128.33 (CH, Bn), 128.30 (CH, Bn), 128.2
(CH, Bn), 127.9 (CH, Bn), 127.8 (CH, Bn), 127.7 (CH, Bn), 127.6 (CH, Bn), 127.5
(CH, Bn), 127.4 (CH, Bn), 114.8 (CH, C-7), 98.9 (CH, C-1), 75.8 (CH, C-4), 75.0
(CH, C-5), 74.3 (CH, C-3), 73.2 (CH2, PhCH2), 72.1 (CH2, PhCH2), 70.6 (CH2,
C-6), 70.5 (CH2, PhCH2), 69.6 (CH2, PhCH2); IR (KBr): νmax 3030, 2864, 1629,
1496, 1453, 1336, 1304, 1207, 1094, 1075, 1026, 819, 735, 696 cm−1; HRMS: m/z
C35H35O
79
5 BrNa
+ [M+Na]+ calcd 637.1566, found 637.1569.
N,N -Diethyl 3,4,6-tri-O-benzyl-(2E)-2-C -(bromomethylene)-2-deoxy-β-
d-arabino-hexopyranosyl amine (240) and N,N -diethyl 3,4,6-tri-O-
benzyl-(2E)-2-C -(bromomethylene)-2-deoxy-α-d-arabino-hexopyranosyl
amine (241)
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Diethylamine (50 µL, 0.53 mmol) was di-
luted with THF (1.7 mL), then treated
with sodium hydride (18 mg, 0.45 mmol).
Once the sodium had reacted, the solu-
tion was treated with cyclopropane 97 (109 mg, 0.185 mmol) and heated at reflux
for six hours. The solution was separated between dichloromethane (10 mL) and
water (10 mL), then the aqueous phase was extracted with dichloromethane (2 x
10 mL). The combined organic fractions were dried, filtered and concentrated to
provide crude products 240 and 241 as a yellow oil. Upon separation by column
chromatography (20:1 hexanes:ethyl acetate), a mixture of glycosylamines 240 and
241 (48 mg, 45%) was obtained as a pale–yellow oil, in addition to recovered start-
ing material (15 mg, 14%).
1,5-Anhydro-3,4,6-tri-O-benzyl-2-deoxy-1,2-C -((S)-bromomethylene)-d-
glycero-d-gulo-hexitol (235)
gem-Dibromocyclopropane 97 (99 mg, 0.17 mmol) was dissolved in THF (1.7 mL),
cooled to −78 ◦C, then treated with n-butyllithium (110 µL, 0.176 mmol). The
reaction was stirred for 10 minutes, then quenched with water (8 µL of a 50% solution
in THF, 0.2 mmol). 10% aqueous hydrochloric acid was then added (10 mL), then
the mixture was extracted with dichloromethane (3 x 10 mL). The organic fractions
were combined, dried and concentrated to provide an orange oil. This oil was purified
by flash chromatography (14:1 hexanes:ethyl acetate), to provide both unreacted
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starting material 97 (26 mg, 26%) and bromocyclopropane 235 as a colourless oil
(22 mg, 26%).
O
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Rf 0.2 (14:1 hexanes:ethyl acetate); [α]
17
D +23 (c 1.7 CHCl3);
1H-NMR: (CDCl3) δH 7.37–7.23 (complex m, 15H, Bn), 4.74
(d, J = 11.7 Hz, 1H, PhCH2), 4.70 (d, J = 11.5 Hz, 1H,
PhCH2), 4.60 (d, J = 11.7 Hz, 1H, PhCH2), 4.55–4.49 (com-
plex m, 3H, PhCH2), 3.81 (dd, J = 7.8, 1.5 Hz, 1H, H-1), 3.77 (ddd, J = 6.0, 5.5,
3.7 Hz, 1H, H-5), 3.74 (dd, J = 6.3, 2.9 Hz, 1H, H-3), 3.66 (d, J = 10.4, 6.0 Hz,
1H, H-6a), 3.56 (d, J = 3.7 Hz, 1H, H-4), 3.54 (d, J = 5.4 Hz, 1H, H-6b), 3.01 (dd,
J = 4.5, 1.6 Hz, 1H, H-7), 1.54 (ddd, J = 7.8, 4.7, 3.0 Hz, 1H, H-2); 13C-NMR:
(CDCl3) δC 138.02 (C, Bn), 137.99 (C, Bn), 137.6 (C, Bn), 128.5 (CH, Bn), 128.41
(CH, Bn), 128.40 (CH, Bn), 127.91 (CH, Bn), 127.86 (CH, Bn), 127.8 (CH, Bn),
127.73 (CH, Bn), 127.70 (CH, Bn), 127.68 (CH, Bn), 75.9 (CH, C-3), 75.3 (CH,
C-5), 74.8 (CH, C-4), 73.3 (CH2, PhCH2), 73.1 (CH2, PhCH2), 71.4 (CH2, PhCH2),
69.3 (CH2, C-6), 56.7 (CH, C-1), 26.3 (CH, C-2), 20.5 (CH, C-7); IR (KBr): νmax
3062, 3030, 2862, 1496, 1453, 1364, 1200, 1094, 1027, 736, 697 cm−1; HRMS: m/z
C28H29O
79
4 BrNa
+ [M+Na]+ calcd 531.1147, found 531.1143.
Methyl 3,4,6-tri-O-benzyl-(2E)-2-C -(but-3-enylidene)-2-deoxy-α-d-
arabino-hexopyranoside (242)
Using a previously reported procedure,156 a solution of brominated sugar 214 (25 mg,
46 µmol) in DMF (1 mL) was treated successively with allyltributylstannane (18 µL,
58 µmol) and palladium-tetrakis(triphenylphosphine) (7 mg, 6 µmol), then stirred
at 100 ◦C for one day. The reaction mixture was treated with additional palladium-
tetrakis(triphenylphosphine) (7 mg, 6 µmol), then stirred for an additional day. The
reaction mixture was diluted with water (10 mL), then extracted with dichlorometh-
ane (3 x 10 mL). The organic fractions were combined, dried and concentrated to
provide a yellow oil. This oil was purified by flash chromatography (9:1 hexanes:ethyl
acetate), to provide diene 242 (12 mg, 52%) as a colourless oil.
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Rf 0.3 (9:1 hexanes:ethyl acetate); [α]
17
D −12 (c 0.5 CHCl3);
1H-NMR: (CDCl3) δH 7.35–7.13 (complex m, 15H, Bn), 5.87
(t, J = 7.6 Hz, 1H, H-7), 5.80 (ddt, J = 17.1, 10.3, 6.2 Hz,
1H, H-9), 5.06 (s, 1H, H-1), 5.02 (ddd, J = 17.1, 3.5, 1.9 Hz,
1H, H-10a), 4.99 (ddd, J = 10.3, 3.9, 1.6 Hz, 1H, H-10b), 4.68
(d, J = 12.0 Hz, 1H, PhCH2), 4.65 (d, J = 12.0 Hz, 1H, PhCH2), 4.63 (d, J =
11.5 Hz, 1H, PhCH2), 4.52 (d, J = 12.2 Hz, 1H, PhCH2), 4.49 (d, J = 12.0 Hz,
1H, PhCH2), 4.49 (m, 1H, H-3), 4.40 (d, J = 11.5 Hz, 1H, PhCH2), 3.77 (ddd, J =
9.3, 4.1, 2.9 Hz, 1H, H-5), 3.72 (dd, J = 9.4, 4.5 Hz, 1H, H-4), 3.66–3.68 (complex
m, 2H, H-6a,b), 3.44 (s, 3H, Me), 2.97 (apparent td, J = 7.0, 1.5 Hz, 2H, H-8a,b);
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13C-NMR: (CDCl3) δC 138.31 (C, 2 x Bn), 138.0 (C, Bn), 136.5 (CH, C-9), 132.4
(C, C-2), 129.9 (CH, C-7), 128.4 (CH, Bn), 128.30 (CH, Bn), 128.28 (CH, Bn),
127.81 (CH, Bn), 127.79 (CH, Bn), 127.64 (CH, Bn), 127.58 (CH, Bn), 127.54 (CH,
Bn), 127.50 (CH, Bn), 115.4 (CH2, C-10), 101.8 (CH, C-1), 79.7 (CH, C-4), 77.3
(CH, C-3), 73.2 (CH2, PhCH2), 73.0 (CH2, PhCH2), 71.5 (CH2, PhCH2), 71.3 (CH,
C-5), 69.4 (CH2, C-6), 54.8 (CH3, Me), 31.4 (CH2, C-8); IR (KBr): νmax 3030, 2920,
1723, 1496, 1453, 1356, 1091, 1067, 1027, 750, 698 cm−1; HRMS: m/z C32H36O5Na
+
[M+Na]+ calcd 523.2460, found 523.2462.
d-Galactal (186)
Using a modification of Kozikowski’s procedure,89 a magnetically stirred solution
of d-galactose (125 mg, 0.7 mmol) in acetic anhydride (75 mL, 790 mmol) was
treated dropwise with conc. perchloric acid (0.45 mL, 6.9 mmol). d-galactose (19.9 g,
110.3 mmol) was slowly added over half an hour, at a rate that maintained a temper-
ature of 40–50 ◦C. Upon complete addition of d-galactose, the solution was allowed
to cool to room temperature, then treated with a 33% (w/w) solution of hydrobromic
acid in acetic acid (75 mL, 410 mmol). After 90 minutes, the solution was diluted
with dichloromethane (180 mL) and washed with ice–cold water (2 x 50 mL), then
with cold sat. sodium bicarbonate solution (4 x 100 mL). The organic phase was
dried, filtered and concentrated to afford crude tetra-O-acetyl-α-d-galactopyranosyl
bromide (248) as a pale–yellow oil.
A mechanically stirred dispersion of zinc dust (48.0 g, 734 mmol) in water (150 mL)
was cooled to 0 ◦C, then diluted with acetic acid (150 mL), then treated drop-
wise with a solution of tetra-O-acetyl-α-d-galactopyranosyl bromide in diethyl ether
(150 mL), over one hour. The reaction was allowed to warm to room temperature
and left to proceed overnight. The solution was filtered, then diluted with dichloro-
methane (200 mL). The solution was then washed successively with water (3 x
60 mL), sat. sodium bicarbonate solution (3 x 50 mL), then brine (60 mL). The or-
ganic phase was dried, filtered and concentrated to provide tri-O-acetyl-d-galactal
(180) (27.7 g) as a pale–yellow oil.
A solution of triethylamine (110 mL, 780 mmol) in methanol (50% of an aqueous
solution, 1100 mL) was treated with tri-O-acetyl-d-galactal (27.7 g) and stirred for
90 minutes. The mixture was concentrated to liberate crude d-galactal, contami-
nated with triethylamine. The crude mixture was successively treated with portions
of methanol, then concentrated to remove the triethylamine. The oil was dissolved
in methanol (15 mL), then diluted successively with acetone (100 mL) and diethyl
ether (200 mL), which led to the precipitation of impurities. The solution was fil-
tered and concentrated to afford d-galactal (186) as a pale–brown solid (6.63 g, 41%
crude yield), which was used without further purification.
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HO
1
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6 1H-NMR: (D2O) δH 6.25 (dd, J = 6.3, 1.2 Hz, 1H, H-1), 4.77 (dd,
J = 6.1, 2.4 Hz, 1H, H-2), 4.66 (complex m, 3H, 3 x OH) 4.19 (dt,
J = 7.1, 2.1 Hz, 1H, H-3), 3.84 (complex m, 3H, H-5,6), 3.64 (dd,
J = 9.0, 7.1 Hz, 1H, H-4); 13C-NMR: (D2O) δH 143.8 (CH, C-1),
102.7 (CH, C-2), 78.0 (CH, C-5), 68.7 (CH, C-4), 68.2 (CH, C-3), 59.9 (CH2, C-6);
IR (KBr): νmax 3383, 3060, 2952, 2892, 1643, 1219, 1020 cm
−1.
Tri-O-benzyl-d-galactal (43)
A solution of d-galactal (186) (2.00 g, 13.7 mmol) in DMF (80 mL) was cooled
to 0 ◦C, then treated with sodium hydride (2.13 g, 53.2 mmol). The solution was
stirred at 0 ◦C for 30 minutes, then treated with benzyl bromide (5.6 mL, 47 mmol)
and allowed to warm to room temperature. After 19 hours, the solution was diluted
with water (40 mL) and the product extracted with diethyl ether (3 x 100 mL).
The organic fractions were combined, dried, filtered and concentrated to provide
the crude product as a concentrated solution in DMF. Purification by column chro-
matography (9:1 hexanes:ethyl acetate) afforded 43 (3.53 g, 62%) as a white solid.
The spectral data matched that reported previously.154
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56 Rf 0.3 (9:1 hexanes:ethyl acetate); m.p. 47–51
◦C (lit.154 m.p. 52–
54 ◦C); 1H-NMR: (CDCl3) δH 7.35–7.26 (complex m, 15H, Bn),
6.38 (dd, J = 6.3, 1.2 Hz, 1H, H-1), 4.89 (d, J = 12.0 Hz, 1H,
PhCH2), 4.86 (m, 1H, H-2), 4.69–4.61 (complex m, 3H, PhCH2),
4.51 (d, J = 12.0 Hz, 1H, PhCH2), 4.43 (d, J = 12.0 Hz, 1H, PhCH2), 4.20–4.19
(complex m, 1H, H-3,5), 3.96 (m, 1H, H-4), 3.79 (dd, J = 10.3, 7.3 Hz, 1H, H-6a),
3.65 (dd, J = 10.3, 5.1 Hz, 1H, H-6b); 13C-NMR: (CDCl3) δC 144.2 (CH, C-1), 138.5
(C, Bn), 138.3 (C, Bn), 138.0 (C, Bn), 128.4 (CH, Bn), 128.3 (CH, Bn), 128.2 (CH,
Bn), 127.9 (CH, Bn), 127.7 (CH, Bn), 127.6 (CH, Bn), 127.4 (CH, Bn), 100.0 (CH,
C-2), 75.7 (CH, C-5), 73.4 (CH2, PhCH2), 73.3 (CH2, PhCH2), 71.2 (CH, C-4), 70.9
(CH2, PhCH2), 70.7 (CH, C-3), 68.4 (CH2, C-6); IR (KBr): νmax 3087, 3064, 3025,
2874, 1951, 1809, 1642, 1453, 1159, 1098, 747 cm−1.
Di-O-acetyl-d-xylal (181)
Using a modification of Kozikowski’s procedure,89 a magnetically stirred solution of
d-xylose (30 mg, 0.2 mmol) in acetic anhydride (15 mL, 160 mmol) was treated drop-
wise with conc. perchloric acid (0.09 mL, 1.4 mmol). Additional d-xylose (3.90 g,
26.0 mmol) was slowly added over half an hour, at a rate that maintained a temper-
ature of 40–50 ◦C. Upon complete addition of d-xylose, the solution was allowed to
cool to room temperature, then treated with a 33% (w/w) solution of hydrobromic
acid in acetic acid (15 mL, 83 mmol). After 90 minutes, the solution was diluted
122
with dichloromethane (40 mL) and washed with ice–cold water (3 x 20 mL), then
with cold sat. sodium bicarbonate solution (2 x 20 mL). The organic phase was
dried, filtered and concentrated to afford crude tetra-O-acetyl-α-d-xylopyranosyl
bromide (249) as an orange oil.
A mechanically stirred dispersion of zinc dust (9.9 g, 150 mmol) in water (30 mL) was
cooled to 0 ◦C, then diluted with acetic acid (30 mL), then treated dropwise with a
solution of tetra-O-acetyl-α-d-xylopyranosyl bromide in diethyl ether (40 mL), over
half an hour, then allowed to react further at 0 ◦C for three hours. The solution
was filtered, then diluted with dichloromethane (40 mL). The resulting solution was
washed successively with water (3 x 20 mL), sat. sodium bicarbonate solution (3 x
20 mL), then brine (20 mL). The organic phase was dried, filtered and concentrated
to provide crude di-O-acetyl-d-xylal as a colourless oil (5.18 g), which was purified
by column chromatography (3:1 hexanes:ethyl acetate) to liberate glycal 181 (2.00 g,
38%) as an off–white solid. The spectral data matched that reported previously.157
O
OAc
AcO
1
2
3
4
5 Rf 0.4 (3:1 hexanes:ethyl acetate); m.p. 54–56
◦C; (lit.110 m.p. 51 ◦C);
1H-NMR: (CDCl3) δH 6.60 (d, J = 5.6 Hz, 1H, H-1), 4.99–4.94 (com-
plex m, 3H, H-2,3,4), 4.18 (ddd, J = 12.2, 3.1, 1.5 Hz, 1H, H-5a), 3.97
(dd, J = 12.2, 1.2 Hz, 1H, H-5b), 2.10 (s, 3H, Ac), 2.07 (s, 3H, Ac);
13C-NMR: (CDCl3) δC 169.9 (C, CH3CO), 169.8 (C, CH3CO), 148.0 (CH, C-1), 97.4
(CH, C-2), 67.2 (CH, C-4), 63.6 (CH2, C-5), 63.4 (CH, C-3), 21.1 (CH3, Ac), 21.0
(CH3, Ac).
Di-O-benzyl-d-xylal (189)
A solution of di-O-acetyl-d-xylal (181) (672 mg, 3.35 mmol) in methanol (35 mL)
was treated with metallic sodium (4 mg, 0.17 mmol) and stirred for 90 minutes at
room temperature. The mixture was treated with water (5 mL) and a piece of dry
ice (5 g), then concentrated to liberate crude d-xylal as a colourless oil (413 mg).
This oil was dissolved in DMF (35 mL), cooled to 0 ◦C, then treated with tetra-
butylammonium iodide (71 mg, 0.19 mmol), followed by sodium hydride (364 mg,
9.10 mmol). The solution was stirred at 0 ◦C for 30 minutes, then treated with ben-
zyl bromide (0.92 mL, 7.7 mmol) and allowed to warm to room temperature. The
mixture was stirred overnight, then quenched with water (30 mL) and sat. copper
sulfate solution (30 mL), then the product was extracted with diethyl ether (3 x
50 mL). The organic fractions were combined, washed with brine (20 mL), dried,
filtered and concentrated to provide crude di-O-benzyl-d-xylal (189). Purification
by column chromatography (9:1 hexanes:ethyl acetate) afforded 189 (665 mg, 66%)
as a white solid. The spectral data matched that reported previously.154
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OOBn
BnO
1
2
3
4
5 Rf 0.35 (9:1 hexanes:ethyl acetate); m.p. 28–30
◦C (lit.154 m.p. 30–
32 ◦C); 1H-NMR: (CDCl3) δH 7.37–7.28 (complex m, 10H, Bn), 6.55
(d, J = 6.1 Hz, 1H, H-1), 4.94 (ddd, J = 6.1, 4.6, 1.5 Hz, 1H, H-
2), 4.65–4.64 (complex m, 2H, PhCH2), 4.60 (d, J = 11.7 Hz, 1H,
PhCH2), 4.53 (d, J = 12.0 Hz, 1H, PhCH2), 4.11 (ddd, J = 11.7, 3.9, 1.5 Hz, 1H,
H-5a), 3.96 (dd, J = 11.6, 1.6 Hz, 1H, H-5b), 3.84 (m, 1H, H-3), 3.67 (m, 1H, H-4);
13C-NMR: (CDCl3) δC 146.7 (CH, C-1), 138.3 (C, Bn), 137.9 (C, Bn), 128.5 (CH,
Bn), 128.4 (CH, Bn), 127.84 (CH, Bn), 127.76 (CH, Bn), 127.67 (CH, Bn), 127.65
(CH, Bn), 98.9 (CH, C-2), 72.6 (CH, C-4), 71.2 (CH2, PhCH2), 70.0 (CH2, PhCH2),
69.0 (CH, C-3), 63.9 (CH2, C-5).
1,5-anhydro-3,4,6-tri-O-benzyl-2-deoxy-1,2-C -(dibromomethylene)-d-
glycero-l-manno-hexitol (45)
As reported by Nagarajan,45 a solution of tri-O-benzyl-d-galactal (43) (375 mg,
0.90 mmol) and TEBAC (4 mg, 0.02 mmol) in bromoform (2.0 mL, 23 mmol) was
treated dropwise with a solution of sodium hydroxide (382 mg, 9.5 mmol) and an-
hydrous potassium fluoride (2.95 g) in water (2.9 mL). The biphasic mixture was
stirred at room temperature for two days, then diluted with water (20 mL). The
mixture was extracted with diethyl ether (3 x 30 mL), then the organic fractions
were combined and washed with brine (20 mL). The ethereal solution was dried,
filtered and concentrated to provide a crude mixture of cyclopropane 45, which was
purified by column chromatography (9:1 hexanes:ethyl acetate) to liberate cyclo-
propane 45 (375 mg, 71%), as a yellow oil. The spectral data matched that which
was previously reported.45
O
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BnO
BnO
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H
Br
Br
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Rf 0.5 (5:1 hexanes:ethyl acetate); [α]
18
D +13 (c 2.2 CHCl3);
1H-NMR: (CDCl3) δH 7.41–7.26 (complex m, 15H, Bn), 4.93
(d, J = 11.5 Hz, 1H, PhCH2), 4.80 (d, J = 12.2 Hz, 1H,
PhCH2), 4.64 (d, J = 12.0 Hz, 1H, PhCH2), 4.59 (d, J = 11.5
Hz, 1H, PhCH2), 4.48 (d, J = 11.7 Hz, 1H, PhCH2), 4.41 (d, J = 12.0 Hz, 1H,
PhCH2), 3.96 (dd, J = 8.8, 1.5 Hz, 1H, H-1), 3.87 (d, J = 2.0 Hz, 1H, H-4), 3.85
(dd, J = 7.1, 6.1 Hz, 1H, H-5), 3.59 (dd, J = 9.3, 7.1 Hz, 1H, H-6a), 3.54 (dd,
J = 9.4, 5.8 Hz, 1H, H-6b), 3.51 (dd, J = 4.3, 1.9 Hz, 1H, H-3), 2.06 (dd, J =
8.9, 4.3 Hz, 1H, H-2); 13C-NMR: (CDCl3) δC 138.5 (C, Bn), 137.8 (C, Bn), 137.5
(C, Bn), 128.5 (CH, Bn), 128.4 (CH, Bn), 128.3 (CH, Bn), 127.88 (CH, Bn), 127.86
(CH, Bn), 127.8 (CH, Bn), 127.6 (CH, Bn), 78.4 (CH, C-5), 77.7 (CH, C-3), 74.5
(CH2, PhCH2), 73.4 (CH2, PhCH2), 71.7 (CH, C-4), 71.0 (CH2, PhCH2), 69.0 (CH2,
C-6), 59.0 (CH, C-1), 35.0 (C, C-7), 32.0 (CH, C-2); IR (KBr): νmax 3088, 3063,
3030, 2917, 2867, 1951, 1876, 1728, 1605, 1586, 1496, 1454, 1363, 1219, 1173, 1126,
1090, 1064, 1028, 750, 699 cm−1; HRMS: m/z C28H28O
79
4 Br2Na
+ [M+Na]+ calcd
124
609.0252, found 609.0251.
1,5-Anhydro-3,4-di-O-benzyl-2-deoxy-1,2-C -(dibromomethylene)-d-
gulo-pentitol (243) and 1,5-anhydro-3,4-di-O-benzyl-2-deoxy-1,2-C -
(dibromomethylene)-d-talo-pentitol (250)
As reported by Nagarajan,45 a solution of di-O-benzyl-d-xylal (189) (287 mg,
0.97 mmol) and TEBAC (6 mg, 0.03 mmol) in bromoform (2.0 mL, 23 mmol) was
treated dropwise with a solution of sodium hydroxide (426 mg, 11 mmol) and an-
hydrous potassium fluoride (3.2 g) in water (3.2 mL). The biphasic mixture was
stirred at room temperature for two days, then diluted with water (20 mL). The
mixture was extracted with diethyl ether (3 x 20 mL), then the organic fractions
were combined and washed with brine (20 mL). The ethereal solution was dried,
filtered and concentrated to provide a crude mixture of cyclopropanes 243 and 250
(3.8:1 ratio), which was purified by column chromatography (9:1 hexanes:ethyl ac-
etate) to liberate cyclopropanes 243 (271 mg, 63%) as a light–yellow oil and 250
(57 mg, 13%) as a yellow oil (76% combined yield).
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243: The spectral data matched that which was previously re-
ported.45 Rf 0.5 (5:1 hexanes:ethyl acetate); [α]
19
D −48 (c 1.2
CHCl3);
1H-NMR: (CDCl3) δH 7.49–7.27 (complex m, 10H, Bn),
4.79 (d, J = 11.7 Hz, 1H, PhCH2), 4.76 (d, J = 12.0 Hz, 1H,
PhCH2), 4.70 (d, J = 11.7 Hz, 1H, PhCH2), 4.61 (d, J = 12.0 Hz, 1H, PhCH2),
3.92 (dd, J = 11.5, 5.6 Hz, 1H, H-5a), 3.84 (d, J = 7.8 Hz, 1H, H-1), 3.78 (dd, J =
11.3, 6.0 Hz, 1H, H-5b), 3.71 (m, 1H, H-4), 3.66 (dd, J = 7.6, 3.9 Hz, 1H, H-3), 1.86
(dd, J = 7.8, 3.7 Hz, 1H, H-2); 13C-NMR: (CDCl3) δC 138.1 (C, Bn), 137.6 (C, Bn),
128.5 (CH, Bn), 128.4 (CH, Bn), 128.0 (CH, Bn), 127.9 (CH, Bn), 127.74 (CH, Bn),
127.72 (CH, Bn), 78.6 (CH, C-3), 75.2 (CH, C-4), 72.8 (CH2, PhCH2), 71.9 (CH2,
PhCH2), 69.4 (CH2, C-5), 60.3 (CH, C-1), 33.9 (CH, C-2), 32.6 (C, C-6); IR (KBr):
νmax 3064, 3028, 2981, 2872, 1720, 1496, 1454, 1365, 1270, 1205, 1097, 1026, 736, 697
cm−1; HRMS: m/z C20H20O
79
3 Br2Na
+ [M+Na]+ calcd 488.9677, found 488.9682.
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250: Rf 0.45 (5:1 hexanes:ethyl acetate); [α]
19
D +3 (c 1.0 CHCl3);
1H-NMR: (CDCl3) δH 7.49–7.28 (complex m, 10H, Bn), 4.91 (d,
J = 12.0 Hz, 1H, PhCH2), 4.76 (d, J = 11.5 Hz, 1H, PhCH2),
4.74 (d, J = 11.5 Hz, 1H, PhCH2), 4.60 (d, J = 11.5 Hz, 1H,
PhCH2), 4.09 (apparent t, J = 7.9 Hz, 1H, H-3), 4.01 (dd, J = 7.8, 1.2 Hz, 1H, H-1),
3.98 (m, 1H, H-4), 3.84 (dd, J = 10.9, 4.8 Hz, 1H, H-5a), 3.17 (apparent t, J = 11.0
Hz, 1H, H-5b), 2.28 (apparent t, J = 8.0 Hz, 1H, H-2); 13C-NMR: (CDCl3) δC 138.2
(C, Bn), 137.9 (C, Bn), 128.5 (CH, Bn), 128.4 (CH, Bn), 127.94 (CH, Bn), 127.86
(CH, Bn), 127.74 (CH, Bn), 127.65 (CH, Bn), 77.2 (CH, C-3), 75.9 (CH, C-4), 73.3
(CH2, PhCH2), 71.1 (CH2, PhCH2), 67.2 (CH2, C-5), 63.4 (CH, C-1), 33.8 (CH,
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C-2), 30.8 (C, C-6); IR (KBr): νmax 3087, 3062, 3031, 2979, 2929, 2873, 1721, 1495,
1454, 1374, 1189, 1094, 1076, 1028, 738, 697 cm−1; HRMS: m/z C20H20O
79
3 Br2Na
+
[M+Na]+ calcd 488.9677, found 488.9673.
Methyl 3,4,6-tri-O-benzyl-(2E)-2-C -(bromomethylene)-2-deoxy-β-d-
lyxo-hexopyranoside (251) and methyl 3,4,6-tri-O-benzyl-(2E)-2-C -
(bromomethylene)-2-deoxy-α-d-lyxo-hexopyranoside (252)
A portion of methanol (100 µL, 2.5 mmol) was treated with metallic sodium (7 mg,
0.3 mmol), then once the sodium had reacted, the solution was diluted with THF
(1.7 mL), then treated with cyclopropane 45 (101 mg, 0.172 mmol) and heated
at reflux for 40 minutes. The solution was diluted with water (10 mL), then ex-
tracted with dichloromethane (3 x 10 mL). The combined organic fractions were
dried, filtered and concentrated to provide crude products 251 and 252 as a yellow
oil. Upon separation by column chromatography (14:1 hexanes:ethyl acetate), 2-C -
substituted sugars 251 and 252 were obtained as an inseparable colourless oil (60
mg, 65% combined yield, 1:3 ratio).
O
OBn
BnO OMe
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251: The following data set was obtained by subtracting the
NMR signals for 252 from that of the mixture obtained.
Rf 0.10 (14:1 hexanes:ethyl acetate);
1H-NMR: (CDCl3) δH
7.39–7.27 (complex m, 15H, Bn), 6.65 (s, 1H, H-7), 4.93 (s,
1H, H-1), 4.82 (m, 1H, H-3), 4.73 (d, J = 12.0 Hz, 1H, PhCH2), 4.68 (d, J = 12.7
Hz, 1H, PhCH2), 4.59 (d, J = 12.0 Hz, 1H, PhCH2), 4.48 (d, J = 12.8 Hz, 1H,
PhCH2), 4.47 (m, 1H, H-6a), 4.43 (d, J = 11.0 Hz, 1H, PhCH2), 4.41 (d, J = 11.7
Hz, 1H, PhCH2), 4.24 (m, 1H, H-5), 3.84 (dd, J = 10.7, 2.2 Hz, 1H, H-6b), 3.72 (dd,
J = 5.9, 3.2 Hz, 1H, H-4), 3.45 (s, 3H, Me); 13C-NMR: (CDCl3) δC 138.6–137.7 (C,
Bn), 136.5 (C, C-2), 128.5–127.5 (CH, Bn), 112.8 (CH, C-7), 101.4 (CH, C-1), 75.7
(CH, C-4), 74.5 (CH, C-5), 73.2 (CH, C-3), 73.5–71.2 (CH2, PhCH2), 70.5 (CH2,
C-6), 55.6 (CH3, Me).
O
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BnO OMe
Br
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252: Rf 0.10 (14:1 hexanes:ethyl acetate);
1H-NMR: (CDCl3)
δH 7.39–7.27 (complex m, 15H, Bn), 6.64 (s, 1H, H-7), 5.05 (s,
1H, H-1), 4.85 (d, J = 11.7 Hz, 1H, PhCH2), 4.80 (d, J = 12.2
Hz, 1H, PhCH2), 4.70 (d, J = 3.2 Hz, 1H, H-3), 4.61 (d, J =
11.7 Hz, 1H, PhCH2), 4.53 (d, J = 11.7 Hz, 1H, PhCH2), 4.52 (m, 1H, PhCH2),
4.46 (d, J = 12.2 Hz, 1H, PhCH2), 4.17 (m, 1H, H-5), 3.88 (apparent t, J = 3.2
Hz, 1H, H-4), 3.80 (dd, J = 10.4, 7.2 Hz, 1H, H-6a), 3.68 (dd, J = 10.3, 5.1 Hz,
1H, H-6b), 3.42 (s, 3H, Me); 13C-NMR: (CDCl3) δC 138.2 (C, Bn), 138.12 (C, Bn),
138.06 (C, Bn), 136.9 (C, C-2), 128.33 (CH, Bn), 128.25 (CH, Bn), 128.2 (CH, Bn),
127.7 (CH, Bn), 127.64 (CH, Bn), 127.59 (CH, Bn), 127.52 (CH, Bn), 127.50 (CH,
Bn), 107.5 (CH, C-7), 100.3 (CH, C-1), 77.1 (CH, C-3), 76.4 (CH, C-4), 73.3 (CH2,
126
PhCH2), 73.0 (CH2, PhCH2), 72.5 (CH, C-5), 72.1 (CH2, PhCH2), 68.3 (CH2, C-6),
55.5 (CH3, Me); HRMS: m/z C29H31O
79
5 BrNa
+ [M+Na]+ calcd 561.1253, found
561.1250.
Methyl 3,4-di-O-benzyl-(2E)-2-C -(bromomethylene)-2-deoxy-β-d-
threo-pentopyranoside (253) and methyl 3,4-di-O-benzyl-(2E)-2-C -
(bromomethylene)-2-deoxy-α-d-threo-pentopyranoside (254)
A portion of methanol (100 µL, 2.5 mmol) was treated with metallic sodium (7 mg,
0.3 mmol), then once the sodium had reacted, the solution was diluted with THF
(1.7 mL), then treated with cyclopropane 243 (84 mg, 0.18 mmol) and heated at
reflux for 20 minutes. The solution was diluted with water (10 mL), then extracted
with dichloromethane (3 x 10 mL). The combined organic fractions were dried,
filtered and concentrated to provide crude products 253 and 254 as a yellow oil (1:5
ratio). Upon separation by column chromatography (14:1 hexanes:ethyl acetate),
the major 2-C -substituted sugar was isolated as a colourless oil (38 mg, 50%), in
addition to an impure mixture of 253 and 254 (20 mg, 17%, 1:2 ratio), isolated as
a colourless oil (67% combined yield).
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The following data set was obtained for the
major isomer, of which the anomeric configu-
ration was not determined. Rf 0.3 (14:1 hex-
anes:ethyl acetate); 1H-NMR: (CDCl3) δH 7.43–7.27 (complex m, 10H, Bn), 6.76 (d,
= 1.9 Hz, 1H, H-6), 5.00 (s, 1H, H-1), 4.76 (m, 1H, H-3), 4.68 (d, J = 111.2 Hz,
1H, PhCH2), 4.65 (d, J = 12.3 Hz, 1H, PhCH2), 4.56 (d, J = 12.2 Hz, 1H, PhCH2),
4.43 (d, J = 11.3 Hz, 1H, PhCH2), 4.28 (d, J = 12.2 Hz, 1H, H-5a), 3.64 (d, J =
12.4 Hz, 1H, H-5b), 3.57 (m, 1H, H-4), 3.43 (s, 3H, Me).
7.3 Chapter Three Experimental
Acetyl 4,5,7-tri-O-benzyl-2-bromo-2,3-dideoxy-β-d-arabino-hept-2-
enoseptanoside (257) and acetyl 4,5,7-tri-O-benzyl-2-bromo-2,3-dideoxy-
α-d-arabino-hept-2-enoseptanoside (258)
A A solution of cyclopropane 97 (101 mg, 0.172 mmol) in acetic acid (1.7 mL)
was treated with silver acetate (39 mg, 0.23 mmol), then stirred at 100 ◦C for 25
hours. The solution was diluted with dichloromethane (20 mL), filtered through a
pad of Celite R©, then washed with water (10 mL). The aqueous phase was extracted
further with dichloromethane (2 x 10 mL), then the organic fractions were combined,
dried, filtered and concentrated to provide a mixture of oxepines 257 and 258 (1:3.5
127
ratio) as a light–yellow oil. Upon purification by column chromatography (14:1
hexanes:ethyl acetate), major oxepine 258 (14 mg, 14%) and mixtures of 257 and
258 (37 mg, 38%) were obtained as colourless oils (1:3.8 ratio, 52% combined yield).
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67 257: The following data set was obtained by subtracting the
NMR signals for 258 from that of the purified mixture.
Rf 0.15 (14:1 hexanes:ethyl acetate);
1H-NMR: (CDCl3) δH
7.36–7.14 (complex m, 15H, Bn), 6.45 (m, 1H, H-3), 6.33 (s,
1H, H-1), 4.69–4.37 (complex m, 6H, PhCH2), 4.15 (m, 1H, H-4), 3.92 (dd, J =
11.0, 5.9 Hz, 1H, H-6), 3.80 (dd, J = 6.3, 4.4 Hz, 1H, H-5), 3.67–3.52 (complex m,
2H, H-7a,b), 2.15 (s, 3H, Ac); 13C-NMR: (CDCl3) δC 169.0 (C, CH3CO), 138.1 (C,
Bn), 137.8 (C, Bn), 137.5 (C, Bn), 133.4 (CH, C-3), 128.5–127.6 (CH, Bn), 125.6 (C,
C-2), 94.4 (CH, C-1), 79.2 (CH, C-5), 78.6 (CH, C-6), 75.4 (CH, C-4), 73.3 (CH2,
PhCH2), 72.7 (CH2, PhCH2), 71.6 (CH2, PhCH2), 70.4 (CH2, C-7), 20.9 (CH3, Ac).
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67 258: Rf 0.15 (14:1 hexanes:ethyl acetate); [α]
19
D −23 (c 0.7
CHCl3);
1H-NMR: (CDCl3) δH 7.36–7.16 (complex m, 15H,
Bn), 6.57 (s, 1H, H-1), 6.46 (dd, J = 6.3, 1.2 Hz, 1H, H-3),
4.68 (d, J = 12.0 Hz, 1H, PhCH2), 4.57 (d, J = 11.2 Hz, 1H,
PhCH2), 4.56 (d, J = 12.0 Hz, 1H, PhCH2), 4.51 (d, J = 11.7 Hz, 1H, PhCH2),
4.45 (d, J = 11.7 Hz, 1H, PhCH2), 4.38 (d, J = 11.2 Hz, 1H, PhCH2), 4.17–4.14
(complex m, 2H, H-4,6), 3.74 (dd, J = 9.1, 4.2 Hz, 1H, H-5), 3.61 (dd, J = 10.5, 2.4
Hz, 1H, H-7a), 3.54 (dd, J = 10.5, 7.1 Hz, 1H, H-7b), 1.93 (s, 3H, Ac); 13C-NMR:
(CDCl3) δC 169.3 (C, CH3CO), 138.0 (C, Bn), 137.8 (C, Bn), 137.5 (C, Bn), 133.5
(CH, C-3), 128.5 (CH, Bn), 128.4 (CH, Bn), 128.3 (CH, Bn), 128.0 (CH, Bn), 127.95
(CH, Bn), 127.93 (CH, Bn), 127.88 (CH, Bn), 127.8 (CH, Bn), 127.6 (CH, Bn), 123.9
(C, C-2), 93.4 (CH, C-1), 81.1 (CH, C-5), 77.2 (CH, C-4), 74.4 (CH, C-6), 73.4 (CH2,
PhCH2), 73.2 (CH2, PhCH2), 71.7 (CH2, PhCH2), 70.3 (CH2, C-7), 20.7 (CH3, Ac);
IR (KBr): νmax 3086, 3058, 3030, 2863, 1753, 1639, 1496, 1454, 1368, 1221, 1071,
1005, 952, 737, 698 cm−1; HRMS: m/z C30H31O
79
6 BrNa
+ [M+Na]+ calcd 589.1202,
found 589.1202.
B A solution of cyclopropane 97 (100 mg, 0.170 mmol) in acetic acid (1.7 mL) was
treated with silver acetate (56 mg, 0.34 mmol) then stirred at room temperature for
five days. No reaction was observed by TLC, therefore this reaction was abandoned.
C A solution of cyclopropane 97 (98 mg, 0.17 mmol) in acetic acid (1.7 mL)
was treated with silver acetate (54 mg, 0.32 mmol) and sodium acetate (70 mg,
0.85 mmol), then stirred at room temperature for four days. The solution was di-
luted with diethyl ether (20 mL), filtered through a pad of Celite R©, then washed
with sat. sodium bicarbonate solution (20 mL), then washed with brine (20 mL).
The ethereal solution was dried, filtered and concentrated to provide a colourless
128
oil. Proton NMR analysis of this material showed only starting material was present.
D A solution of cyclopropane 97 (97 mg, 0.17 mmol) in acetic acid (1.7 mL) was
treated with silver acetate (60 mg, 0.36 mmol), then stirred at 70 ◦C for three days.
The solution was treated with a further portion of silver acetate (61 mg, 0.37 mmol),
then stirred at 70 ◦C for an additional two days. The solution was diluted with wa-
ter (10 mL), then extracted with dichloromethane (3 x 10 mL), then the organic
fractions were combined, dried, filtered and concentrated to provide a mixture of
oxepines 257 and 258 as a light–yellow oil. Upon purification by column chromatog-
raphy (9:1 hexanes:ethyl acetate), starting material (10 mg, 10%) was obtained, in
addition to a mixture of oxepines 257 and 258 (1:3.4 ratio, 25 mg, 27%).
E A solution of cyclopropane 97 (98 mg, 0.17 mmol) in acetic acid (1.7 mL) was
treated with silver acetate (54 mg, 0.32 mmol), then stirred at 90 ◦C for 36 hours.
The solution was diluted with water (10 mL), then extracted with dichloromethane
(3 x 10 mL), then the organic fractions were combined, dried, filtered and concen-
trated to provide a mixture of oxepines 257 and 258 as a light–yellow oil. Upon
purification by column chromatography (20:1 hexanes:ethyl acetate), mixtures of
oxepines 257 and 258 (1:2.9 ratio, 35 mg, 37%) were obtained.
F A solution of cyclopropane 97 (103 mg, 0.175 mmol) in acetic acid (1.7 mL) was
treated with silver acetate (56 mg, 0.34 mmol), then stirred at reflux for five hours.
The solution was diluted with water (10 mL), then extracted with dichloromethane
(3 x 10 mL), then the organic fractions were combined, dried, filtered and concen-
trated to provide a light–yellow oil. Upon purification by column chromatography
(8:1 hexanes:diethyl ether), mixtures of oxepines 257 and 258 (1:1.7 ratio, 15 mg,
15%) were obtained, in addition to a mixture of two unidentified aldehydic products
(18 mg).
G A solution of cyclopropane 97 (100 mg, 0.170 mmol) in toluene (1.7 mL) was
treated with sodium acetate (70 mg, 0.85 mmol), then stirred at 100 ◦C for two days.
The solution was diluted with water (10 mL) and extracted with dichloromethane
(3 x 10 mL), then the organic fractions were combined, dried, filtered and concen-
trated to provide a mixture of oxepines 257 and 258 as a pale–yellow oil. Upon
purification by column chromatography (14:1 hexanes:ethyl acetate), a mixture of
oxepines 257 and 258 (1:2.1 ratio, 17 mg, 18%) was obtained.
H A solution of cyclopropane 97 (102 mg, 0.173 mmol) in DMF (1.7 mL) was treated
with silver acetate (42 mg, 0.25 mmol) and sodium acetate (75 mg, 0.91 mmol), then
stirred at 100 ◦C for two days. The solution was diluted with water (10 mL) and sat.
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copper sulfate solution (10 mL), then extracted with dichloromethane (3 x 10 mL).
The organic fractions were combined, dried, filtered and concentrated to provide
a mixture of oxepines 257 and 258 as a brown oil. Upon purification by column
chromatography (9:1 hexanes:ethyl acetate), a mixture of oxepines 257 and 258
(1.2:1 ratio, 48 mg, 49%).
3-O-Acetyl-1,6-anhydro-4,5,7-tri-O-benzyl-2-bromo-2-deoxy-d-arabino-
hept-1-enitol (259)
A A solution of cyclopropane 97 (100 mg, 0.170 mmol) in toluene (3.4 mL) was
treated with silver acetate (44 mg, 0.26 mmol) and sodium acetate (138 mg, 1.68
mmol), then stirred at 100 ◦C for two days. The solution was diluted with di-
chloromethane (10 mL), then washed with water (10 mL). The aqueous phase was
extracted further with dichloromethane (2 x 10 mL), then the organic fractions
were combined, filtered through a pad of Celite R©, dried, filtered and concentrated
to provide a mixture of oxepines 257 and 258 (1:3.5 ratio) as a light–yellow oil, in
addition to 3-acetate oxepine 259. Upon purification by column chromatography
(9:1 hexanes:ethyl acetate), starting material 97 (22 mg, 22%) was recovered, in
addition to 3-acetate oxepine 259 (5 mg, 5%), obtained as a colourless oil and a
mixture of oxepines 257 and 258 (1:3.7 ratio, 51 mg, 53%).
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259: Rf 0.4 (5:1 hexanes:ethyl acetate); [α]
18
D +78 (c 0.5CHCl3);
1H-NMR: (CDCl3) δH 7.43–7.06 (complex m, 15H, Bn), 6.94 (s,
1H, H-1), 5.63 (d, J = 5.9 Hz, 1H, H-3), 4.69 (d, J = 12.2 Hz,
1H, PhCH2), 4.62 (d, J = 12.5 Hz, 1H, PhCH2), 4.58 (d, J =
12.2 Hz, 1H, PhCH2), 4.50 (d, J = 12.2 Hz, 1H, PhCH2), 4.45 (dd, J = 10.5, 4.6
Hz, 1H, H-6), 4.16 (d, J = 10.7 Hz, 1H, PhCH2), 4.14 (d, J = 5.9 Hz, 1H, H-4), 4.07
(d, J = 10.7 Hz, 1H, PhCH2), 3.73 (d, J = 10.2 Hz, 1H, H-5), 3.66–3.60 (complex
m, 2H, H-7a,b), 1.89 (s, 3H, Ac); 13C-NMR: (CDCl3) δC 170.6 (C, CH3CO), 151.8
(CH, C-1), 137.9 (C, Bn), 137.5 (C, Bn), 137.0 (C, Bn), 128.5 (CH, Bn), 128.4 (CH,
Bn), 128.3 (CH, Bn), 128.21 (CH, Bn), 128.20 (CH, Bn), 128.1 (CH, Bn), 128.0 (CH,
Bn), 127.8 (CH, Bn), 127.7 (CH, Bn), 99.4 (C, C-2), 84.1 (CH, C-6), 78.8 (CH, C-5),
75.6 (CH, C-3), 75.3 (CH, C-4), 73.4 (CH2, PhCH2), 72.5 (CH2, PhCH2), 72.2 (CH2,
PhCH2), 69.8 (CH2, C-7), 20.9 (CH3, Ac); IR (KBr): νmax 3065, 3027, 2928, 2871,
1739, 1454, 1367, 1223, 1072, 1025, 750, 698 cm−1; HRMS: m/z C30H31O
79
6 BrNa
+
[M+Na]+ calcd 589.1202, found 589.1198.
B A solution of cyclopropane 97 (102 mg, 0.173 mmol) in toluene (1.7 mL) was
treated with silver acetate (41 mg, 0.24 mmol) and sodium acetate (72 mg, 0.88
mmol), then stirred at reflux for 28 hours. The solution was filtered through a pad
of silica, eluting further with dichloromethane (40 mL), then the organic fractions
130
were combined, dried, filtered and concentrated to provide a mixture of 3-acetate
oxepine 259 and oxepines 257 and 258 as a colourless oil. Upon purification by
column chromatography (14:1 hexanes:ethyl acetate), 3-acetate oxepine 259 (14 mg,
14%) and a mixture of oxepines 257 and 258 (1:3.8 ratio, 64 mg, 65%).
Methyl 4,5,7-tri-O-benzyl-2-bromo-2,3-dideoxy-β-d-arabino-hept-2-
enoseptanoside (98) and methyl 4,5,7-tri-O-benzyl-2-bromo-2,3-dideoxy-
α-d-arabino-hept-2-enoseptanoside (99)
A A solution of cyclopropane 97 (91 mg, 0.15 mmol) in methanol (1.7 mL) was
treated with silver tetrafluoroborate (88 mg, 0.45 mmol), then stirred at 40 ◦C for
one day, followed by heating at reflux for one further day. The solution was diluted
with diethyl ether (20 mL), filtered through a pad of Celite R©, then washed with
sat. sodium bicarbonate solution (20 mL), followed by brine (20 mL). The ethereal
solution was dried, filtered and concentrated to provide a light–yellow oil, comprised
predominantly of starting material 97. Upon separation by column chromatogra-
phy (9:1 hexanes:ethyl acetate), oxepines 98 (5 mg, 6%) and 99 (6 mg, 7%) were
obtained, isolated as colourless oils (13% combined yield).
O
BnO
BnO
BnO
Br
OMe
1
2
34
5
67 98: Rf 0.3 (9:1 hexanes:ethyl acetate);
1H-NMR: (CDCl3) δH
7.36–7.15 (complex m, 15H, Bn), 6.33 (d, J = 5.1 Hz, 1H,
H-3), 5.14 (s, 1H, H-1), 4.68 (d, J = 12.0 Hz, 1H, PhCH2),
4.65 (d, J = 11.2 Hz, 1H, PhCH2), 4.59 (d, J = 11.7 Hz, 1H,
PhCH2), 4.59 (d, J = 12.2 Hz, 1H, PhCH2), 4.51 (d, J = 12.0 Hz, 1H, PhCH2), 4.45
(d, J = 11.2 Hz, 1H, PhCH2), 4.17–4.14 (complex m, 2H, H-4,6), 3.77 (dd, J = 8.9,
5.7 Hz, 1H, H-5), 3.70 (dd, J = 10.5, 5.6 Hz, 1H, H-7a), 3.61 (dd, J = 10.5, 2.7 Hz,
1H, H-7b), 3.46 (s, 3H, Me); 13C-NMR: (CDCl3) δC 138.2 (C, Bn), 138.1 (C, Bn),
137.9 (C, Bn), 132.1 (CH, C-3), 128.5 (CH, Bn), 128.4 (CH, Bn), 128.3 (CH, Bn),
127.90 (CH, Bn), 127.87 (CH, Bn), 127.85 (CH, Bn), 127.8 (CH, Bn), 127.7 (CH,
Bn), 127.6 (CH, Bn), 124.7 (C, C-2), 102.1 (CH, C-1), 80.5 (CH, C-5), 78.9 (CH,
C-4), 73.7 (CH2, PhCH2), 73.2 (CH2, PhCH2), 72.1 (CH2, PhCH2), 71.5 (CH, C-6),
70.4 (CH2, C-7), 56.5 (CH3, Me).
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67 99: Rf 0.25 (9:1 hexanes:ethyl acetate);
1H-NMR: (CDCl3) δH
7.37–7.14 (complex m, 15H, Bn), 6.44 (dd, J = 7.1, 1.0 Hz,
1H, H-3), 5.05 (s, 1H, H-1), 4.68 (d, J = 12.2 Hz, 1H, PhCH2),
4.57–4.56 (complex m, 2H, PhCH2), 4.51 (d, J = 12.4 Hz, 1H,
PhCH2), 4.49 (d, J = 12.2 Hz, 1H, PhCH2), 4.33 (d, J = 11.5 Hz, 1H, PhCH2),
4.09 (dd, J = 7.1, 1.2 Hz, 1H, H-4), 3.70–3.69 (complex m, 2H, H-5,6), 3.65–3.63
(complex m, 2H, H-7a,b), 3.47 (s, 3H, Me); 13C-NMR: (CDCl3) δC 138.2 (C, Bn),
137.9 (C, Bn), 137.4 (C, Bn), 132.2 (CH, C-3), 128.5 (CH, Bn), 128.42 (CH, Bn),
128.37 (CH, Bn), 128.0 (CH, Bn), 127.93 (CH, Bn), 127.85 (CH, Bn), 127.7 (CH,
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Bn), 127.6 (CH, Bn), 123.5 (C, C-2), 104.2 (CH, C-1), 80.0 (CH, C-5), 77.4 (CH,
C-6), 75.3 (CH, C-4), 73.3 (CH2, PhCH2), 72.7 (CH2, PhCH2), 71.3 (CH2, PhCH2),
71.0 (CH2, C-7), 55.8 (CH3, Me); HRMS: m/z C29H31O
79
5 BrNa
+ [M+Na]+ calcd
561.1253, found 561.1256.
B A solution of cyclopropane 97 (49 mg, 0.083 mmol) in methanol (1.7 mL) was
treated with silver tetrafluoroborate (22 mg, 0.11 mmol) and 3A˚ molecular sieves,
then stirred in the dark at room temperature for two days. The solution was di-
luted with diethyl ether (20 mL), filtered through a pad of Celite R©, washed with
sat. sodium bicarbonate solution (20 mL), then washed with brine (20 mL). The
ethereal solution was dried, filtered and concentrated to provide a light–yellow oil.
Proton NMR analysis of this material indicated only starting material was present.
C A solution of cyclopropane 97 (104 mg, 0.177 mmol) in methanol (1.7 mL) was
treated with silver acetate (37 mg, 0.22 mmol), then stirred at reflux for five days.
The solution was diluted with diethyl ether (10 mL), filtered through a pad of
Celite R©, then washed with water (10 mL). The aqueous wash was extracted further
with ether (2 x 10 mL), then the ethereal solutions were combined, dried, filtered and
concentrated to provide a light–yellow oil. Upon separation by column chromatog-
raphy (9:1 hexanes:ethyl acetate), recovered starting material 97 (63 mg, 61%) was
obtained, in addition to oxepines 98 (4 mg, 4%) and 99 (11 mg, 11%) (15% com-
bined yield).
D A solution of cyclopropane 97 (101 mg, 0.172 mmol) in methanol (1.7 mL) was
treated with silver tetrafluoroborate (67 mg, 0.34 mmol) and potassium carbonate
(44 mg, 0.32 mmol), then stirred at reflux for 16 hours. The solution was diluted
with diethyl ether (20 mL), filtered through a pad of Celite R©, then washed with
sat. sodium bicarbonate solution (20 mL), then washed with brine (20 mL). The
ethereal solution was dried, filtered and concentrated to provide a light–yellow oil.
Proton NMR analysis of this crude mixture indicated the presence of primarily start-
ing material 97, in addition to oxepines 98 and 99 (approx. 17% combined yield)
and previously isolated 2-C -branched sugars 213 and 214 (approx. 22% combined
yield).
Allyl 4,5,7-tri-O-benzyl-2-bromo-2,3-dideoxy-β-d-arabino-hept-2-
enoseptanoside (260) and allyl 4,5,7-tri-O-benzyl-2-bromo-2,3-dideoxy-α-
d-arabino-hept-2-enoseptanoside (261)
A A solution of cyclopropane 97 (102 mg, 0.173 mmol) in allyl alcohol (1.7 mL) was
treated with silver nitrate (39 mg, 0.23 mmol), then stirred at reflux for 29 hours.
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The solution was diluted with dichloromethane (10 mL), filtered through a pad of
Celite R©, then washed with water (10 mL). The aqueous phase was extracted further
with dichloromethane (2 x 10 mL), then the organic fractions were combined, dried,
filtered and concentrated to provide a light–yellow oil. Upon separation by column
chromatography (14:1 hexanes:ethyl acetate), recovered starting material 97 (16 mg,
16%), plus oxepines 260 (18 mg, 18%) and 261 (31 mg, 32%) were obtained as white
solids (50% combined yield).
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67 260: Rf 0.25 (14:1 hexanes:ethyl acetate); m.p. 48–51
◦C;
[α]19D −4.3 (c 1.0 CHCl3);
1H-NMR: (CDCl3) δH 7.37–
7.15 (complex m, 15H, Bn), 6.32 (d, J = 5.1 Hz, 1H,
H-3), 5.89 (ddt, J = 17.1, 10.5, 6.4 Hz, 1H, H-9), 5.29
(ddd, J = 17.3, 3.2, 1.7 Hz, 1H, H-10a), 5.27 (s, 1H, H-1), 5.18 (ddd, J = 10.5, 2.9,
1.2 Hz, 1H, H-10b), 4.68 (d, J = 12.0 Hz, 1H, PhCH2), 4.64 (d, J = 11.2 Hz, 1H,
PhCH2), 4.58 (d, J = 12.0 Hz, 1H, PhCH2), 4.56 (d, J = 12.2 Hz, 1H, PhCH2),
4.50 (d, J = 12.0 Hz, 1H, PhCH2), 4.44 (d, J = 11.2 Hz, 1H, PhCH2), 4.28 (ddt,
J = 12.9, 5.1, 1.5 Hz, 1H, H-8a), 4.19 (ddd, J = 9.0, 6.1, 2.4 Hz, 1H, H-6), 4.16
(apparent t, J = 5.4 Hz, 1H, H-4), 4.06 (ddd, J = 12.9, 6.3, 1.2 Hz, 1H, H-8b), 3.75
(dd, J = 9.0, 5.6 Hz, 1H, H-5), 3.68 (dd, J = 10.5, 5.9 Hz, 1H, H-7a), 3.59 (dd,
J = 10.5, 2.4 Hz, 1H, H-7b); 13C-NMR: (CDCl3) δC 138.0 (C, Bn), 137.91 (C, Bn),
137.86 (C, Bn), 133.5 (CH, C-9), 132.1 (CH, C-3), 128.5 (CH, Bn), 128.4 (CH, Bn),
128.3 (CH, Bn), 127.9 (CH, Bn), 127.84 (CH, Bn), 128.76 (CH, Bn), 127.7 (CH,
Bn), 127.6 (CH, Bn), 124.8 (C, C-2), 117.9 (CH2, C-10), 99.7 (CH, C-1), 80.5 (CH,
C-5), 78.9 (CH, C-4), 73.7 (CH2, PhCH2), 73.2 (CH2, PhCH2), 72.0 (CH2, PhCH2),
71.4 (CH, C-6), 70.4 (CH2, C-7), 69.2 (CH2, C-8); IR (KBr): νmax 3060, 3029, 2925,
2871, 1723, 1647, 1496, 1453, 1364, 1111, 1072, 1049, 735, 697 cm−1; HRMS: m/z
C31H33O
79
5 BrNa
+ [M+Na]+ calcd 587.1409, found 587.1406.
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67 261: Rf 0.2 (14:1 hexanes:ethyl acetate); m.p. 28–30
◦C;
[α]19D −37 (c 2.2 CHCl3);
1H-NMR: (CDCl3) δH 7.35–7.14
(complex m, 15H, Bn), 6.43 (d, J = 7.1 Hz, 1H, H-3),
5.95 (ddt, J = 17.0, 10.8, 5.7 Hz, 1H, H-9), 5.31 (d, J =
17.3 Hz, 1H, H-10a), 5.20 (d, J = 10.3 Hz, 1H, H-10b), 5.11 (s, 1H, H-1), 4.69 (d,
J = 12.2 Hz, 1H, PhCH2), 4.55 (s, 2H, PhCH2), 4.52 (d, J = 12.2 Hz, 1H, PhCH2),
4.50 (d, J = 11.2 Hz, 1H, PhCH2), 4.34 (d, J = 11.2 Hz, 1H, PhCH2), 4.33 (m,
1H, H-8a), 4.21 (dd, J = 12.8, 6.4 Hz, 1H, H-8b), 4.10 (d, J = 6.8 Hz, 1H, H-4),
3.69–3.66 (complex m, 2H, H-5,6), 3.64–3.60 (complex m, 2H, H-7a,b); 13C-NMR:
(CDCl3) δC 138.2 (C, Bn), 137.9 (C, Bn), 137.4 (C, Bn), 133.8 (CH, C-9), 132.2
(CH, C-3), 128.42 (CH, Bn), 128.40 (CH, Bn), 128.35 (CH, Bn), 128.1 (C, C-2),
127.98 (CH, Bn), 127.96 (CH, Bn), 127.9 (CH, Bn), 127.8 (CH, Bn), 127.7 (CH,
Bn), 127.6 (CH, Bn), 118.0 (CH2, C-10), 102.1 (CH, C-1), 80.0 (CH, C-5), 77.3
(CH, C-6), 75.5 (CH, C-4), 73.3 (CH2, PhCH2), 72.8 (CH2, PhCH2), 71.3 (CH2,
133
PhCH2), 71.0 (CH2, C-7), 69.2 (CH2, C-8); IR (KBr): νmax 3087, 3063, 3029, 2863,
1637, 1496, 1453, 1360, 1264, 1075, 1027, 736, 697 cm−1.
B A solution of cyclopropane 97 (103 mg, 0.175 mmol) in allyl alcohol (1.7 mL) was
treated with silver acetate (32 mg, 0.19 mmol), then stirred at reflux for 27 hours.
The solution was diluted with dichloromethane (10 mL), filtered through a pad of
Celite R©, then washed with water (10 mL). The aqueous phase was extracted further
with dichloromethane (2 x 10 mL), then the organic fractions were combined, dried,
filtered and concentrated to provide a colourless oil. Upon separation by column
chromatography (14:1 hexanes:ethyl acetate), recovered starting material (13 mg,
13%), plus oxepines 260 (27 mg, 27%) and 261 (24 mg, 24%) were obtained (51%
combined yield) in addition to major acetate oxepine 258 (4 mg, 4%).
C A solution of cyclopropane 97 (100 mg, 0.170 mmol) in allyl alcohol (1.7 mL)
was treated with potassium carbonate (139 mg, 1.00 mmol), then stirred at reflux
for 11 hours. The solution was diluted with water (10 mL), extracted with dichloro-
methane (3 x 10 mL), then the organic fractions were combined, dried, filtered and
concentrated to provide a colourless oil. Upon separation by column chromatog-
raphy (9:1 hexanes:ethyl acetate), recovered starting material (6 mg, 6%), plus a
mixture of oxepine 260 (9%) and 2-C -branched sugar 236 (20%) (28 mg combined
yield) and a mixture of oxepine 261 (2%) and 2-C -branched sugar 237 (21%) (22 mg
combined yield), were obtained (percentages determined by NMR analysis).
Benzyl 4,5,7-tri-O-benzyl-2-bromo-2,3-dideoxy-β-d-arabino-hept-2-
enoseptanoside (262) and benzyl 4,5,7-tri-O-benzyl-2-bromo-2,3-dideoxy-
α-d-arabino-hept-2-enoseptanoside (263)
A A solution of cyclopropane 97 (100 mg, 0.170 mmol) in toluene (1.7 mL) was
treated with silver acetate (39 mg, 0.23 mmol), followed by benzyl alcohol (90 µL,
0.85 mmol), then stirred at 100 ◦C for two days. The solution was diluted with
dichloromethane (10 mL), filtered through a pad of Celite R©, then washed with wa-
ter (10 mL). The aqueous phase was extracted further with dichloromethane (2 x
10 mL), then the organic fractions were combined, dried, filtered and concentrated
to provide a yellow oil. Upon separation by column chromatography (14:1 hex-
anes:ethyl acetate), oxepine 262 (23 mg, 22%) was obtained as a white solid and
oxepine 263 (24 mg, 23%) as a colourless oil (45% combined yield), plus a mixture
of acetate oxepines 257 and 258 (26 mg, 26%, 1:4.6 ratio).
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67 262: Rf 0.25 (14:1 hexanes:ethyl acetate); m.p. 67–71
◦C; [α]19D
+3.2 (c 1.8 CHCl3);
1H-NMR: (CDCl3) δH 7.40–7.16 (complex
m, 20H, Bn), 6.34 (d, J = 5.4 Hz, 1H, H-3), 5.32 (s, 1H, H-1),
4.85 (d, J = 12.0 Hz, 1H, PhCH2), 4.68 (d, J = 11.7 Hz, 1H,
PhCH2), 4.65 (d, J = 11.2 Hz, 1H, PhCH2), 4.59 (d, J = 11.7 Hz, 1H, PhCH2),
4.58 (d, J = 12.0 Hz, 1H, PhCH2), 4.57 (d, J = 12.0 Hz, 1H, PhCH2), 4.51 (d, J =
12.0 Hz, 1H, PhCH2), 4.45 (d, J = 11.2 Hz, 1H, PhCH2), 4.19 (ddd, J = 8.3, 6.2,
2.0 Hz, 1H, H-6), 4.16 (apparent t, J = 5.4 Hz, 1H, H-4), 3.76 (dd, J = 8.9, 5.5 Hz,
1H, H-5), 3.69 (dd, J = 10.5, 5.9 Hz, 1H, H-7a), 3.59 (dd, J = 10.5, 2.0 Hz, 1H,
H-7b); 13C-NMR: (CDCl3) δC 138.0 (C, Bn), 137.9 (C, Bn), 137.8 (C, Bn), 137.1
(C, Bn), 132.0 (CH, C-3), 128.5 (CH, Bn), 128.36 (CH, Bn), 128.35 (CH, Bn), 128.3
(CH, Bn), 128.1 (CH, Bn), 127.89 (CH, Bn), 127.86 (CH, Bn), 127.83 (CH, Bn),
127.76 (CH, Bn), 127.6 (CH, Bn), 124.9 (C, C-2), 100.0 (CH, C-1), 80.7 (CH, C-5),
78.7 (CH, C-4), 73.7 (CH2, PhCH2), 73.2 (CH2, PhCH2), 72.0 (CH2, PhCH2), 71.6
(CH, C-6), 70.5 (CH2, C-7), 70.4 (CH2, PhCH2); IR (KBr): νmax 3087, 3062, 3030,
2864, 1736, 1639, 1496, 1453, 1363, 1110, 1070, 1027, 736, 697 cm−1; HRMS: m/z
C35H35O
79
5 BrNa
+ [M+Na]+ calcd 637.1566, found 637.1568.
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67 263: Rf 0.2 (14:1 hexanes:ethyl acetate); [α]
19
D −30 (c 0.7
CHCl3);
1H-NMR: (CDCl3) δH 7.41–7.13 (complex m, 20H,
Bn), 6.44 (d, J = 7.1 Hz, 1H, H-3), 5.11 (s, 1H, H-1), 4.86 (d,
J = 11.7 Hz, 1H, PhCH2), 4.73 (d, J = 12.0 Hz, 1H, PhCH2),
4.69 (d, J = 12.0 Hz, 1H, PhCH2), 4.56 (s, 2H, PhCH2), 4.51 (d, J = 12.2 Hz, 1H,
PhCH2), 4.49 (d, J = 11.5 Hz, 1H, PhCH2), 4.33 (d, J = 11.5 Hz, 1H, PhCH2), 4.09
(dd, J = 6.9, 3.1 Hz, 1H, H-4), 3.71–3.61 (complex m, 4H, H-5,6,7a,b); 13C-NMR:
(CDCl3) δC 138.2 (C, Bn), 137.9 (C, Bn), 137.4 (C, Bn), 137.1 (C, Bn), 132.2 (CH,
C-3), 128.5 (CH, Bn), 128.43 (CH, Bn), 128.41 (CH, Bn), 128.37 (CH, Bn), 128.31
(CH, Bn), 128.26 (CH, Bn), 128.2 (C, C-2), 127.99 (CH, Bn), 127.96 (CH, Bn),
127.9 (CH, Bn), 127.8 (CH, Bn), 127.7 (CH, Bn), 127.6 (CH, Bn), 102.0 (CH, C-1),
80.0 (CH, C-5), 77.3 (CH, C-6), 75.5 (CH, C-4), 73.3 (CH2, PhCH2), 72.8 (CH2,
PhCH2), 71.2 (CH2, PhCH2), 71.0 (CH2, C-7), 69.7 (CH2, PhCH2); IR (KBr): νmax
3062, 3030, 2864, 1737, 1637, 1496, 1453, 1363, 1210, 1072, 1027, 736, 697 cm−1.
B A solution of cyclopropane 97 (100 mg, 0.170 mmol) in toluene (1.7 mL) was
treated with silver nitrate (48 mg, 0.28 mmol), followed by benzylamine (90 µL,
0.85 mmol), then stirred at 100 ◦C for two days. The solution was treated with
additional silver nitrate (42 mg, 0.25 mmol) and after refluxing for one further day,
the mixture was diluted with dichloromethane (10 mL), filtered through a plug of
silica, then washed with water (10 mL). The aqueous phase was extracted further
with dichloromethane (2 x 10 mL), then the organic fractions were combined, dried,
filtered and concentrated to provide a yellow oil. Upon separation by column chro-
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matography (14:1 hexanes:ethyl acetate), oxepines 262 and 263 were obtained (4:1
ratio, 16 mg, 15% combined yield).
Phenyl 4,5,7-tri-O-benzyl-2-bromo-2,3-dideoxy-β-d-arabino-hept-2-
enoseptanoside (264) and phenyl 4,5,7-tri-O-benzyl-2-bromo-2,3-
dideoxy-α-d-arabino-hept-2-enoseptanoside (265)
A solution of cyclopropane 97 (101 mg, 0.172 mmol) in toluene (1.7 mL) was treated
with silver nitrate (53 mg, 0.31 mmol) and phenol (86 mg, 0.91 mmol), then stirred
at 100 ◦C for two days. The solution was diluted with water (10 mL), then extracted
with dichloromethane (3 x 10 mL), then the organic fractions were combined, dried,
filtered and concentrated to provide a yellow oil. Upon separation by column chro-
matography (14:1 hexanes:ethyl acetate), an inseparable mixture of oxepines 264
and 265 (6.7:1 ratio) was obtained as a colourless oil (46 mg, 45%).
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67 The given NMR data set is of major
β-oxepine 264, unless otherwise stated.
Rf 0.55 (5:1 hexanes:ethyl acetate);
1H-NMR: (CDCl3) δH 7.36–7.12 (complex
m, 19H, Bn, Ph), 7.03 (t, J = 7.3 Hz, 1H, Ph), 6.51 (d, J = 7.1 Hz, 1H, H-3 (265)),
6.45 (d, J = 5.4 Hz, 1H, H-3), 5.91 (s, 1H, H-1), 5.64 (s, 1H, H-1 (265)), 4.72 (d,
J = 12.0 Hz, 1H, PhCH2), 4.67–4.62 (complex m, 2H, PhCH2), 4.51–4.46 (complex
m, 2H, PhCH2), 4.40 (d, J = 11.9 Hz, 1H, PhCH2), 4.29 (ddd, J = 8.6, 4.6, 2.9 Hz,
1H, H-6), 4.25 (t, J = 5.5 Hz, 1H, H-4), 3.92 (dd, J = 8.6, 5.5 Hz, 1H, H-5), 3.68
(dd, J = 10.7, 4.6 Hz, 1H, H-7a), 3.45 (dd, J = 10.6, 2.6 Hz, 1H, H-7b); 13C-NMR:
(CDCl3) δC 157.2 (C, Ph), 138.0 (C, Bn), 137.9 (C, Bn), 137.8 (C, Bn), 133.1 (CH,
C-3), 129.5 (CH, Ph), 128.5 (CH, Bn), 128.4 (CH, Bn), 128.3 (CH, Bn), 127.92
(CH, Bn), 127.90 (CH, Bn), 127.8 (CH, Bn), 127.7 (CH, Bn), 127.5 (CH, Bn), 123.8
(C, C-2), 122.6 (CH, Ph), 116.8 (CH, Ph), 99.8 (CH, C-1), 80.2 (CH, C-5), 78.7
(CH, C-4), 73.7 (CH2, PhCH2), 73.2 (CH2, PhCH2), 72.4 (CH, C-6), 72.1 (CH2,
PhCH2), 70.0 (CH2, C-7); IR (KBr): νmax 3077, 3060, 3030, 2912, 2862, 1590, 1495,
1454, 1363, 1222, 1102, 1070, 1028, 736, 697 cm−1; HRMS: m/z C34H33O
79
5 BrNa
+
[M+Na]+ calcd 623.1409, found 623.1405.
1,7-Anhydro-4,5-di-O-benzyl-2-bromo-2,3-dideoxy-β-d-arabino-hept-2-
enoseptanose (267)
A A solution of cyclopropane 97 (106 mg, 0.180 mmol) in toluene (1.7 mL) was
treated with silver acetate (35 mg, 0.21 mmol), then stirred at 100 ◦C for 22 hours.
The solution was diluted with water (10 mL), extracted with dichloromethane (3 x
10 mL), then the organic fractions were combined, dried, filtered and concentrated
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to provide a yellow oil. Upon purification by column chromatography (9:1 hex-
anes:ethyl acetate), bicyclic sugar 267 (30 mg, 38%) was obtained as a colourless
oil.
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267: Rf 0.35 (9:1 hexanes:ethyl acetate); [α]
20
D −22 (c 0.4 CHCl3);
1H-NMR: (CDCl3) δH 7.40–7.27 (complex m, 10H, Bn), 6.20 (dd,
J = 2.2, 1.2 Hz, 1H, H-3), 5.66 (s, 1H, H-1), 4.79 (d, J = 11.7
Hz, 1H, PhCH2), 4.73 (d, J = 11.5 Hz, 1H, PhCH2), 4.68 (d,
J = 11.5 Hz, 1H, PhCH2), 4.61 (d, J = 11.7 Hz, 1H, PhCH2), 4.60 (m, 1H, H-4),
4.48 (dd, J = 8.0, 5.5 Hz, 1H, H-6), 4.13 (apparent t, J = 8.1 Hz, 1H, H-7a), 3.63
(d, J = 8.5 Hz, 1H, H-5), 3.55 (dd, J = 8.4, 5.5 Hz, 1H, H-7b); 13C-NMR: (CDCl3)
δC 137.9 (C, Bn), 137.7 (C, Bn), 134.1 CH, C-3), 128.49 (CH, Bn), 128.47 (CH,
Bn), 127.9 (CH, Bn), 127.84 (CH, Bn), 127.82 (CH, Bn), 118.8 (C, C-2), 104.2
(CH, C-1), 88.7 (CH, C-5), 78.6 (CH, C-4), 77.8 (CH, C-6), 73.5 (CH2, PhCH2),
73.3 (CH2, PhCH2), 66.4 (CH2, C-7); IR (KBr): νmax 3063, 3031, 2928, 2862, 1725,
1639, 1601, 1539, 1496, 1453, 1349, 1272, 1210, 1091, 1027, 933, 865, 737, 698 cm−1;
HRMS: m/z C21H21O
79
4 BrNa
+ [M+Na]+ calcd 439.0521, found 439.0515.
B A solution of Meldrum’s acid (41 mg, 0.28 mmol) in DMF (1.7 mL) was treated
with sodium hydride (7 mg, 0.2 mmol) and allowed to react at room temperature.
Upon completion of hydrogen evolution, the solution was treated with silver acetate
(53 mg, 0.32 mmol), then cyclopropane 97 (108 mg, 0.184 mmol), then stirred at
100 ◦C for two days. The solution was diluted with dichloromethane (20 mL), filtered
through a silica plug, then washed with water (10 mL) and extracted further with
dichloromethane (2 x 10 mL). The organic fractions were combined, dried, filtered
and concentrated to provide a brown oil. Upon purification by column chromatog-
raphy (9:1 hexanes:ethyl acetate), bicyclic sugar 267 (10 mg, 13%) was obtained,
in addition to a mixture of acetate oxepines 257 and 258 (7 mg, 7%).
1,6-Anhydro-4,7-di-O-benzyl-2-bromo-2,3-dideoxy-β-d-lyxo-hept-2-
enopyranose (270) and acetyl 4,5,7-tri-O-benzyl-2-bromo-2,3-dideoxy-α-
d-lyxo-hept-2-enoseptanoside (269)
A solution of cyclopropane 45 (103 mg, 0.175 mmol) in toluene (1.7 mL) was treated
with silver acetate (42 mg, 0.25 mmol) and sodium acetate (71 mg, 0.86 mmol),
then stirred at 100 ◦C for two days. The solution was diluted with dichloromethane
(10 mL), filtered through a pad of silica, then eluted further with dichloromethane
(30 mL). The organic fractions were combined, dried, filtered and concentrated to
provide a mixture of bicyclic compound 270 and oxepine 269 as a yellow oil. Upon
purification by column chromatography (14:1 hexanes:ethyl acetate), bicyclic sugar
270 (7 mg, 7%) and oxepine 269 (51 mg, 52%) were obtained as colourless oils.
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270: Rf 0.5 (5:1 hexanes:ethyl acetate); [α]
18
D −69 (c 0.3CHCl3);
1H-NMR: (CDCl3) δH 7.40–7.24 (complex m, 10H, Bn), 6.10 (d,
J = 3.5 Hz, 1H, H-3), 5.51 (s, 1H, H-1), 4.64 (s, 2H, PhCH2),
4.61 (m, 1H, H-6), 4.56 (s, 2H, PhCH2), 3.79 (m, 1H, H-5), 3.63
(d, J = 4.6 Hz, 1H, H-4), 3.58 (dd, J = 9.6, 5.2 Hz, 1H, H-7a), 3.43 (dd, J = 9.4,
7.5 Hz, 1H, H-7b); 13C-NMR: (CDCl3) δC 137.6 (C, Bn), 137.5 (C, Bn), 128.6 (CH,
Bn), 128.5 (CH, Bn), 128.0 (CH, Bn), 127.9 (CH, Bn), 127.8 (CH, Bn), 127.6 (CH,
Bn), 126.3 (C, C-2), 123.9 (CH, C-3), 101.4 (CH, C-1), 76.5 (CH, C-6), 74.0 (CH,
C-4), 73.8 (CH, C-5), 73.6 (CH2, PhCH2), 70.8 (CH2, PhCH2), 70.2 (CH2, C-7);
IR (KBr): νmax 3029, 2917, 2866, 1756, 1630, 1496, 1454, 1261, 1217, 1105, 1064,
1026, 920, 737, 698 cm−1; HRMS: m/z C21H21O
79
4 BrNa
+ [M+Na]+ calcd 439.0521,
found 439.0516.
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67 269: Rf 0.4 (5:1 hexanes:ethyl acetate); [α]
18
D −25 (c 2.0
CHCl3);
1H-NMR: (CDCl3) δH 7.34–7.24 (complex m, 15H,
Bn), 6.44 (s, 1H, H-1), 6.38 (s, 1H, H-3), 4.80 (d, J = 12.0
Hz, 1H, PhCH2), 4.64 (d, J = 12.0 Hz, 1H, PhCH2), 4.54 (d,
J = 11.2 Hz, 1H, PhCH2), 4.49 (d, J = 11.7 Hz, 1H, PhCH2), 4.43 (m, 1H, H-4),
4.38 (d, J = 11.7 Hz, 1H, PhCH2), 4.38 (d, J = 11.7 Hz, 1H, PhCH2), 4.11 (m,
1H, H-6), 4.09 (m, 1H, H-5), 3.68 (apparent d, J = 6.3 Hz, 2H, H-7a,b), 2.08 (s,
3H, Ac); 13C-NMR: (CDCl3) δC 168.8 (C, CH3CO), 138.2 (C, Bn), 138.0 (C, Bn),
137.4 (C, Bn), 134.4 (CH, C-3), 128.6 (CH, Bn), 128.4 (CH, Bn), 128.3 (CH, Bn),
128.00 (CH, Bn), 127.95 (CH, Bn), 127.9 (CH, Bn), 127.7 (CH, Bn), 127.62 (CH,
Bn), 127.61 (CH, Bn), 119.9 (C, C-2), 91.6 (CH, C-1), 80.4 (CH, C-4), 77.0 (CH,
C-5), 75.4 (CH, C-6), 73.6 (CH2, PhCH2), 73.2 (CH2, PhCH2), 71.9 (CH2, PhCH2),
67.5 (CH2, C-7), 20.9 (CH3, Ac); IR (KBr): νmax 3063, 3030, 2870, 1775, 1604,
1496, 1454, 1370, 1219, 1061, 1027, 752, 698 cm−1; HRMS: m/z C30H31O
79
6 BrNa
+
[M+Na]+ calcd 589.1202, found 589.1199.
Acetyl 4,5-di-O-benzyl-2-bromo-2,3-dideoxy-β-d-threo-hex-2-
enoseptanoside (271) and acetyl 4,5-di-O-benzyl-2-bromo-2,3-dideoxy-α-
d-threo-hex-2-enoseptanoside (272)
A Cyclopropane 243 (95 mg, 0.20 mmol) in toluene (2.1 mL) was treated with silver
acetate (53 mg, 0.32 mmol) and sodium acetate (89 mg, 1.1 mmol), then stirred
at 100 ◦C for two days. The solution was filtered through a pad of silica, then
eluted further with diethyl ether (100 mL). The organic fractions were combined,
dried, filtered and concentrated to provide a mixture of oxepines 271 and 272
as a yellow oil. Upon purification by column chromatography (14:1 hexanes:ethyl
acetate), oxepines 271 and 272 (41 mg, 45%) were obtained as an inseparable
colourless oil (1:1 ratio).
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6 271 and 272: Rf 0.5 (5:1 hexanes:ethyl ac-
etate); 1H-NMR: (CDCl3) δH 7.35–7.28
(complex m, 10H, Bn), 6.55 (apparent t, J =
1.7 Hz, 1H, H-1), 6.40 (dd, J = 3.0, 1.5 Hz,
1H, H-3), 6.38 (d, J = 3.4 Hz, 1H, H-3), 6.18 (d, J = 1.7 Hz, 1H, H-1), 4.72–4.60
(complex m, 5H, PhCH2 and H-4), 4.53 (ddd, J = 7.6, 3.4, 1.5 Hz, 1H, H-4), 4.25
(dd, J = 13.8, 5.0 Hz, 1H, H-6a), 4.03 (m, 1H, H-6a), 3.88 (td, J = 4.7, 1.5 Hz,
1H, H-5), 3.85 (d, J = 13.9 Hz, 1H, H-6b), 3.83–3.78 (complex m, 2H, H-5,6b), 2.15
(s, 3H, Ac), 2.13 (s, 3H, Ac); 13C-NMR: (CDCl3) δC 169.1 (C, CH3CO), 138.1 (C,
Bn), 137.9 (C, Bn), 137.7 (C, Bn), 137.6 (C, Bn), 137.5 (CH, C-3), 136.5 (CH, C-3),
128.5 (CH, Bn), 128.41 (CH, Bn), 128.38 (CH, Bn), 127.9 (CH, Bn), 127.79 (CH,
Bn), 127.78 (CH, Bn), 127.68 (CH, Bn), 127.67 (CH, Bn), 119.2 (C, C-2), 118.5 (C,
C-2), 95.6 (CH, C-1), 94.3 (CH, C-1), 82.7 (CH, C-5), 80.3 (CH, C-5), 80.0 (CH,
C-4), 79.2 (CH, C-4), 73.1 (CH2, PhCH2), 73.0 (CH2, PhCH2), 72.8 (CH2, PhCH2),
72.4 (CH2, PhCH2), 66.0 (CH2, C-6), 65.3 (CH2, C-6), 20.8 (CH3, Ac); IR (KBr):
νmax 3061, 3030, 2939, 2880, 1755, 1640, 1496, 1454, 1370, 1273, 1218, 1092, 997,
946, 738, 698 cm−1; HRMS: m/z C22H23O
79
5 BrNa
+ [M+Na]+ calcd 469.0627, found
469.0630.
B A solution of cyclopropane 243 (820 mg, 1.75 mmol) in toluene (17.5 mL) was
treated with silver acetate (437 mg, 2.62 mmol) and sodium acetate (724 mg,
8.82 mmol), then stirred at 95 ◦C for three days. The solution was filtered through a
pad of silica, then eluted further with diethyl ether (100 mL). The organic fractions
were combined, dried, filtered and concentrated to provide a mixture of oxepines
271 and 272 as a yellow oil. Upon purification by column chromatography (14:1
hexanes:ethyl acetate), oxepines 271 and 272 (313 mg, 40%) were obtained as an
inseparable mixture (1:1 ratio).
C A solution of cyclopropane 243 (89 mg, 0.19 mmol) in toluene (2.1 mL) was
treated with sodium acetate (82 mg, 1.0 mmol), then stirred at 100 ◦C for two days.
The solution was diluted with water (10 mL), then extracted with dichloromethane
(3 x 10 mL). The organic fractions were combined, dried, filtered and concentrated
to provide a mixture of oxepines 271 and 272 as a pale–yellow oil. Upon purifi-
cation by column chromatography (14:1 hexanes:ethyl acetate), oxepines 271 and
272 (20 mg, 24%) were obtained as an inseparable mixture (1.5:1 ratio).
Allyl 4,5,7-tri-O-benzyl-2,3-dideoxy-α-d-arabino-hept-2-enoseptanoside
(273)
A solution of oxepine 261 (7 mg, 12 µmol) in THF (0.5 mL) was cooled to −78 ◦C,
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then treated with n-butyllithium (20 µL, 32 µmol) and stirred for one hour. The
solution was then treated with water (20 µL, 1.1 mmol) and immediately allowed
to warm to room temperature. After an additional 30 minutes reaction, the solu-
tion was diluted with water (10 mL), extracted with dichloromethane (3 x 10 mL),
then the organic fractions were combined, dried, filtered and concentrated to pro-
vide a yellow oil. Upon purification by column chromatography (14:1 hexanes:ethyl
acetate), diene 273 (2 mg, 34%) was obtained as a colourless oil.
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67 Rf 0.2 (14:1 hexanes:ethyl acetate);
1H-NMR: (CDCl3)
δH 7.47–7.15 (complex m, 15H, Bn), 5.89 (ddd, J = 12.0,
5.4, 1.5 Hz, 1H, H-3), 5.86 (m, 1H, H-9), 5.74 (dd, J =
12.1, 1.8 Hz, 1H, H-2), 5.38 (s, 1H, H-1), 5.21 (dd, J =
17.2, 1.1 Hz, 1H, H-10a), 5.12 (dd, J = 10.4, 0.6 Hz, 1H, H-10b), 4.68 (d, J =
12.2 Hz, 1H, PhCH2), 4.58 (d, J = 12.0 Hz, 1H, PhCH2), 4.57 (d, J = 11.2 Hz, 1H,
PhCH2), 4.55 (d, J = 12.0 Hz, 1H, PhCH2), 4.48 (d, J = 12.2 Hz, 1H, PhCH2), 4.36
(d, J = 11.2 Hz, 1H, PhCH2), 4.32 (dd, J = 12.6, 5.0 Hz, 1H, H-8a), 4.14 (apparent
t, J = 4.8 Hz, 1H, H-4), 4.10 (ddd, J = 8.8, 6.2, 2.4 Hz, 1H, H-6), 4.00 (dd, J =
12.7, 5.9 Hz, 1H, H-8b), 3.75 (dd, J = 8.9, 4.0 Hz, 1H, H-5), 3.68 (dd, J = 10.5, 5.9
Hz, 1H, H-7a), 3.59 (dd, J = 10.5,2.2 Hz, 1H, H-7b); 13C-NMR: (CDCl3) δC 138.3
(C, Bn), 138.2 (C, Bn), 137.9 (C, Bn), 134.4 (CH, C-9), 132.3 (CH, C-2), 129.3 (CH,
C-3), 128.4 (CH, Bn), 128.32 (CH, Bn), 128.27 (CH, Bn), 127.9 (CH, Bn), 127.8
(CH, Bn), 127.70 (CH, Bn), 127.67 (CH, Bn), 127.5 (CH, Bn), 117.1 (CH2, C-10),
97.9 (CH, C-1), 81.4 (CH, C-5), 76.2 (CH, C-4), 73.1 (CH2, PhCH2), 72.9 (CH2,
PhCH2), 71.6 (CH, C-6), 71.3 (CH2, PhCH2), 70.7 (CH2, C-7), 68.3 (CH2, C-8);
HRMS: m/z C31H34O5Na
+ [M+Na]+ calcd 509.2304, found 509.2300.
4-Methylene-2-(4,5,7-tri-O-benzyl-1,2,3-dideoxy-α-d-arabino-hept-2-
enoseptanoso)[1,2-b]oxolane (274)
A solution of allyl oxepine 261 (15 mg, 27 µmol) in THF (1 mL) was treated suc-
cessively with triphenylphosphine (2 mg, 8 µmol), triethylamine (8 µL, 60 µmol)
and palladium(II)diacetate (1 mg, 5 µmol), then stirred at reflux for one day. The
reaction was then charged with additional triphenylphosphine (10 mg 38 µmol) and
palladium(II)diacetate (4 mg, 18 µmol), then reacted for an additional three hours.
The solution was diluted with water (10 mL), extracted with dichloromethane (3 x
10 mL), then the organic fractions were combined, dried, filtered and concentrated
to provide a yellow solid. Upon separation by column chromatography (5:1 hex-
anes:ethyl acetate), starting material 261 was recovered (3 mg, 20%), in addition
to diene 274 (6 mg, 47%), obtained as a yellow solid.
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67 Rf 0.3 (5:1 hexanes:ethyl acetate); m.p. 78–81
◦C; [α]19D −2
(c 0.4 CHCl3);
1H-NMR: (CDCl3) δH 7.73–7.69 (complex m,
2H, Bn), 7.43–7.12 (complex m, 13H, Bn), 6.19 (dd, J = 3.5,
1.6 Hz, 1H, H-3), 5.50 (d, J = 1.7 Hz, 1H, H-1), 5.29 (appar-
ent t, J = 2.2 Hz, 1H, H-10a), 4.94 (s, 1H, H-10b), 4.91 (d, J = 10.5 Hz, 1H, H-8a),
4.78 (dt, J = 12.7, 2.4 Hz, 1H, PhCH2), 4.73 (d, J = 12.0 Hz, 1H, PhCH2), 4.62 (d,
J = 12.2 Hz, 1H, PhCH2), 4.54–4.50 (complex m, 4H, PhCH2, H-8b), 4.41 (dd, J =
9.1, 3.5 Hz, 1H, H-4), 3.94 (dd, J = 10.0, 3.9 Hz, 1H, H-7a), 3.90 (ddd, J = 8.7,
3.9, 2.1 Hz, 1H, H-6), 3.77 (dd, J = 10.0, 2.0 Hz, 1H, H-7b), 3.63 (apparent t, J =
9.0 Hz, 1H, H-5); 13C-NMR: (CDCl3) δC 141.4 (C, C-9), 141.2 (C, C-2), 138.3 (C,
Bn), 138.2 (C, Bn), 138.1 (C, Bn), 135.2 (CH, Bn), 128.4 (CH, Bn), 128.3 (CH, Bn),
127.99 (CH, Bn), 127.97 (CH, Bn), 127.9 (CH, Bn), 127.7 (CH, Bn), 127.60 (CH,
Bn), 127.56 (CH, Bn), 125.0 (CH, C-3), 105.2 (CH, C-1), 103.3 (CH2, C-10), 82.5
(CH, C-4), 80.7 (CH, C-6), 76.1 (CH, C-5), 75.3 (CH2, C-8), 73.6 (CH2, PhCH2),
73.2 (CH2, PhCH2), 72.7 (CH2, PhCH2), 70.7 (CH2, C-7); IR (KBr): νmax 3063,
3030, 2918, 2866, 1723, 1604, 1496, 1453, 1359, 1091, 1072, 1027, 750, 697 cm−1;
HRMS: m/z C31H32O5Na
+ [M+Na]+ calcd 507.2147, found 507.2148.
3,6-Anhydro-4,5,7-tri-O-benzyl-2-bromo-2-deoxy-d-arabino-septanose
dimethyl acetal (275) and 3,6-anhydro-4,5,7-tri-O-benzyl-2-bromo-2-
deoxy-d-arabino-septanose dimethyl acetal (276) and (Z )-3,6-anhydro-
4,5,7-tri-O-benzyl-2-bromo-2-deoxy-1-O-methyl-d-arabino-hept-1-enitol
(277)
A A solution of cyclopropane 97 (96 mg, 0.16 mmol) in methanol (1.7 mL) was
subjected to microwave reaction at 130 ◦C (pressure approximately eight bar) for
periods of 10, 30 and 20 minutes (total one hour). The mixture was transferred
from the reaction vessel by dilution with methanol (10 mL) and dichloromethane
(20 mL), then concentrated to provide a yellow oil. This oil was purified by column
chromatography (14:1 hexanes:ethyl acetate) to provide a trace of starting material
97 (4 mg, 4%), in addition to dimethyl acetals 275 (14 mg, 15%) and 276 (43 mg,
46%) and olefin 277 (11 mg, 13%), isolated as colourless oils.
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275: Rf 0.4 (5:1 hexanes:ethyl acetate); [α]
20
D +29 (c 1.2
CHCl3);
1H-NMR: (CDCl3) δH 7.36–7.26 (complex m,
15H, Bn), 4.61 (d, J = 11.7 Hz, 1H, PhCH2), 4.58–4.55
(complex m, 6H, PhCH2, H-1), 4.33 (dd, J = 6.6, 4.7 Hz,
1H, H-4), 4.25 (apparent q, J = 5.0 Hz, 1H, H-6), 4.22 (dd, J = 6.6, 3.2 Hz, 1H, H-
3), 4.19 (apparent t, J = 5.0 Hz, 1H, H-5), 4.04 (dd, J = 7.3, 2.9 Hz, 1H, H-2), 3.59
(apparent t, J = 5.0 Hz, 2H, H-7a,b), 3.40 (s, 3H, Me), 3.38 (s, 3H, Me); 13C-NMR:
(CDCl3) δC 138.1 (C, Bn), 137.87 (C, 2 x Bn), 128.5 (CH, Bn), 128.41 (CH, Bn),
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128.38 (CH, Bn), 127.9 (CH, Bn), 127.84 (CH, Bn), 127.81 (CH, Bn), 127.79 (CH,
Bn), 127.7 (CH, Bn), 127.6 (CH, Bn), 104.4 (CH, C-1), 85.9 (CH, C-4), 84.3 (CH,
C-5), 81.8 (CH, C-6), 79.9 (CH, C-3), 73.4 (CH2, PhCH2), 72.4 (CH2, PhCH2), 72.2
(CH2, PhCH2), 70.1 (CH2, C-7), 55.7 (CH3, Me), 55.0 (CH, C-2), 54.4 (CH3, Me);
IR (KBr): νmax 3088, 3063, 3030, 2930, 2862, 1723, 1496, 1454, 1362, 1108, 1072,
1027, 737, 698 cm−1.
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276: Rf 0.3 (5:1 hexanes:ethyl acetate); [α]
20
D −5.0 (c
3.3 CHCl3);
1H-NMR: (CDCl3) δH 7.37–7.19 (complex m,
15H, Bn), 4.64 (d, J = 12.2 Hz, 1H, PhCH2), 4.59 (d, J =
12.0 Hz, 1H, PhCH2), 4.53 (d, J = 12.2 Hz, 1H, PhCH2),
4.52 (d, J = 12.0 Hz, 1H, PhCH2), 4.46 (d, J = 11.7 Hz, 1H, PhCH2), 4.28 (dd,
J = 9.0, 3.2 Hz, 1H, H-2), 4.24 (d, J = 11.2 Hz, 1H, PhCH2), 4.24 (dd, J = 9.0,
3.4 Hz, 1H, H-3), 4.17 (ddd, J = 7.7, 5.1, 2.5 Hz, 1H, H-6), 4.12 (d, J = 3.2 Hz,
1H, H-1), 4.11 (d, J = 2.2 Hz, 1H, H-5), 3.90 (d, J = 3.7 Hz, 1H, H-4), 3.71 (dd,
J = 9.8, 5.1 Hz, 1H, H-7a), 3.51 (td, J = 9.8, 2.0 Hz, 1H, H-7b), 3.33 (s, 3H, Me),
3.28 (s, 3H, Me); 13C-NMR: (CDCl3) δC 138.2 (C, Bn), 137.8 (C, Bn), 137.1 (C,
Bn), 128.52 (CH, Bn), 128.50 (CH, Bn), 128.4 (CH, Bn), 128.2 (CH, Bn), 128.1
(CH, Bn), 127.9 (CH, Bn), 127.84 (CH, Bn), 127.81 (CH, Bn), 127.7 (CH, Bn),
103.7 (CH, C-1), 83.2 (CH, C-5), 82.3 (CH, C-4), 82.0 (CH, C-6), 81.1 (CH, C-3),
73.3 (CH2, PhCH2), 71.3 (CH2, PhCH2), 70.9 (CH2, PhCH2), 70.1 (CH2, C-7), 56.2
(CH3, Me), 55.5 (CH3, Me), 51.5 (CH, C-2); IR (KBr): νmax 3087, 3062, 3030, 2926,
2865, 1726, 1604, 1496, 1454, 1362, 1210, 1090, 1072, 738, 698 cm−1; HRMS: m/z
C30H35O
79
6 BrNa
+ [M+Na]+ calcd 593.1515, found 593.1506.
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277: Rf 0.25 (5:1 hexanes:ethyl acetate); [α]
20
D +8 (c 0.6
CHCl3);
1H-NMR: (CDCl3) δH 7.35–7.25 (complex m,
15H, Bn), 6.60 (s, 1H, H-1), 4.62–4.51 (complex m, 6H,
PhCH2), 4.38–4.34 (complex m, 2H, H-3,4), 4.23–4.19
(complex m, 2H, H-5,6), 3.74 (s, 3H, Me), 3.60 (dd, J = 10.4, 3.5 Hz, 1H, H-7a), 3.55
(dd, J = 10.0, 3.9 Hz, 1H, H-7b); 13C-NMR: (CDCl3) δC 147.9 (CH, C-1), 138.1 (C,
Bn), 138.0 (C, Bn), 137.9 (C, Bn), 128.41 (CH, Bn), 128.39 (CH, Bn), 128.37 (CH,
Bn), 127.82 (CH, Bn), 127.79 (CH, Bn), 127.76 (CH, Bn), 127.7 (CH, Bn), 127.6
(CH, Bn), 101.2 (C, C-2), 85.9 (CH, C-4), 83.6 (CH, C-5), 82.4 (CH, C-3), 81.1 (CH,
C-6), 73.4 (CH2, PhCH2), 72.5 (CH2, PhCH2), 72.2 (CH2, PhCH2), 70.2 (CH2, C-7),
60.7 (CH3, Me); IR (KBr): νmax 3054, 2986, 2917, 2848, 1666, 1496, 1454, 1421,
1363, 1265, 1098, 1027, 895, 738, 703 cm−1; HRMS:m/z C29H31O
79
5 BrNa
+ [M+Na]+
calcd 561.1253, found 561.1246.
B A solution of cyclopropane 97 (60 mg, 0.10 mmol) in methanol (3.4 mL) was
treated with silver acetate (25 mg, 0.15 mmol), then subjected to microwave reac-
tion at 100 ◦C (pressure approximately three bar) for a period of 10 minutes. The
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mixture was transferred with methanol (20 mL), then concentrated to provide a
yellow oil. This oil was purified by column chromatography (14:1 hexanes:ethyl ac-
etate) to provide a large proportion of starting material 97, in addition to oxepines
98 (0.6 mg, 1%) and 99 (1.5 mg, 3%). Traces of the higher moving dimethyl acetal
275 and olefin 277 were detected by TLC.
C A solution of cyclopropane 97 (100 mg, 0.17 mmol) in methanol (3.4 mL) was
treated with silver nitrate (38 mg, 0.21 mmol), then subjected to microwave reaction
at 100 ◦C (pressure approximately three bar) for periods of 10, 50 and 50 minutes
(total 110 minutes). The mixture was transferred with methanol (20 mL), then
concentrated to provide a yellow oil. Proton NMR analysis of this crude oil showed
the presence of starting material 97 and C -furanosyl sugars 275, 276 and olefin
277, indicating conversion of approximately 60%.
D A solution of cyclopropane 97 (100 mg, 0.17 mmol) in methanol (1.7 mL) was
treated with silver tetrafluoroborate (29 mg, 0.15 mmol), then refluxed for three
days. The solution was diluted with diethyl ether (10 mL), filtered through a pad of
Celite R©, then washed with water (10 mL). The aqueous wash was extracted further
with ether (2 x 10 mL), then the ethereal solutions were combined, dried, filtered
and concentrated to provide a yellow oil. Upon separation by column chromatogra-
phy (9:1 hexanes:ethyl acetate), starting material 97 (26 mg, 26%) was recovered,
in addition to C -furanosyl sugars 275 (9 mg, 9%) and 276 (21 mg, 22%).
3,6-Anhydro-4,5,7-tri-O-benzyl-2-bromo-2-deoxy-d-arabino-septanose
diallyl acetal (278) and 3,6-anhydro-4,5,7-tri-O-benzyl-2-bromo-2-deoxy-
d-arabino-septanose diallyl acetal (279) and (Z )-1-O-allyl-3,6-anhydro-
4,5,7-tri-O-benzyl-2-bromo-2-deoxy-d-arabino-hept-1-enitol (280)
A A solution of cyclopropane 97 (100 mg, 0.170 mmol) in allyl alcohol (1.7 mL) was
heated under reflux for two days, then filtered through a plug of silica, which was
eluted further with 5:1 hexanes:ethyl acetate (30 mL). The eluents were concentrated
to provide a colourless oil, which was purified by column chromatography (14:1
hexanes:ethyl acetate). A complex mixture of unidentified products was isolated
(30 mg, Rf 0.2), in addition to diallyl acetals 278 (18 mg, 17%) and 279 (30 mg,
28%) and olefin 280 (11 mg, 12%), all isolated as colourless oils.
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278: Rf 0.15 (14:1 hexanes:ethyl acetate); [α]
21
D −3 (c
0.3 CHCl3);
1H-NMR: (CDCl3) δH 7.40–7.26 (com-
plex m, 15H, Bn), 5.95–5.82 (complex m, 2H, H-9),
5.30 (d, J = 17.1 Hz, 1H, H-10a), 5.26 (d, J = 17.1
Hz, 1H, H-10a), 5.18 (d, J = 10.5 Hz, 1H, H-10b), 5.14 (d, J = 10.5 Hz, 1H, H-10b),
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4.80 (dd, J = 7.2, 2.1 Hz, 1H, H-1), 4.60–4.48 (complex m, 6H, PhCH2), 4.38 (dd,
J = 6.6, 4.6 Hz, 1H, H-4), 4.31 (dd, J = 5.7, 2.3 Hz, 1H, H-6), 4.28 (dd, J = 6.3,
3.2 Hz, 1H, H-3), 4.25 (apparent t, J = 4.9 Hz, 1H, H-5), 4.22–4.17 (complex m, 2H,
H-8a,b), 4.14–4.07 (complex m, 3H, H-2,8), 3.58 (apparent td, J = 5.0, 2.0 Hz, 2H,
H-7a,b); 13C-NMR: (CDCl3) δC 138.1 (C, Bn), 137.8 (C, Bn), 137.7 (C, Bn), 134.1
and 133.9 (C, C-9), 128.4 (CH, Bn), 128.3 (CH, Bn), 127.82 (CH, Bn), 127.78 (CH,
Bn), 127.75 (CH, Bn), 127.71 (CH, Bn), 127.65 (CH, Bn), 127.6 (CH, Bn), 117.5
and 117.3 (CH2, C-10), 101.9 (CH, C-1), 85.8 (CH, C-4), 84.3 (CH, C-5), 81.7 (CH,
C-3), 79.9 (CH, C-6), 73.4 (CH2, PhCH2), 72.4 (CH2, PhCH2), 72.1 (CH2, PhCH2),
70.2 (CH2, C-7), 69.2 and 68.3 (CH2, C-8), 55.7 (CH, C-2); IR (KBr): νmax 3060,
3027, 2912, 2862, 1723, 1454, 1361, 1219, 1095, 925, 770, 698 cm−1.
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279: Rf 0.1 (14:1 hexanes:ethyl acetate); [α]
21
D −8 (c
0.7 CHCl3);
1H-NMR: (CDCl3) δH 7.33–7.14 (com-
plex m, 15H, Bn), 5.85–5.77 (complex m, 2H, H-9),
5.20 (dd, J = 17.1, 1.5 Hz, 1H, H-10a), 5.17 (dd,
J = 17.1, 1.5 Hz, 1H, H-10a), 5.14 (d, J = 10.5 Hz, 1H, H-10b), 5.10 (d, J =
10.4 Hz, 1H, H-10b), 4.58 (d, J = 12.0 Hz, 1H, PhCH2), 4.55 (d, J = 12.0 Hz, 1H,
PhCH2), 4.49 (d, J = 12.2 Hz, 1H, PhCH2), 4.48 (d, J = 12.2 Hz, 1H, PhCH2), 4.44
(apparent t, J = 2.2 Hz, 1H, H-1), 4.41 (d, J = 11.5 Hz, 1H, PhCH2), 4.29–4.25
(complex m, 2H, H-2,3), 4.22 (d, J = 11.5 Hz, 1H, PhCH2), 4.13 (m, 1H, H-6),
4.10 (m, 1H, H-8), 4.06 (m, 1H, H-5), 4.00 (ddd, J = 12.8, 5.4, 1.2 Hz, 1H, H-8),
3.94 (ddd, J = 12.8, 5.4, 1.2 Hz, 1H, H-8), 3.92 (m, 1H, H-4), 3.88 (ddd, J = 13.0,
6.3, 1.2 Hz, 1H, H-8), 3.67 (ddd, J = 9.8, 5.2, 2.0 Hz, 1H, H-7a), 3.48 (ddd, J =
9.8, 7.9, 2.0 Hz, 1H, H-7b); 13C-NMR: (CDCl3) δC 138.2 (C, Bn), 137.8 (C, Bn),
137.3 (C, Bn), 133.89 and 133.85 (CH, C-9), 128.44 (CH, Bn), 128.41 (CH, Bn),
128.3 (CH, Bn), 127.9 (CH, Bn), 127.81 (CH, Bn), 127.80 (CH, Bn), 127.79 (CH,
Bn), 127.7 (CH, Bn), 127.6 (CH, Bn), 117.8 and 117.4 (CH2, C-10), 100.2 (CH,
C-1), 83.1 (CH, C-5), 82.4 (CH, C-4), 82.0 (CH, C-6), 81.0 (CH, C-3), 73.3 (CH2,
PhCH2), 71.3 (CH2, PhCH2), 70.9 (CH2, PhCH2), 70.1 (CH2, C-7), 69.4 and 68.4
(CH2, C-8), 52.3 (CH, C-2); IR (KBr): νmax 3064, 3031, 2918, 2867, 1723, 1647,
1603, 1496, 1455, 1363, 1340, 1270, 1208, 1106, 1055, 1028, 928, 738, 699 cm−1;
HRMS: m/z C34H39O
79
6 BrNa
+ [M+Na]+ calcd 645.1828, found 645.1823
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280: Rf 0.05 (14:1 hexanes:ethyl acetate);
1H-NMR:
(CDCl3) δH 7.35–7.22 (complex m, 15H, Bn), 6.69 (d,
J = 2.0 Hz, 1H, H-1), 5.90 (dddd, J = 17.1, 10.4,
5.0, 2.0 Hz, 1H, H-9), 5.33 (dt, J = 17.1, 1.5 Hz, 1H,
H-10a), 5.26 (dt, J = 10.5, 1.3 Hz, 1H, H-10b), 4.63–4.51 (complex m, 6H, PhCH2),
4.40 (d, J = 5.4 Hz, 2H, H-8a,b), 4.37 (complex m, 2H, H-3,4), 4.21–4.20 (complex
m, 2H, H-5,6), 3.60 (dd, J = 10.5, 3.0 Hz, 1H, H-7a), 3.55 (dd, J = 10.5, 1.5 Hz,
1H, H-7b); 13C-NMR: (CDCl3) δC 146.2 (CH, C-1), 138.1 (C, Bn), 137.91 (C, Bn),
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137.90 (C, Bn), 132.8 (CH, C-9), 128.44 (CH, Bn), 128.38 (CH, Bn), 128.35 (CH,
Bn), 128.3 (CH, Bn), 127.9 (CH, Bn), 127.79 (CH, Bn), 127.77 (CH, Bn), 127.7 (CH,
Bn), 127.6 (CH, Bn), 118.7 (CH2, C-10), 101.6 (CH, C-2), 85.8 (CH, C-4), 83.4 (CH,
C-5), 82.4 (CH, C-3), 81.0 (CH, C-6), 73.7 (CH2, C-8), 73.4 (CH2, PhCH2), 72.5
(CH2, PhCH2), 72.2 (CH2, PhCH2), 70.1 (CH2, C-7).
B A solution of cyclopropane 97 (104 mg, 0.177 mmol) in allyl alcohol (1.7 mL)
was treated with silver nitrate (31 mg, 0.19 mmol), then heated under reflux for
three days. The solution was separated between water (10 mL) and dichlorometh-
ane (10 mL), then the aqueous phase was extracted further with dichloromethane
(2 x 10 mL). The organic fractions were combined, filtered through a pad of silica,
then dried, filtered and concentrated to provide a yellow oil, which was purified by
column chromatography (14:1 hexanes:ethyl acetate). A complex mixture of alde-
hydes and oxepines 260 and 261 (9 mg) was obtained, in addition to previously
isolated C -furanosyl sugars 278 (12 mg, 11%), 279 (28 mg, 25%) and olefin 280
(16 mg, 15%).
C A solution of cyclopropane 97 (100 mg, 0.170 mmol) in allyl alcohol (1.7 mL) was
treated with silver trifluoroacetate (54 mg, 0.24 mmol), then heated under reflux for
three days. The solution was separated between water (10 mL) and dichloromethane
(10 mL), then the aqueous phase was extracted further with dichloromethane (2 x
10 mL). The organic fractions were combined, filtered through a pad of Celite R©,
then dried, filtered and concentrated to provide a yellow oil, which was purified by
column chromatography (14:1 hexanes:ethyl acetate). Starting material 97 (5 mg,
5%), oxepines 260 (8 mg, 8%) and 261 (13 mg, 14%), diallyl acetal 279 (8 mg, 8%)
and olefin 280 (23 mg, 22%) were isolated.
7.4 Chapter Four Experimental
Tri-O-acetyl-d-galactal (180)
Using a modification of Kozikowski’s procedure,89 a magnetically stirred solution of
d-galactose (124 mg, 0.7 mmol) in acetic anhydride (75 mL, 790 mmol) was treated
dropwise with conc. perchloric acid (0.45 mL, 6.9 mmol). d-Galactose (20.00 g,
111.0 mmol) was slowly added over half an hour, at a rate that maintained a tem-
perature of 40–50 ◦C. Upon complete addition of d-galactose, the solution was
allowed to cool to room temperature, then treated with a 33% (w/w) solution of hy-
drobromic acid in acetic acid (75 mL, 410 mmol). After 90 minutes, the solution was
diluted with dichloromethane (180 mL) and washed with ice–cold water (2 x 50 mL),
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then with cold sat. sodium bicarbonate solution (4 x 100 mL). The organic phase was
dried, filtered and concentrated to afford crude tetra-O-acetyl-α-d-galactopyranosyl
bromide (248) as a pale–yellow oil.
A mechanically stirred dispersion of zinc dust (48.1 g, 736 mmol) in water (150 mL)
was cooled to 0 ◦C, then diluted with acetic acid (150 mL), then treated drop-
wise with a solution of tetra-O-acetyl-α-d-galactopyranosyl bromide in diethyl ether
(150 mL), over 20 minutes. The reaction was allowed to warm to room temperature
and left to proceed overnight. The solution was filtered, then diluted with dichloro-
methane (200 mL). The solution was then washed with water (3 x 60 mL), sat.
sodium bicarbonate solution (2 x 50 mL), then brine (60 mL). The organic phase
was dried, filtered and concentrated to provide tri-O-acetyl-d-galactal (180) as a
pale–yellow oil. Purification by flash chromatography (3:1 hexanes:ethyl acetate),
provided glycal 180 as a pale–yellow oil (15.9 g, 52%). The spectral data matched
that reported previously.157
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Rf 0.3 (3:1 hexanes:ethyl acetate);
1H-NMR: (CDCl3) δH 6.46 (dd,
J = 6.1, 1.8 Hz, 1H, H-1), 5.54 (m, 1H, H-3), 5.42 (dt, J = 4.5, 1.5
Hz, 1H, H-4), 4.72 (ddd, J = 6.3, 2.6, 1.5 Hz, 1H, H-2), 4.31 (m,
1H, H-5), 4.26 (dd, J = 11.5, 7.3 Hz, 1H, H-6a), 4.21 (dd, J = 11.5,
5.1 Hz, 1H, H-6b), 2.12 (s, 3H, Ac), 2.08 (s, 3H, Ac), 2.03 (s, 3H, Ac); 13C-NMR:
(CDCl3) δC 170.6 (C, CH3CO), 170.3 (C, CH3CO), 170.2 (C, CH3CO), 145.4 (CH,
C-1), 98.8 (CH, C-2), 72.8 (CH, C-5), 63.9 (CH, C-3), 63.7 (CH, C-4), 61.9 (CH2,
C-6), 20.83 (CH3, Ac), 20.78 (CH3, Ac), 20.7 (CH3, Ac).
Phenyl 4,6-di-O-acetyl-2,3-dideoxy-1-thio-α-d-threo-hex-2-enopyranoside
(289)
Using a known procedure,122 a solution of tri-O-acetyl-d-galactal (180) (4.06 g,
14.9 mmol) in dichloromethane (70 mL) was treated with thiophenol (1.79 g, 16.2
mmol), then iron trichloride (2.5 mL of a 0.01 molL−1 solution in dichloromethane,
0.025 mmol) and stirred under argon for 20 hours. Further iron trichloride was
added (3 mL of a 0.01 molL−1 solution in dichloromethane, 0.03 mmol), then the
reaction allowed to proceed for 5 hours. The mixture was then diluted with sat.
sodium bicarbonate (75 mL) and the phases separated. The aqueous fraction was
extracted further with dichloromethane (2 x 75 mL), then the organic fractions were
combined, dried, filtered and concentrated. The oil obtained was then subjected to
flash chromatography (5:1 hexanes:ethyl acetate), to provide 2,3-unsaturated sugar
289 (2.23 g, 46% yield) as a white crystalline solid. The spectral data matched that
reported previously.123
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6 SPh Rf 0.35 (5:1 hexanes:ethyl acetate); m.p. 87–90 ◦C (lit.123 m.p.
92–93 ◦C); 1H-NMR: (CDCl3) δH 7.59–7.55 (complex m, 2H,
Ph), 7.34–7.28 (complex m, 3H, Ph), 6.23 (dd, J = 10.0, 3.4
Hz, 1H, H-2), 6.11 (ddd, J = 9.9, 5.5, 1.7 Hz, 1H, H-3), 5.85 (dd, J = 3.1, 1.6 Hz,
1H, H-1), 5.13 (dd, J = 5.4, 2.4 Hz, 1H, H-4), 4.71 (td, J = 6.0, 2.4 Hz, 1H, H-5),
4.28–4.26 (complex m, 2H, H-6a,b), 2.02 (s, 3H, Ac), 1.97 (s, 3H, Ac); 13C-NMR:
(CDCl3) δC 170.6 (C, CH3CO), 170.3 (C, CH3CO), 134.6 (C, Ph), 131.8 (CH, Ph),
131.3 (CH, C-2), 128.9 (CH, Ph), 127.6 (CH, Ph), 124.5 (CH, C-3), 83.4 (CH, C-1),
67.2 (CH, C-5), 63.3 (CH, C-4), 62.7 (CH2, C-6), 20.8 (CH3, Ac), 20.7 (CH3, Ac);
IR (KBr): νmax 3061, 3004, 2964, 2934, 2902, 1739, 1370, 1265, 1241, 1080, 1053,
1020, 817, 789, 690 cm−1.
Phenyl 2,3-dideoxy-1-thio-α-d-threo-hex-2-enopyranoside (300)
Diacetate 289 (331 mg, 1.03 mmol) was dissolved in methanol (20 mL) and treated
with a small piece of sodium metal (4 mg, 0.2 mmol). The mixture was stirred for
45 minutes, then neutralised with Amberlite R© IR 120 resin (H+ form) (0.7 g). The
solution was concentrated to afford diol 300 (242 mg, 99% yield) as a white solid,
which was used without further purification.
OHO
HO
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6 SPh Rf 0.2 (2:1 hexanes:ethyl acetate); m.p. 112–114 ◦C (lit.158 m.p.
108–110 ◦C); [α]20D +138 (c 0.7 CH2Cl2);
1H-NMR: (CDCl3) δH
7.56–7.54 (complex m, 2H, Ph), 7.35–7.29 (complex m, 3H, Ph),
6.16–6.14 (complex m, 2H, H-2,3), 5.85 (d, J = 2.2 Hz, 1H, H-1), 4.41 (ddd, J =
6.4, 4.5, 2.2 Hz, 1H, H-5), 4.03 (ddd, J = 9.0, 4.6, 2.4 Hz, 1H, H-4), 3.99 (m, 1H,
H-6a), 3.91 (ddd, J = 12.0, 8.0, 4.7 Hz, 1H, H-6b), 2.00 (dd, J = 8.0, 4.9 Hz, 1H,
OH), 1.90 (d, J = 9.3 Hz, 1H, OH); 13C-NMR: (CDCl3) δC 134.6 (C, Ph), 132.0
(CH, Ph), 129.5 (CH, C-2), 129.1 (CH, Ph), 128.5 (CH, C-3), 127.7 (CH, Ph), 83.9
(CH, C-1), 70.9 (CH, C-5), 63.1 (CH, C-4), 62.8 (CH2, C-6); IR (KBr): νmax 3366,
2969, 2931, 2893, 1582, 1479, 1437, 1331, 1078, 1037, 972, 865, 792, 736, 688 cm−1.
Phenyl 2,3-dideoxy-4,6-O-((S)-p-methoxyphenylmethylene)-1-thio-α-d-
threo-hex-2-enopyranoside (290)
A magnetically stirred solution of diol 300 (97 mg, 0.41 mmol) in DMF (3.8 mL)
was treated with anisaldehyde dimethyl acetal (86 mg, 0.47 mmol) and (1S )-(+)-
10-camphorsulfonic acid (0.4 mL of a 0.01 molL−1 solution in DMF, 4 µmol). The
solution was heated to 50 ◦C and allowed to proceed for 22 hours. The reaction was
quenched with triethylamine (1 drop) and concentrated under reduced pressure. The
mixture was then separated between water (50 mL) and dichloromethane (50 mL).
The aqueous layer was extracted further with dichloromethane (2 x 50 mL) and the
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organic fractions were combined and washed with brine (50 mL). The organic phase
was dried, filtered and concentrated to afford the crude product as a white solid.
Recrystallisation from ethanol provided 290 (98 mg, 67% yield) as white crystalline
needles.
OO
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Rf 0.4 (3:1 hexanes:ethyl acetate); m.p. 174–176
◦C; [α]20D
−260 (c 0.3 CH2Cl2);
1H-NMR: (CDCl3) δH 7.52 (d, J =
8.1 Hz, 2H, Ph), 7.42 (d, J = 8.5 Hz, 2H, PMP), 7.28 (ap-
parent t, J = 7.4 Hz, 2H, Ph), 7.22 (m, 1H, Ph), 6.84 (d, J = 8.8 Hz, 2H, PMP),
6.20 (dd, J = 10.0, 3.4 Hz, 1H, H-2), 6.07 (dd, J = 9.8, 5.4 Hz, 1H, H-3), 6.00 (s,
1H, H-1), 5.55 (s, 1H, PMPCH), 4.34 (d, J = 12.9 Hz, 1H, H-6a), 4.26 (dd, J =
12.9, 1.8 Hz, 1H, H-6b), 4.24 (m, 1H, H-4), 4.16 (m, 1H, H-5), 3.76 (s, 3H, Me);
13C-NMR: (CDCl3) δC 160.0 (C, PMP), 135.4 (C, Ph), 130.9 (C-2), 130.7 (CH, Ph),
130.3 (C, PMP), 129.0 (CH, Ph), 127.5 (CH, PMP), 127.1 (CH, Ph), 125.2 (C-3),
113.5 (CH, PMP), 100.7 (CH, PMPC), 84.1 (CH, C-1), 69.9 (CH2, C-6), 67.8 (CH,
C-4), 62.5 (CH, C-5), 55.3 (CH3, Me); IR (KBr): νmax 3045, 3001, 2981, 2859, 2840,
1614, 1517, 1312, 1250, 1134, 1073, 1060, 1031, 983, 827, 789, 689 cm−1; HRMS: m/z
C20H20O4SNa
+ [M+Na]+ calcd 379.0980, found 379.0984.
1-(p-Methoxyphenyl)-pentan-1-ol (301) and phenyl (2E,4E)-6-hydroxy-
thiohexadienoate (302)
A solution of thioglycoside 290 (201 mg, 0.564 mmol) in THF (5.6 mL) was cooled
to −78 ◦C, then treated with n-butyllithium (0.5 mL, 0.8 mmol) and stirred for
one hour.The reaction was quenched through addition of water (1 mL), then was
diluted further with water (20 mL) and extracted with dichloromethane (3 x 20 mL).
The organic fractions were dried, filtered and concentrated to provide a white solid.
Purification by flash chromatography (9:1 to 3:1 hexanes:ethyl acetate) provided
starting material 290 (73 mg, 36%), in addition to alcohol 301 (55 mg, 50%) and
diene 302 (31 mg, 25%), both isolated as yellow oils.
1
2
3
4
5
OH
PMP
Rf 0.35 (5:1 hexanes:ethyl acetate);
1H-NMR: (CDCl3) δH 7.27
(d, J = 8.8 Hz, 2H, PMP), 6.89 (d, J = 8.5 Hz, 2H, PMP), 4.61
(t, J = 6.7 Hz, 1H, H-1), 3.81 (s, 3H, Me), 1.81–1.68 (complex m,
3H), 1.37–1.23 (complex m, 4H), 0.89 (t, J = 7.1 Hz, 3H, H-5); 13C-NMR: (CDCl3)
δC 128.2 (CH, PMP), 127.2 (CH, PMP), 113.6 (CH, PMP), 77.6 (CH, C-1), 55.2
(CH3, Me), 38.2 (CH2), 28.0 (CH2), 22.6 (CH2), 14.0 (CH3, C-5).
1 2
3
4
5
6
O
PhS OH
Rf 0.1 (5:1 hexanes:ethyl acetate);
1H-NMR: (CDCl3) δH
7.48–7.42 (complex m, 5H, Ph), 7.23 (dd, J = 15.1, 11.0
Hz, 1H, H-3), 6.44 (dd, J = 15.3, 10.9 Hz, 1H, H-4), 6.34
(dt, J = 15.3, 4.6 Hz, 1H, H-5), 6.26 (d, J = 15.1 Hz, 1H, H-2), 4.34 (d, J = 4.6 Hz,
2H, H-6a,b); 13C-NMR: (CDCl3) δC 188.1 (C, C-1), 143.1 (CH, C-5), 140.6 (CH,
148
C-3), 134.6 (CH, Ph), 129.4 (CH, Ph), 129.2 (CH, Ph), 127.6 (C, Ph), 127.4 (CH,
C-4), 127.3 (CH, C-2), 62.7 (CH2, C-6).
4,6-O-((S)-p-methoxyphenylmethylene)-d-galactal (303)
A solution of d-galactal (186) (298 mg, 2.04 mmol) in acetonitrile (10 mL) was
treated with anisaldehyde dimethyl acetal (500 µL, 2.9 mmol) and PPTS (27 mg,
0.11 mmol), then the reaction was allowed to proceed at room temperature for four
hours. The mixture was then diluted with water (20 mL), extracted with dichloro-
methane (3 x 40 mL), then the organic fractions were combined, dried, filtered and
concentrated. The oil obtained was then subjected to flash chromatography (5:1
hexanes:ethyl acetate) to provide glycal 303 (169 mg, 31% yield) as a colourless oil.
OO
O
1
2
3
4
5
6
PMP
OH
Rf 0.3 (2:1 hexanes:ethyl acetate); [α]
18
D −22 (c 0.05 CHCl3);
1H-NMR: (CDCl3) δH 7.44 (d, J = 8.5 Hz, 2H, PMP), 6.90 (d,
J = 8.8 Hz, 2H, PMP), 6.42 (dd, J = 6.3, 2.0 Hz, 1H, H-1),
5.63 (s, 1H, PMPH), 4.74 (dt, J = 6.3, 1.7 Hz, 1H, H-2), 4.49
(dddd, J = 11.7, 5.1, 2.6, 0.9 Hz, 1H, H-3), 4.35 (dd, J = 12.5, 1.8 Hz, 1H, H-6a),
4.21 (d, J = 5.2 Hz, 1H, H-4), 4.03 (dd, J = 12.7, 5.2 Hz, 1H, H-6b), 3.91 (m, 1H,
H-5), 3.81 (s, 3H, Me), 2.38 (d, J = 11.7 Hz, 1H, OH); 13C-NMR: (CDCl3) δC 160.2
(C, PMP), 143.8 (CH, C-1), 129.8 (C, PMP), 127.6 (CH, PMP), 113.6 (CH, PMP),
102.1 (CH, C-2), 101.3 (CH, PMPC), 72.3 (CH, C-4), 69.4 (CH2, C-6), 68.0 (CH,
C-5), 62.9 (CH, C-3), 55.3 (CH3, Me); IR (KBr): νmax 3417, 2951, 2912, 2835, 1709,
1605, 1518, 1251, 1169, 1029, 830 cm−1.
3-O-methoxycarbonyl-4,6-O-((S)-p-methoxyphenylmethylene)-d-
galactal (304)
A A solution of glycal 303 (35 mg, 0.13 mmol) in DMF (2 mL) was treated with
sodium hydride (9 mg, 0.23 mmol) at room temperature, then stirred for 30 min-
utes. The reaction mixture was then treated with methyl chloroformate (25 µL,
0.32 mmol) and reacted at room temperature overnight. The mixture was then di-
luted with water (20 mL), extracted with dichloromethane (3 x 20 mL), then the
organic fractions were combined, dried, filtered and concentrated. The liquid ob-
tained was then subjected to flash chromatography (2:1 hexanes:ethyl acetate) to
provide carbonate 304 (8 mg, 19% yield) as a colourless oil.
OO
O
1
2
3
4
5
6
PMP
O OMe
O
Rf 0.5 (1:1 hexanes:ethyl acetate); [α]
18
D +72 (c 0.1 CHCl3);
1H-NMR: (CDCl3) δH 7.42 (d, J = 8.4 Hz, 2H, PMP), 6.87
(d, J = 8.5 Hz, 2H, PMP), 6.52 (d, J = 6.1 Hz, 1H, H-1),
5.59 (s, 1H, PMPH), 5.38 (m, 1H, H-3), 4.75 (d, J = 6.3
Hz, 1H, H-2), 4.53 (d, J = 4.9 Hz, 1H, H-4), 4.36 (d, J =
149
12.0 Hz, 1H, H-6a), 4.05 (d, J = 12.4 Hz, 1H, H-6b), 3.95 (m, 1H, H-5), 3.79 (s, 6H,
2 x Me); 13C-NMR: (CDCl3) δC 160.0 (C, PMP), 155.3 (C, CH3OCO), 145.5 (CH,
C-1), 130.0 (C, PMP), 127.5 (CH, PMP), 113.5 (CH, PMP), 100.9 (CH, PMPC),
96.9 (CH, C-2), 69.5 (CH, C-4), 69.1 (CH2, C-6), 69.0 (CH, C-3), 67.8 (CH, C-5),
55.3 and 54.9 (CH3, Me); IR (KBr): νmax 2995, 2956, 2912, 2846, 1745, 1616, 1519,
1443, 1369, 1268, 1235, 1172, 1099, 998, 830, 794 cm−1.
B A solution of protected glycal 304 (5 mg, 16 µmol) in dichloromethane (1
mL) was treated with p-methoxybenzyl alcohol (14 mg, 0.1 mmol) and palladium-
tetrakis(triphenylphosphine) (2 mg, 2 µmol), then stirred at room temperature for
one day, followed by heating at reflux for one further day. The reaction mixture was
diluted with water (10 mL), then extracted with dichloromethane (2 x 10 mL). The
organic fractions were combined, dried and concentrated to provide a pale–yellow
oil. Proton NMR analysis of this crude mixture showed the presence of a significant
amount of starting material; no peaks corresponding to 2,3-unsaturated sugars were
observed.
Tri-O-acetyl-d-gulal (305) and acetyl 4,6-di-O-acetyl-2,3-dideoxy-β-d-
threo-hex-2-enopyranoside (306)
Tri-O-acetyl-d-galactal (180) (231 mg, 0.85 mmol) in acetic anhydride (3 mL) was
treated with ammonium heptamolybdate tetrahydrate (209 mg, 0.17 mmol), then
stirred at 110 ◦C for 30 minutes. The reaction mixture was diluted with water
(10 mL), extracted twice with diethyl ether (2 x 10 mL), then concentrated to pro-
vide a yellow oil. Chromatographic purification of this material (5:1 hexanes:ethyl
acetate), provided glycal 305 (18 mg, 8%) and 2,3-unsaturated sugar 306 (22 mg,
10%) as colourless oils, in addition to mixtures of more polar sugars.
O
OAc
AcO
AcO
1
2
3
4
5
6
305: The spectral data matched that which was previously re-
ported.157 Rf 0.2 (5:1 hexanes:ethyl acetate);
1H-NMR: (CDCl3) δH
6.63 (d, J = 6.1 Hz, 1H, H-1), 5.04–5.02 (complex m, 2H, H-2,4),
4.91 (dd, J = 4.8, 2.4 Hz, 1H, H-3), 4.28–4.21 (complex m, 3H,
H-5,6a,b), 2.11 (s, 3H, Ac), 2.10 (s, 3H, Ac), 2.07 (s, 3H, Ac); 13C-NMR: (CDCl3)
δC 170.6 (C, CH3CO), 169.7 (C, CH3CO), 169.6 (C, CH3CO), 147.6 (CH, C-1), 97.5
(CH, C-2), 70.6 (CH, C-5), 66.3 (CH, C-4), 63.4 (CH, C-3), 62.5 (CH2, C-6), 21.1
(CH3, Ac), 20.8 (CH3, Ac), 20.7 (CH3, Ac).
OAcO
AcO
1
2
3
4
5
6 OAc 306: Rf 0.15 (5:1 hexanes:ethyl acetate); 1H-NMR: (CDCl3)
δH 6.36 (d, J = 3.0 Hz, 1H, H-1), 6.24 (dd, J = 10.0, 5.3 Hz,
1H, H-3), 6.04 (dd, J = 10.0, 3.2 Hz, 1H, H-2), 5.06 (dd, J =
5.6, 3.4 Hz, 1 H, H-4), 4.34 (m, 1H, H-5), 4.26–4.18 (complex m, 2H, H-6a,b), 2.08
(s, 3H, Ac), 2.07 (s, 3H, Ac), 2.06 (s, 3H, Ac); 13C-NMR: (CDCl3) δC 170.6 (C,
150
CH3CO), 170.3 (C, CH3CO), 169.7 (C, CH3CO), 128.7 (CH, C-2), 126.3 (CH, C-3),
87.9 (CH, C-1), 68.8 (CH, C-5), 62.3 (CH2, C-6), 62.0 (CH, C-4), 21.1 (CH3, Ac),
20.75 (CH3, Ac), 20.73 (CH3, Ac).
4,6-Di-O-acetyl-2,3-dideoxy-d-threo-hex-2-enopyranoside (307)
A solution of tri-O-acetyl-d-galactal (180) (116 mg, 0.426 mmol) in water (2.7 mL)
was stirred at reflux for 100 minutes. The reaction mixture was concentrated, then
co–evaporated with methanol (2 x 5mL) to provide an orange oil. Chromatographic
purification of this material (3:1 hexanes:ethyl acetate), provided starting material
180 (16 mg, 16%) and 2,3-unsaturated sugar 307 (35 mg, 36%), isolated as a
colourless oil, in addition to mixtures of unidentified aldehydes.
OAcO
AcO
1
2
3
4
5
6 OH Rf 0.1 (3:1 hexanes:ethyl acetate); 1H-NMR: (CDCl3) δH 6.15
(dd, J = 10.0, 5.4 Hz, 1H, H-3), 6.08 (dd, J = 10.0, 2.9 Hz, 1H,
H-2), 5.51 (apparent t, J = 3.7 Hz, 1H, H-1), 5.03 (dd, J = 5.4,
2.7 Hz, 1 H, H-4), 4.46 (ddd, J = 7.5, 5.2, 2.3 Hz, 1H, H-5), 4.27 (dd, J = 11.5, 5.1
Hz, 1H, H-6a), 4.19 (dd, J = 11.5, 7.3 Hz, 1H, H-6b), 2.99 (d, J = 4.6 Hz, OH), 2.08
(s, 6H, Ac); 13C-NMR: (CDCl3) δC 170.8 (C, CH3CO), 170.4 (C, CH3CO), 131.1
(CH, C-2), 125.2 (CH, C-3), 88.6 (CH, C-1), 66.6 (CH, C-5), 62.9 (CH2, C-6), 62.2
(CH, C-4), 21.0 (CH3, Ac), 20.7 (CH3, Ac).
Di-O-p-methoxybenzyl-d-xylal (314)
A solution of di-O-acetyl-d-xylal (181) (505 mg, 2.52 mmol) in methanol (10 mL)
was treated with metallic sodium (4 mg, 0.17 mmol) and stirred for one hour at room
temperature. The mixture was treated with a piece of dry ice (ca. 5 g) and stirred for
15 minutes, then concentrated to liberate crude d-xylal as a colourless oil (298 mg).
The oil was dissolved in DMF (25 mL), cooled to 0 ◦C, then treated with sodium
hydride (266 mg, 6.65 mmol). The solution was stirred at 0 ◦C for 30 minutes,
then treated with p-methoxybenzyl chloride (0.75 mL, 5.5 mmol) and allowed to
warm to room temperature. The mixture was stirred overnight, then quenched
with water (20 mL) and sat. copper sulfate solution (20 mL), then the product was
extracted with diethyl ether (3 x 50 mL). The organic fractions were combined,
washed with brine (50 mL), dried, filtered and concentrated to provide crude di-
O-p-methoxybenzyl-d-xylal (314). Purification by column chromatography (3:1
hexanes:ethyl acetate) afforded 314 (360 mg, 40%) as a pale–yellow oil.
O
OPMB
PMBO
1
2
3
4
5 Rf 0.4 (3:1 hexanes:ethyl acetate); [α]
18
D −101 (c 0.5 CHCl3);
1H-NMR: (CDCl3) δH 7.26 (d, J = 8.5 Hz, 2H, PMB), 7.23 (d,
J = 8.5 Hz, 2H, PMB), 6.88 (d, J = 8.4 Hz, 2H, PMB), 6.87 (d,
J = 8.8 Hz, 2H, PMB), 6.54 (d, J = 6.1 Hz, 1H, H-1), 4.91 (ddd,
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J = 6.1, 4.6, 1.2 Hz, 1H, H-2), 4.56 (s, 2H, PMPCH2), 4.52 (d, J = 11.5 Hz, 1H,
PMPCH2), 4.45 (d, J = 11.5 Hz, 1H, PMPCH2), 4.07 (ddd, J = 11.6, 4.0, 1.4 Hz,
1H, H-5a), 3.93 (dd, J = 11.7, 2.0 Hz, 1H, H-5b), 3.81–3.79 (complex m, 7H, 2
x Me, H-3), 3.63 (m, 1H, H-4); 13C-NMR: (CDCl3) δC 159.3 (C, PMP), 159.2 (C,
PMP), 146.6 (CH, C-1), 130.5 (C, PMP), 130.0 (C, PMP), 129.4 (CH, PMP), 129.3
(CH, PMP), 113.9 (CH, PMP), 113.8 (CH, PMP), 99.1 (CH, C-2), 72.3 (CH, C-4),
70.9 (CH2, PMPCH2), 69.7 (CH2, PMPCH2), 68.7 (CH, C-3), 64.0 (CH2, C-5), 55.3
(CH3, 2 x Me); IR (KBr): νmax 3082, 3005, 2929, 2851, 1713, 1612, 1513, 1463,
1245, 1172, 1091, 1033, 820, 668 cm−1; HRMS: m/z C21H24O5Na
+ [M+Na]+ calcd
379.1521, found 379.1516.
1,5-Anhydro-3,4-di-O-p-methoxybenzyl-2-deoxy-1,2-C -
(dibromomethylene)-d-gulo-pentitol (315) and 1,5-anhydro-3,4-di-O-p-
methoxybenzyl-2-deoxy-1,2-C -(dibromomethylene)-d-talo-pentitol (316)
A solution of di-O-p-methoxybenzyl-d-xylal (314) (90 mg, 0.25 mmol) and TEBAC
(10 mg, 0.05 mmol) in bromoform (1.0 mL, 12 mmol) was treated dropwise with a
solution of sodium hydroxide (200 mg, 5.0 mmol) and anhydrous potassium fluoride
(1.5 g) in water (1.5 mL). The biphasic mixture was stirred at room temperature
for one day, then diluted with water (20 mL). The mixture was extracted with
diethyl ether (3 x 40 mL), the organic fractions were then combined, dried, filtered
and concentrated to provide a crude mixture of cyclopropanes 315 and 316 (3.2:1
ratio), which was purified by column chromatography (5:1 hexanes:ethyl acetate)
to liberate cyclopropane 315 (27 mg, 20%) as a light–yellow oil and a mixture of
cyclopropanes 315 and 316 (1:1 ratio, 13 mg, 10%) as a yellow oil (30% combined
yield).
O
OPMB
PMBO
H
H
Br
Br
1
23
4
5
6
315: Rf 0.3 (5:1 hexanes:ethyl acetate);
1H-NMR: (CDCl3) δH
7.35 (d, J = 8.3 Hz, 2H, PMB), 7.22 (d, J = 8.1 Hz, 2H,
PMB), 6.92 (d, J = 8.5 Hz, 2H, PMB), 6.86 (d, J = 8.3 Hz,
2H, PMB), 4.71 (d, J = 11.2 Hz, 1H, PMPCH2), 4.67 (d, J =
11.5 Hz, 1H, PMPCH2), 4.63 (d, J = 11.2 Hz, 1H, PMPCH2), 4.52 (d, J = 11.5
Hz, 1H, PMPCH2), 3.88 (dd, J = 11.5, 6.0 Hz, 1H, H-5a), 3.83–3.81 (complex m,
4H, Me, H-1), 3.80 (s, 3H, Me), 3.73 (dd, J = 11.7, 5.8 Hz, 1H, H-5b), 3.66 (m, 1H,
H-4), 3.62 (m, 1H, H-3), 1.83 (dd, J = 7.8, 1.8 Hz, 1H, H-2); 13C-NMR: (CDCl3)
δC 159.4 (C, PMP), 159.2 (C, PMP), 130.2 (C, PMP), 129.7 (CH, PMP), 129.6 (C,
PMP), 129.4 (CH, PMP), 113.9 (CH, PMP), 113.8 (CH, PMP), 78.2 (CH, C-3),
74.8 (CH, C-4), 72.5 (CH2, PMPCH2), 71.6 (CH2, PMPCH2), 69.3 (CH2, C-5), 60.2
(CH, C-1), 55.29 (CH3, Me), 55.26 (CH3, Me), 34.0 (CH, C-2), 32.7 (C, C-6).
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1
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5
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316: The following data set was obtained from a mixture of
315 and 316 (2:3 ratio). Rf 0.25 (5:1 hexanes:ethyl acetate);
1H-NMR: (CDCl3) δH 7.40 (d, J = 8.5 Hz, 2H, PMB), 7.21
(d, J = 8.3 Hz, 2H, PMB), 6.92 (d, J = 8.3 Hz, 2H, PMB),
6.85 (d, J = 8.6 Hz, 2H, PMB), 4.82 (d, J = 11.5 Hz, 1H, PMPCH2), 4.69–4.66
(complex m, 2H, PMPCH2), 4.51 (d, J = 10.9 Hz, 1H, PMPCH2), 4.03 (apparent
t, J = 8.0 Hz, 1H, H-4), 3.99 (d, J = 7.8 Hz, 1H, H-1), 3.82 (s, 3H, Me), 3.80–3.78
(complex m, 4H, Me,H-5a), 3.93 (m, 1H, H-3), 3.13 (apparent t, J = 11.1 Hz, 1H,
H-5b), 2.24 (apparent t, J = 8.1 Hz, 1H, H-2); 13C-NMR: (CDCl3) δC 159.3 (C,
PMP), 159.2 (C, PMP), 129.9 (C, PMP), 129.6 (CH, PMP), 129.4 (CH, PMP),
129.3 (C, PMP), 113.9 (CH, PMP), 113.8 (CH, PMP), 76.9 (CH, C-4), 75.5 (CH,
C-3), 73.0 (CH2, PMPCH2), 70.8 (CH2, PMPCH2), 67.2 (CH2, C-5), 63.4 (CH,
C-1), 55.28 (CH3, Me), 55.25 (CH3, Me), 33.9 (CH, C-2), 30.9 (C, C-6); IR (KBr):
νmax 2994, 2932, 2835, 1716, 1611, 1513, 1463, 1302, 1248, 1173, 1096, 1033, 820,
769 cm−1; HRMS:m/z C22H24O
79
5 Br2Na
+ [M+Na]+ calcd 548.9888, found 548.9885.
1,6-Anhydro-4-O-p-methoxybenzyl-2-bromo-2,3-dideoxy-α-d-threo-hex-
2-enopyranose (319)
A solution of cyclopropane (315) (31 mg, 59 µmol) in acetic acid (0.6 mL) was
treated with silver acetate (14 mg, 84 µmol) and stirred in the dark at 100 ◦C for
two days. Further silver acetate was added (16 mg, 96 µmol) and the reaction was
allowed to proceed for an additional six hours. The reaction mixture was diluted with
water (20 mL), then extracted with diethyl ether (2 x 20 mL). The organic fractions
were combined, washed with sat. sodium bicarbonate (10 mL), then washed with
brine (10 mL), dried, filtered and concentrated to provide a yellow oil. Purification
by column chromatography (5:1 hexanes:ethyl acetate) provided bicyclic acetal 319
(8 mg, 41%) as a colourless oil, in addition to p-methoxybenzylacetate.
O
PMBO
Br
1
2
34
5
6
O
319: Rf 0.45 (5:1 hexanes:ethyl acetate);
1H-NMR: (CDCl3) δH
7.23 (d, J = 7.8 Hz, 2H, PMB), 6.89 (d, J = 8.8 Hz, 2H, PMB),
6.06 (d, J = 1.2 Hz, 1H, H-3), 5.44 (s, 1H, H-1), 4.60 (d, J = 11.5
Hz, 1H, PMPCH2), 4.54 (m, 1H, H-5), 4.51 (m, 1H, H-4), 4.46 (d,
J = 11.5 Hz, 1H, PMPCH2), 4.26 (d, J = 8.1 Hz, 1H, H-6a), 3.88 (apparent t, J =
7.0 Hz, 1H, H-6b), 3.82 (s, 3H, Me); 13C-NMR: (CDCl3) δC 159.5 (C, PMP), 129.44
(C, PMP), 129.42 (CH, PMP), 126.8 (CH, C-3), 122.0 (C, C-2), 114.0 (CH, PMP),
101.0 (CH, C-1), 75.4 (CH, C-4), 73.0 (CH, C-5), 71.2 (CH2, PMPCH2), 63.3 (CH2,
C-6), 55.3 (CH3, Me); IR (KBr): νmax 2932, 2857, 1722, 1613, 1511, 1463, 1302,
1249, 1174, 1121, 1101, 1033, 913, 896, 820, 727 cm−1.
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Ethyltriphenylphosphonium iodide (324)
As reported previously,132 a solution of ethyl iodide (5.87 g, 37.6 mmol) in toluene
(50 mL) was treated with triphenylphosphine (10.7 g, 40.9 mmol), then stirred at
80 ◦C for 18 hours. The mixture was filtered, then the precipitate was washed with
cold toluene (150 mL), then dried under vacuum to provide phosphine salt 324 as
a white solid (12.2 g, 77%).
P
Ph
Ph
Ph I
1
2 m.p. 161–162 ◦C (lit.132 m.p. 168–169 ◦C); 1H-NMR: (CDCl3) δH 7.84–
7.67 (complex m, 15H, Ph), 3.77 (dq, JP−H = 12.5 Hz, J = 7.5 Hz,
2H, H-1), 1.38 (dt, JP−H = 20.1 Hz, J = 7.5 Hz, 3H, H-2);
13C-NMR:
(CDCl3) δC 135.1 (CH, Ph), 133.7 (d, JC−P = 10.0 Hz, CH, Ph), 130.6 (d, JC−P
= 12.5 Hz, CH, Ph), 117.8 (d, JC−P = 88.3 Hz, C, Ph), 17.6 (d, JC−P = 51.4 Hz,
CH2, C-1), 6.9 (d, JC−P = 5.2 Hz, CH3, C-2);
31P-NMR: (CDCl3) δP 26.3 (s, 1P).
3,6-Anhydro-4,5-di-O-benzyl-d-threo-hexanose dimethyl acetal (325)
A solution of ethyltriphenylphosphonium iodide (186 mg, 0.445 mmol) in THF
(2 mL) was cooled to −78 ◦C, then treated with KHMDS (0.9 mL, 0.45 mmol)
and stirred for 30 minutes. To this was added a solution of oxepines 271 and 272
(102 mg, 0.228 mmol) and potassium carbonate (64 mg, 0.46 mmol) in methanol
(1 mL). The reaction mixture was immediately warmed to room temperature, then
allowed to react for five hours. The mixture was then diluted with sat. ammonium
chloride solution and extracted with dichloromethane (3 x 10 mL). The organic frac-
tions were combined, dried, filtered and concentrated to provide a yellow oil. Upon
purification by column chromatography (2:1 hexanes:ethyl acetate), acetal 325 was
obtained as a colourless oil (21 mg, 24%).
O
BnO OBn
OH
OMe
OMe
1
2
3
4
5
6
Rf 0.45 (1:1 hexanes:ethyl acetate); [α]
18
D +13 (c 1.9 CHCl3);
1H-NMR: (CDCl3) δH 7.34–7.19 (complex m, 10H, Bn), 4.54–
4.40 (complex m, 4H, PhCH2), 4.31 (dd, J = 7.1, 2.0 Hz, 1H,
H-1), 4.14 (dd, J = 2.3, 1.1 Hz, 1H, H-4), 4.04 (m, 1H, H-3),
4.00 (m, 1H, H-6a), 3.96 (m, 1H, H-5), 3.83 (ddd, J = 9.9, 3.7, 2.0 Hz, 1H, H-6b),
3.62 (m, 1H, H-2), 3.37 (s, 6H, Me), 2.76 (d, J = 5.6 Hz, 1H, OH); 13C-NMR:
(CDCl3) δC 137.6 (C, Bn), 137.2 (C, Bn), 128.51 (CH, Bn), 128.49 (CH, Bn), 127.94
(CH, Bn), 127.90 (CH, Bn), 127.85 (CH, Bn), 127.7 (CH, Bn), 104.7 (CH, C-1), 84.0
(CH, C-4), 83.3 (CH, C-3), 82.3 (CH, C-5), 72.0 and 71.8 (CH2, PhCH2 and CH2,
C-6), 71.1 and 71.0 (CH2, PhCH2 and CH, C-2), 55.8 (CH3, Me), 54.0 (CH3, Me);
IR (KBr): νmax 3514, 3027, 2925, 2868, 1731, 1496, 1455, 1368, 1260, 1206, 1075,
800, 749, 698 cm−1; HRMS: m/z C22H28O6Na
+ [M+Na]+ calcd 411.1784, found
411.1778.
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7.5 Chapter Five Experimental
2,3:5,6-Di-O-isopropylidene-d-mannofuranose (333)
A solution of d-mannose (27.0 g, 150 mmol) in acetone (1.35 L) was treated with
iodine (7.70 g, 30.3 mmol), then stirred at room temperature for three hours. The
solution was diluted with sat. sodium thiosulfate solution (400 mL) and sat. sodium
bicarbonate solution (400 mL), extracted with chloroform (3 x 400 mL), then dried,
filtered and concentrated to provide a pale–yellow solid. This crude product was
dissolved in acetone (300 mL), diluted with hexanes (600 mL), then concentrated by
rotary evaporation at 50 ◦C, until crystallisation occurred. The solution was cooled
and filtered to provide 333 as pale off-white crystals (23.8 g, 61%). The mother
liquor was concentrated further, until crystallisation reoccurred. The mixture was
left overnight in the freezer, then filtered to provide a second crop of off–white
crystals (9.8 g, 25%). The spectral data matched that reported previously.34
O
O
O
O O
OH
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6
4
H
m.p. 117–119 ◦C (lit.159 m.p. 121–122 ◦C); 1H-NMR: (CDCl3)
δH 5.38 (d, J = 3.5 Hz, 1H, H-1), 4.82 (dd, J = 5.8, 3.6 Hz,
1H, H-3), 4.62 (d, J = 5.8 Hz, 1H, H-2), 4.40 (dd, J = 11.3,
6.7 Hz, 1H, H-5), 4.19 (dd, J = 7.1, 3.6 Hz, 1H, H-4), 4.09
(dd, J = 8.7, 6.2 Hz, 1H, H-6a), 4.04 (dd, J = 8.7, 4.8 Hz, 1H,
H-6b), 2.60 (s, 1H, OH), 1.464 (s, 3H, (CH3)2C), 1.457 (s, 3H, (CH3)2C), 1.38 (s,
3H, (CH3)2C), 1.33 (s, 3H, (CH3)2C);
13C-NMR: (CDCl3) δC 112.6 (C, (CH3)2C),
109.1 (C, (CH3)2C), 101.3 (CH, C-1), 85.4 (CH, C-2), 80.3 (CH, C-4), 79.6 (CH,
C-3), 73.2 (CH, C-5), 66.6 (CH2, C-6), 26.8 (CH3, (CH3)2C), 25.8 (CH3, (CH3)2C),
25.1 (CH3, (CH3)2C), 24.4 (CH3, (CH3)2C).
2,3:5,6-Di-O-isopropylidene-α-d-mannofuranosyl chloride (334)
2,3:5,6-Di-O-isopropylidene-d-mannofuranose (333) (10.2 g, 39.0 mmol) was dis-
solved in dichloromethane (190 mL), then treated sequentially with DMAP (2.86 g,
23.4 mmol), tosyl chloride (8.81 g, 46.2 mmol) and triethylamine (5.4 mL, 39 mmol).
The mixture was stirred at room temperature for four hours, then washed sequen-
tially with sat. copper sulfate solution (200 mL), sat. sodium bicarbonate solution
(200 mL) and brine (100 mL). The solution obtained was dried, filtered and concen-
trated to provide a viscous yellow–orange oil. This material was purified by column
chromatography (9:1 hexanes:ethyl acetate) to provide mannosyl chloride 334 as a
colourless oil (7.76 g, 71%). The spectral data matched that reported previously.34
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Rf 0.35 (9:1 hexanes:ethyl acetate);
1H-NMR: (CDCl3) δH 6.07
(d, J = 1.9 Hz, 1H, H-1), 4.96 (dd, J = 5.6, 2.7 Hz, 1H, H-2),
4.89 (m, 1H, H-3), 4.44 (m, 1H, H-5), 4.21 (dd, J = 7.8, 3.0 Hz,
1H, H-4), 4.10 (ddd, J = 8.9, 6.3, 2.7 Hz, 1H, H-6a), 4.02 (ddd,
J = 8.8, 4.4, 2.7 Hz, 1H, H-6b), 1.47 (s, 6H, (CH3)2C), 1.39 (s,
3H, (CH3)2C), 1.33 (s, 3H, (CH3)2C);
13C-NMR: (CDCl3) δC 113.3 (C, (CH3)2C),
109.5 (C, (CH3)2C), 97.6 (CH, C-1), 89.1 (CH, C-2), 82.3 (CH, C-4), 78.5 (CH,
C-3), 72.3 (CH, C-5), 66.7 (CH2, C-6), 26.9 (CH3, (CH3)2C), 25.8 (CH3, (CH3)2C),
25.1 (CH3, (CH3)2C), 24.6 (CH3, (CH3)2C).
1,4-Anhydro-3-O-benzyl-2-deoxy-5,6-O-isopropylidene-d-arabino-hex-1-
enitol (209)
A solution of naphthalene (38.4 g, 299 mmol) in THF (100 mL) was treated with
freshly cut sodium (2.71 g, 118 mmol) and stirred at room temperature for two hours
to generate the deep–green coloured sodium naphthalenide radical. The mixture was
cooled to 0 ◦C, then treated with mannosyl chloride 334 (7.54 g, 27.1 mmol) as a
solution in THF (60 mL). The reaction mixture was allowed to stir for ten min-
utes, then quenched with sat. ammonium chloride solution (100 mL), followed by
dilution with water (100 mL). The phases were separated, then the aqueous layer
was extracted with diethyl ether (2 x 100 mL). The combined organic fractions were
washed with brine (100 mL), then dried, filtered and concentrated to provide a mix-
ture of naphthalene and furanoglycal 335. This mixture was immediately dissolved
in a minimum volume of THF (100 mL), cooled to 0 ◦C, then treated successively
with tetrabutylammonium iodide (506 mg, 1.37 mmol), sodium hydride (1.43 g, 35.8
mmol) and benzyl bromide (4.0 mL, 33 mmol). The mixture was allowed to warm
to room temperature, then stirred overnight. The reaction was quenched with brine
(100 mL) and water (100 mL), then the mixture was extracted with diethyl ether (3
x 200 mL). The combined organic fractions were washed with brine (100 mL), then
dried, filtered and concentrated to provide a mixture of naphthalene and glycal 209.
This crude product was purified by column chromatography (20:1 hexanes:ethyl ac-
etate) to provide glycal 209 as a pale–yellow oil (5.30 g, 71%). The spectral data
matched that reported previously.34
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Rf 0.4 (9:1 hexanes:ethyl acetate);
1H-NMR: (CDCl3) δH 7.36–7.27
(complex m, 5H, Bn), 6.62 (d, J = 2.7 Hz, 1H, H-1), 5.29 (appar-
ent t, J = 2.5 Hz, 1H, H-2), 4.65 (dd, J = 7.1, 2.4 Hz, 1H, H-3),
4.59 (dd, J = 11.6, 6.5 Hz, 1H, H-5), 4.57 (d, J = 11.4 Hz, 1H,
PhCH2), 4.51 (d, J = 11.7 Hz, 1H, PhCH2), 4.44 (dd, J = 6.8, 5.4 Hz, 1H, H-4), 4.11
(dd, J = 8.6, 6.8 Hz, 1H, H-6a), 3.99 (dd, J = 8.5, 6.4 Hz, 1H, H-6b), 1.48 (s, 3H,
(CH3)2C), 1.40 (s, 3H, (CH3)2C);
13C-NMR: (CDCl3) δC 150.6 (CH, C-1), 138.4 (C,
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Bn), 128.4 (CH, Bn), 127.6 (CH, Bn), 127.5 (CH, Bn), 108.7 (C, (CH3)2C), 101.9
(CH, C-2), 84.1 (CH, C-4), 79.2 (CH, C-3), 73.1 (CH, C-5), 71.0 (CH2, PhCH2),
65.9 (CH2, C-6), 26.5 (CH3, (CH3)2C), 25.2 (CH3, (CH3)2C).
Ethyl 3-O-benzyl-2-deoxy-5,6-O-isopropylidene-α-d-arabino-
hexofuranoside (338) and ethyl 3-O-benzyl-2-deoxy-5,6-O-
isopropylidene-β-d-arabino-hexofuranoside (339)
A solution of glycal 209 (171 mg, 0.62 mmol) in bromoform (1 mL) was treated
with TEBAC (4 mg, 0.02 mmol), then a solution of sodium hydroxide (212 mg,
5.3 mmol) and potassium fluoride (1.56 g) in water (1.6 mL) and stirred rapidly
for 90 minutes. The mixture was diluted with water (10 mL), then extracted with
diethyl ether (3 x 10 mL). The combined ethereal fractions were dried, filtered and
concentrated to provide a dark–brown liquid. This crude product was purified by
column chromatography (9:1 hexanes:ethyl acetate) to afford complicated mixtures
of unidentified material, plus ethyl glycosides 338 (38 mg, 12%) and 339 (46 mg,
14%), isolated as yellow oils (26% combined yield).
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338: Rf 0.5 (5:1 hexanes:ethyl acetate); [α]
22
D +27 (c 0.9
CHCl3);
1H-NMR: (CDCl3) δH 7.36–7.26 (complex m, 5H,
Bn), 5.26 (dd, J = 5.4, 3.4 Hz, 1H, H-1), 4.57 (d, J = 12.0
Hz, 1H, PhCH2), 4.52 (d, J = 12.0 Hz, 1H, PhCH2), 4.43
(q, J = 6.5 Hz, 1H, H-4), 4.21 (m, 1H, H-3), 4.11 (dd, J = 7.8, 6.6 Hz, 1H, H-6a),
4.04 (dd, J = 7.2, 4.2 Hz, 1H, H-5), 4.00 (dd, J = 8.3, 6.0 Hz, 1H, H-6b), 3.74
(dq, J = 9.8, 7.1 Hz, 1H, Et), 3.45 (dq, J = 9.8, 7.0 Hz, 1H, Et), 2.26 (ddd, J =
14.4, 5.7, 2.0 Hz, 1H, H-2a), 2.06 (ddd, J = 14.3, 6.0, 3.3 Hz, 1H, H-2b), 1.44 (s,
3H, (CH3)2C), 1.39 (s, 3H, (CH3)2C), 1.18 (td, J = 7.1, 0.7 Hz, 3H, Et);
13C-NMR:
(CDCl3) δC 138.3 (C, Bn), 128.3 (CH, Bn), 127.5 (CH, Bn), 127.4 (CH, Bn), 108.8
(C, (CH3)2C), 103.2 (CH, C-1), 80.9 (CH, C-5), 78.3 (CH, C-3), 73.4 (CH, C-4),
71.5 (CH2, PhCH2), 67.1 (CH2, C-6), 63.4 (CH2, Et), 40.0 (CH2, C-2), 26.7 (CH3,
(CH3)2C), 25.5 (CH3, (CH3)2C), 15.2 (CH3, Et); IR (KBr): νmax 3030, 2979, 2938,
2907, 2360, 1727, 1455, 1371, 1255, 1212, 1067, 1048, 955, 849, 737, 698 cm−1;
HRMS: m/z C18H26O5Na
+ [M+Na]+ calcd 345.1678, found 345.1682.
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339: Rf 0.35 (5:1 hexanes:ethyl acetate); [α]
22
D −58 (c 1.5
CHCl3);
1H-NMR: (CDCl3) δH 7.38–7.28 (complex m, 5H,
Bn), 5.15 (d, J = 5.9 Hz, 1H, H-1), 4.64 (d, J = 12.2 Hz,
1H, PhCH2), 4.49 (d, J = 12.0 Hz, 1H, PhCH2), 4.45 (q,
J = 6.6 Hz, 1H, H-4), 4.17 (td, J = 5.1, 0.9 Hz, 1H, H-5), 4.13 (m, 1H, H-3), 4.08
(d, J = 6.6 Hz, 2H, H-6a,b), 3.80 (dq, J = 8.3, 7.1 Hz, 1H, Et), 3.48 (dq, J =
8.3, 7.1 Hz, 1H, Et), 2.20 (dd, J = 14.3, 1.5 Hz, 1H, H-2a), 2.14 (ddd, J = 14.3,
6.0, 1.2 Hz, 1H, H-2b), 1.45 (s, 3H, (CH3)2C), 1.38 (s, 3H, (CH3)2C), 1.23 (td, J =
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7.1, 1.2 Hz, 3H, Et); 13C-NMR: (CDCl3) δC 138.4 (C, Bn), 128.5 (CH, Bn), 128.2
(CH, Bn), 127.5 (CH, Bn), 108.4 (C, (CH3)2C), 103.4 (CH, C-1), 82.9 (CH, C-5),
77.1 (CH, C-3), 74.5 (CH, C-4), 71.2 (CH2, PhCH2), 66.7 (CH2, C-6), 63.5 (CH2,
Et), 37.9 (CH2, C-2), 26.6 (CH3, (CH3)2C), 25.4 (CH3, (CH3)2C), 15.1 (CH3, Et);
IR (KBr): νmax 3027, 2983, 2891, 1752, 1454, 1370, 1253, 1210, 1113, 1067, 1048,
973, 852, 737, 698 cm−1.
1,4-Anhydro-3-O-benzyl-2-deoxy-1,2-C -(dichloromethylene)-5,6-O-
isopropylidene-d-glycero-d-gulo-hexitol (340)
A Glycal 209 (161 mg, 0.582 mmol) was dissolved in chloroform (2 mL), treated
with TEBAC (7 mg, 0.03 mmol), then a solution of sodium hydroxide (1.42 g,
35.5 mmol) in water (1.5 mL) and allowed to stir at room temperature for four
hours. The reaction mixture was dissolved in water (20 mL), then extracted with
diethyl ether (3 x 20 mL). The ethereal fractions were combined, dried, filtered and
concentrated to afford a brown oil. This oil was purified by column chromatography
(9:1 hexanes:ethyl acetate) to afford gem-dichlorocyclopropane 340 as a pale–yellow
oil (104 mg, 50%).
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Rf 0.45 (9:1 hexanes:ethyl acetate); [α]
22
D +16 (c 1.2 CHCl3);
1H-NMR: (CDCl3) δH 7.39–7.31 (complex m, 5H, Bn), 4.67
(d, J = 11.8 Hz, 1H, PhCH2), 4.61 (d, J = 11.5 Hz, 1H,
PhCH2), 4.48 (apparent t, J = 5.9 Hz, 1H, H-5), 4.33 (d,
J = 6.4 Hz, 1H, H-3), 4.31 (d, J = 5.9 Hz, 1H, H-4), 4.27 (dd, J = 5.9, 0.8 Hz,
1H, H-1), 4.05 (dd, J = 8.3, 6.9 Hz, 1H, H-6a), 3.93 (dd, J = 7.9, 6.5 Hz, 1H,
H-6b), 2.47 (d, J = 5.9 Hz, 1H, H-2), 1.44 (s, 3H, (CH3)2C), 1.36 (s, 3H, (CH3)2C);
13C-NMR: (CDCl3) δC 137.2 (C, Bn), 128.5 (CH, Bn), 128.0 (CH, Bn), 127.6 (CH,
Bn), 108.8 (C, (CH3)2C), 87.6 (CH, C-5), 80.0 (CH, C-3), 73.5 (CH, C-4), 73.2
(CH2, PhCH2), 67.9 (CH, C-1), 66.2 (CH2, C-6), 61.2 (C, C-7), 39.3 (CH, C-2),
26.5 (CH3, (CH3)2C), 25.3 (CH3, (CH3)2C); IR (KBr): νmax 2986, 2937, 2885, 1497,
1455, 1370, 1255, 1211, 1157, 1129, 1108, 1069, 1052, 1029, 909, 853, 737, 698 cm−1;
HRMS: m/z C18H23O
35
5 ClNa
+ (product of methanol–mediated ring opening reac-
tion during HRMS acquisition) [M+Na]+ calcd 377.1132, found 377.1132.
B Glycal 209 (508 mg, 1.84 mmol) was dissolved in chloroform (3 mL), treated
with TEBAC (9 mg, 0.04 mmol), then a solution of sodium hydroxide (2.97 g, 74.3
mmol) in water (3.0 mL) and allowed to stir at room temperature for three hours.
The reaction mixture was dissolved in water (20 mL), then extracted with diethyl
ether (3 x 20 mL). The ethereal fractions were combined, dried, filtered and concen-
trated to afford a brown oil. This oil was purified by column chromatography (14:1
hexanes:ethyl acetate) to afford gem-dichlorocyclopropane 340 as a pale–yellow oil
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(519 mg, 79%), contaminated with a minor amount of an impurity.
3-O-Acetyl-1,5-anhydro-4-O-benzyl-2-chloro-2-deoxy-6,7-O-
isopropylidene-d-gluco-hept-1-enitol (344), acetyl 4-O-benzyl-2-chloro-
2,3-dideoxy-6,7-O-isopropylidene-α-d-arabino-hept-2-enopyranoside
(342) and acetyl 4-O-benzyl-2-chloro-2,3-dideoxy-6,7-O-isopropylidene-
β-d-arabino-hept-2-enopyranoside (343)
A A solution of cyclopropane 340 (151 mg, 0.420 mmol) in THF (4.2 mL) was
treated with silver acetate (104 mg, 0.623 mmol) and sodium acetate (180 mg,
2.19 mmol), then refluxed for four hours. The solution was filtered through a silica
plug and eluted with diethyl ether (50 mL). The solution was concentrated to provide
a mixture of ring–opened products as a yellow oil. This mixture was purified by
column chromatography (5:1 hexanes:ethyl acetate), providing acetylated glycal 344
(26 mg, 16%), in addition to acetyl pyranosides 342 and 343 (3:1 ratio, 79 mg, 49%),
as an inseparable yellow oil.
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344: Rf 0.5 (5:1 hexanes:ethyl acetate);
1H-NMR: (CDCl3) δH
7.37–7.30 (complex m, 5H, Bn), 6.79 (d, J = 1.6 Hz, 1H, H-1),
5.36 (d, J = 2.0 Hz, 1H, H-3), 4.83 (d, J = 11.7 Hz, 1H,
PhCH2), 4.66 (d, J = 11.7 Hz, 1H, PhCH2), 4.28 (m, 1H, H-5),
4.08 (ddd, J = 8.6, 6.0, 1.8 Hz, 1H, H-7a), 4.01 (ddd, J = 8.7,
4.9, 1.7 Hz, 1H, H-7b), 3.81 (d, J = 1.5 Hz, 1H, H-4), 3.68 (d, J = 8.3 Hz, 1H, H-6),
2.13 (s, 3H, Ac), 1.37 (s, 3H, (CH3)2C), 1.32 (s, 3H, (CH3)2C);
13C-NMR: (CDCl3)
δC 170.0 (C, CH3CO), 145.0 (CH, C-1), 137.2 (C, Bn), 128.4 (CH, Bn), 128.1 (CH,
Bn), 128.0 (CH, Bn), 109.4 (C, (CH3)2C), 107.3 (C, C-2), 74.5 (CH, C-6), 72.8 (CH,
C-4), 72.5 (CH2, PhCH2), 72.4 (CH, C-5), 67.2 (CH, C-3), 66.8 (CH2, C-7), 26.8
(CH3, (CH3)2C), 25.2 (CH3, (CH3)2C), 21.0 (CH3, Ac).
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342: Rf 0.4 (5:1 hexanes:ethyl acetate);
1H-NMR: (CDCl3)
δH 7.42–7.30 (complex m, 5H, Bn), 6.28–6.24 (complex m,
2H, H-1,3), 4.70 (s, 2H, PhCH2), 4.39 (m, 1H, H-6), 4.12 (dd,
J = 8.8, 6.3 Hz, 1H, H-7a), 3.98 (dd, J = 5.9, 2.5 Hz, 1H,
H-4), 3.88 (dd, J = 8.8, 4.7 Hz, 1H, H-7b), 3.84 (dd, J = 8.5, 2.4 Hz, 1H, H-5),
2.13 (s, 3H, Ac), 1.41 (s, 3H, (CH3)2C), 1.38 (s, 3H, (CH3)2C);
13C-NMR: (CDCl3)
δC 169.5 (C, CH3CO), 137.8 (C, Bn), 132.4 (C, C-2), 128.42 (CH, Bn), 127.96 (CH,
Bn), 127.93 (CH, Bn), 125.9 (CH, C-3), 109.4 (C, (CH3)2C), 89.0 (CH, C-1), 73.1
(CH, C-5), 72.9 (CH, C-6), 72.0 (CH2, PhCH2), 68.3 (CH, C-4), 67.1 (CH2, C-7),
26.9 (CH3, (CH3)2C), 25.2 (CH3, (CH3)2C), 20.90 (CH3, Ac); IR (KBr): νmax 2986,
2935, 2874, 1754, 1655, 1455, 1372, 1213, 1133, 1074, 1004, 930, 849, 698 cm−1;
HRMS: m/z C19H23O6Na
+ [M+Na]+ calcd 405.1081, found 405.1078.
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343: Rf 0.4 (5:1 hexanes:ethyl acetate);
1H-NMR: (CDCl3)
δH 7.42–7.30 (complex m, 5H, Bn), 6.28–6.24 (complex m,
2H, H-1,3), 4.68 (s, 2H, PhCH2), 4.38 (m, 1H, H-6), 4.10 (m,
1H, H-7a), 4.04 (dd, J = 8.8, 4.7 Hz, 1H, H-7b), 4.00 (m, 1H,
H-4), 3.67 (dd, J = 8.6, 1.9 Hz, 1H, H-5), 2.16 (s, 3H, Ac), 1.40 (s, 3H, (CH3)2C),
1.37 (s, 3H, (CH3)2C);
13C-NMR: (CDCl3) δC 169.2 (C, CH3CO), 138.0 (C, Bn),
133.7 (C, C-2), 128.35 (CH, Bn), 128.02 (CH, Bn), 127.85 (CH, Bn), 127.2 (CH,
C-3), 109.4 (C, (CH3)2C), 90.0 (CH, C-1), 76.8 (CH, C-5), 73.0 (CH, C-6), 71.9
(CH2, PhCH2), 68.5 (CH, C-4), 67.0 (CH2, C-7), 27.0 (CH3, (CH3)2C), 25.3 (CH3,
(CH3)2C), 20.86 (CH3, Ac).
B A solution of cyclopropane 340 (175 mg, 0.487 mmol) in THF (4 mL) was treated
with acetic acid (1 mL) and silver acetate (124 mg, 0.743 mmol), then refluxed for
four hours. The solution was filtered through a silica plug and eluted with diethyl
ether (100 mL). The solution was concentrated to provide a mixture of acetylated
glycal 344 and acetyl pyranosides 342 and 343 (344:342 and 343, 1:12 ratio), as a
yellow oil. This mixture was purified by column chromatography (5:1 hexanes:ethyl
acetate), providing acetyl pyranosides 342 and 343 (3:1 ratio, 105 mg, 56%), as an
inseparable mixture.
C A solution of cyclopropane 340 (499 mg, 1.39 mmol) in acetic acid (14 mL) was
treated with silver acetate (353 mg, 2.11 mmol), then stirred at 90 ◦C for two hours.
The solution was filtered through Celite R© and eluted with diethyl ether (50 mL). The
solution was concentrated to provide a mixture of acetylated glycal 344 and acetyl
pyranosides 342 and 343 (344:342 and 343, 1:21 ratio), as a yellow oil. This mix-
ture was purified by column chromatography (9:1 hexanes:ethyl acetate), providing
acetyl pyranosides 342 and 343 (3:1 ratio, 442 mg, 83%), as an inseparable mixture.
D Glycal 209 (462 mg, 1.67 mmol) was dissolved in chloroform (3 mL), treated
with TEBAC (8 mg, 0.04 mmol), then a solution of sodium hydroxide (3.01 g, 75.3
mmol) in water (3.0 mL) and allowed to stir under air at room temperature for 2.5
hours. The reaction mixture was dissolved in water (20 mL), then extracted with
diethyl ether (3 x 20 mL). The ethereal fractions were combined, dried, filtered and
concentrated to afford a brown oil. This oil was purified by column chromatography
(5:1 hexanes:ethyl acetate) to afford impure cyclopropane 340 as a yellow oil. This
sample was dissolved in acetic acid (17 mL), treated with silver acetate (435 mg,
2.61 mmol), then stirred at 80 ◦C for two hours. The solution was filtered through
Celite R© and eluted with diethyl ether (20 mL). The solution was concentrated to
provide a mixture of acetylated glycal 344 and acetyl pyranosides 342 and 343
(344:342 and 343, 1:30 ratio), as a yellow oil. This mixture was purified by column
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chromatography (5:1 hexanes:ethyl acetate), providing acetyl pyranosides 342 and
343 (3:1 ratio, 495 mg, 77%), as an inseparable mixture.
4-O-Benzyl-2-chloro-2,3-dideoxy-6,7-O-isopropylidene-d-arabino-hept-2-
enopyranose (345)
Using a previously reported procedure,122 a solution of acetates 342 and 343 (574
mg, 1.50 mmol) in methanol (15 mL) was treated with a small piece of sodium (3 mg,
0.1 mmol), then stirred at room temperature for one hour. The mixture was concen-
trated, then passed through a silica plug, which was eluted with dichloromethane
(10 mL). The organic solution was concentrated to provide hemiacetal 345 (517 mg,
quantitative) as a viscous yellow oil, which was used without further purification.
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Rf 0.2 (5:1 hexanes:ethyl acetate); [α]
23
D −79 (c 1.1 CHCl3);
1H-NMR: (CDCl3) δH 7.36–7.30 (complex m, 5H, Bn), 6.17
(d, J = 5.7 Hz, 1H, H-3), 5.34 (d, J = 4.6 Hz, 1H, H-1), 4.68
(s, 2H, PhCH2), 4.40 (m, 1H, H-6), 4.14 (dd, J = 8.4, 6.6
Hz, 1H, H-7a), 4.02 (m, 1H, H-5), 3.99 (m, 1H, H-7b), 3.92 (d, J = 5.9 Hz, 1H,
H-4), 2.82 (brs, 1H, OH), 1.42 (s, 3H, (CH3)2C), 1.40 (s, 3H, (CH3)2C);
13C-NMR:
(CDCl3) δC 137.9 (C, Bn), 134.6 (C, C-2), 128.4 (CH, Bn), 128.0 (CH, Bn), 127.9
(CH, Bn), 124.6 (CH, C-3), 109.3 (C, (CH3)2C), 90.9 (CH, C-1), 73.2 (CH, C-6),
72.1 (CH2, PhCH2), 71.2 (CH, C-5), 68.8 (CH, C-4), 67.2 (CH2, C-7), 26.9 (CH3,
(CH3)2C), 25.4 (CH3, (CH3)2C); IR (KBr): νmax 3400, 2986, 2933, 2874, 1654, 1455,
1372, 1254, 1213, 1073, 1043, 913, 850, 738, 698 cm−1; HRMS: m/z C17H21O5Na
+
[M+Na]+ calcd 363.0975, found 363.0971.
(2Z,4E)-6-O-Benzyl-4-chloro-1,2,3,4,5-pentadeoxy-8,9-O-isopropylidene-
d-arabino-nona-2,4-dienitol (346) and (2E,4E)-6-O-benzyl-4-chloro-
1,2,3,4,5-pentadeoxy-8,9-O-isopropylidene-d-arabino-nona-2,4-dienitol
(347)
A solution of ethyl triphenylphosphonium iodide (860 mg, 2.05 mmol) in THF (6 mL)
was cooled to −78 ◦C, then treated with n-butyllithium (1.25 mL, 2.00 mmol) and
stirred at −78 ◦C for one hour. The mixture was then treated with a solution of
hemiacetal 345 (304 mg, 0.892 mmol) in THF (4 mL), then heated at reflux for
4.5 hours. The reaction mixture was diluted with sat. ammonium chloride solution
(20 ml) and extracted with dichloromethane (3 x 20 mL). The organic fractions
were combined, dried, filtered and concentrated to provide a crude brown oil. Upon
purification by column chromatography (5:1 hexanes:ethyl acetate), an insepara-
ble mixture of dienes 346 and 347 (2.0:1 ratio, 245 mg, 77%) was obtained as a
colourless oil.
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346: Rf 0.45 (5:1 hexanes:ethyl acetate);
1H-NMR: (CDCl3)
δH 7.36–7.28 (complex m, 5H, Bn), 5.99 (d, J = 10.3 Hz, 1H,
H-5), 5.95 (dd, J = 11.3, 1.5 Hz, 1H, H-3), 5.79 (dq, J =
11.3, 7.1 Hz, 1H, H-2), 4.59 (d, J = 11.5 Hz, 1H, PhCH2),
4.36 (d, J = 11.3 Hz, 1H, PhCH2), 4.19 (dd, J = 10.0, 2.2 Hz, 1H, H-6), 4.11–4.05
(complex m, 2H, H-8,9a), 3.98 (dd, J = 8.3, 5.4 Hz, 1H, H-9b), 3.45 (m, 1H, H-7),
2.37 (d, J = 9.1 Hz, 1H, OH), 1.77 (dd, J = 7.1, 1.6 Hz, 3H, H-1), 1.37 (s, 3H,
(CH3)2C), 1.33 (s, 3H, (CH3)2C);
13C-NMR: (CDCl3) δC 137.7 (C, Bn), 132.3 (CH,
C-2), 128.37 (C, C-4), 128.34 (CH, Bn), 127.82 (CH, Bn), 127.80 (CH, Bn), 127.4
(CH, C-5), 124.3 (CH, C-3), 109.2 (C, (CH3)2C), 75.2 (CH, C-8), 74.9 (CH, C-7),
74.7 (CH, C-6), 70.5 (CH2, PhCH2), 67.0 (CH2, C-9), 26.7 (CH3, (CH3)2C), 25.2
(CH3, (CH3)2C), 15.1 (CH3, C-1); HRMS: m/z C19H25O
35
4 ClNa
+ [M+Na]+ calcd
375.1339, found 375.1344.
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1 347: The following data set was obtained by subtracting the
NMR signals for 346 from that of the purified mixture.
1H-NMR: (CDCl3) δH 7.37–7.28 (complex m, 5H, Bn), 6.31 (m,
1H, H-2), 6.25 (d, J = 14.7 Hz, 1H, H-3), 5.82 (d, J = 10.0 Hz,
1H, H-5), 4.64 (d, J = 11.7 Hz, 1H, PhCH2), 4.45 (dd, J = 9.8, 3.0 Hz, 1H, H-6),
4.41 (d, J = 11.7 Hz, 1H, PhCH2), 4.14–3.96 (complex m, 3H, H-8,9a,b), 3.52 (td,
J = 7.6, 2.7 Hz, 1H, H-7), 2.45 (d, J = 8.0 Hz, 1H, OH), 1.84 (d, J = 6.3 Hz, 3H,
H-1), 1.40 (s, 3H, (CH3)2C), 1.35 (s, 3H, (CH3)2C);
13C-NMR: (CDCl3) δC 137.5
(C, Bn), 134.5 (CH, C-4), 133.4 (CH, C-2), 128.3 (CH, Bn), 127.9 (CH, Bn), 127.84
(CH, Bn), 125.1 (CH, C-5), 123.3 (CH, C-3), 109.1 (C, (CH3)2C), 75.5 (CH, C-8),
74.8 (CH, C-7), 73.3 (CH, C-6), 70.4 (CH2, PhCH2), 66.5 (CH2, C-9), 26.8 (CH3,
(CH3)2C), 25.3 (CH3, (CH3)2C), 18.1 (CH3, C-1).
(E)-2,3-Anhydro-6-O-benzyl-4-chloro-1,4,5-trideoxy-8,9-O-
isopropylidene-d-glycero-d-talo-nona-4-enopyranitol (330) and (E)-2,3-
anhydro-6-O-benzyl-4-chloro-1,4,5-trideoxy-8,9-O-isopropylidene-d-
glycero-d-gulo-nona-4-enopyranitol (348)
A A solution of dienes 346 and 347 (2.0:1 ratio, 90 mg, 0.26 mmol) in dichloro-
methane (4 mL) was treated with m-CPBA (129 mg, 0.52 mmol). The mixture was
stirred at room temperature for two days, then diluted with sat. sodium bicarbonate
solution (20 mL) and dichloromethane (10 mL). The biphasic mixture was stirred
rapidly for ten minutes, then separated. The organic fraction was dried, filtered
and concentrated to provide a colourless oil. Upon purification by column chro-
matography (4:1 hexanes:ethyl acetate, 1% triethylamine), a mixture of epoxides
330 and 348 (1.3:1 ratio), in addition to a minor amount of a mixture of all four
stereoisomeric epoxides, all obtained as colourless oils (53 mg, 56% combined yield).
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330 and 348: Rf 0.35 (3:1 hexanes:ethyl
acetate); 1H-NMR: (CDCl3) δH
7.37–7.28 (complex m, 5H, Bn), 6.09 (d,
J = 9.5 Hz, 1H, H-5), 6.05 (dd, J =
10.2 Hz, 1H, H-5), 4.81 (apparent dt, J = 9.7, 3.2 Hz, 1H, H-6), 4.65 (d, J = 11.2
Hz, 1H, PhCH2), 4.59 (d, J = 11.5 Hz, 1H, PhCH2), 4.50–4.46 (complex m, 2H,
PhCH2), 4.15–3.99 (complex m, 3H, H-8,9a,b), 3.60 (m, 1H, H-3), 3.55 (dd, J =
7.0, 3.2 Hz, 1H, H-7), 3.50 (m, 1H, H-7), 3.24 (dq, J = 5.4, 0.7 Hz, 1H, H-2), 3.16
(dq, J = 5.4, 1.7 Hz, 1H, H-2), 2.28 (brs, 1H, OH), 1.42 (s, 3H, (CH3)2C), 1.36–1.34
(complex m, 6H, H-1,(CH3)2C), 1.28 (dd, J = 5.4, 1.7 Hz, 3H, H-1);
13C-NMR:
(CDCl3) δC 137.8 (C, Bn), 137.7 (C, Bn), 131.1 (C, C-5), 129.9 (C, C-5), 128.4 (CH,
Bn), 127.9 (CH, Bn), 127.8 (CH, Bn), 109.2 (C, (CH3)2C), 109.1 (C, (CH3)2C), 75.8
(CH, C-8), 75.7 (CH, C-8), 75.0 (CH, C-7), 74.5 (CH, C-7), 74.0 (CH, C-6), 73.8
(CH, C-6), 71.4 (CH2, PhCH2), 71.0 (CH2, PhCH2), 66.6 (CH2, C-9), 66.4 (CH2,
C-9), 56.7 (CH, C-3), 56.2 (CH, C-3), 54.5 (CH, C-2), 52.9 (CH, C-2), 26.73 (CH3,
(CH3)2C), 26.71 (CH3, (CH3)2C), 25.34 (CH3, (CH3)2C), 25.32 (CH3, (CH3)2C),
13.5 (CH3, C-1), 13.2 (CH3, C-1); HRMS: m/z C19H25O
35
5 ClNa
+ [M+Na]+ calcd
391.1288, found 391.1289.
B Using a known procedure,91 a solution of dienes 346 and 347 (2.0:1 ratio, 69 mg,
0.20 mmol) in dichloromethane (2 mL) was treated with (R,R)-Jacobsen’s catalyst
313 (4 mg, 6 µmol), then bleach (0.55 molL−1, pH 11.3, 2 mL).91 The mixture was
stirred at room temperature for two days, then diluted with water (20 mL) and ex-
tracted with diethyl ether (2 x 20 mL). The ethereal fractions were combined, dried,
filtered and concentrated to provide a brown oil. Upon purification by column chro-
matography (3:1 hexanes:ethyl acetate), starting material 346 was obtained (17 mg,
25%), in addition to a minor amount of impure epoxides 330 and 348 (1.5:1 ratio,
2 mg, 3%), which was not able to be characterised.
3,7-Anhydro-6-O-benzyl-4-chloro-1,4,5-trideoxy-8,9-O-isopropylidene-d-
arabino-nona-4-enopyranitol (349)
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A solution of epoxides 330 and 348 (2:1 ratio, 76 mg, 0.21
mmol) in DMF (2 mL) was treated with sodium hydride
(13 mg, 0.33 mmol). The mixture was stirred at room tem-
perature for 24 hours, then diluted with sat. copper sulfate
solution (20 mL) and diethyl ether (20 mL). The phases were separated, then the
ethereal fraction was dried, filtered and concentrated to provide a yellow oil. Upon
purification by column chromatography (5:1 hexanes:ethyl acetate), a mixture of
starting materials 330 and 348 was obtained (19 mg, 25%), in addition to com-
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plicated mixtures of epoxide–opened products (349) as colourless oils (11 mg, 14%
combined yield), which were not sufficiently pure for characterisation.
bis(2,4,6-Trimethylpyridine)silver(I) hexafluorophosphate (351)
As reported previously,137 a solution of silver nitrate (4.99 g, 29.4 mmol) and potas-
sium hexafluorophosphate (5.49 g, 29.8 mmol) in water (100 mL) was treated with
2,4,6-trimethylpyridine (11 mL, 81 mmol), then stirred at room temperature for one
hour. The mixture was filtered and the precipitate washed with water (50 mL), then
dried to provide silver salt 351 as a white solid (12.8 g, 88%).
AgN N
PF6
m.p. 213–216 ◦C (lit.137 m.p. 210–253 ◦C).
3,7-Anhydro-6-O-benzyl-4-chloro-1,2,4,5-tetradeoxy-2-iodo-8,9-O-
isopropylidene-d-arabino-nona-4-enopyranitol (352)
A solution of silver salt 351 (418 mg, 0.844 mmol) in dichloromethane (5 mL) was
treated with iodine (154 mg, 0.606 mmol) and stirred at room temperature for ten
minutes, in which the iodine was consumed. A solution of dienes 346 and 347
(2.0:1 ratio, 135 mg, 0.383 mmol) in dichloromethane (3 mL) was added, then the
solution was stirred at room temperature for five days, in which the solution turned
dark brown due to decomposition of the iodine complex. The mixture was filtered
through Celite R© and eluted with dichloromethane (20 mL). The eluents were washed
successively with sat. sodium thiosulfate solution (20 mL), 10% aqueous hydrochloric
acid (20 mL), then sat. sodium bicarbonate solution (20 mL). The organic fraction
was dried, filtered and concentrated to provide an orange oil. Upon purification
by column chromatography (9:1 hexanes:ethyl acetate), iodopyranose sugars were
obtained (352), of which two were obtained as an inseparable yellow oil (Rf 0.55
(5:1 hexanes:ethyl acetate), 6 mg, 3%); a third iodopyranose sugar (Rf 0.45 (5:1
hexanes:ethyl acetate), 4 mg, 2%) was obtained as a yellow oil (5% combined yield),
in addition to unreacted starting materials 346 and 347 (1.1:1 ratio, 44 mg, 33%).
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Rf 0.55 (5:1 hexanes:ethyl acetate);
1H-NMR: (CDCl3) δH
7.37–7.28 (complex m, 5H, Bn), 6.31 (d, J = 6.1 Hz, 1H,
H-5), 6.24 (d, J = 5.8 Hz, 1H, H-5), 4.71 (qd, J = 7.3, 2.7
Hz, 1H, H-2), 4.68–4.67 (complex m, 2H, PhCH2), 4.64 (dd,
J = 8.0, 1.7 Hz, 1H, H-3), 4.51 (qd, J = 7.1, 2.7 Hz, 1H, H-2), 4.44 (m, 1H, H-3),
4.41–4.35 (m, 1H, H-8), 4.30 (dd, J = 8.8, 4.9 Hz, 1H, H-9a), 4.22 (m, 1H, H-9a),
4.19 (m, 1H, H-9b), 4.17 (m, 1H, H-9b), 4.02 (dd, J = 6.2, 2.1 Hz, 1H, H-6), 3.99
(dd, J = 5.9, 2.2 Hz, 1H, H-6), 3.93 (m, 1H, H-7), 3.89 (m, 1H, H-7), 2.02 (d, J =
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7.0 Hz, 3H, H-1), 1.87 (d, J = 7.4 Hz, 3H, H-1), 1.42 (s, 3H, (CH3)2C), 1.41 (s, 3H,
(CH3)2C), 1.39 (s, 3H, (CH3)2C);
13C-NMR: (CDCl3) δC 138.0 (C, Bn), 136.4 (C,
C-4), 133.8 (C, C-4), 128.4 (CH, Bn), 128.0 (CH, Bn), 127.9 (CH, Bn), 127.8 (CH,
Bn), 125.0 (CH, C-5), 124.3 (CH, C-5), 109.3 (C, (CH3)2C), 109.2 (C, (CH3)2C),
79.4 (CH, C-3), 78.1 (CH, C-7), 75.7 (CH, C-7), 74.2 (CH, C-3), 73.7 (CH, C-8),
73.6 (CH, C-8), 71.79 (CH2, PhCH2), 71.76 (CH2, PhCH2), 69.5 (CH, C-6), 69.4
(CH, C-6), 67.42 (CH2, C-9), 67.37 (CH2, C-9), 27.1 (CH3, (CH3)2C), 26.7 (CH2,
C-2), 26.5 (CH2, C-2), 25.6 (CH3, C-1) 25.5 (CH3, (CH3)2C), 25.4 (CH3, (CH3)2C),
25.1 (CH3, (CH3)2C), 24.0 (CH3, C-1); IR (KBr): νmax 2985, 2932, 2868, 1728, 1650,
1455, 1380, 1260, 1214, 1139, 1069, 1046, 1024, 912, 847, 737, 698 cm−1; HRMS: m/z
C19H24O
35
4 ClINa
+ [M+Na]+ calcd 501.0306, found 501.0301.
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Rf 0.45 (5:1 hexanes:ethyl acetate); [α]
22
D −60 (c 0.35 CHCl3);
1H-NMR: (CDCl3) δH 7.42–7.27 (complex m, 5H, Bn), 6.27
(dd, J = 6.1, 1.7 Hz, 1H, H-5), 4.77 (d, J = 11.9 Hz, 1H,
PhCH2), 4.64 (m, 1H, H-2), 4.63 (d, J = 12.0 Hz, 1H, PhCH2),
4.41 (dd, J = 12.2, 6.2 Hz, 1H, H-8), 4.11 (apparent d, J = 5.9 Hz, 2H, H-9a,b), 4.00
(apparent dt, J = 6.1, 2.0 Hz, 1H, H-6), 3.68 (dd, J = 6.5, 2.1 Hz, 1H, H-7), 3.44 (d,
J = 1.7 Hz, 1H, H-3), 1.97 (d, J = 7.0 Hz, 3H, H-1), 1.41 (s, 3H, (CH3)2C), 1.37 (s,
3H, (CH3)2C);
13C-NMR: (CDCl3) δC 138.54 and 138.50 (C, Bn and C, C-4), 128.3
(CH, Bn), 127.6 (CH, Bn), 127.5 (CH, Bn), 124.5 (CH, C-5), 108.9 (C, (CH3)2C),
80.5 (CH, C-3), 77.4 (CH, C-7), 74.2 (CH, C-8), 70.6 (CH2, PhCH2), 69.2 (CH, C-6),
66.4 (CH2, C-9), 26.8 (CH3, (CH3)2C), 26.6 (CH2, C-2), 25.4 (CH3, (CH3)2C), 25.0
(CH3, C-1); IR (KBr): νmax 2985, 2924, 2874, 1645, 1454, 1371, 1250, 1212, 1144,
1071, 1046, 1027, 850, 737, 698 cm−1; HRMS: m/z C19H24O
35
4 ClINa
+ [M+Na]+
calcd 501.0306, found 501.0304.
(3E)-5-O-Benzyl-3-chloro-1,2,3,4-tetradeoxy-7,8-O-isopropylidene-d-
arabino-octa-1,3-dienitol (353)
A solution of methyl triphenylphosphonium bromide (1.06 g, 2.97 mmol) in THF
(10 mL) was cooled to −78 ◦C, then treated with KHMDS (6.0 mL, 3.0 mmol) and
stirred at −78 ◦C for one hour. The mixture was treated with a solution of hemi-
acetal 345 (478 mg, 1.40 mmol) in THF (10 mL), then allowed to warm to room
temperature. The reaction was stirred at room temperature for two hours, then
diluted with sat. ammonium chloride solution (50 ml) and extracted with diethyl
ether (2 x 50 mL). The organic fractions were combined, dried, filtered and concen-
trated to provide a crude brown oil. Upon purification by column chromatography
(5:1 hexanes:ethyl acetate), diene 353 (326 mg, 69%) was obtained as a colourless
oil.
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Rf 0.3 (5:1 hexanes:ethyl acetate); [α]
19
D −34 (c 1.4 CHCl3);
1H-NMR: (CDCl3) δH 7.37–7.30 (complex m, 5H, Bn), 6.61
(dd, J = 16.3, 10.7 Hz, 1H, H-2), 5.99 (dd, J = 9.8, 0.8 Hz,
1H, H-4), 5.82 (d, J = 16.1 Hz, 1H, H-1a), 5.40 (dd, J = 10.8,
1.0 Hz, 1H, H-1b), 4.64 (d, J = 11.5 Hz, 1H, PhCH2), 4.49 (dd, J = 9.8, 3.0 Hz, H-
5), 4.41 (d, J = 11.8 Hz, 1H, PhCH2), 4.11 (dt, J = 7.5, 5.9 Hz, 1H, H-7), 4.04 (dd,
J = 8.4, 6.2 Hz, 1H, H-8a), 3.98 (dd, J = 8.4, 5.5 Hz, 1H, H-8b), 3.51 (dd, J = 7.5,
2.7 Hz, 1H, H-6), 2.40 (brs, 1H, OH), 1.38 (s, 3H, (CH3)2C), 1.34 (s, 3H, (CH3)2C);
13C-NMR: (CDCl3) δC 137.4 (C, Bn), 134.9 (C, C-3), 128.5 (CH, Bn), 128.4 (CH,
C-2), 128.2 (CH, C-4), 127.9 (CH, Bn), 120.7 (CH2, C-1), 109.2 (C, (CH3)2C), 75.4
(CH, C-7), 75.0 (CH, C-6), 73.3 (CH, C-5), 70.6 (CH2, PhCH2), 66.7 (CH2, C-8),
26.8 (CH3, (CH3)2C), 25.3 (CH3, (CH3)2C); IR (KBr): νmax 3454, 3065, 3031, 2987,
2934, 2879, 1587, 1455, 1381, 1371, 1253, 1216, 1152, 1059, 847, 736, 698 cm−1;
HRMS: m/z C18H23O
35
4 ClNa
+ [M+Na]+ calcd 361.1183, found 361.1180.
(E)-1,2-Anhydro-5-O-benzyl-3-chloro-3,4-dideoxy-7,8-O-isopropylidene-
d-gluco-octa-3-enopyranitol (355) and (E)-1,2-anhydro-5-O-benzyl-3-
chloro-3,4-dideoxy-7,8-O-isopropylidene-d-manno-octa-3-enopyranitol
(356)
A A solution of diene 353 (112 mg, 0.33 mmol) in dichloromethane (5 mL) was
treated with m-CPBA (163 mg, 0.66 mmol). The mixture was stirred at room tem-
perature for two days, then diluted with sat. sodium bicarbonate solution (20 mL)
and water (10 mL), then diethyl ether (30 mL). The biphasic mixture was stirred
rapidly for ten minutes, then the phases were separated. The ethereal fraction was
washed with brine (10 mL), dried, filtered and concentrated to provide a colourless
oil. Upon purification by column chromatography (3:1 hexanes:ethyl acetate), a
mixture of epimeric epoxides 355 and 356 were obtained as a colourless oil (1.5:1
ratio, 57 mg, 49%), in addition to complicated mixtures of unidentified products.
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355 and 356: Rf 0.3 (3:1 hexanes:ethyl
acetate); 1H-NMR: (CDCl3) δH 7.41–7.29
(complex m, 5H, Bn), 6.17 (d, J = 9.8 Hz,
1H, H-4), 6.14 (d, J = 9.8 Hz, 1H, H-4),
4.68 (d, J = 11.4 Hz, 1H, PhCH2), 4.59 (dd, J = 9.8, 2.7 Hz, 1H, H-5), 4.48 (d, J =
11.5 Hz, 1H, PhCH2), 4.14–3.97 (complex m, 3H, H-7,8a,b), 3.72 (m, 1H, H-2), 3.66
(m, 1H, H-2), 3.53–3.48 (complex m, 1H, H-6), 3.05 (dd, J = 5.5, 2.3 Hz, 1H, H-1a),
2.99 (dd, J = 5.5, 2.4 Hz, 1H, H-1a), 2.92 (dd, J = 5.4, 4.2 Hz, 1H, H-1b), 2.86
(dd, J = 5.4, 4.1 Hz, 1H, H-1b), 2.46 (brs, 1H, OH), 1.39 (s, 3H, (CH3)2C), 1.37 (s,
3H, (CH3)2C), 1.35 (s, 3H, (CH3)2C), 1.33 (s, 3H, (CH3)2C);
13C-NMR: (CDCl3) δC
137.2 (C, 2 x Bn), 133.7 (C, C-3), 133.5 (C, C-3), 132.0 (CH, C-4), 131.3 (CH, C-4),
166
128.5 (CH, Bn), 128.03 (CH, Bn), 128.00 (CH, Bn), 127.96 (CH, Bn), 127.92 (CH,
Bn), 109.3 (C, (CH3)2C), 109.2 (C, (CH3)2C), 75.5 (CH, 2 x C-7), 75.2 (CH, C-6),
75.0 (CH, C-6), 73.3 (CH, C-5), 73.1 (CH, C-5), 70.9 (CH2, 2 x PhCH2), 66.8 (CH2,
C-8), 66.7 (CH2, C-8), 49.4 (CH, C-2), 48.7 (CH, C-2), 46.6 (CH2, C-1), 46.5 (CH2,
C-1), 26.8 (CH3, (CH3)2C), 26.7 (CH3, (CH3)2C), 25.3 (CH3, (CH3)2C), 25.2 (CH3,
(CH3)2C); HRMS: m/z C18H23O
35
5 ClNa
+ [M+Na]+ calcd 377.1132, found 377.1128.
B Using a known procedure,91 a solution of diene 353 (27 mg, 80 µmol) in dichloro-
methane (1 mL) was treated with (R,R)-Jacobsen’s catalyst 313 (2 mg, 3 µmol),
then bleach (0.55 molL−1, pH 11.3, 1 mL).91 The mixture was stirred at room tem-
perature for two days, then separated between water (20 mL) and diethyl ether
(20 mL). The ethereal fraction was washed with brine (10 mL), dried, filtered and
concentrated to provide a brown oil. Upon purification by column chromatogra-
phy (3:1 hexanes:ethyl acetate), a mixture of epimeric epoxides 355 and 356 were
obtained (1.2:1 ratio, 5 mg, 18%), in addition to complex mixtures of unidentified
material.
(E)-2,6-Anhydro-5-O-benzyl-3-chloro-3,4-dideoxy-7,8-O-isopropylidene-
d-gluco-octa-3-enopyranitol (357) and (E)-2,6-anhydro-5-O-benzyl-3-
chloro-3,4-dideoxy-7,8-O-isopropylidene-d-manno-octa-3-enopyranitol
(358)
A A solution of epoxides 355 and 356 (69 mg, 0.19 mmol) in DMF (2 mL) was
treated with sodium hydride (11 mg, 0.28 mmol). The mixture was stirred at room
temperature for one day, then diluted with sat. copper sulfate solution (10 mL)
and water (10 mL), then extracted with dichloromethane (2 x 20 mL). The organic
fractions were combined, dried, filtered and concentrated to provide a yellow oil.
Upon purification by column chromatography (3:1 hexanes:ethyl acetate), a mixture
of epimeric alcohols 357 and 358 were obtained as an inseparable pale–yellow oil
(1.5:1 ratio, 16 mg, 23%), in addition to recovered starting material (24 mg, 35%).
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357 and 358: Rf 0.3 (2:1 hexanes:ethyl acetate);
1H-NMR:
(CDCl3) δH 7.35–7.29 (complex m, 5H, Bn), 6.29 (d, J = 6.3
Hz, 1H, H-4), 6.19 (d, J = 5.9 Hz, 1H, H-4), 4.694 (d, J =
11.7 Hz, 1H, PhCH2), 4.688 (d, J = 11.7 Hz, 1H PhCH2),
4.61 (d, J = 11.7 Hz, 2H, PhCH2), 4.38–4.33 (complex m, 3H, H-2,6), 4.25 (m, 1H,
H-2), 4.16–4.10 (complex m, 2H, H-8a), 4.06–3.98 (complex m, 3H, H-5,8b), 3.91 (m,
1H, H-5), 3.89–3.86 (complex m, 5H, H-1a,b,7), 3.54 (d, J = 8.0 Hz, 1H, H-7), 1.89
(brs, 1H, OH), 1.41 (s, 3H, (CH3)2C), 1.40 (s, 3H, (CH3)2C), 1.39 (s, 3H, (CH3)2C),
1.38 (s, 3H, (CH3)2C);
13C-NMR: (CDCl3) δC 138.0 (C, Bn), 137.9 (C, Bn), 136.0
(C, C-3), 134.8 (C, C-3), 128.42 (CH, Bn), 128.37 (CH, Bn), 128.0 (CH, Bn), 127.9
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(CH, Bn), 127.8 (CH, Bn), 125.0 (CH, C-4), 123.6 (CH, C-4), 109.2 (C, (CH3)2C),
108.9 (C, (CH3)2C), 78.1 (CH, C-2), 77.6 (CH, C-7), 77.0 (CH, C-2), 74.2 (CH, C-6),
73.5 (CH, C-6), 72.4 (CH, C-7), 71.6 (CH2, PhCH2), 71.4 (CH2, PhCH2), 69.29 (CH,
C-5), 69.26 (CH, C-5), 67.0 (CH2, C-8), 66.7 (CH2, C-8), 62.6 (CH2, C-1), 60.6 (CH2,
C-1), 26.9 (CH3, (CH3)2C), 26.6 (CH3, (CH3)2C), 25.4 (CH3, (CH3)2C), 25.3 (CH3,
(CH3)2C); IR (KBr): νmax 3463, 2988, 2933, 2874, 1651, 1455, 1372, 1255, 1219,
1121, 1072, 914, 850, 771, 698 cm−1; HRMS: m/z C18H23O
35
5 ClNa
+ [M+Na]+ calcd
377.1132, found 377.1137.
B Using a previously reported procedure,160 a solution of epoxides 355 and 356
(73 mg, 0.20 mmol) in methanol (2 mL) was treated with sodium (12 mg, 0.52 mmol),
then stirred at room temperature for two days. The mixture was concentrated, then
passed through a silica plug, which was eluted with dichloromethane (10 mL). The
solution was dried and concentrated to provide a yellow oil. Upon purification by
column chromatography (3:1 hexanes:ethyl acetate), a mixture of epimeric alcohols
357 and 358 were obtained as an inseparable pale–yellow oil (3.3:1 ratio, 31 mg,
42%), in addition to minor amounts of unidentified products (13 mg).
2,6-Anhydro-5-O-benzyl-3-chloro-1,3,4-trideoxy-1-iodo-7,8-O-
isopropylidene-d-manno-octa-1,3-dienopyranitol (359)
A A solution of silver salt 351 (113 mg, 0.228 mmol) in dichloromethane (2 mL)
was treated with iodine (53 mg, 0.21 mmol) and stirred at room temperature for
five minutes, in which the iodine was consumed. A solution of diene 353 (50 mg,
0.15 mmol) in dichloromethane (1 mL) was added, then the solution was stirred
at room temperature for 22 hours. The mixture was filtered through Celite R© and
eluted with dichloromethane (20 mL). The eluents were washed successively with
sat. sodium thiosulfate solution (20 mL), 10% aqueous hydrochloric acid (20 mL),
then sat. sodium bicarbonate solution (20 mL). The organic fraction was dried,
filtered and concentrated to provide a yellow oil. Upon purification by column
chromatography (9:1 hexanes:ethyl acetate), iodopyranose sugar 359 (29 mg, 42%)
was obtained as a yellow oil, in addition to unreacted starting material 353 (19 mg,
38%).
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Rf 0.4 (9:1 hexanes:ethyl acetate); [α]
22
D −87 (c 0.45 CHCl3);
1H-NMR: (CDCl3) δH 7.38–7.29 (complex m, 5H, Bn), 6.13
(dd, J = 5.9, 1.5 Hz, 1H, H-4), 4.69 (s, 2H, PhCH2), 4.41 (m,
1H, H-2), 4.37 (m, 1H, H-6), 4.25 (dd, J = 8.8, 4.9 Hz, 1H,
H-8a), 4.18 (dd, J = 8.8, 6.1 Hz, 1H, H-8b), 3.89 (dd, J = 5.9, 2.2 Hz, 1H, H-5), 3.61
(dd, J = 8.6, 2.2 Hz, 1H, H-7), 3.58 (dd, J = 11.5, 2.7 Hz, 1H, H-1a), 3.32 (apparent
t, J = 11.1 Hz, 1H, H-1b), 1.43 (s, 3H, (CH3)2C), 1.40 (s, 3H, (CH3)2C);
13C-NMR:
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(CDCl3) δC 138.0 (C, Bn), 135.4 (C, C-3), 128.4 (CH, Bn), 128.0 (CH, Bn), 127.8
(CH, Bn), 123.6 (CH, C-4), 109.3 (C, (CH3)2C), 76.1 (CH, C-6), 73.2 (CH, C-2),
72.6 (CH, C-7), 72.0 (CH2, PhCH2), 69.3 (CH, C-5), 67.8 (CH2, C-8), 27.0 (CH3,
(CH3)2C), 25.3 (CH3, (CH3)2C), 2.3 (CH2, C-1); IR (KBr): νmax 2952, 2930, 2874,
1723, 1652, 1454, 1422, 1335, 1185, 1131, 1083, 1048, 1013, 994, 917, 885, 860, 748,
694 cm−1; HRMS: m/z C18H22O
35
4 ClINa
+ [M+Na]+ calcd 487.0149, found 487.0149.
B A solution of iodide 359 (60 mg, 0.13 mmol) in THF (2 mL) was cooled to
−78 ◦C, then treated with n-butyllithium (80 µL of a 2.0 molL−1 solution in cy-
clohexane, 0.16 mmol). The mixture was stirred for 30 minutes, then warmed to
0 ◦C and stirred for an additional 30 minutes. Carbon dioxide was bubbled through
the solution for 30 minutes, then the solution was quenched with sat. ammonium
chloride solution (10 ml), then extracted with dichloromethane (3 x 10 mL). The
organic fractions were combined, dried, filtered and concentrated to provide a yellow
oil. Upon purification by column chromatography (9:1 hexanes:ethyl acetate), start-
ing material 359 (38 mg, 63%) was obtained, in addition to diene 353 (12 mg, 27%).
Ethyl (2E,4E)-6-O-benzyl-4-chloro-2,3,4,5-tetradeoxy-8,9-O-
isopropylidene-d-arabino-nona-2,4-dienoate (360)
A solution of hemiacetal 345 (36 mg, 0.11 mmol) in THF (1 mL) was treated with
(ethoxycarbonylmethylene)triphenylphosphorane (112 mg, 0.321 mmol) and stirred
at room temperature overnight, then heated at reflux for 24 hours. The reaction
mixture was diluted with sat. ammonium chloride solution (10 ml) and extracted
with dichloromethane (3 x 10 mL). The organic fractions were combined, dried,
filtered and concentrated to provide a crude yellow oil. Upon purification by column
chromatography (3:1 hexanes:ethyl acetate), diene 360 (27 mg, 63%) was obtained
as a colourless oil.
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1CO2Et Rf 0.3 (5:1 hexanes:ethyl acetate); [α]23D −74 (c 0.3 CHCl3);
1H-NMR: (CDCl3) δH 7.55 (d, J = 14.7 Hz, 1H, H-3), 7.37–
7.29 (complex m, 5H, Bn), 6.41 (d, J = 14.7 Hz, 1H, H-2),
6.27 (dd, J = 9.7, 0.5 Hz, 1H, H-5), 4.61 (d, J = 11.5 Hz,
1H, PhCH2), 4.58 (d, J = 2.7 Hz, 1H, H-6), 4.44 (d, J = 11.5 Hz, 1H, PhCH2), 4.24
(qd, J = 7.1, 1.1 Hz, 2H, Et), 4.12–4.04 (complex m, 2H, H-8,9a), 3.98 (dd, J =
8.4, 5.0 Hz, 1H, H-9b), 3.47 (td, J = 8.0, 2.6 Hz, 1H, H-7), 2.43 (d, J = 8.5 Hz, 1H,
OH), 1.39 (s, 3H, (CH3)2C), 1.34 (s, 3H, (CH3)2C), 1.31 (t, J = 7.1 Hz, 3H, Et);
13C-NMR: (CDCl3) δC 166.0 (C, C-1), 137.0 (C, Bn), 135.4 (CH, C-5), 134.9 (CH,
C-3), 132.1 (C, C-4), 128.5 (CH, Bn), 128.1 (CH, Bn), 128.0 (CH, Bn), 124.7 (CH,
C-2), 109.4 (C, (CH3)2C), 75.3 (CH, C-8), 75.1 (CH, C-7), 73.8 (CH, C-6), 71.2
(CH2, PhCH2), 66.8 (CH2, C-9), 60.9 (CH2, Et), 26.8 (CH3, (CH3)2C), 25.3 (CH3,
(CH3)2C), 14.2 (CH3, Et); IR (KBr): νmax 3443, 2985, 2933, 1716, 1635, 1455, 1371,
169
1303, 1266, 1182, 1070, 964, 848, 740, 699 cm−1; HRMS: m/z C21H27O
35
6 ClNa
+
[M+Na]+ calcd 433.1394, found 433.1391.
Ethyl 3,7-anhydro-6-O-benzyl-4-chloro-2,4,5-trideoxy-8,9-O-
isopropylidene-d-manno-non-4-enoate (361) and ethyl 3,7-anhydro-6-O-
benzyl-4-chloro-2,4,5-trideoxy-8,9-O-isopropylidene-d-gluco-non-4-
enoate (362)
A A solution of α, β unsaturated ester 360 (47 mg, 0.11 mmol) in THF (2 mL) was
treated with sodium hydride (10 mg, 0.25 mmol), then stirred at room temperature
for 15 minutes. The reaction mixture was diluted with sat. ammonium chloride
solution (10 ml) and extracted with dichloromethane (2 x 10 mL). The organic
fractions were combined, dried, filtered and concentrated to provide a crude yellow
oil. Upon purification by column chromatography (9:1 hexanes:ethyl acetate), ring–
closed products 361 and 362 were obtained as an inseparable colourless oil (1:1.2
ratio, 44 mg, 94%).
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361 and 362: Rf 0.3 (5:1 hex-
anes:ethyl acetate); 1H-NMR:
(CDCl3) δH 7.42–7.27 (complex
m, 5H, Bn), 6.11 (m, 1H, H-5),
4.76 (ddd, J = 9.3, 3.1, 1.5 Hz, 1H, H-3 (361)), 4.69–4.64 (complex m, 2H, PhCH2),
4.59 (ddd, J = 7.6, 3.2, 1.6 Hz, 1H, H-3 (362)), 4.34 (m, 1H, H-8), 4.22–4.13 (com-
plex m, 2H, Et), 4.08 (d, J = 8.6 Hz, 1H, H-9a), 4.06 (d, J = 8.5 Hz, 1H, H-9a),
3.99–3.95 (complex m, 2H, H-6,9b), 3.91 (dd, J = 8.5, 5.4 Hz, 1H, H-9b), 3.58 (dd,
J = 8.3, 2.2 Hz, 1H, H-7 (361)), 3.51 (dd, J = 8.1, 2.0 Hz, 1H, H-7 (362)), 2.98 (dd,
J = 15.6, 3.5 Hz, 1H, H-2a (362)), 2.79 (dd, J = 14.9, 3.0 Hz, 1H, H-2a (361)),
2.67 (dd, J = 14.9, 10.8 Hz, 1H, H-2b (361)), 2.58 (dd, J = 15.6, 9.3 Hz, 1H,
H-2b (362)), 1.40 (s, 3H, (CH3)2C), 1.39 (s, 3H, (CH3)2C), 1.38 (s, 3H, (CH3)2C),
1.37 (s, 3H, (CH3)2C), 1.28 (t, J = 7.1 Hz, 3H, Et), 1.25 (t, J = 7.1 Hz, 3H, Et);
13C-NMR: (CDCl3) δC 170.3 (C, C-1), 170.1 (C, C-1), 138.2 (C, Bn), 138.1 (C,
Bn), 137.4 (C, C-4), 136.6 (C, C-4), 128.3 (CH, Bn), 128.1 (CH, Bn), 128.0 (CH,
Bn), 127.9 (CH, Bn), 127.8 (CH, Bn), 123.8 (CH, C-5), 123.1 (CH, C-5), 109.2 (C,
(CH3)2C), 109.1 (C, (CH3)2C), 78.4 (CH, C-7 (362)), 74.8 (CH, C-3 (362)), 73.6
(CH, C-3 (361)), 73.4 (CH, C-8), 73.2 (CH, C-8), 72.6 (CH, C-7 (361)), 71.8 (CH2,
PhCH2), 71.5 (CH2, PhCH2), 69.5 (CH, C-6), 69.2 (CH, C-6), 67.2 (CH2, C-9), 66.9
(CH2, C-9), 61.0 (CH2, Et), 60.7 (CH2, Et), 38.4 (CH2, C-2 (362)), 35.4 (CH2, C-2
(361)), 26.86 (CH3, (CH3)2C), 26.84 (CH3, (CH3)2C), 25.4 (CH3, (CH3)2C), 25.3
(CH3, (CH3)2C), 24.8 (CH3, Et), 14.2 (CH3, Et); IR (KBr): νmax 2986, 2934, 2885,
1734, 1652, 1455, 1372, 1272, 1181, 1095, 1072, 847, 737, 698 cm−1; HRMS: m/z
C21H27O
35
6 ClNa
+ [M+Na]+ calcd 433.1394, found 433.1386.
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B A solution of α, β unsaturated ester 360 (21 mg, 0.05 mmol) in THF (2 mL)
was cooled to 0 ◦C, then treated with sodium hydride (5 mg, 0.1 mmol). The reac-
tion was stirred for one hour at 0 ◦C, then quenched with sat. ammonium chloride
solution (10 ml) and extracted with dichloromethane (2 x 10 mL). The organic
fractions were combined, dried, filtered and concentrated to provide a crude yellow
oil. Upon purification by column chromatography (9:1 hexanes:ethyl acetate), ring–
closed products 361 and 362 (4:1 ratio) were obtained (11 mg, 55%).
C A solution of diisopropyl amine (20 µL, 0.14 mmol) in THF (1 mL) was cooled to
−78 ◦C, then treated with n-butyllithium (70 µL of a 2.0 molL−1 solution in cyclo-
hexane, 0.14 mmol) and stirred for 30 minutes to generate a solution of LDA. This
solution was then treated with a solution of ring–closed pyranosyl sugars 361 and
362 (4:1 ratio, 30 mg, 73 µmol) in THF (1 mL) and allowed to react for 20 minutes.
The mixture was treated with iodine (39 mg, 0.15 mmol), then the solution was
stirred at −78 ◦C for 30 minutes. The mixture was warmed to room temperature
and stirred for 30 minutes, then the reaction mixture was diluted with dichloro-
methane (20 mL), then washed sequentially with sat. sodium thiosulfate solution
(20 ml), 10% aqueous hydrochloric acid (20 mL) and sat. sodium bicarbonate solu-
tion (20 mL). The organic fraction was dried, filtered and concentrated to provide
a crude yellow oil. Upon purification by column chromatography (5:1 hexanes:ethyl
acetate), ring–closed products 361 and 362 (4:1 ratio) were obtained (18 mg, 60%),
in addition to previously isolated diene 360 (9 mg, 30%).
Diethyl methylsulfonylmethylphosphonate (366)
A solution of diethyl methylthiomethylphosphonate (1.99 g, 10.0 mmol) in ethanol
(50 mL) was treated successively with a 30% aqueous solution of hydrogen per-
oxide (10 mL, 100 mmol) and ammonium heptamolybdate tetrahydrate (1.24 g,
1.00 mmol), then stirred at room temperature for one hour. The mixture was then
diluted with water (200 mL) and extracted with dichloromethane (3 x 100 mL),
to provide diethyl methylsulfonylmethylphosphonate (366) as a white solid (2.22 g,
96%).
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m.p. 89–91 ◦C (lit.161 m.p. 96 ◦C); 1H-NMR: (CDCl3) δH 4.24
(apparent quintet, J = 7.1 Hz, 4H, H-2), 3.59 (d, JP−H = 16.3
Hz, 2H, H-1), 3.21 (s, 3H, Me), 1.37 (t, J = 7.1 Hz, 6H, H-3);
13C-NMR: (CDCl3) δC 63.8 (d, JC−P = 6.7 Hz, CH2, C-2), 52.3 (d, JC−P = 6.7 Hz,
CH2, C-1), 42.6 (CH3, Me), 16.3 (d, JC−P = 6.2 Hz, CH3, C-3);
31P-NMR: (CDCl3)
δP 11.6 (s, 1P).
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2,6-Anhydro-5-O-benzyl-3-chloro-1,3,4-trideoxy-7,8-O-isopropylidene-1-
[(methyl)sulfonyl]-d-gluco-oct-3-enopyranitol (371) and 2,6-anhydro-5-O-
benzyl-3-chloro-1,3,4-trideoxy-7,8-O-isopropylidene-1-[(methyl)sulfonyl]-
d-manno-oct-3-enopyranitol (367)
A A solution of sulfone 366 (274 mg, 1.19 mmol) in THF (6 mL) was treated
with sodium hydride (46 mg, 1.2 mmol), then stirred at 0 ◦C for 15 minutes. To
this was added hemiacetal 345 (249 mg, 0.73 mmol) in THF (3 mL), then the
mixture was allowed to warm to room temperature and reacted for two hours. The
reaction mixture was diluted with sat. ammonium chloride solution (20 ml), then
extracted with dichloromethane (3 x 20 mL). The organic fractions were combined,
dried, filtered and concentrated to provide a crude yellow oil. Upon purification by
column chromatography (1:1 hexanes:ethyl acetate), pyranosyl sugar 371 (15 mg,
5%) was obtained as a colourless oil and pyranosyl sugar 367 (220 mg, 72%) was
obtained as a white crystalline solid (77% combined yield).
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371: Rf 0.4 (1:1 hexanes:ethyl acetate); [α]
21
D −70 (c 0.7
CHCl3);
1H-NMR: (CDCl3) δH 7.40–7.30 (complex m,
5H, Bn), 6.23 (dd, J = 6.3, 1.6 Hz, 1H, H-4), 4.72–4.67
(complex m, 2H, PhCH2, H-2), 4.61 (d, J = 11.7 Hz, 1H,
PhCH2), 4.34 (dd, J = 11.7, 6.3 Hz, 1H, H-7), 4.09–4.02 (complex m, 2H, H-8a,b),
3.96 (apparent dt, J = 6.1, 2.0 Hz, 1H, H-5), 3.65–3.59 (complex m, 2H, H-1a,6),
3.34 (dd, J = 15.1, 10.0 Hz, 1H, H-1b), 3.02 (s, 3H, Me), 1.41 (s, 3H, (CH3)2C),
1.36 (s, 3H, (CH3)2C);
13C-NMR: (CDCl3) δC 137.7 (C, Bn), 134.9 (CH, C-3), 128.5
(CH, Bn), 128.05 (CH, Bn), 127.98 (CH, Bn), 124.9 (CH, C-4), 109.2 (C, (CH3)2C),
78.4 (CH, C-6), 73.8 (CH, C-2), 73.5 (CH, C-7), 71.8 (CH2, PhCH2), 69.2 (CH,
C-5), 66.4 (CH2, C-8), 57.3 (CH2, C-1), 43.5 (CH3, Me), 26.7 (CH3, (CH3)2C), 24.8
(CH3, (CH3)2C); IR (KBr): νmax 3027, 2987, 2933, 2868, 1646, 1455, 1372, 1305,
1133, 1071, 1044, 963, 861, 771, 753, 699 cm−1.
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367: Rf 0.3 (1:1 hexanes:ethyl acetate);
m.p. 109–112 ◦C; [α]19D −69 (c 0.3 CHCl3);
1H-NMR:
(CDCl3) δH 7.38–7.31 (complex m, 5H, Bn), 6.22 (dd,
J = 5.8, 1.6 Hz, 1H, H-4), 4.95 (dt, J = 8.6, 1.5 Hz, 1H,
H-2), 4.68 (d, J = 11.4 Hz, 1H, PhCH2), 4.59 (d, J = 11.5 Hz, 1H, PhCH2), 4.32 (dd,
J = 12.0, 6.4 Hz, 1H, H-7), 4.07–4.05 (complex m, 2H, H-8a,b), 3.93 (dd, J = 5.7,
2.5 Hz, 1H, H-5), 3.80 (dd, J = 5.5, 2.3 Hz, 1H, H-6), 3.42 (dd, J = 15.2, 10.0 Hz,
1H, H-1a), 3.31 (d, J = 15.1 Hz, 1H, H-1b), 3.04 (s, 3H, Me), 1.37 (s, 3H, (CH3)2C),
1.35 (s, 3H, (CH3)2C);
13C-NMR: (CDCl3) δC 137.5 (C, Bn), 134.5 (CH, C-3), 128.5
(CH, Bn), 128.1 (CH, Bn), 128.0 (CH, Bn), 124.0 (CH, C-4), 108.5 (C, (CH3)2C),
74.3 (CH, C-7), 72.1 (CH, C-2), 71.8 (CH, C-6), 71.7 (CH2, PhCH2), 68.9 (CH, C-5),
66.0 (CH2, C-8), 53.2 (CH2, C-1), 42.5 (CH3, Me), 26.7 (CH3, (CH3)2C), 25.1 (CH3,
172
(CH3)2C); IR (KBr): νmax 3027, 2987, 2933, 2896, 1655, 1456, 1372, 1338, 1306,
1133, 1091, 1070, 1044, 926, 860, 755, 699 cm−1; HRMS: m/z C19H25O6S
35ClNa+
[M+Na]+ calcd 439.0958, found 439.0953.
B A solution of sulfone 366 (87 mg, 0.38 mmol) in THF (2 mL) was treated with
sodium hydride (15 mg, 0.38 mmol), then stirred at 0 ◦C for 30 minutes. To this
was added hemiacetal 345 (93 mg, 0.27 mmol) in THF (2 mL), then the mixture
was stirred at 0 ◦C for two hours. Upon completion of the HWE reaction (as de-
termined by TLC), iodine (149 mg, 0.587 mmol) was added, then the reaction was
stirred at room temperature for one hour. The reaction mixture was diluted with
sat. sodium thiosulfate solution (10 ml) and water (10 mL), then extracted with
dichloromethane (2 x 20 mL). The organic fractions were combined, dried, filtered
and concentrated to provide a crude sample of pyranosyl sugar 367.
C A solution of sulfone 366 (116 mg, 0.504 mmol) in THF (5 mL) was treated
with sodium hydride (22 mg, 0.55 mmol), then stirred at 0 ◦C for 30 minutes. To
this was added hemiacetal 345 (129 mg, 0.378 mmol) in THF (2 mL), then the
mixture was stirred at 0 ◦C for three hours. Upon completion of the HWE reac-
tion (as determined by TLC), iodine (149 mg, 0.587 mmol) was added, followed
by a further portion of sodium hydride (16 mg, 0.4 mmol), then the reaction was
stirred at room temperature for one hour. The reaction mixture was diluted with
sat. sodium thiosulfate solution (10 ml) and water (10 mL), then extracted with di-
chloromethane (2 x 20 mL). The organic fractions were combined, dried, filtered and
concentrated to provide a crude yellow oil. Upon purification by column chromatog-
raphy (1:1 hexanes:ethyl acetate), pyranosyl sugar 367 (100 mg, 70%) was obtained.
D A solution of sugar sulfone 367 (29 mg, 70 µmol) in THF (1 mL) was cooled to
0 ◦C, then treated with NIS (23 mg, 0.10 mmol). The solution was slowly treated
with KHMDS (170 µL, 85 µmol) over a period of 15 minutes. The mixture was
stirred at 0 ◦C for an hour, then stirred at room temperature for two hours. The
reaction mixture was diluted with sat. sodium thiosulfate solution (10 ml) and water
(10 mL), then extracted with dichloromethane (2 x 20 mL). The organic fractions
were combined, dried, filtered and concentrated to provide a crude mixture of NIS
and starting material sugar 367.
E A solution of diisopropyl amine (20 µL, 0.14 mmol) in THF (1 mL) was cooled
to 0 ◦C, then treated with n-butyllithium (60 µL of a 2.0 molL−1 solution in cyclo-
hexane, 0.12 mmol) and stirred for 15 minutes to generate a solution of LDA. This
solution was then treated with a solution of sugar sulfone 367 (42 mg, 0.10 mmol)
in THF (1 mL). The solution was allowed to react for 15 minutes, then treated with
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NBS (32 mg, 0.18 mmol). The mixture was stirred at 0 ◦C for an additional hour,
then stirred at room temperature for two hours. The reaction mixture was diluted
with sat. sodium thiosulfate solution (10 ml) and water (10 mL), then extracted with
dichloromethane (2 x 20 mL). The organic fractions were combined, dried, filtered
and concentrated to provide a crude mixture of NBS and starting material sugar 367.
F A solution of sulfone 367 (47 mg, 0.11 mmol) in tert-butanol (0.5 mL) and
dichloromethane (1 mL) was treated with KOH-Al2O3 (212 mg, 0.9 mmol) and di-
bromodifluoromethane (50 µL, 0.5 mmol), then stirred at 5 ◦C for one hour. The
mixture was warmed to room temperature, then stirred for one hour. Additional
dibromodifluoromethane (50 µL, 0.5 mmol) was introduced, then the mixture was
stirred for one hour. The reaction was heated to reflux, then a further portion
of dibromodifluoromethane (50 µL, 0.5 mmol) was flashed onto the reaction mix-
ture. After 30 minutes additional stirring, the reaction mixture was diluted with
water (20 ml) and extracted with diethyl ether (2 x 20 mL). The organic fractions
were combined, washed with brine (10 mL), then dried, filtered and concentrated to
provide a crude yellow oil. Upon purification by column chromatography (3:1 hex-
anes:ethyl acetate), a complex mixture of products was obtained (5 mg), in addition
to pyranosyl sugar 367 (27 mg, 57%).
G A solution of sulfone 367 (57 mg, 0.14 mmol) in tert-butanol (0.5 mL) and
dichloromethane (1 mL) was treated with KOH-Al2O3 (286 mg, 1.2 mmol) and di-
bromodifluoromethane (50 µL, 0.5 mmol), then stored in the fridge for eight hours.
Additional dibromodifluoromethane (50 µL, 0.5 mmol) was introduced, then the
mixture was stored in the fridge for 16 hours. The reaction mixture was filtered
through Celite R©, eluting with dichloromethane (20 mL). The organic fraction was
dried, filtered and concentrated to provide a crude yellow oil. Upon purification by
column chromatography (3:1 hexanes:ethyl acetate), a complex mixture of products
was obtained (8 mg), in addition to pyranosyl sugar 367 (38 mg, 67%).
H A solution of sulfone 367 (27 mg, 0.07 mmol) in tert-butanol (1 mL) and di-
chloromethane (2 mL) was treated with KOH-Al2O3 (154 mg, 0.7 mmol) and di-
bromodifluoromethane (50 µL, 0.5 mmol), then subjected to microwave reaction at
60 ◦C (dibromodifluoromethane pressure approximately four bar) for a period of
30 minutes. The reaction mixture was filtered through Celite R©, eluting with di-
chloromethane (20 mL). The organic fraction was dried, filtered and concentrated
to provide a crude yellow oil. Upon purification by column chromatography (3:1
hexanes:ethyl acetate), complex mixtures of products and starting material were
obtained (9 mg), in addition to diene 353 (3 mg, 14%).
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(2E,4E)-5-O-Benzyl-3-chloro-1,2,3,4-tetradeoxy-7,8-O-isopropylidene-1-
[(methyl)sulfonyl]-d-arabino-octa-1,3-dienopyranitol (372)
A A solution of diisopropyl amine (50 µL, 0.36 mmol) in THF (4 mL) was cooled
to −78 ◦C, then treated with n-butyllithium (0.18 mL of a 2.0 molL−1 solution
in cyclohexane, 0.36 mmol) and stirred for 30 minutes to generate a solution of
LDA. This solution was warmed to 0 ◦C and treated with sulfone 366 (86 mg,
0.37 mmol), then stirred at 0 ◦C for one hour. To this was added hemiacetal 345
(108 mg, 0.317 mmol) in THF (2 mL), then the mixture was stirred for three hours
at 0 ◦C. Upon completion of the HWE reaction (as determined by TLC), iodine
(126 mg, 0.496 mmol) was added, then the reaction was stirred at room temperature
for 17 hours. The reaction mixture was diluted with sat. sodium thiosulfate solution
(10 ml) and water (10 mL), then extracted with dichloromethane (2 x 20 mL). The
organic fractions were combined, dried, filtered and concentrated to provide a crude
yellow oil. Upon purification by column chromatography (1:1 hexanes:ethyl acetate),
starting material 345 (32 mg, 30%) was obtained, in addition to α, β-unsaturated
sulfone 372 and a minor quantity of pyranosyl sugar 367 (17 mg, 13%), obtained
as a colourless oil.
OH
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SO2Me 372: Rf 0.3 (1:1 hexanes:ethyl acetate); 1H-NMR: (CDCl3)
δH 7.54 (d, J = 14.2 Hz, 1H, H-2), 7.38–7.29 (complex m,
5H, Bn), 6.91 (d, J = 14.5 Hz, 1H, H-1), 6.40 (d, J = 9.5
Hz, 1H, H-4), 4.59–4.55 (complex m, 2H, PhCH2, H-5),
4.46 (d, J = 11.2 Hz, 1H, PhCH2), 4.11–4.04 (complex m, 2H, H-7,8a), 3.98 (dd,
J = 7.8, 4.1 Hz, 1H, H-8b), 3.45 (m, 1H, H-6), 2.98 (s, 3H, Me), 2.50 (d, J = 8.0
Hz, 1H, OH), 1.39 (s, 3H, (CH3)2C), 1.33 (s, 3H, (CH3)2C);
13C-NMR: (CDCl3) δC
138.8 (CH, C-4), 136.7 (C, Bn), 134.7 (CH, C-2), 132.4 (CH, C-1), 129.5 (CH, C-3),
128.6 (CH, Bn), 128.2 (CH, Bn), 128.1 (CH, Bn), 109.5 (C, (CH3)2C), 75.2 (CH,
C-7), 75.1 (CH, C-6), 74.1 (CH, C-5), 71.6 (CH2, PhCH2), 66.9 (CH2, C-8), 42.9
(CH3, Me), 26.8 (CH3, (CH3)2C), 25.2 (CH3, (CH3)2C).
B A solution of diisopropyl amine (100 µL, 0.71 mmol) in THF (4 mL) was cooled
to −78 ◦C, then treated with n-butyllithium (0.36 mL of a 2.0 molL−1 solution in
cyclohexane, 0.72 mmol) and stirred for 30 minutes to generate a solution of LDA.
This solution was treated with sulfone 366 (83 mg, 0.36 mmol), then allowed to
warm to 0 ◦C over the course of 90 minutes. To this was added hemiacetal 345
(87 mg, 0.26 mmol) in THF (1 mL), then the mixture was stirred at 0 ◦C for 2.5
hours at 0 ◦C. The reaction mixture was diluted with sat. ammonium chloride solu-
tion (10 ml) and water (10 mL), then extracted with dichloromethane (2 x 20 mL).
The organic fractions were combined, dried, filtered and concentrated to provide a
crude yellow oil containing starting material 345, diene sulfone 372 and cyclised
sulfone 367 (1:1:2.5 ratio as judged by the proton NMR spectrum). Upon purifica-
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tion by column chromatography (1:1 hexanes:ethyl acetate), an inseparable mixture
of diene sulfone 372 and cyclised sulfone 367 (66 mg, 62%, 1:2.6 ratio) was obtained.
C A solution of sugar sulfone 367 (28 mg, 67 µmol) in THF (1 mL) was cooled to
−78 ◦C, then treated with n-butyllithium (40 µL of a 2.0 molL−1 solution in cyclo-
hexane, 80 µmol). The solution was allowed to react for 30 minutes, then treated
with NBS (22 mg, 0.12 mmol). The mixture was stirred at −78 ◦C for an additional
hour, then diluted with sat. ammonium chloride solution (20 ml) and extracted with
dichloromethane (2 x 20 mL). The organic fractions were combined, dried, filtered
and concentrated to provide a crude mixture of NBS and sugar sulfones 367 and
372 (1:1 ratio as judged by the proton NMR spectrum).
D A solution of silver salt 351 (39 mg, 79 µmol) in dichloromethane (1 mL) was
treated with iodine (16 mg, 63 µmol) and stirred at room temperature for five min-
utes, in which the iodine was consumed. A solution of diene 372 (12 mg, 29 µmol)
in dichloromethane (1 mL) was added, then the solution was stirred at room tem-
perature for three days. The mixture was diluted with dichloromethane (10 mL),
then washed successively with sat. sodium thiosulfate solution (10 mL), 10% aque-
ous hydrochloric acid (10 mL) and sat. sodium bicarbonate solution (10 mL). The
organic fraction was dried, filtered and concentrated to provide a crude sample of
starting material 372 (11 mg, 92%).
2,6-Anhydro-5-O-benzyl-3-chloro-1,3,4-trideoxy-7,8-O-isopropylidene-
d-gluco-octa-1,3-dienopyranitol (398)
A A solution of sulfone 367 (57 mg, 0.14 mmol) in tert-butanol (1.25 mL) was
treated with KOH-Al2O3 (230 mg, 1.0 mmol) and carbon tetrachloride (2 mL), then
stirred at 35 ◦C for one hour. The reaction mixture was diluted with water (20 ml)
and extracted with diethyl ether (2 x 20 mL). The organic fractions were combined,
washed with brine (10 mL), then dried, filtered and concentrated to provide a crude
yellow oil. Upon purification by column chromatography (2:1 hexanes:ethyl acetate),
diene 373 (12 mg, 26%) was obtained as a colourless oil, in addition to pyranosyl
sugar 371 (22 mg, 39%).
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373: Rf 0.7 (2:1 hexanes:ethyl acetate); [α]
21
D −99 (c 0.25
CHCl3);
1H-NMR: (CDCl3) δH 7.37–7.29 (complex m, 5H, Bn),
6.22 (d, J = 6.4 Hz, 1H, H-4), 4.94 (s, 1H, H-1a), 4.74 (s, 1H,
H-1b), 4.70 (d, J = 11.7 Hz, 1H, PhCH2), 4.65 (d, J = 11.7
Hz, 1H, PhCH2), 4.44 (dt, J = 8.0, 5.7 Hz, 1H, H-7), 4.18 (dd, J = 8.5, 6.3 Hz,
1H, H-8a), 4.11–4.07 (complex m, 2H, H-5,8b), 3.76 (dd, J = 8.3, 1.9 Hz, 1H, H-6),
1.41 (s, 3H, (CH3)2C), 1.39 (s, 3H, (CH3)2C);
13C-NMR: (CDCl3) δC 151.7 (C, C-2),
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138.0 (C, Bn), 130.9 (CH, C-3), 128.4 (CH, Bn), 127.9 (CH, Bn), 127.8 (CH, Bn),
123.7 (CH, C-4), 109.3 (C, (CH3)2C), 95.9 (CH2, C-1), 78.5 (CH, C-6), 73.2 (CH, C-
7), 71.4 (CH2, PhCH2), 69.0 (CH, C-5), 66.9 (CH2, C-8), 26.9 (CH3, (CH3)2C), 25.4
(CH3, (CH3)2C); IR (KBr): νmax 2988, 2931, 2885, 1635, 1598, 1455, 1381, 1372,
1254, 1224, 1128, 1081, 1028, 845, 738, 698 cm−1; HRMS: m/z C18H21O
35
4 ClNa
+
[M+Na]+ calcd 359.1024, found 359.1026.
B A solution of sulfone 367 (105 mg, 0.25 mmol) in tert-butanol (1.25 mL) was
treated with powdered KOH (297 mg, 5.29 mmol) and carbon tetrachloride (1.25
mL), then stirred at 35 ◦C for 30 minutes. The reaction mixture was diluted with
sat. ammonium chloride solution (10 ml) and extracted with dichloromethane (3 x
10 mL). The organic fractions were combined, dried, filtered and concentrated to
provide a crude yellow oil. Upon purification by column chromatography (5:1 hex-
anes:ethyl acetate), a mixture of several inseparable products including diene 373
(31 mg) was obtained.
(3E)-5-O-Benzyl-3-O-methoxycarbonyl-1,2,3,4-tetradeoxy-7,8-O-
isopropylidene-d-arabino-octa-1,3-dienitol (380)
A solution of diene 353 (50 mg, 0.15 mmol) in methanol (2 mL) was treated with bis-
(triphenylphosphine)palladium(II) chloride (21 mg, 0.03 mmol) and triethylamine
(30 µL, 0.2 mmol), then purged with carbon monoxide three times. The mixture
was stirred at reflux for seven hours, then diluted with ethyl acetate (20 ml), washed
with water (20 mL), then brine (20 mL). The organic fraction was combined, dried,
filtered and concentrated to provide a crude brown oil. Upon purification by column
chromatography (5:1 hexanes:ethyl acetate), ester 380 (22 mg, 41%) was obtained
as a light–brown oil.
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Rf 0.3 (3:1 hexanes:ethyl acetate); [α]
19
D −42 (c 1.0 CHCl3);
1H-NMR: (CDCl3) δH 7.36–7.29 (complex m, 5H, Bn), 6.77
(d, J = 9.5 Hz, 1H, H-4), 6.44 (dd, J = 17.7, 11.7 Hz, 1H,
H-2), 5.60 (dd, J = 17.8, 1.7 Hz, 1H, H-1a), 5.43 (dt, J =
11.5, 1.2 Hz, 1H, H-1b), 4.65 (dd, J = 9.4, 2.4 Hz, H-5), 4.59 (d, J = 11.4 Hz, 1H,
PhCH2), 4.40 (d, J = 11.4 Hz, 1H, PhCH2), 4.14 (m, 1H, H-7), 4.07 (dd, J = 8.4,
6.2 Hz, 1H, H-8a), 4.00 (dd, J = 8.6, 5.1 Hz, 1H, H-8b), 3.80 (s, 3H, Me), 3.51 (td,
J = 7.9, 2.2 Hz, 1H, H-6), 2.47 (d, J = 8.6 Hz, 1H, OH), 1.39 (s, 3H, (CH3)2C),
1.33 (s, 3H, (CH3)2C);
13C-NMR: (CDCl3) δC 166.7 (C, CH3OCO), 139.6 (CH, C-4),
137.5 (C, Bn), 133.5 (C, C-3), 128.41 (CH, C-2), 128.40 (CH, Bn), 127.95 (CH, Bn),
127.93 (CH, Bn), 121.6 (CH2, C-1), 109.2 (C, (CH3)2C), 75.5 (CH, C-7), 75.2 (CH,
C-6), 73.6 (CH, C-5), 71.2 (CH2, PhCH2), 66.8 (CH2, C-8), 52.1 (CH3, Me), 26.8
(CH3, (CH3)2C), 25.2 (CH3, (CH3)2C); IR (KBr): νmax 3456, 2988, 2934, 1724,
177
1455, 1372, 1248, 1219, 1153, 1069, 848, 771, 698 cm−1; HRMS: m/z C20H26O6Na
+
[M+Na]+ calcd 385.1627, found 385.1631.
2,6-Anhydro-5-O-benzyl-3-O-methoxycarbonyl-1,3,4-trideoxy-1-iodo-
7,8-O-isopropylidene-d-manno-octa-1,3-dienopyranitol (381) and
2,6-anhydro-5-O-benzyl-3-O-methoxycarbonyl-1,3,4-trideoxy-1-iodo-
7,8-O-isopropylidene-d-gluco-octa-1,3-dienopyranitol (382)
A solution of silver salt 351 (86 mg, 0.17 mmol) in dichloromethane (1 mL) was
treated with iodine (32 mg, 0.13 mmol) and stirred at room temperature for five min-
utes, in which the iodine was consumed. A solution of diene 380 (24 mg, 66 µmol)
in dichloromethane (1 mL) was added, then the solution was stirred at room tem-
perature for one day. The mixture was diluted with dichloromethane (20 mL), then
washed successively with sat. sodium thiosulfate solution (20 mL), 10% aqueous hy-
drochloric acid (20 mL) and sat. sodium bicarbonate solution (20 mL). The organic
fraction was dried, filtered and concentrated to provide a yellow oil. Upon purifi-
cation by column chromatography (3:1 hexanes:ethyl acetate), iodopyranose sugars
381 and 382 (15 mg, 47%) was obtained as a off–white solid.
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Rf 0.4 (3:1 hexanes:ethyl acetate);
1H-NMR: (CDCl3) δH
7.40–7.28 (complex m, 5H, Bn), 7.07 (dd, J = 5.2, 1.3
Hz, 1H, H-4), 4.78–4.71 (complex m, 2H, PhCH2), 4.69
(d, J = 9.3 Hz, 1H, H-2), 4.44 (dt, J = 8.5, 5.6 Hz, 1H,
H-6), 4.32 (dd, J = 8.8, 5.1 Hz, 1H, H-8a), 4.20 (dd, J = 8.8, 6.3 Hz, 1H, H-8b),
3.90 (dd, J = 5.3, 2.5 Hz, 1H, H-5), 3.78 (s, 3H, Me), 3.61–3.56 (complex m, 2H,
H-1a,7), 3.26 (apparent t, J = 11.1 Hz, 1H, H-1b), 1.44 (s, 3H, (CH3)2C), 1.40 (s,
3H, (CH3)2C);
13C-NMR: (CDCl3) δC 164.9 (C, CH3OCO), 138.0 (C, Bn), 135.8 (C,
C-4), 133.1 (CH, C-3), 128.4 (CH, Bn), 128.1 (CH, Bn), 127.9 (CH, Bn), 109.2 (C,
(CH3)2C), 73.2 (CH, C-6), 72.7 (CH2, PhCH2), 72.18 and 72.17 (CH, C-2 and CH,
C-7), 68.0 (CH2, C-8), 67.4 (CH, C-5), 52.3 (CH3, Me), 27.1 (CH3, (CH3)2C), 25.3
(CH3, (CH3)2C), 3.8 (CH2, C-1); IR (KBr): νmax 2988, 2929, 2868, 1718, 1454, 1438,
1371, 1273, 1249, 1144, 1076, 913, 851, 741, 698 cm−1; HRMS: m/z C20H25O6INa
+
[M+Na]+ calcd 511.0594, found 511.0589.
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Rf 0.4 (3:1 hexanes:ethyl acetate);
1H-NMR: (CDCl3) δH
7.40–7.28 (complex m, 5H, Bn), 7.14 (dd, J = 5.8, 1.7 Hz,
1H, H-4), 4.78–4.71 (complex m, 2H, PhCH2), 4.38 (m,
1H, H-6), 4.15 (dd, J = 8.7, 6.3 Hz, 1H, H-8a), 4.08 (dd,
J = 8.8, 5.2 Hz, 1H, H-8b), 4.03 (dt, J = 5.9, 1.8 Hz, 1H, H-5), 3.78 (s, 3H, Me),
3.64 (dd, J = 10.4, 2.5 Hz, 1H, H-2), 3.61–3.56 (complex m, 2H, H-1a,b), 3.44 (dd,
J = 7.8, 2.0 Hz, 1H, H-7), 1.40 (s, 3H, (CH3)2C), 1.37 (s, 3H, (CH3)2C);
13C-NMR:
(CDCl3) δC 165.1 (C, CH3OCO), 138.4 (C, Bn), 136.4 (C, C-4), 135.5 (CH, C-3),
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128.3 (CH, Bn), 127.8 (CH, Bn), 127.7 (CH, Bn), 109.1 (C, (CH3)2C), 77.4 (CH,
C-7), 73.7 (CH, C-2), 73.5 (CH, C-6), 71.7 (CH2, PhCH2), 67.2 (CH, C-5), 67.0
(CH2, C-8), 52.1 (CH3, Me), 26.9 (CH3, (CH3)2C), 25.4 (CH3, (CH3)2C), 8.3 (CH2,
C-1); IR (KBr): νmax 2988, 2929, 2868, 1718, 1454, 1438, 1371, 1273, 1249, 1144,
1076, 913, 851, 741, 698 cm−1.
2,6-Anhydro-5-O-benzyl-3-O-methoxycarbonyl-1,3,4-trideoxy-1-iodo-
7,8-O-isopropylidene-d-manno-octa-1,3-dienopyranitol (381) and
2,6-anhydro-5-O-benzyl-3-O-methoxycarbonyl-1,3,4-trideoxy-1-iodo-
7,8-O-isopropylidene-d-gluco-octa-1,3-dienopyranitol (382)
A solution of iodopyranose sugars 381 and 382 (8 mg, 16 µmol) in 50% (v/v)
aqueous THF (1 mL) was treated with sodium hydroxide (12 µL of a 2.0 molL−1
aqueous solution, 24 µmol) and stirred at room temperature for one day. The
mixture was diluted with diethyl ether (20 mL), then washed successively with 10%
aqueous hydrochloric acid (20 mL), water (20 mL) and brine (20 mL). The organic
fraction was dried, filtered and concentrated to provide a yellow oil, in which TLC
and NMR evidence indicated this material was composed of hydroxy acids 387 and
388. This crude product was diluted with dichloromethane (1 mL), then treated
with DCC (5 mg, 0.02 mol) and DMAP (2 mg, 0.02 mmol), then stirred at room
temperature for 16 hours. The reaction mixture was diluted with sat. ammonium
chloride solution (10 ml), then extracted with dichloromethane (3 x 10 mL). The
organic fractions were combined, dried, filtered and concentrated to provide a crude
yellow oil. Upon purification by column chromatography (9:1 hexanes:ethyl acetate),
a mixure of iodopyranose sugars 381 and 382 (2 mg, 25%) was obtained, in addition
to impure mixtures of products (3 mg, Rf 0.5, 0.6 (1:1 hexanes:ethyl acetate)),
tentatively assigned as lactones 378 and 379.
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Spectra
Selected spectra of key compounds
1H-NMR spectrum of 2-C -branched sugar 213 (500 MHz, CDCl3)
180
13C-NMR spectrum of 2-C -branched sugar 213 (125 MHz, CDCl3)
181
1H-NMR spectrum of 2-C -branched sugar 214 (500 MHz, CDCl3)
182
13C-NMR spectrum of 2-C -branched sugar 214 (125 MHz, CDCl3)
183
1H-NMR spectrum of oxepine sugar 258 (500 MHz, CDCl3)
184
13C-NMR spectrum of oxepine sugar 258 (125 MHz, CDCl3)
185
1H-NMR spectrum of oxepine sugar 98 (500 MHz, CDCl3)
186
13C-NMR spectrum of oxepine sugar 98 (125 MHz, CDCl3)
187
1H-NMR spectrum of oxepine sugar 99 (500 MHz, CDCl3)
188
13C-NMR spectrum of oxepine sugar 99 (125 MHz, CDCl3)
189
1H-NMR spectrum of cyclopropane 340 (500 MHz, CDCl3)
190
1H-NMR spectrum of diene 353 (500 MHz, CDCl3)
191
1H-NMR spectrum of iodoesters 381 and 382 (500 MHz, CDCl3)
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